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ABSTRACT
The substrate specificity, classification, expression and control of the adenovirus 
encoded protease, the activity of which is required for the production of virions, is described. 
The use of synthetic peptides has shown that the protease cleaves sites of the form 
(M,L,I)XGG-X or (M,L,I)XGX-G and these consensus sequences have been used to 
identify potential cleavage sites in all the known substrates of the protease. Putative cleavage 
sites have also been found in a number of other adenovirus proteins including the major coat 
proteins, the hexon and the penton, that had not previously been considered as substrates of 
the protease. The octapeptide, MSGGAFSW, has been used to develop a specific assay for 
the protease where digestion is monitored by HPLC reverse phase chromatography.
Purification of the protease from adenovirus particles and the preparation of 
antipfptide sera against the L3 23-kDa protein have been used to confirm that the latter is the 
protease and that it is not proteolytically activated. Inhibitor studies reveal that the enzyme is 
inhibited by the thiol directed reagents iodoacetatf, PCMB and DTDP, and activated by DTT 
or cysteine suggesting that it is a member of the cysteine class of proteases. Analysis of the 
sequence of the enzyme, however, shows that it is not a papain-like enzyme and it is 
suggested that it might be a member of the recently identified subclass of cysteine proteases 
that are related to trypsin.
The 23-kDa protease has been expressed using E.coli and baculovirus expression 
systems and a purification schedule for the protein was developed using anion exchange and 
hydrophobic interaction chromatography. The purified enzyme, however, was not able to 
cleave the peptide substrate MSGGAFSW and the conclusion was drawn that the protein is 
probably synthesised as an apoenzyme.
One of the substrates of the protease, the pre-terminal (pTP) protein was expressed in 
insect cells using a recombinant baculovirus. Coinfections of cells with recombinant 23-kDa 
and pTP baculoviruses resulted in efficient processing of the pTP to the intermediate terminal 
protein (iTP) in situ. The partially purified baculovirus expressed 23-kDa protein was not, 
however, found to digest the pTP in vitro, supplying further evidence that the adenovirus 
protease requires a cofactor.
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INTRODUCTION
The broad aim of this study is to further characterise the adenovirus protease and to
investigate its mode of action at the molecular level. In particular, the substrate specificity, 
mechanism and expression of the virus encoded enzyme will be considered. Active protease is 
an essential requirement for the production of virions and so the information presented here 
provides a basis for future studies aimed at designing and synthesising specific inhibitors as 
anti-viral agents. It is hoped further that the work on the adenovirus protease will be extended 
to provide a model for the study of proteolysis in other DNA viruses and that the similarities 
and differences between RNA and DNA viral proteases can be highlighted. Finally it is 
envisaged that, through its substrates, the protease could provide the key to unravelling some 
of the complex protein chemistry of the adenovirus and perhaps give an insight into control 
mechanisms in general.
The work will be presented in 4 chapters. The aim of chapter 1 is to use synthetic 
peptides to examine the substrate specificity of the protease while chapter 2 is primarily 
concerned with the classification of the enzyme. Attempts to express and purify active protease 
from E.Coli and baculovirus systems will be discussed in chapter 3 along with possible 
mechanisms for the control of its activity. The final chapter will be devoted to one of the 
substrates of the protease, the pre-terminal protein, and the central role that it plays in DNA 
replication. Before considering these topics in detail it is important to put the project into 
context and this will be done from 2 viewpoints. First, the epidemiology and replicative cycle 
of the adenoviruses will be outlined, with particular reference being made to the structure and 
function of the viral proteins. The second part of the introduction aims to underline the 
essential role that proteolysis plays in virus infections. Specific examples, including the well 
characterised proteases from HIV and poliovirus, will be used in an attempt to demonstrate the 
scope and diversity of viral proteases.
1ADENQYIRUSES
1.1 EPIDEMI0LQKY AND CIlASSIFICATTON
The adenovirus was first recognised as an etiological agent of acute respiratory disease 
in the early 1950s (Rowe et a/.,1953). Subsequently over 100 distinct serotypes have been 
identified that infect many different animal species (Horwitz, 1990b). A number of criteria have 
been used to subdivide the adenoviruses into related groups and as a result the Adenoviridae 
family is made up of 2 genera, the Aviadenoviruses and the Mastadenoviruses (Ishibashi 
and Yasue,1984). At least 15 different serotypes of Aviadenoviruses have been isolated from a 
variety of avian species including hens, ducks, turkeys and pheasants and one such virus, 
FAV-1, has been shown to be responsible for a condition known as egg drop syndrome 
(McFerran et al.117). The disease causes hens to lay abnormal, soft shelled eggs for 3-4 
days and is economically significant in the poultry industry (Ishibashi and Yasue,1984).
Most studies, however, have concentrated on the Mastadenoviruses which infect a 
range of mammalian species including foxes, sheep, cows, pigs, horses, dogs, monkeys, mice 
and humans. These viruses share a common antigenic determinant which is located on the 
major viral coat protein, the hexon (Norrby et a/.,1976). To date, 47 serotypes have been 
shown to infect man and these are responsible for a number of diseases (Hierholzer et 
aZ. 1991). Different serotypes are specific for different tissues with the respiratory tract, 
gastrointestinal tract and ocular tissue being the favoured targets (Table la). Epidemics of 
acute respiratory disease (Ad4, 7) and keratoconjuntivitis (Ad8, 19, 37) are well documented 
and can have severe consequences for the individuals concerned (Huebner et a/., 1958; Guyer 
et a/.,1975 and Kemp et a/., 1983). Less severe respiratory and eye infections are common 
amongst infants and most children acquire antibodies to one or more of the adenovirus 
serotypes before entering adolescence (reviewed in Straus, 1984). Adenovirus types 40 and 41 
are enteric viruses that replicate in the gastrointestinal tract and are a major cause of death from 
diarrhoea in children of the third world (Hammond et a/., 1987).
The observation that Ad 12 induces tumours in rodents created much interest and raised 
questions as to whether adenoviruses are responsible for some human cancers (Trentin et al., 
1962). Thirty years on and there is still no direct evidence to link any of the adenoviruses with
3Associated Disease Principal Serotypes
Acute febrile pharyngitis 1, 2, 3, 5, 6,7
Pharyngoconjunctival fever 3, 1, 14
Acute respiratory disease 3, 4, 1, 14, 21
Pneumonia lr 2, 3, 4, 7
Epidemic keratoconjunctivitis 8, 11, 19, 37
Pertussis-like syndrome 5
Acute hemorrhagic cystitis ll, 21
Gastroenteritis 40, 41
Hepatitis 1, 2, 5
Persistence of virus in urinary tract 34,35
Table la Adenovirus serotypes and their associated diseases 
A list of the human adenovirus serotypes and the conditions with which they are 
normally associated.
Subgroup Serotypes Oncogenic % GC in DNA
A 12, 18, 31 High 48-49
B 3, 7, 11, 14, 16, 21, 34, 35 Moderate 50-52
C 1, 2, 5, 6 Low or none 57-59
D
8, 9, 19, 37, 10, 13, 15, 17, 
19, 20, 22-30, 32, 33, 36, 37, 
38, 39, 42-47
Low or none 57-61 '
E 4 Low or none 57-59
F 40, 41 Unknown —
Table lb Classification of Human Adenoviruses
Classification of the human adenoviruses based on their DNA homologies and 
their ability to induce tumours in animals. Modified from Horwitz (1990a).
4human tumours; but their ability to transform rodent cells has served as a useful animal model 
to study the molecular basis of cell transformation (Graham,1984).
The 47 human serotypes have been classified into 6 groups (A-F) based on DNA 
sequence homologies, common antigenic determinants, hemagglutination reactions and their 
oncogenic properties (Horwitz, 1990a) and these are listed in Table lb. DNA sequence 
homologies between members of the same group are usually very high (48-85%) with the most 
significant differences occurring in the coding regions for the major coat proteins. In contrast, 
less than 20% DNA sequence homology has been demonstrated between viruses from different 
groups (Garon et a/., 1973). Despite their differences all the adenoviruses have the same basic 
structure and genome organisation, with the sequences of many functional proteins being 
highly conserved between viruses from different subgroups. Most reference will be made to 
Ad2 when considering the structure and organisation of the virus since its entire genome has 
been sequenced (Roberts et a/., 1986) and Ad2 was the serotype used throughout this project. 
The general principles and structural features, however, are equally applicable to the other 
mastadenoviruses and aviadenoviruses that have been characterised.
WINFECTIOUSCYCJS
Individual cells generally have 2 fates following their infection by an adenovirus. They 
can (1) be transformed by the integration of part or all of the viral DNA into their genome or 
(2) play host to a full lytic infection and act as a factory for the production of thousands of
progeny virions.
Transformation takes place in semi- or non-permissive cells and, depending on the 
adenovirus serotype and the nature of the host, it may be a malignant event. All of the human 
adenoviruses are able to transform new bom rodent cells, but only serotypes from groups A 
and B are known to be oncogenic. The transformation and oncogenic properties of 
adenoviruses will be considered further in section 1.5b, The primary concern of this project, 
however, is the adenovirus protease which has an essential role in the development of the 
infectious cycle in permissive cells. The adenovirus lytic cycle can be divided into 6 stages as 
follows:
5(a) Uptake of the vims by the cell. .
(b) Transcription of early viral mRNAs; translation of early proteins.
(c) Replication of viral DNA.
(d) Transcription of late viral mRNAs; translation of late proteins.
(e) Assembly of virus particles.
(f) Maturation of virions.
The adenovims protease has been shown to be responsible for the maturation of virions 
(f); but its involvement at earlier stages in the infectious cycle cannot be mled out. In 
particular, there is a suggestion that the enzyme may play a role in the uncoating of vims 
particles soon after they enter the cell (Hannan et a/., 1*983). Before considering each of the 
stages of the lytic cycle in turn, the structural organisation of the adenovirus particle will be 
described.
1.3 STTUCCUUR QFTTH .WDNOVIRUS
Adenovimses are double stranded DNA viruses with a 34-36K base pair genome. The 
genome contains open reading frames with the potential to code for at least 50 distinct 
polypeptides and is encapsidated by a protein shell (Green et aLil961\ Nermut,1984; 
Tussenbach.1984). Analysis of purified virions by TDT polyacrylamide gel electrophoresis 
revealed 12 distinct polypeptides and these were termed II-XII according to their relative 
mobilities, with protein II having the largest apparent MW and protein XII the smallest (Maizel 
et a/.,1968a). Fig.l shows a schematic representation of the virus and an TDT-PAGE 
separation of its major stmctural proteins. Seven of these, II, III, Ilia, IV, VI, VIII and IX 
have been shown to be associated with the viral coat and, as in many other non-enveloped 
DNA and RNA vimses, including the polyoma- and picorna- viruses, the adenovims coat 
proteins adopt an icosahedral conformation (Harrison, 1991).
Dismption of the virion by treatment with acetone, 5M Urea, 10%o pyridine or 0.5% 
deoxycholate removes the coat proteins leaving the viral cores (Russell et a/.,1968; Maizel et 
a/.,1968b; Prage et a/.,1970; Nermut,1984). The cores are made up of the viral DNA and a 
number of proteins including V, VII, mu and the terminal protein (Chatterjee et a/.,1986).
The external stmcture of the adenovirus has been studied using a variety of techniques
6r VIRAL DNA
VIRION VIRION
TOLYFTPTT^S
DISRUPTED
VIRION
Fig. 1. Structure of the Adenovirus.
The diagrammatic representation of the Ad2 virion on the left shows the locations of the hexon 
(H), penton (III) and fibre (IV) proteins in the outer capsid. Alongside is a polyacrylamide gel 
showing the relative mobilities of the Ad2 structural proteins. Disruption of the virion by dialysis 
against a hypotonic buffer removes the coat proteins to reveal the double stranded DNA genome 
and associated core proteins (from Precious and Russell, 1982).
including electron microscopy, cryo-electron microscopy and X-ray crystallography and there 
is general agreement with respect to its organisation and protein composition. Much less 
certainty, however, exists with regards to the structural organisation of the DNA and associated 
proteins that make up the viral cores.
13 a The. Adenovirus Coat
As mentioned above, the adenovirus has an outer shell made up entirely of proteins. 
This serves as a permeability barrier to protect the viral DNA; but must also be able to undergo 
a number of morphological changes during the infectious cycle. This combination of strength 
and versatility relies upon the formation of many specific protein-protein interactions. Electron 
microscopy studies in the mid 1960s revealed that the adenovirus protein coat is made up of 
252 subunits or capsomers and, based oh their relative geometric positions, these subunits 
were termed hexons and pentons (Valentine and Pereira, 1965; Ginsberg et a/., 1966). Each 
particle is made up of 240 hexons and 12 pentons with a penton occupying each of the 12 
vertex positions in the icosahedron. Projecting away from each penton is a fibrous structure, 
termed the fibre, which can be seen in the diagrammatic representation of the virion shown in
7fig.l. Of the 7 proteins that form the viral coat, II, III and IV make up the capsomers, which 
constitute the main body of the coat, whilst Ilia, VI, VIII and IX are thought to stabilise the 
overall structure and so are often referred to as cementing proteins (Ginsberg, 1979; Everitt et 
a/., 1973; Boulanger et a/., 1979).
Hexon (Protein II)
The Ad2 hexon monomer (II) comprises 967 amino acids and has an apparent MW of 
110-kDa (Akusjarvi et a/., 1984). Crystallisation of the hexon (Pereira and Russell, 1969; 
Franklin et a/.,1971) and the solution of its 3D structure from X-ray diffraction data were 
major breakthroughs and make it the best characterised of the viral structural proteins (Roberts 
et a/., 1*986). The most striking features of secondary structure are 2 very similar 8 stranded 
p-barrels present in each hexon monomer. Projecting away from these are 4 loop structures 
designated li, l^, I3 and I4 (see fig.2a). In the virion coat 3 hexon monomers come together to 
form each of the 240 hexon capsomers (Grutter and Franklin, 1974). The 3 polypeptide chains 
are folded together by a novel pathway which is catalysed by another virus encoded protein, 
the L4 100-kDa protein (Cepko and Sharp,1983). The resulting trimer has 2 main structural 
regions, a pseudohexagonal base and a tower region as is shown in fig.2b (Burnett, 1985).
The base includes the 2 p-barrel domains from each monomer with the direction of the ^-t^rurrels 
being perpendicular to the surface of the virion. The hexon bases are tightly packed to form a 
protective protein shell that is 33A° thick (Roberts et </.,1986). Projecting away from each 
base, on the outside of the virion, are 3 towers and it is in this region that most of the sequence 
variation exists between hexons of different serotypes (Toogood and Hay,1988; Toogood et 
a/.,1989). Each tower is 73A° high and is made up of 3 loops (1^, I2 and I4) with one loop 
being donated by each of the hexon monomers (Roberts et a/., 1986).
Penton ('proteins III and IV)
Each penton capsomer is made up of 2 viral proteins. III and IV, which are often 
referred to as the penton base and fibre respectively. Five copies of protein III associate to 
form the base of each capsomer, whilst 3 copies of protein IV form the fibrous structure, on 
the exterior of the virion, which contains the viral receptor binding site (fig.3).
In Ad2, protein III contains 571 amino acids and has an apparent MW of 85-kDa. Five
8P2
Fig. 2a Structure of the Ad2 Hexon
Alpha carbon trace of an Ad2 hexon subunit (from Roberts et o/.,1986). The loops 11,12 and 14 
protrude from the 8 strand P-barrels (Pl and P2) and form 3 towers (T) which project from the 
main body of the virion. The 13 loop is sandwiched between the Pl and P2 domains. The dotted 
lines indicate regions where the structure has not been solved. The orientation of the trace is 
looking from the central cavity of the trimeric molecule toward the B hexon; hexon contact face 
(see below).
Fig. 2b The Hexon Trimer
The hexon is made up of three copies of protein ll and contains two 
distinct regions: the base and the tower. The base of the hexon is shaded 
and the arrangement of the Pl and P2 P- barrels means that each hexon 
has two distinct faces (A and B). Projecting out from the base are three 
towers, with each A face lying under an apex of the triangular tower.
9copies of HI are non-covalently bound to give a ring like pentamer, which appears less dense in 
its centre (Stewart et a/.,1991). Projecting out from the centre of each penton base is the fibre 
(protein IV) which is made up of 3 distinct domains, an N-terminal region that attaches the 
protein to the penton base, a central section comprising 60% of the protein that forms a long 
flexible shaft and a C-terminal knob like domain (Devaux et a/.,1987; Stewart et a/.,1991).
The N-terminal 49 amino acids are relatively well conserved between adenovirus serotypes and 
resemble a signal sequence in that a negative stretch of amino acids is followed by a 
hydrophobic region and then by a second negative region (Ruigrok et a/.,1990). It has been 
shown conclusively that the N-terminus of the protein is responsible for locking the Ad2 fibre 
into the penton base and that the removal of the N-terminal 17 amino acids, by proteolysis, is 
sufficient to prevent the association (Deveaux et a/.,1987). Although the amino acid sequence 
of the remainder of protein IV is not well conserved, its overall structure is. Ih Ad2, the shaft 
of protein IV comprises 360 of the 582 amino acids and includes a 15 residue motif that is 
repeated 22 times. Ih the Ad3 protein IV there are only 6 such repeats Ih the shaft, a difference 
which explains why the length of the fibre varies significantly between serotypes 
(Norrby,1969). At the end of the fibre the C-terminal domain ' appears as a globular p-barrel 
and is thought to contain the receptor binding site (Green et a/.,1983).
Although it has been well established that each penton capsomer contains 5 copies of 
protein III, the number of copies of protein IV making up the fibre has been the subject of 
controversy, with 2 and 3 copies being reported (Green et a/., 1983; van Oostrum and 
Burnett, 1985). Recent chemical crosslinking studies prove, however, that each fibre is made 
up of 3 copies of protein IV and suggest that the shaft is a triple helix and not an extended 
p-pleat structure as suggested previously (Deveux et aL, 1990; Ruigrok et a/.,1990). Ih 
contrast to the hexon capsomers which require the L4 100-kDa protein for assembly, proteins 
Hi and IV are able to associate in vitro and in vivo, without assistance, to form penton 
capsomers (Boudin et a/., 1979).
Proteins Ilia, VI, VIII and DC
Four other viral proteins appear to be associated with the viral capsid and are thought to 
stabilise the virion by reinforcing existing intermolecular contacts.
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PENTON BASE
Fig. 3 The Ad2 Penton
Diagram of the Ad2 penton capsomer, comprising the 
penton base and the fibre. The penton base is made up of 
five copies of protein III and the fiber of three copies of 
protein IV.
Fig. 4 Capsid Face.
Schematic diagram showing the anrratgement of capsomers and associated proteins on 
one face of the icosahedral capsid of the adenovirus. The hexons are shown as 
hexagons, with a superimposed triangle representing the towers, and the pentons as 
pentagons. The 4 non-equivalent hexons are numbered with hexons 2, 3 and 4 
making up the group-of-nine (GON). The shaded hexons are from adjacent faces of 
the capsid. The positions thought to be occupied by proteins VI ©), VIII (m# and 
IX (/L) are also shown. Adapted from Stewart et al(1991).
■ ■ • ■ ■ -m
1 1
Hla is a phosphoprotein with an apparent MW of 66-kDa in Ad2. Dissociation of virus 
particles suggests that it is associated with the peripentonal hexons and labelling studies 
indicate that there are 5-6 copies of Ilia present at each vertex. Additional work has revealed 
associations between protein Ilia and the core proteins V and VII, leading to the proposal that it 
may be responsible for stabilising the interactions between the viral core and coat proteins 
(Boudin et a/., 1*980). The significance of the phosphorylation of nia is not known, although it 
has been suggested that it is carried out by a virion associated kinase and that it takes place 
early in infection (Blair and Russell, 1978; Tsuzuki and Luftig,L983).
Proteins VI and VIII, with apparent MWs of 24-kDa and 14-kDa respectively, are both 
thought to be associated with hexon capsomers on the internal surface of the virion coat (Everitt 
et a/.,1975; Philipson,1983; Horwitz, 1990a). Possible locations for these proteins have been 
proposed on the basis of cryo-EM studies and the assumption is that proteins VI and Vffl exist 
as trimers and dimers respectively (Stewart et ftZ.,1991; van Oostrum and Burnett, 1985).
Reports that protein VI may also bind to the viral DNA have led to the suggestion that, like 
mia, VI may play some role in linking the ordered capsid to the viral cores (Russell and 
Precious,1982).
The association of protein IX with hexons on the outer surface of the virus coat has 
been well established using a range of biochemical and physical techniques (Boulanger et 
a/.,1979; van Oostrum and Bumett,1985; Furcinitti et Stewart er al., 1991). Protein
DC, which comprises 140 amino acids, has an apparent MW of 14-kDa and trimers of the 
polypeptide are located between specific hexon capsomers, with 4 trimers being associated 
with each of the 20 faces. The exact position of the IX trimers has been shown to be just 
above the pseudohexagonal base at the contact point between 3 hexon capsomers.
Overall Geometry of the Virus Coat
The asymmetrical nature of the hexon capsomers (fig.2b) and the presence of a penton 
at each vertex means that the hexons occupy 4 non-equivalent positions in the virion capsid. A 
diagram of the capsomers making up one face is included to illustrate this point (fig.4). Also 
shown are the proposed locations of proteins Ilia, VI, VIII and IX (Stewart et a/., 1991). The 
contacts formed between adjacent hexons are much stronger than those between hexons and
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pentons. This is illustrated by the fact that groups of 9 hexons (GONs), peripentonal hexons 
and pentons can be readily dissociated from the virions by a number of mild treatments 
including dialysis against a hypotonic buffer (Prage et a/.,1970). Penton-less virions are 
referred to as sub-viral particles and their genome is much more susceptible to nucleases than 
the complete virion. The relative ease with which the pentons can be removed is thought to be 
an important step in the uncoating stage of the lytic cycle (see section 1.4).
1,3b Adenovirus Cores.
DNA and RNA viruses have adopted a number of strategies for neutralising the charge 
of their packaged nucleic acids. For example, the coat proteins of a number of simple plant 
viruses contain a stretch of basic amino acids, close to their N-terminus, which interacts with 
the phosphates of the nucleic acids, inside the virion, whilst animal picomaviruses co-package 
polyamines with their RNA. Generally speaking, it appears that viral nucleic acids are not 
arranged in an ordered way within the virion, although X-ray crystallography has been used to 
show that the RNA of bean pod motde virus and the single stranded DNA of canine parvovirus 
are packaged in an ordered icosahedral structure within their respective coats (Johnson, 1991). 
Even in these relatively simple viruses much more information is required before there is a clear 
picture of how they package their nucleic acids.
When more complex viruses, such as the adenovirus, are considered surprisingly little 
is known about the structural organisation of their nucleic acids. Several theories have been 
put forward including the idea that the adenovirus DNA adopts a chromatin like structure, that 
it is packaged in 12 loops with one interacting with each of the 12 vertices in the outer capsid 
and that it forms an icosahedral cage within the outer capsid (Mirza and Weber, 1982; Brown et 
a/.,1975; Nermut,1979). Recently, the use of the restriction enzyme, Bal31, which cleaves 
supercoiled DNA, in parallel with electron microscopy, has led Wong and Hsu (1989) to 
suggest a continuous helix model for adenovirus DNA (fig.5). They propose that in the 
virion the DNA forms 8 supercoiled loops which are wrapped round a central protein filament. 
Furthermore, they have demonstrated that the promoters of Ela and E4, along with the 2 
origins of replication, are insensitive to Bai31 and so include these regions outside the 
supercoiled domains in their model. The significance of this will be discussed in section 1.6.
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Fig. 5 Model for the structure of adenovirus DNA in virions.
The above diagram is modified from Wong and Hsu (1989). They propose an 8 loop domain structure for the 
adenovirus DNA with each loop being anchored to a central protein core. The locations of the early genes 
(E1-E4), the late genes (L1-L5) and the major late promoter (MLP) are indicated. The 2 termini of the genome, 
containing the origins of replication and the El A and E4 promoters, are proposed to be located outwith the 
supercoiled domains.
Although it is well established that the adenovirus relies on a number of basic 
histone-like proteins to neutralise its DNA and to package it within the virion, the nature of the 
DNA-protein interactions remains uncertain. Two of these proteins V and VII, present at 180 
and 1070 copies per virion, are termed the minor and major core proteins, respectively (Russell 
et a/., 1968). Protein VO has an apparent MW of 18-kDa, is arginine rich and binds 
particularly tightly to the DNA, with 3M NaCl being required to dissociate it (Cupo et 
a/., 1987). Protein V, on the other hand, can be removed from the viral DNA by relatively mild 
treatments leading to the suggestion that it forms a protein shell on the surface of the cores 
(Vayda et a/., 1983). An alternative proposal is that 3 dimers of VII associate with 150 base 
pairs of DNA to form nucleosome like structures which are separated by variable lengths of 
DNA associated with the minor core protein, V (Corden et a/., 1976). Neither of these models, 
however, is consistent with the results of Wong and Hsu (1989) and neither accounts for the 
presence of a third core protein termed mu (p). Mu is a 19 amino acid protein, including 9 
arginines and 3 histidines, which binds very tightly to DNA and is estimated to be present at 
180-340 copies per virion (Weber and Anderson, 1988). In addition to V, VII and mu, other
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proteins are present in the viral cores at low copy number. One of these, the terminal protein 
(TP), is a hydrophobic protein with apparent molecular weight 55-kDa, which is covalently 
linked to the dCMP residue at the 5' end of each DNA strand. This protein plays a key role in 
viral replication and will be discussed further in section 1.6 and also in chapter 4.
Finally, with regard to the adenovirus cores, recent cryo-EM work, examining intact 
Ad2 particles, produced density maps suggesting that the centre of the virion is less dense than 
the outer core; but that no highly ordered inner structure exists (Stewart et a/.,- 1991).
Six of the structural viral polypeptides described above, namely Hla, VI, VIE, VU, mu 
and the TP are the products of the digestions of larger precursor molecules termed pllla, pVI, 
pVni, pvn, 1 IK and the pTP respectively (Anderson et al, 1973; Boudin et a/., 1980; 
Tremblay et al, 1983). The digestions are all thought to be carried out by the virus encoded 
protease, in a final maturation step, which is essential for the production of infectious virions 
(see section 1.8). The effect that the limited proteolysis has on the individual proteins and, 
indeed, on the overall structure of the virus remains ' to be elucidated.
1.4 UPTAKE OF THE ADENOVIRUS BV THE CELL
The knob at the end of each fibre is thought to contain the sequence required for the 
binding of the adenovirus to a specific cell surface receptor. The presence of 12 fibres per 
virion enables multivalent attachments and EM studies show that the virus is taken into the cell 
by receptor mediated endocytosis; a process involving the formation of clathrin coated pits, 
which bud off into the cells (Pastan et a/., 1987). The resulting clathrin coated vesicles fuse 
with endosomes to give receptosomes, which have an internal pH of 5 and the low pH is 
thought to induce a change in morphology of the viral coat releasing the penton capsomers. It 
has been suggested that the low pH exposes hydrophobic epitopes in the hexon that can interact 
with the lipid bilayer and so allow the viral particles to penetrate the membrane (Everitt et 
a/., 1988). The virus is then transported to the nucleus possibly through a specific interaction 
between the hexon and the microtubules (Dales and Chardonnet,1973). At the nuclear 
membrane the uncoating of the virions is completed and the viral DNA passes into the nucleus 
along with closely associated proteins. The remainder of the viral proteins are left behind in the
1 5
cytoplasm.
As is evident from this description of the uptake of the virions by the cell, the molecular 
mechanisms involved are poorly understood and much more work is required in this area to 
characterise the cell surface receptor and to define the binding epitopes on the fibre. In addition 
the transport pathway of the virion through the cell remains to be confirmed and the 
mechanisms and degree of uncoating of the virus particle are anything but clear. One of the 
viral proteins, Ilia, has been shown to be phosphorylated soon after the uptake of the virus by 
the cell (Tsuzuki and Luftig,1983). It is possible that changes in the phosphorylation state of 
mia or other viral proteins could cause morphological changes in the particles. Another 
phenomenon which is puzzling, but may be of relevance, is that purified penton bases are able 
to induce cytopathic changes when added to cell monolayers in tissue culture (Boudin et 
al.,1979). The mechanism behind this is not known, but it is possible that the adenovirus 
recognises 2 cell surface receptors, with the penton base binding to a receptor distinct from that 
of the fibre. With this in mind, it may be significant that the penton base (protein IE) contains 
the amino acid sequence RGD, which has been shown to be responsible for the binding of a 
number of proteins including fibronectin to cell surface receptors (Ruoslahti and 
Pierschbacher, 1986). Finally, it has also been noted that viruses lacking the protease are 
defective in uncoating, so specific cleavages by the adenovirus protease might have an 
important role to play in uncoating (Hannan et a/.,1983).
1.5 ADENOVIRUS TRANSCRIPTION
The study of adenovirus transcription is of great interest not least because of the 
relationship between viral transcription regulatory proteins and malignant transformation, 
which will be discussed in section 1.5b (Heintz,1991). First, however, consider the complex 
organisation and control of transcription during the infectious cycle.
1.5a The Lytic Cycle
On entering the nucleus, the viral DNA is transcribed in a precise and ordered manner. 
Ten primary RNA transcripts have been identified that are each differentially spliced to give 
families of related mRNAs. The capped, polyadenylated mRNAs are then transported to the 
cytoplasm where translation takes place and at least 50 viral proteins are synthesised. The
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regulation of gene expression is fundamental to the progression of the lytic cycle and is exerted 
at a number of levels with transcriptional control being paramount. In the first instance, the 
order and amounts in which the primary transcripts are synthesised is critical and then each 
must be processed to give its progeny mRNAs at the appropriate levels. The transportation of 
the mRNAs out of the nucleus and their stability in the cytoplasm are also subject to differential 
control (Sharp, 1984).
Early infection is defined as the time prior to the onset of viral DNA replication. At this 
stage there are only 1-3 copies of the viral genome in the nucleus and transcription of the early 
genes takes place. Broadly speaking the products of these genes are required to modify the 
host cell to the advantage of the virus, to control the transcription of viral and cellular genes and 
to carry out viral DNA replication.
DNA replication begins 6-8 hours post infection with maximum rates being achieved by 
18 hours post infection. By 24 hours post infection 10 (XX) -100 000 copies of viral DNA are 
present in the nucleus of each cell (Green et. a/., 1970). Transcription of all the early genes 
continues after the onset of DNA replication; but, in addition, intermediate and late genes are 
transcribed at increasing levels as the lytic cycle progresses. The maximum levels of 
transcription from the late genes are achieved at 18 hours post infection and are maintained for 
at least 10 hours (Lucas and Ginsberg, 1971). The intermediate and late genes nearly all code 
for structural proteins or proteins involved in virion assembly and maturation which, by 
definition, are not required until late stages of infection.
The factors governing the switch between early and late transcription are of great 
interest and a number of models have been proposed. An attractive theory is that the DNA 
from the original infectious virion, which is the template for early transcription, adopts a 
different conformation from its progeny DNA, which are synthesised during replication and are 
the templates for late transcription.
Before describing the events of early and late transcription in detail consider the 
structure and organisation of the viral DNA.
Adenovirus DNA and Organisation of the Genome
Adenovirus DNA varies in size from 34-36Kbase pairs in different human serotypes
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and is asymmetric with respect to its distribution of A-T and G-C base pairs. By definition the 
right hand side is the A-T rich part and the right or positive strand is that which is transcribed 
from left to right (Doerfler and Kleinschmidt,1970). The complementary strand is transcribed 
from right to left and is termed the left or negative strand. The DNA from all adenovirus 
serotypes contain inverted terminal repeats ranging in length from 63-165 base pairs (Alestrom 
et al.,1982). In other words the 5' and 3' ends of the DNA are complementary to each other. 
These repeats include specific sequences necessary for DNA replication and transcription (see 
section 1.6) and are also important in terms of the structure of the DNA (Sussenbach,1984). A 
distinguishing feature of the adenovirus DNA is that it has a protein covalently attached to the 
5' end of each of its strands. In the mature virion the protein is the 55-kDa terminal protein 
(TP), which is the digestion product of the virally encoded 87-kDa pre-terminal protein (pTP). 
The pTP is processed, by the adenovirus encoded protease, to the TP via an intermediate and 
the significance of this will be discussed in chapter 4 (Smart and Stillman, 1982). Fig.6 
shows the transcriptional organisation of the Ad2 genome. Although there is substantial
IV*2 I05K
87K
78K
72K HK.13K.17K
19K.21K.24K
Fig. 6 Transcriptional organisation of the Ad2 genome.
Schematic representation of the adenovirus type 2 genome, divided into 100 map units; showing the locations of 
the major transcripts including their leader sequences and the protein coding regions. Early, intermediate and late 
transcripts are represented by solid, narrow and open arrows respectively (from Sussenbach,1984).
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sequence divergence between some serotypes, most of the adenovirus genomes are similar 
with respect to the overall organisation of their transcriptional units. As can be seen 
transcription takes place off the right and left strands of the 36K base pair genome, which has 
been divided into 100 map units so that the locations of the individual genes can be readily 
identified (Gingeras et a/., 1*982).
Detailed examinations of the appearance of the various Ad2 mRNAs during infection 
has revealed further divisions of early and late transcription, namely immediate early (Ela), 
delayed early (Elb, E2a, E2b, E3, E4, LI), intermediate (IX, IYa2) and late (L1-L5) with 
synthesis of all these transcripts being carried out by the cellular enzyme, RNA polymerase II. 
In addition, there are 2 non-coding viral associated RNAs, VA-RNAj and VA-RNA2, which 
are transcribed by RNA polymerase III. These are coded for by less than 1% of the viral 
genome and have been shown to play a key role in translational control (Sussenbach, 1984; 
Mathews and Shenk,1991).
Immediate Early Transcription - El A
The immediate early genes (El) are switched on at 30 minutes post infection and their 
products are required for cellular transformation and for the transcriptional control of both viral 
and cellular genes. The El A region is located at the 5' end of the right strand and gives rise to 
a complex transcriptional unit that generates 4 distinct mRNAs termed 13S, 12S, 11S and lOS, 
based on their sedimentation values (Nevins,1987). These are translated in the same reading 
frame to give 289,243, 217 and 171 amino acid proteins respectively. The proteins all share 
the same amino and carboxy termini, with the differences in length resulting from RNA 
splicing. The 289 and 243 amino acid proteins, termed E1A13S and ElA12S, are identical apart 
from 46 residues present at positions 140-185 in the former (Perricaudet et at.,1979). They are 
nuclear localised phosphoproteins and thus far all the functions attributed to the El A region 
have been assigned to them.
El A13s contains 3 conserved domains, the first 2 of which are shared by El Aj2s 
(fig.7). Extensive mutagenesis studies by a number of groups have enabled functional 
assignments to be made to the various domains of the proteins (reviewed in Moran and 
Mathews, 1987). Regions 1 and 2, present in both proteins, are primarily responsible for
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Fig. 7. Functional domains of the El— proteins.
Diagram showing the wigin and organisation of the El— 12S and 13S mRN—s and their 
respective protein products. The El — region is located at the 5' end of the right strand of 
the adenovirus genome and the map positions are included at the top of the figure. The 
important functional domains of the proteins, and their coding regions in the mRN—s, are 
shaded and the amino acid position numbers are shown above the bars.
transcriptional repression, transformation and DNA synthesis induction, whilst region 3, 
which is unique to El A13S, is essential for the transcriptional activation of viral and cellular 
genes. Indeed, a synthetic peptide comprising the 46 amino acids of region 3, along with 3 
adjacent conserved residues, was found to be sufficient to stimulate transcription from several 
adenovirus promoters (Green et a/.,1988). E1A13S switches on the transcription of all the viral 
early genes (ElB, E2A, E2B, E3 and E4) and also activates the major late promoter (MLP); but 
has not been shown to bind directly to the DNA (Berk, 1986). Instead, it appears to modulate 
transcription by an indirect means. The current theory is that E1A13S operates by modifying 
existing cellular transcription factors including E2F, E4F, AP-1 and TFIIIC (reviewed in 
Nevins,1991). Two mechanisms for this activation have been put forward. The first proposal 
is that the cellular transcription factors are phosphorylated as a result of their association with 
El A13S. It is suggested that the kinase is a cellular protein complexed with El A13S (Hoeffler
et a/., 15988; Herrman et aZ. 1991). Alternatively, there is some evidence to suggest that El Aj3s 
binds directly to the transcription factors, which serve to escort it to the appropriate promoters
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(Lillie and Green, 1989). The full range of these interactions and the nature of the modifications 
remain to be established, but what is certain is that the El A proteins direct the transcription of 
the other early viral genes and tailor the cells' machinery to suit its own requirements. In 
addition to their role in the lytic cycle, the adenovirus El A proteins are also essential for 
cellular transformation and this will be discussed further in section 1.5b.
Delayed Early Transcription - ElB, E2A, E2B, E3, E4 and LI.
The delayed early transcripts are termed ElB, E2A, E2B, E3, E4 and LI and, as with 
El A, the individual families of mRNAs are created by differential splicing of the primary 
transcripts. All the delayed early genes are activated by El ABs and are switched on from 1.5 
to 7 hours post infection. Transcription of the LI region continues until late in infection and 
will be discussed with the other products of the major late promoter in the late transcription 
section (see below).
The ElB region maps between 4.8 and 11.2 map units and differential splicing of the 
primary ElB transcript produces 2 major mRNA species with sedimentation coefficients of 
13S and 22S. In addition, 14S and 14.5S mRNAs have been detected, but the functional 
significance of these is not known (Virtanen and Pettersson,1985). The 22S message carries 2 
initiation codons in different, but overlapping reading frames, . resulting in the synthesis of 2 
unrelated proteins with apparent molecular weights of 55-kDa and 19-kDa (Bos et a/.,1981). 
Thus far, these are the only well characterised ElB proteins and both are required for cellular 
transformation (see section 1.5b). In addition to its essential role in transformation, the ElB 
55-kDa protein is required, in the infectious cycle, for the shut-off of cellular DNA synthesis, 
efficient DNA replication and the transport of late viral mRNAs across the nuclear membrane 
into the cytoplasm. It is thought that it perfomis some, if not all of these functions, in 
association with the E4 34-kDa protein (Samow et aZ.,1984; Bridge and Ketner,1990). The 
ElB 19-kDa protein is also required for the lytic cycle and appears to play an important role in 
stabilising cellular and viral DNA during replication. It has also been shown to trans-activate 
the other delayed early regions (White et a/., 1988).
E2A is located at 61.5-75.4 map units on the left strand and codes for the 72-kDa
single stranded DNA binding protein (DBP), that is essential for DNA replication (see section
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1.6 and chapter 4). TTe DBP also has a roleto play intranscriptional controland has been 
shown tn arparcc tanachaiptina nf ter E4 angina (Hnadn et n/., 1983). Ter tanaoraiptind nf E2A 
onatidurc lntr in idfeotioa, but whilst the panmntrr used nt rnaly times, nt mnp pncitina 75, is 
notivntnd by E1A13S, the lntr panmntea nt mnp pnsitina 72 is El A iadrpnndnat. It hns been 
suggested thnt the N-teamianl dnmnia nf the BPP is iavnlvrd ia the splioiag nf the lnte vianl 
mRNAs nad thnt, thanugh this anle, it is nble tn iafluraoe the hnst anage speoifioity nf the viaus 
(Andea^a nad Klessig,1984). The nthea 2 vianl panteias arquiaed foa vianl BNA aeplioptinn, 
the 80-kBn pae-teamianl panteia nad the 140-kBn BNA pnlymeahse, nae onded foa by the E2P 
aegina nt pnsitiod 75.4-14.2 mnp uaits m the left strand. Althnugh the E2P tandsoaipt shnaes 
the sme panmnteas nad lendea sequraoes ns E2A, it is parsrat nt muoh lnwea hnnhentaptiods. 
Is Ad2 n srquraoe nt 39 mnp uaits ondiag foa Met-Aln-Leu is jniaed by RNA splioiag tn the 5' 
end nf the mnia ondiag aeginns nf bnth the pTP nad pnlymeayse pantrins (fig.8). This exna 
inoludes the iaitistioa ondna fna bnth the pTP nad pn^mra^ nad rffeotively ndds 18 nad 142 
nmim noids tn the pardioted pantria sequraoes (Stuaaenbeag et n/.,1988). The stmotuaes nnd 
fuaotinas nf the E2 panteias will be disoussed ia full ia seotina 1.6 nnd ohyptra 4.
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Fig. 8. Organisation of Ad2 pTP and pol mRNAs
Schematic diagram showing the organisation of the pTP and pol coding regions within the E2B 
region. The E2B region is transcribed from the reverse strand which is shown with the map 
units indicated. Three short exons are spliced to the main reading frames, at coordinates 28.9 
and 24.1, to give the pTP and pol mRNAs respectively. The sections of the mRNAs coding 
for each protein are shaded. pTP and pol share the same initiation codon which is marked with 
an asterisk.
The E3 aegina is lnonted nt mnp pnsitina 75-86 os the right stannd nad deletinn nf these 
genes hns been senwa tn epve sn effeot na the pangarssina nf the lyaio oyole ia tissue oultuae. 
It dnes, hnwevea, onatnia n aumbea nf npea amding frames raondiag panteias thnt ppprsa tn
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reduce the effects of the host's immune response. These include a 19-kDa glycoprotein that 
has been shown to bind to the MHC heavy chain preventing its transport to the cell surface and 
so lowering the cytotoxic T-cell response (Rawle et a/.,1989). It has also been proposed that a 
14.7-kDa E3 protein inhibits lysis of adenovirus cells by the tumour necrosis factor and that a 
10.4-kDa E3 protein binds to the epidermal growth factor receptor (Gooding et a/., 1988; 
ToUefson et a/., 1990).
The E4 region is essential for the progression of the infectious cycle and is required for 
viral DNA replication and the synthesis of late viral proteins. It is located at the extreme right 
of the genome on the left strand at map units 99-91.3. The E4 transcript is processed to give a 
large family of mRNAs with the potential to produce at least 7 proteins (Virtanen et a/.,1984). 
The E4 34-kDa protein carries out most of the functions assigned to the E4 region. In deletion 
mutants, lacking the 34-kDa protein, an 11-kDa protein, also encoded by E4, is able to 
deputise for the larger protein albeit not with quite the same efficiency. Mutant viruses lacking 
the genes for both proteins were found to be non-viable (Huang and Hearing, 1989). As 
mentioned above the 34-kDa protein binds to the 55-kDa ElB protein and mutational analysis 
suggests that they perform some of their regulatory functions jointly. A third E4 protein, 
19-kDa, transcriptionally activates the E2A gene by binding to the cellular factor E2F and 
increasing its affinity for the E2A promoter (Neill et a/.,1990). The binding of the E4 19-kDa 
protein to E2F is enhanced by the presence of El Ai^. R appears that the El A protein is 
required to release the cellular factor from interactions with other proteins leaving it free to bind 
the 19-kDa protein.
The interaction between E2F, ElA^s and the 19-kDa E4 protein serves to emphasise 
the complex associations and interactions taking place between cellular and viral proteins 
during the early stages of adenovirus infection in preparation for viral replication and late
transcription.
Intermediate Transcription - IX and IVa2
Transcription of the IX and IVa2 genes takes place at 6-8 hours post infection, from 
separate promoters. The gene for protein IX is contained within the ElB region, but is 
switched on independently to produce a 9S mRNA and is silent early in infection. Protein IX,
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has already been described as a structural component of the virus capsid (section 1.3) and the 
reason why it is synthesised before the other structural proteins is not apparent.
The IVa2 gene is located on the left strand between 11.3 and 16 map units and the 
primary transcript is spliced to join 2 exons in the IVa2 mRNA (Grassland and Raskas,1983). 
IVa2 is a 449 amino acid protein with apparent molecular weight 50-kDa, but its function 
remains to be established. Originally it was thought to be a scaffolding protein required for 
assembly and not present in the mature virion. It has recently been shown to be a minor 
component of the mature virus and it has been suggested that its-function is not confined to 
virus assembly (Winter and D'Halluin,1991). The observations that it contains a potential 
nucleotide binding site, that it is highly conserved in different adenovirus serotypes and that it 
has an affinity for viral DNA would appear to add weight to this argument (Gorbalenya and 
Koonin,1989; Kring and Spindler,1990; Russell and Precious, 1982).
Late Transcription
The major late transcription unit is present on the right strand from 16.5 -99 map units, 
with the primary transcript being synthesised from the major late promoter. This is then 
spliced to give at least 18 distinct mRNAs which all share the same tripartite leader sequence at 
their 5’ end. The mRNAs are divided into 5 families (L1-L5) according to their different poly- 
adenylation sites (fig.6). All the late mRNAs have 150-200 adenine bases at their 3' end and 
this appears to be required for their transportation to the cytoplasm and stability. The proteins 
encoded by the late transcription unit are either structural components of the virus or are 
required for assembly and are expressed maximally at 20 hours post infection (Fraser et 
a/., 1979).
The LI family of mRNAs encode 3 proteins, the 52-kDa, 55-kDa and pH3a proteins, 
pnia is the precursor of Ilia which is a structural component of the viral capsid whilst the ' 
related 52-kDa and 55-kDa phosphoproteins are required for virion assembly (sections 1.3 and 
1.7). In contrast to the other late mRNAs, the messages for the 52 and 55-kDa proteins have 
been detected in the cytoplasm early in infection, with the proteins themselves appearing at 6-7 
hours post infection. This results from transcription from the major late promoter early in 
infection which is terminated midway through the late transcription unit. At early times
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preferential poly-adenylation takes place at the LI site and interestingly the other LI protein 
pDIa does not appear to be expressed. The role of the LI 52/55-kDa proteins at this stage in 
the infectious cycle is not known, but synthesis of the proteins continues late in infection 
(Shaw and Ziff,1980; Hasson era/.,1989).
The L2 family of mRNAs codes for III (penton base), V, pVII and an 11-kDa protein. 
pVII and 11K are the precursors of the basic core proteins VII and mu respectively. Protein V 
is also a core protein required for packaging the viral DNA, while the penton base is a major 
structural component of the virus capsid. All these proteins have been described previously 
(section 1.3).
L3 includes the genes for protein II (hexon), pVI and a 23-kDa protein. The 23-kDa 
gene product is required to carry out maturation cleavages of other viral proteins and is 
assumed to be the virally encoded protease, whilst the hexon and VI are structural components 
of the virion (sections 1.8 and 1.3). The genes for pVIII, the 100-kDa chaperone protein and a 
33-kDa protein are located in L4 whilst the coding region for protein IV (penton fibre) is in L5. 
The functions of all these proteins are described elsewhere (sections 1.3 and 1.7).
It should be noted that the late transcription unit includes a number of other open 
reading frames that have not been included in this report and the significance of these remains 
to be established.
Viral Associated mRNAs (VA-RNAs)
The genes encoding the viral associated mRNAs are contained within the major late 
transcription unit, at map position 28.8-29.5, and are transcribed by RNA polymerase III to 
give two 160 nucleotide transcripts. Synthesis of these non-coding RNAs, termed VA-RNAj
and VA-RNA2, begins early after infection; but their transcription is increased dramatically late 
in infection, with up to 108 copies of VA-RNAj being present in the cytoplasm. Mutant 
adenovimses lacking the genes for the VA-RNAs grow less well than the wild type virus, 
apparently as a result of defective initiation of viral protein synthesis in the mutants 
(Thimmappaya et a/.,1982). The molecular basis for this defect has not been completely 
elucidated, but there is a strong suggestion that VA-RNAj is able to block one of the main
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anti-viral activities induced by interferon. Interferon activates a double stranded RNA 
dependent protein kinase (DAI), which phosphorylates a serine residue on the a-subunit of 
eIF-2. This has the effect of blocking the initiation of protein synthesis during viral infection. 
The VA-RNAs are able to prevent this process by binding to the kinase, blocking its activation 
by interferon and so allowing initiation of protein synthesis to proceed (Schneider et a/.,1984; 
Mathews and Shenk,1991). Other mechanisms to control translation also operate late in 
infection. The cap binding complex (eIF-4F) is inactivated by dephosphorylation which 
confers a selective advantage for the translation of late viral mRNAs. This is because, unlike 
most host cell mRNAs, their poly(A) extensions enable them to bind to ribosomes in the 
absence of active eIF-4F (Huang and Schneider, 1991). Recently, the L4,1C0)-kDa, chaperone 
protein has been shown to bind to RNA and there is a suggestion that it plays a role in 
translational selectivity of late viral proteins (Hayes et a/.,1990).
52-TrmsIQmatiQnmidAdmomms.OncQgenes^.
Adenovirus transformed cells contain a portion of the viral DNA integrated into their 
DNA which includes the El A and ElB regions. They constitutively express the El A and ElB 
proteins; but interestingly the IX transcription unit which is contained within ElB is inactive 
(Sharp, 1984; Boulanger and Blair,1991). All adenovirus serotypes are able to transform cells, 
but not all are oncogenic. Comparisons between the sequences of the El A regions of human 
Ad 12 and simian SA7 viruses, which are both oncogenic, reveals a conserved stretch of 7 
amino acids in ElA13s not present in the non-oncogenic viruses. The suggestion is that this 
sequence may be involved in tumorigenicity (Kimelman et al, 1985).
The binding of El A proteins to a number of cellular proteins including cyclin A and the 
retinoblastoma susceptibility gene product (pRB) takes place through domains that are essential 
for transformation and so has created much interest (fig.7). pRB is an anti-oncogene that 
binds to the cellular transcription factor E2F and so controls its activity. El A proteins are able 
to interact with pRB in a way that nullifies its anti-oncogenic properties (Whyte et a/.,1988). 
The association between El A12s and cyclin A, along with evidence that a serine/threonine
protein kinase forms a complex with ElA12s, has led to the suggestion that a cell cycle 
regulated kinase such as p34cd32 may be important in El A mediated transformation (Herrmann
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et a/.,1991). The El A region is necessary; but not sufficient, for transformation and requires 
the ElB 55-kDa protein for the cells to become fully transformed (van den Elsen et a/., 1983). 
The cooperative role of ElB can also be carried out by a number of oncogenes including ras 
(Ruley,1983). The function of the 55-kDa protein in transformation is thought to involve its 
interaction with the cellular anti-oncogene product p53 and may serve to release the cells from 
controlled growth. The ElB 19-kDa protein has been shown to associate with vimentin- 
containing intermediate filaments and with the nuclear lamina. The resulting disruption of the 
cell is thought to be an important part of the transformation process (Boulanger and Blair, 
1991).
1.6 ADENOVIRUS DNA REPLICATION
The onset of viral DNA replication takes place at 6 hours post infection, is coincidental 
with a virtual shutdown of cellular DNA synthesis and forms the natural division between the 
early and late transcription events described in section 1.5a. The process continues until 24 
hours post infection when up to 100 000 copies of the viral DNA are present in each cell. Only 
about 20% of these genomes are, however, ultimately packaged into progeny virions (Pina and 
Green, 1969; Green et a/.,1970).
Adenovirus DNA replication has been studied extensively using both in vivo and in 
vitro systems (Pearson and Hanawalt,1971; Challberg and Kelly,1979; Hay and 
Russell, 1989). Electron microscopy studies of replication intermediates, isolated from Ad2 
infected cells, led to the proposal of a strand displacement mechanism for replication (Flint et 
a/., 1976). Fig.9 shows a model for one cycle of adenovirus replication which operates by a 
protein primer mechanism and can be divided into 2 stages. The first stage, termed initiation, 
involves the formation of an ester linkage between the phosphate of a dCMP base and the 
p-hydroxyl group of Ser580 in the pre-terminal protein (pTP). The 3' hydroxyl group of the 
resulting pTP-dCMP then acts as a primer for the synthesis of a new strand of DNA using one 
strand of the parent DNA as a template. This process is termed elongation. The non-template 
strand of the parent DNA is displaced and fonns a 'pan handle' circular structure, resulting 
from the annealing of the inverted terminal repeats present at each end of the single strand of 
DNA (Challberg et a/., 1980; Hay et a/., 1984).
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Fig. 9 Model for Adenovirus DNA Replication
A model for the replication of Ad2 DNA with schematic representations 
of pTP, TP, polymerase, DBP, NFl, NF3 and the inverted terminal repeats.
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The inverted terminal repeats play a central role in replication with bases 1-18 being absolutely 
required for initiation. The structure of the DNA template in vivo is the subject of much 
controversy, but templates effective in in vitro assays include linearised plasmids containing 
bases 1-18, deproteinised adenovirus DNA, adenovirus DNA with the terminal proteins 
attached to each 5' end, viral cores and subviral particles (Challberg and Kelly, 1979; Harris 
and Hay, 1988; Leith et a/., 1989). Interestingly, the efficiencies of these templates vary 
considerably in initiation reactions and although bases 1-18 are sufficient for initiation in vitro, 
the process is stimulated up to 200 fold by the presence of bases 19-50 (Hay et a/., 1984). 
Furthermore, the presence of the terminal protein at the 5' end of the DNA considerably 
enhances the process (Tamanoi and Stillman, 1982). The observation that subviral particles are 
able to act as efficient templates for initiation and elongation is noteworthy since subviral 
particles, prepared by dialysis against a hypotonic buffer, lack only the apical penton 
capsomers from their coat. This means that Ad2 DNA can act as the template for replication 
even in the presence of bound viral proteins (Leith et a/., 1989). Indeed this work lends 
support to the model of the viral DNA proposed by Wong and Hsu (1989) shown in fig.5. 
This model suggests that the termini of the DNA are not supercoiled in the virus particle and so 
presumably are free to participate in DNA replication. It is also worth noting that the El and 
E4 regions are free and an extension of the work by Leith et a/.(1989) is that subviral particles 
could act as templates for early transcription.
Two proteins are essential for the initiation of Ad2 DNA replication in vitro, the virus 
encoded pTP and polymerase. The process is significantly enhanced, however, in the presence 
of the 72-kDa DNA binding protein (DBP) and 2 cellular factors termed NFl and NFIII. The 
latter also serve as transcription factors and bind to sequences at 22-39 and 40-51 in the Ad2 
DNA (reviewed in Kelly, 1984; Hay and Russell,1989; Salas,1991). The involvement of these 
factors explains the importance of bases 19-50 in Ad2 DNA replication, as discussed above.
In contrast, studies carried out on the replication of Ad4 DNA reveal that it requires only bases 
1-18 at the origin of replication and that the presence of the NFl and NFIII binding sites have 
no effect on the efficiency of initiation of replication (Harris and Hay, 1988).
The proteins involved in adenovirus DNA replication will be described in more detail in
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chapter 4, which is concerned with the processing of the pTP by the virus encoded protease.
1,7 vmoN ASSEMBLY
Adenovirus assembly is a complex process the details of which are poorly understood. 
The large number of proteins involved means that it is difficult to establish whether a particular 
protein plays a direct or an indirect role in assembly. A protein may be indirectly involved if it 
is required for the transcriptional, translational or post-translational activation of a structural or 
scaffolding protein. A further problem is that most studies have involved the analysis of the 
protein/DNA composition of incomplete or mutant virus particles. Some of these intermediate 
particles will be incorrectly assembled and, therefore, not true precursors of the mature virus. 
Furthermore, the isolation and analysis of intermediate or mutant particles frequently involves 
harsh treatments such as high salt, detergents, urea, centrifugation and chemical crosslinking. 
These procedures may shear DNA and remove proteins associated with the virus or, 
alternatively, create artifactual associations.
The viral proteins are synthesised in the cytoplasm before being transported to the 
nucleus where assembly takes place. The uptake of proteins by the nucleus is extremely 
selective and it is believed that nuclear proteins contain a sequence that allows their specific 
accumulation in the nucleus (Dingwall and Laskey,1991). These sequences are rich in the 
positively charged amino acids, arginine and lysine, and the N-terminal sequence from the Ad2 
fibre, MKKARPSEDTF, has been shown to be sufficient for nuclear localisation (Hong and 
Engler,1991). Nuclear localisation signals have been identified in a number of other 
adenovirus proteins including KRPRP in E1A13S and RLPVRRRRRRVP in the pre-terminal 
protein (Lyons et a/.,1987; Zhao and Padmanabhan,1988). The nuclear transport of viral 
proteins lacking a nuclear targeting sequence may be facilitated by their association with a 
nuclear protein containing such a sequence. This has been shown in the case of the Ad2 
polymerase, which is escorted to the nucleus by the pre-terminal protein (Zhao and 
Padmanabhan,1988).
The first step in adenovirus assembly is the formation of the hexon capsomers, which 
requires protein II (hexon monomer) and the L4 100-kDa protein. The 100-kDa protein binds 
to II in stoichiometric amounts while the latter is still attached to the polyribosomes. The
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resulting II/1OOK heterodimers aggregate and trimers of II are folded together. The trimers 
(hexon capsomers) dissociate from the l(X)-kDa protein and are transported to the nucleus. 
Mutation studies suggest that the 100-kDa protein is involved in the transport of the hexon to 
the nucleus, but it is possible that this could be an indirect consequence of incorrect folding of 
the hexon by the mutant proteins (Cepko and Sharp, 1983). It has also been suggested that the 
structural protein, pVI, is required to chaperone the hexon to the nucleus (Morin and 
Boulanger, 1986), This is based on an established association between pVI and the hexon and 
the characterisation of a temperature sensitive mutant, H5tsl47,lhe defect of which apparently 
maps to pVI (Everitt et a/.,1973; Kauffman and Ginsberg,1976). On reaching the nucleus, the 
hexon capsomers appear to be able to self assemble to form empty icosahedral shells. In Ad2 
infections only 10% of the hexons synthesised are incorporated into mature virions and free 
hexons; but not virion associated hexons, have been found to contain a reactive serine residue 
that binds to diisopropylfluorophosphate (DFP). The suggestion is that the reactive serine 
might be required for the folding process (Devaux and Boulanger, 1980).
After the construction of the hexon shells it is suggested that pVI, pVHI and pllla 
associate with the virions along with 50-kDa and 39-kDa proteins (D'Halluin et a/., 1978). The 
50-kDa and 39-kDa proteins do not appear to be present in the mature virions and it is thought 
that they are scaffolding proteins required for correct assembly. The L4 l(X)-kDa protein has 
been isolated from intermediate particles and is also believed to function as a scaffolding 
protein. Furthermore, a 90-kDa protein, related to the l(X-kDa protein, has been found in 
intermediate particles and there is a suggestion that it is the product of limited proteolysis of the 
l(X)-kDa species, perhaps by the adenovirus protease (Morin and Boulanger, 1986).
The next step in assembly is the insertion of the viral DNA and core proteins into the 
empty capsids. Some reports suggest that the naked DNA enters first, followed by the core 
proteins, but it would seem more likely that the basic core proteins would be required to 
neutralise the charge of the DNA prior to its packaging in the virion. The left end of the viral 
genome including the El A region has been shown to be inserted into the virions first and 
nucleotide sequences at 200-400 base pairs appear to be essential for the packaging of the 
genome (Hammarskjold and Winberg,1980). It is assumed that specific proteins must bind to
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these sequences (Grable and Hearing, 1990). Mutation studies have revealed that 2 proteins, 
the LI 52/55-kDa protein and IX are essential for the incorporation of the viral DNA into the 
particles. A temperature sensitive mutant in the 52/55-kDa phosphoproteins was isolated and 
shown to be normal with regards to viral replication; but defective in particle assembly at 
non-permissive temperatures. Although the 52/55-kDa proteins have not been detected in 
mature virus particles, this does not rule out the possibility that they are present at low copy 
numbers (Hasson et a/., 1989). Protein IX which is a cementing protein located on the external 
side of the coat is required for stability of the mature virus. Initially it was thought that it was 
not required for assembly. More recent mutant studies, involving complementation assays, 
however, suggest that IX is required for the correct insertion of the viral genome (Colby and 
Shenk,1981; GhosC-ChoudCury et o/., 1987). The role of the penton capsomers and 
particularly of the fibre in assembly is controversial. One theory is that proteins III and IV self 
assemble to form the pentons, which don't associate with the virus until after the insertion of 
the DNA and core proteins (Falgout and Ketner,1988). Other reports suggest, however, that 
the fibre is required at earlier stages in the assembly process (Chee-Sheung and Ginsberg, 
1982). It has also been proposed that mutants in pTP, pol and E4 proteins are defective in 
assembly (Horwitz, 1990a).
In conclusion, many proteins are involved in assembly; but in most cases their exact 
roles are poorly understood. Once assembled the virions undergo a morphological change that 
converts them from young to mature virions. The antigenicities of the young and mature virus 
particles differ considerably and although a virally encoded protease is thought to be solely 
responsible for the process it cannot be ruled out that other proteins are involved.
1.8 THE ADENOVIRUS PROTEASE AND MATURATION.
The final step in the production of infectious virus particles is carried out by the subject 
of this thesis, the adenovirus protease, and involves limited proteolysis of a number of viral 
proteins (Anderson et a/., 1973). These include the pre-terminal protein (pTP), pVI, pVII, 
pVnI, mo and the L2 11-kDa protein (Boudin et a/., 1980, Tremblay et o/., 1983, Weber and 
Anderson, 1988). It is possible that other viral, and perhaps cellular proteins, ore cleaved by 
the adenovirus protease during the infectious cycle. Indeed, Morin and Boulanger (1986)
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suggest that the L4 100-kDa scaffolding protein is processed by the protease at its N-terminus 
to give a 90-kDa protein (see section 1.7). The cleavage sites in pVI and pVII have been 
identified by amino acid sequencing and, based on this information, cleavage sites have been 
proposed in pVIII and the pTP (Akusjarvi and Persson,1981; Sung gf a/., 1983; Smart and 
Stillman, 1983). Tremblay et al. (1983) suggest that the enzyme is specific for glycine, alanine 
containing bonds, but concede that there must be other determinants in specificity for such a 
selective enzyme. A detailed examination of the substrate specificity of the Ad2 protease will 
be carried out in chapter 1. ,
The isolation of a temperature sensitive mutant, Ad2ts 1, defective in processing at 
non-permissive temperatures, proved a major discovery and suggested that a virus encoded 
enzyme was responsible (Weber, 1976). Ad2tsl accumulates the precursor proteins and 
although viral particles are assembled at non-permissive temperatures they are not infectious. 
The mutation in Ad2tsl has been mapped to a gene in the L3 region, coding for a 23-kDa 
protein, and gives rise to a Pro -> Leu change at residue 136 (Yeh-Kai et a/.,1983). It is, 
therefore, generally accepted that the L3 23-kDa protein is the protease (Krausslich and 
Wimmer,1988). The gene has been sequenced in 7 different human serotypes and is 
remarkably well conserved suggesting that it must have an important function in the virus 
(Houde and Weber,1990a). It bears no obvious resemblance, however, to any established 
viral or cellular proteases.
Limited inhibitor studies have shown that the enzyme is inhibited by PMSF and TPCK 
and based on these it has been reported that the 23-kDa protein is a chynaotrypsin-like serine 
protease (Bhatti and Weber,1979a; Tremblay et a/., 1983). It has been suggested further that 
His^, Aspi02 and Ser187 could form the catalytic triad of such an enyzme despite the fact that 
there are no homologies between the 23-kDa protein and chymotrypsin in the surrounding 
residues (Houde and Weber, 1987). Chapter 2 aims to carry out a more rigorous examination 
of the classification of the adenovirus protease.
The observation by Chatterjee and Flint (1987), that a 23-kDa phosphoprotein is 
processed to give a 19-kDa protein led to the conclusion that the adenovirus protease is 
phosphorylated and autocatalytically cleaved. The possibility that the activity of the enzyme is
33
controlled by phosphorylation and/or proteolysis is an interesting one which will be explored 
further in chapters 3 and 4.
The location of the protease activity has been shown to be nuclear and activity can also 
be extracted from purified virions. The 23-kDa protein is, however, present at a low copy 
number and has not been visualised by SDS-PAGE (Anderson, 1990). The timing/ 
coordination of the cleavages of the different substrates is another aspect that has not been 
addressed. Is it that the protease is not required before the final maturation step as suggested 
by Ad2tsl studies or is it that in the absence of active protease defective particles are 
assembled? In other words in wild type infections do any or all of the cleavages take place 
before the formation of the virions? With the exception of the pTP, which is required for 
replication, all the other substrates have been assigned structural roles. Chapter 4 attempts to 
study in more detail the processing of the pTP and the role that it plays in the lytic cycle. A 
more detailed description of the properties of the adenovirus protease will be given in the 
introductions to chapters 1-4.
Like many other viruses the adenovirus codes for a protease the activity of which is 
essential for infectivity. In section 2 the importance of proteolysis in the replicative cycles of 
other viruses will be considered.
2_LIM^ED_PROI£OLYSIS_OEVlEAL_PKOTEjNS.
Most viruses rely on the action of specific proteases at some point in their infectious 
cycle. These proteases may be cellular, as in the case of influenza, but in many instances are 
coded for by the viruses themselves. The adenovirus is the only example of a DNA virus that 
is known to code for its own protease; but limited proteolysis has also been shown to take 
place in vaccinia, African swine fever and herpes viruses (section 2.6). In contrast, numerous 
RNA viruses code for their own proteases and some of these have been very well 
characterised.
The positive strand RNA viruses translate their genomes as polyproteins and require 
proteases to divide these up into functional units. This is usually a prerequisite for viral 
replication and particle assembly. Before considering the processing of specific viral proteins,
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it is necessary to define some terminology that will be used when referring to the polyproteins 
of RNA viruses. Cis cleavages are those carried out when the protease and substrate are part 
of the same polypeptide, whilst trans cleavages take place when the protease and scissile bonds 
are in separate molecules. Structural proteins form part of the mature virus particles, whereas 
nonstructural proteins are enzymes or other gene products that are not packaged in the virion.
2.1 . ORTHO- AND PARAMYXOVIRUSES
Ortho- and paramyxoviruses are negative strand, enveloped viruses that include the 
influenza and respiratory syncytial viruses, respectively. Although these viruses have not been 
shown to code for their own proteases they are included as the best characterised examples of 
the processing of viral proteins by cellular proteases (Kingsbury,1990; Chanock and 
McIntosh, 1990; Kawahara et at.,\992). The ortho- and paramyxoviruses share a number of 
common features, including an absolute requirement for the cleavage of a surface viral 
glycoprotein before membrane fusion can take place. The hemagglutinin (HA) protein of 
influenza A is by far the best defined of these glycoproteins and so its processing will be 
described as a typical example.
The HA protein mediates the initial attachment of the influenza A virus to its receptor 
and after uptake into the cell, initiates the fusion of the virus envelope with an intracellular 
membrane. The protein is synthesised as a 566 amino acid precursor and its insertion into the 
endoplasmic reticulum is directed by a 16 amino acid signal sequence, which is later removed 
by a signalase. After assembly of the virus, the HA protein is cleaved at the C-terminai side of
Arg328 by a cellular trypsin-like enzyme to give HAj and HA2, which are connected by a 
disulphide bridge (fig.lO). The resulting conformational change exposes a hydrophobic
Fig. 10 Influenza Virus Haemagglutinin
Schematic diagram of the haemagglutinin glycoprotein from influenza virus showing the 
position of the cleavage necessary for the development of infectivity (Y ). Cleavage at 
this site exposes a hydrophobic fusion domain (EI). The open arrow indicates the site of 
cleavage of a cellular signalase which removes the signal peptide. The shaded area close 
to the C-terminus represents the membrane spanning region.
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sequence at the N-terminus of HA2 which is capable of directing membrane fusion 
(Kingsbury, 1990; Klenk et a/., 1975; Lazarowitz et a/., 1973). The cleavage sites in the other 
ortho- and paramyxovirus glycoproteins are relatively well conserved and are rich in basic 
amino acids. In some of the viruses the maturation cleavage of the surface glycoprotein is an 
extracellular event.
Interestingly, it has been noted that combined influenza/ SAureus pneumonia is 
approximately 3 times more common than primary viral pneumonia (Tashiro et a/., 1 <987). The 
reason for this appears to be that certain strains of SAureus secrete proteases that accelerate the 
processing of the HA protein and so increase the amount of infectious virus present.
2.2 PICORNAVIRUSES
The picomaviruses are positive strand RNA viruses that have been divided into 4 
genera termed rhino-, entero-, cardio- and aphtho- viruses. They are non-enveloped, 
icosahedral particles and are the causative agents of a range of diseases including polio, 
hepatitis A, the common cold, and foot and mouth disease. Their RNA genomes are very 
small, comprising less than 8000 bases, and contain a single open reading frame that codes for 
a large polyprotein of molecular weight 200-300-kDa. These polyproteins are then cleaved to 
release all the structural and non-structural proteins of the virus (Jacobson and Baltimore,1968; 
Wimmer,1989). Proteolytic processing was first observed in the enterovirus, polio and as a 
result all the cleavage sites in the poliovirus polyprotein and the functions of many of its 
individual proteins have been well defined (Kitamura et </., 1981; Nicklin et a/.,1986). 
Subsequent work on the other picomaviruses has revealed that their genome organisations and 
processing sites are very similar to those found in poliovirus (reviewed in Krausslich and 
Wimmer,1988).
The organisation of the poliovirus polyprotein is shown in fig.lla and the positions 
of the cleavage sites are marked. The processing is carried out by 3 distinct proteases and 2 of 
these are the viral proteins 2A and 3C, which have been well characterised. The first 
processing event is the separation of the structural and non-structural proteins and this 
co-translational cleavage takes place at a Y-G bond at the C-terminus of VPl. This is an 
autocatalytic event carried out by the 17-kDa, 2A protein which cleaves at its own N-terminus.
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In poliovirus this cleavage is a prerequisite for viral assembly and the formation of replication 
complexes. The only other site in the polyprotein that is cleaved by 2A is a second Y-G bond 
in the 3D polymerase protein. This is not essential for virus replication, but is thought to 
provides a means of regulating the activities of the 3C protease and 3D polymerase (Lee and 
Wimmer,1988). A further function performed by the 2A protease is the shutting off of host 
cell protein synthesis. The precise mechanism for this remains to be elucidated, but it has been 
shown that 2A and the eukaryotic initiation factor 3 (eIF3) act together to cleave the p220 
subunit of eIF4 (Wyckoff et <3/.,1990-. The latter is required for the binding of capped mRNA 
to the ribosome and its cleavage results in the inhibition of host cell protein synthesis. The 
poliovirus RNA is not capped at its 5' end and can be translated by a cap independent 
mechanism in the absence of p220 (Sonenberg, 1991 ). Whether 2A or eIF3 carries out the 
cleavage of p220 is a matter of controversy and until recently it was thought that 2A played 
only an indirect role (Krausslich gf a/., 1987). Mutational analysis of the 2A protein, however, 
reveals that its proteolytic activity correlates with its ability to induce the cleavage of p220 
suggesting that 2A is directly responsible (Hellen et al, 1991). The function of eIF3 may be to 
bind to the p220 protein and to present it to the protease in the correct conformation for 
cleavage (Wyckoff et a/.,1990). Thus it appears that the 2A protease of poliovirus plays 2 
essential roles in the replicative cycle of the virus, one involving the separation of the structural 
and non-structural viral proteins and the other, the cleavage of the cellular protein p220.
Eight of the 11 cleavages of the poliovirus polyprotein are catalysed, by the 3C protease 
(3C), either alone or in association with the 3D polymerase (3CD), as shown in fig.lla. 
Although all the cleavage sites are Q-G bonds, the separation of the capsid proteins VPO, VP3 
and VPl is carried out by 3CD and not by 3C. It has been proposed that elements in 3D are 
required to bind to the capsid protein precursor and so increase the affinity of 3C for its 
structural substrates. This may be necessary as a result of the initial separation of the structural 
and non-structural proteins catalysed by 2A. The 6 remaining Q-G sites that link the 
non-structural proteins are readily cleaved by the 3C protease. It has been suggested that the 
different affinities of the 3C protease for the various substrates may be important in the 
regulation of the lytic cycle (Hellen et a/., 1989). Like 2A, the 3C protease has also been
37
(a)
?
Y \ 7 1F T 1F T1 F V
i vpo VP3 VP1
w
n 2B 2C 3A
3
B i 3D
(b)
? ?
lFV T V ▼ 1r T 1F
L VPO VP3 VP1 2A 2B 2C 3A 3H 3D
L ?
7 V T T
?
V 1 1FT T
: VPO VP3 VP1
J a2b 2C 3A
3
B■ 3D
Fig. 11 Polyproteins of the Picornaviridae
Schematic diagrams showing the organisation of the polyproteins of (a) entero- and rhino-viruses;
(b) cardioviruses; (c) aphthoviruses. The 2A, 3C and Leader proteases are shaded and arrows 
indicate the scissile bonds cleaved by 2A (V), 3C (▼) and 3CD (V). A question mark is 
shown above cleavage sites where the protease has not been identified while L indicates cleavage 
by the Leader protease.
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associated with host cell control. Clark et al. (1991) have shown that 3C is required for the 
inhibition of host cell RNA polymerase III during poliovirus infection. The effect is mediated 
by the transcription factor, TFIIIC, which is converted from an active to an inactive form. The 
suggestion is that 3C is responsible for the cleavage of TFIIIC; but proof is still required.
The final processing event in polio is the cleavage of the structural protein VPO at an 
N-S bond to give VP4 and VP2 and this takes place after assembly of the virus particles. At 
first it was assumed that this was an autocatalytic event with Seri0 of VP2 being an active site 
residue and the viral RNA playing a catalytic role (Arnold et al.1987). Mutants with alanine or 
cysteine at position 10 of VP2, however, were able to process VPO correctly and the 
mechanism by which the cleavage is carried out remains in doubt (Harber et al.,199l).
The organisation and processing of the other entero- and rhino- viruses are to all intents 
and purposes identical to those described for poliovirus, but there are interesting differences in 
the aphtho- and cardio- viruses (fig.llb,c)« Viruses from these genera contain leader 
proteins at the N-termini of their polyproteins and do not contain a functional 2A protease. In 
the case of the cardiovirus, encephalomyocarditis (EMC), a 2A protein is present; but it is 
unrelated to the proteases from entero- and rhino- viruses and has no proteolytic activity. The 
primary co-translational cleavage that separates the structural from the non-structural proteins in 
EMC is between 2A and 2B, not at the N-terminus of 2A as in polio. The protein responsible 
for this cleavage remains to be identified and as yet there is no evidence that a viral protein is 
involved. The 3C protein of EMC is a protease and has been shown to cleave at least 9 bonds 
in the polyprotein. These include the bond between the leader protein and VPO and the VP1/2A 
site, cleaved by 2A in polio (Palmenberg and Parks,1989). As with the other picomaviruses, 
the mechanism by which the final maturation cleavage of VPO is carried out remains to be 
established.
In the aphthovirus, foot and mouth disease virus (FMDV) the 2A protein is absent and 
in its place is found a 16 amino acid peptide. The primary cleavage takes place at the 
N-terminus of 2B; but as with EMC the protease responsible has not been identified. One 
proposal is that the event is autocatalytic and is dependent on sequences at either side of the 
scissile bond (Krausslich and Wimmer,1988). Ryan et al. (1991) go further to propose that
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the cleavage is catalysed by a 19 amino acid peptide spanning the 2A region of the FMDV 
polyprotein. Although this cannot be ruled out, perhaps more likely is the possibility that the 
19 amino acid sequence contains a conserved structural domain that is cleaved by a host 
protease in a similar way to the HA protein of influenza (section 2.1). The removal of the 
leader protein from the FMDV polyprotein, on the other hand, does appear to be an 
autocatalytic event with the leader protein itself being the protease. Interestingly, it has been 
suggested that the L protein of FMDV, like the 2A protease of poliovirus, is responsible for the 
cleavage of the p220 eIF4 protein and the resulting shut off of host cell protein synthesis 
(Devaney et a/., 1988).
The substrate specificities and classification of the picomavirus proteases will be 
discussed later in chapters 1 and 2 respectively.
2.3 POSITIVE STRAND RNA PLANT VIRUSES
A group of positive strand RNA viruses including the como-, poty and nepo viruses 
have very similar genome organisations to the picomaviruses and employ similar strategies 
with regards to polyprotein processing (Wellink and van Kammen,1988; Riechmann et al.,
1992). The comovirus, cowpea mosaic virus (CPMV), and the potyvirus, tobacco etch virus
I
(TEV), have been particularly well studied and will be described here.
CPMV has a bipartite genome consisting of 2 positive strands of RNA termed B-RNA 
and M-RNA. Each has a 3-kDa protein, VPg, covalently attached to its 5' end, a poly(A) tail at 
its 3' end and contains a single, large open reading frame that is translated to give a 
polyprotein. The M-RNA codes for the capsid proteins, whilst the B-RNA codes for the 
non-structural proteins (Wellink et a/., 1989). It is the non-structural polyprotein that is similar 
in organisation to the picomaviruses and the 24-kDa sequence in the corresponding position to 
3C contains the proteolytic activity (fig. 12a). Sequence alignments reveal that the 24-kDa 
protein is homologous to the 3C proteases of picomaviruses (Argos et a/.,1984). The 24-kDa 
protein is responsible for 6 cleavages in the viral polyprotein, 2 in the M-protein and 4 in the 
B-protein. Whilst the separation of the non-structural B-proteins only requires the 24-kDa 
protein, complete processing of the M-protein also requires the 32-kDa non-stmctural protein 
(Vos et a/., 1988). The 32-kDa protein is not thought to be a protease, but instead appears to
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act as a cofactor in a similar fashion to 3D of polio (section 2.2).
TEV has a positive strand RNA genome of around 10 000 bases that includes a single
open reading frame with the potential to code for a.. 350-kDa polyprotein and has a 6-kDa viral
protein attached to its 5' end (Dougherty and Carrington, 1988).
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Fig. 12 Polyproteins of Plant Viruses
Schematic diagrams showing the organisation of the poiyproteins from (a) cow pea mosaic 
virus (CPMV) and (b) tobacco etch virus (TEV). The proteases are shaded and the filled arrows 
indicate the scissile bonds cleaved by the 24K and NIa proteases. The TEV 35K and HC-Pro 
proteases carry out autocatalytic cleavages at their C-termini.
The organisation of the polyprotein is similar to that of the picomaviruses and is shown in 
fig.l2b. It is processed by 3 distinct proteases, all of which are believed to be virus encoded 
and are termed NIa, HC-Pro and 35-kDa proteins. NIa is a 49-kDa multifunctional protein, 
with its C-terminal 241 amino acids containing the protease activity (Dougherty and 
Parks, 1991). The N-terminal 189 amino acids are thought to be required for RNA replication 
and it has been proposed that NIa is cleaved in vivo to give 21-kDa and 27-kDa proteins. The 
NIa protein would appear, therefore, to be equivalent to 3BC in the picomavims poiyproteins 
(fig.ll). The C-terminal domain of NIa is related to the 3C proteases and catalyses the 
cleavages at 5 sites in the TEV polyprotein. It has an extended substrate specificity recognising 
at least 7 amino acids (Dougherty and Parks, 1989).
The 87-kDa N-terminal portion of the TEV polyprotein is removed by an autocatalytic 
event and is then further processed to give a 35-kDa protein and the 52-kDa HC-Pro. The 
HC-Pro domain of the 87-kDa protein is responsible for the initial cleavage, whilst the 35-kDa 
N-terminal domain is thought to carry out the second cleavage at its C-terminus (Camngton et
41
a/., 1990; Verchot et al., 1991).
2.4JCOGAV0RUSESAN3DFLAVIV1RUSES
The toga- and flaviviruses are enveloped animal viruses containing a single positive 
strand RNA genome that is encapsidated by a viral protein shell. They have in common their 
ability to replicate in and be transmitted by arthropods such as the mosquito. The Togaviridae 
comprises 2 genera, namely the alpha- and rubiviruses whilst the Flaviviridae includes the 
flavi- and pestiviruses (Schlesinger and Schlesinger,1990). Proteolytic processing of the 
poiyproteins of the alphaviruses, Sindbis and Semliki Forest virus (SFV), the flavivirus, 
yellow fever virus (YFV) and the pestivirus, bovine viral diarrhoea virus (BVDV) have all been 
shown to require virally encoded proteases and will be discussed in turn below. It is likely, 
however, that proteolytic processing is involved in the replication of all the members of the 
Toga- and Flaviviridae (Krausslich and Wimmer,1988).
Alphaviruses - Sindbis Virus,
The alphavirus, Sindbis, is by far the best characterised of the Toga- and Flaviviridae in 
terms of its processing. It has an 11 700 base RNA genome that is capped and polyadenylated 
and the organisation of the genome is shown in fig, 13. It codes for 3 poiyproteins, p230 and 
p250 which include the non-structural proteins and are translated directly from the genomic 
RNA and pi 30 which comprises the structural proteins and is translated from subgenomic 
mRNA. p230 and p250 are translated from the same initiation codon and in most cases 
translation is terminated at an opal codon just downstream from the nsP3 gene to give the p230 
polyprotein. The p250 polyprotein which includes nsP4 results from read through of the 
termination codon (Strauss et nl.,1984). The non-structural poiyproteins p230 and p250 are 
cleaved by the virus encoded protease nsP2 to give nsPl, nsP2, nsP3 and nsP4. Although 
nsp2 carries out the processing, the other non-structural proteins are able to influence the order 
in which the different sites are cleaved. The regulation of processing is achieved by different 
affinities of the nsP2 protein for the 3 cleavage sites. It has been shown that whilst all nsP2 
containing poiyproteins are able to cleave the nsPl-nsP2 site in trans, the nsp2-nsP3 bond can 
only be cleaved if the nsPl protein has first been removed. Trans cleavages at the nsP3-nsP4 
site can only be carried out by nsP2 if nsP3 is attached to its C-terminus (de Groot et at.,
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1990). This would explain why nsP4 is present at early times of infection, but that late in 
infection nsP3-nsP4 accumulates as a result of incomplete processing. It has been proposed 
that nsP4, the polymerase, is responsible for the synthesis of minus strand RNA early in 
infection. Four hours post infection this synthesis is switched off and the subgenomic RNA is 
synthesised, possibly by nsP3-nsP4. Thus in the case of the sindbis virus, the order in which 
the non-structural proteins are cleaved appears to play an important regulatory role in the lytic 
cycle of the virus (de Groot et a/., 1990).
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Fig. 13 Sindbis Virus Genome and Polyprotein Organisation
A schematic diagram showing the Sindbis virus genome and the organisation of the 
poyproteins containing the non-structural and structural proteins. The poiyproteins 
coding for the nonstructural proteins (p230 and p250) are translated directly from the 
positive strand RNA genome while the structural proteins (pl30) are translated from 
sub-genomic RNA. The nsP2 protease is shaded and its cleavage sites are indicated 
by the filled arrows. The capsid protein (C) carries out an autocatalytic cleavage at
its C-terminus. Question marks indicate sites thought to be cleaved by cellular 
proteases.
The structural proteins of sindbis are also separated by proteases and the first event is 
the removal of the N-terminal capsid protein. This is an autocatalytic event, with the active site 
residues being identified as His141, Asp163 and Ser2j5 in the capsid protein (Hahn and 
Strauss,1990). The structure of the C-terminal, protease-containing domain of the protein has 
been successfully elucidated by X-Ray crystallography and comparisons with cellular enzymes 
have confirmed that it is a chymotrypsin-like serine protease (Choi et a/., 1991). This is in 
keeping with the fact that it cleaves on the C-terminal side of a tryptophan residue which has 
been shown to remain in the active site cleft after catalysis. This led Choi et al. (1991) to
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propose that the cleaved capsid protein is devoid of activity after the single autoprocessing 
events. This, however, conflicts with the observation that mutants which fail to cleave the 
capsid protein can be complemented by mutant viruses of a different phenotype, 
suggesting that trans cleavages are possible (Scupham et a/,,1977). In any case, after 
cleavage, the capsid protein forms an icosahedral shell round the viral RNA and adopts a 
structural role. The protein binds to the RNA, probably through sequences in its N-terminal 
half, outwith the protease domain (Choi et a/.,1991). Removal of the capsid protein exposes 
an N-terminal signal sequence in the PE2 glycoprotein which isjesponsible for the insertion of 
the polyprotein in the endoplasmic reticulum. The remainder of the processing events of the 
structural proteins are thought to be carried out by cellular proteases. The last of these, the 
maturation cleavage of the membrane glycoprotein PE2 to give E2 and E3, appears to be very 
similar to the cleavage of the influenza HA protein described in section 2.1 (Strauss et 
a/., 1987).
Flaviviruses - Yellow Fever Virus.
Processing in the flavivirus poiyproteins is not as well understood as in the 
alphaviruses; but nevertheless yellow fever virus (YFV) and dengue virus (DEN) have been 
shown to code for their own proteases. YFV contains a single strand positive RNA genome of 
about 11 000 bases which includes a single open reading frame encoding a 350-kDa 
polyprotein (fig. 14a). The 3 structural proteins; the capsid protein (C), glycoprotein 
precursor (PrM) and the envelope protein (E), are located at the N-terminal end of the 
polyprotein and are thought to be separated by a cellular signalase located at the endoplasmic 
reticulum. Unlike the capsid proteins of the alphaviruses, the capsid protein of YFV does not 
appear to be a protease; but instead is thought to contain a membrane-spanning anchor at its 
C-terminal end. This would be consistent with its cleavage by a signalase (Strauss et a/., 
1987). The PrM glycoprotein undergoes a maturation cleavage late in infection in a similar 
way to PE2 from sindbis and HA from influenza. The processing of the non-structural 
proteins of YFV requires the N-terminal third of the 70-kDa viral protein NS3 (Chambers et 
a/., 1991). This confirms the prediction that NS3 is a protease made on the basis of sequence 
comparisons with cellular and viral proteases (Bazan and Fletterick,1989). The NS3 protein is
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Fig. 14 Poiyproteins of the Flavi- and Pesti-viruses
Schematic diagrams showing the organisation of the poiyproteins in (a) Yellow Fever virus (YFV) 
and (b) Bovine Viral Diarrhoea virus (BVDV). The YFV NS3 protease and the BVDV p20 and p80 
proteases are shaded and filled arrows indicate the scissile bonds cleaved by NS3 and p80. p20 carries 
out a single cleavage at its own C-terminus. A question mark indicates where cleavages are thought 
to be carried out by cellular proteases.
required for the separation of all the non-structural proteins of YFV with the exception of 
NSl-NS2a and NS4a-NS4b which are thought to be cleaved by cellular enzymes. The 
separation of the non-structural proteins also requires NS2 to be present either in cis, at the 
N-terminus of the NS3 protease, or in trans. It is postulated that the requirement for NS2 may 
be a means of regulating the processing at the different sites (Chambers et a/., 1991). 
Pestiviruses - Bovine Viral Diarrhoea Virus.
Pestiviruses are responsible for a range of infections in cattle and sheep and contain a 
positive strand RNA genome of 12-13 000 bases with a single open reading frame coding for a 
polyprotein of around 350-kDa. The structural proteins are located at the N-terminal end of the 
polyprotein as can be seen in fig. 14b. Sequence comparisons between the bovine viral 
diarrhoea virus (BVDV) polyprotein and other viral and cellular proteases revealed that 2 of the 
BVDV proteins contain putative protease sequences, the capsid protein (p20) and the 
non-structural p80 protein (Bazan and Fletterick,1989; Gorbalenya et a/.,1989). Subsequent 
biochemical analysis has revealed that both these proteins are proteases responsible for the 
processing of the BVDV polyprotein. The p20 capsid protein is responsible for its own 
removal from the other structural proteins in a similar way to the capsid protein of Sindbis 
(Wiskerchen et a/., 1991). The p80 protein carries out the 5 cleavages that separate the 
non-structural proteins including 2 cis cleavages that serve to cut itself out of the polyprotein. 
The remaining cleavages can be carried out in trans by p8O, but the separation of p58-p75
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appears to require an additional cofactor. Although the predicted catalytic triad is at the 
N-terminus of p80, the first two thirds of the protein are required for activity indicating that the 
central region of the molecule must play some role, perhaps a structural one (Wiskerchen and 
Collet, 1991). The remaining 4 processing sites, separating the structural proteins are thought 
to be cleaved by cellular proteases in a similar way to that discussed for YFV.
2.5 RETROVIRUSES
The retroviruses are enveloped single strand RNA viruses that are responsible for a 
wide range of serious diseases including acute T-cell leukemia and AIDS. They utilise both 
cellular and virus encoded proteases to separate their poiyproteins into functional units. They 
are unusual amongst the RNA viruses in that the viral protease is not required for assembly of 
the virus particles; but instead carries out maturation cleavages after the virions have been 
formed. Nevertheless, activity of the retroviral proteases is a prerequisite for the formation of 
infectious particles.
On entering the cell the viral genome is reverse transcribed by a retroviral enzyme and 
the resulting double stranded DNA is integrated into the host cell chromosome. The genome 
organisations of the different retroviruses vary slightly and have been extensively reviewed, 
but basically speaking they all consist of 3 major genetic elements that are arranged in order 
5'-gag-pol-env-3. The gag genes code for the structural proteins present in the nuclear capsid, 
whilst pol codes for the viral replication enzymes and env for the membrane associated 
glycoproteins. Some of the retroviruses also include oncogenes in their genomes. For 
example Rous Sarcoma Virus (RSV) carries the src gene, but the oncogene products are not 
proteolytically processed so will not be included in this discussion. Following integration into 
the host cell chromosome, the viral DNA lies silent until the cell is activated. Upon activation 
the viral genes are transcribed by the host cell machinery to give at least 2 species of mRNA. 
The first is produced by splicing and contains the env gene which codes for the viral 
glycoproteins. These are translated as a polyprotein and are processed by cellular proteases in 
the Golgi apparatus as the polyprotein is transported to the plasma membrane. The second 
species approximates to the viral RNA and is translated to give 2 poiyproteins termed gag and 
gag-pol (or gag-pro-pol). The gag and gag-pol poiyproteins are translated from the same
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initiation codon and whilst termination usually occurs downstream from gag, occasional read 
through takes place as a result of suppression of the termination codon. Alternatively in some 
retroviruses a frame shift is required to produce the gag-pol polyprotein (reviewed in 
Oroszlan,1989; Krausslich and Wimmer,1988).
The processing of the gag and gag-pol poiyproteins is carried out by virally encoded 
enzymes and, as mentioned above, takes place after the assembly of the virion. Although 
protease genes have been identified in most of the retroviruses, the enzymes from Rous 
sarcoma virus (RSV), avian myeloblastosis virus (AMV) and human immunodeficiency virus 
types 1 and 2 (HIV-1, HIV-2) are by far the best characterised. For this reason, this 
discussion will concentrate on these viruses, with particular emphasis being put on recent work 
on the HIV-1 and HIV-2 proteases. Many of the properties attributed to these proteins are also 
likely to apply to their counterparts in other retroviruses.
Avian Sarcoma Leukosis Viruses.
The avian sarcoma leukosis viruses (ASLV), RSV and AMV are highly related and 
share the same genome organisation, with the protease (PR) being located at the C-terminal end 
of the gag polyprotein (fig.15). The inclusion of the protease in the nucleocapsid polyprotein 
is unusual among the retroviruses and means that in RSV and AMV the protease is synthesised 
in the same amounts as the structural proteins.
Fig. 15 RSV Poiyproteins
Schematic diagram showing the organisation of the gag and gag-pol poiyproteins of Rous sarcoma 
virus (RSV). The gag-pol is produced by readthrough of the stop codon at the end of the gag 
reading frame. The arrows indicate the txinds cleaved by the retroviral protease (shaded).
This property has proved useful and has enabled the purification of the p 15 putative protease 
from virus particles. Incubation of the purified protein with precursor proteins in vitro 
provided proof that pl5 was indeed the enzyme responsible for the proteolytic processing (von 
der Helm, 1977). The pl5 proteases from RSV and AMV have been expressed in E.Coli,
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purified and crystallised in the presence and absence of substrate analogues (Miller et 
al., 1989a; Leis et al., 1989; Foundling et al., 1989). Elucidation of the crystal structures 
revealed that the enzymes are active as dimers and are members of the aspartic class of 
proteases. The requirement for dimerisation raises a number of interesting questions with 
regards to activation of the retroviral proteases during the lytic cycle. Most of the aspects of 
dimerisation will be discussed for the HIV proteases (see below); but the unusual genome 
organisation of RSV and AMV gives them some distinct properties that merit consideration. 
The inclusion of the protease coding region in the gag gene mean that it is present in a 
potentially active form in both the gag and gag-pol poiyproteins. The gag and gag-pol 
poiyproteins are synthesised at a ratio of 20:1, with the gag-pol protein being produced as the 
result of a ribosomal frame shift. Recently it has been shown that a recombinant AMV, 
producing only the gag-pol protein, is not capable of assembly thus revealing that the gag 
protein must direct the assembly process (Craven et al., 1991). Furthermore no proteolytic 
processing of the gag-pol proteins took place. It appears that only protease present at the 
C-terminus of the gag protein is active and that gag-pol must be cleaved in trans. Presumably 
the presence of pol in cis with the protease must put some conformational restraints on the 
protease that prevent activity (Stewart and Vogt, 1991). It has also been shown that in the 
absence of proteolysis the viral reverse transcriptase (RT) is not active (Craven et al., 1991). 
Human Immunodeficiency Viruses - HIV-1 and HIV-2.
As mentioned previously the proteases of HIV-1 and HIV-2 have been subject to a 
great deal of attention recently and, as a consequence, our understanding of retroviral proteases 
in general has been greatly increased. The organisation of the gag and gag-pol poiyproteins is 
given in fig.16. In the case of HIV-1 and -2, the gag-pol protein is translated as a result of 
ribosomal frame shifting. Unlike RSV and AMV, the protease is not part of the gag 
polyprotein, but instead is at the N-terminal end of the pol region of gag-pol. This means that 
the protease is expressed at much lower levels and so cannot be isolated from virus particles in 
significant amounts. Nevertheless the 99 amino acid sequence making up an 11-kDa protein at 
the N-terminal end of pol has been shown to be the protease in HIV-1 and -2. It is responsible 
for 8 specific cleavages, 4 in each of the gag and pol regions. The primary processing event is
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at the N-terminus of the protease sequence at (p6-PR) and since different sites are cleaved at 
different rates the cleavages may be carried out sequentially (Fitzgerald and Springer, 1991). 
Much sequence and structural homology exists between the 99 amino acid HIV-1 and -2 
proteases and other retroviral proteases (Weber, 1989).
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Fig. 16 HIV Poiyproteins
Schematic diagram showing the organisation of the HIV gag and gag-pol poiyproteins. Gag-pol 
results from a frameshift event within gag p6 resulting in p6*. The arrows indicate the bonds 
cleaved by the HIV protease (shaded).
The HIV proteases have been successfully cloned in an active form in E.Coli and when 
expressed as fusion proteins are capable of carrying out autocatalytic processing (Graves et 
al., 1988; Louis et a/.,1991). Perhaps of even more significance is the fact that the HIV-1 
protease has been chemically synthesised in its entirety by solid phase peptide synthesis and the 
resulting protein is active (Schneider and Kent, 1988). The E.Coli expressed and chemically 
synthesised HTV-1 proteases have been successfully crystallised both alone and in the presence 
of a range of peptide substrates and inhibitors (Miller et al., 1989b; Navia et a/.,1989; 
Wlodawer et al., 1989). The enzymes are functional as dimers and have structures which are 
remarkably similar to the RSV protease (fig.17). Prominent features include the active site 
cleft which contains the active site aspartyl residues and the 2 flaps which partially cover it. 
These flaps are mobile with a 7A° shift taking place following the binding of the substrate 
(Gustchina and Weber, 1990). The presence of the flaps may account for the extended 
substrate specificity of the protease. Complete mutagenesis of the HIV-1 protease has been 
carried out with each residue being substituted by at least one alternative amino acid and the 
mutants have been assessed for protease activity. The resulting activity profile is given in 
Fig.18 (Loeb et <3/., 1989). In addition to the active site residues a number of other residues 
are required for activity. These are involved in substrate binding or dimer formation or, 
alternatively, are essential for the structural integrity of the protein.
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RSV HIV-1
Fig.17. Structure of the RSV and HIV-1 proteases.
The above are a-carbon structures of the RSV and HIV-1 proteases were taken from Miller et al. 
(1989a) and Navia et al. (1989) respectively. The side views show the active site clefts and flaps. 
The N- and C- termini of the proteases are marked and one of the subunits is shown in bold in each 
case.
Fig. 18 Mutagenesis of the HIV-1 protease.
(b)
Complete mutagenesis of the HIV-1 protease was 
carried out by Loeb et al. (1989) and the diagrams 
in (a) and (b) were both taken from their paper.
Site directed mutagenesis was used to change each 
residue of the enzyme to at least one other amino 
acid. The activity profile in (a) shows the effects 
of non-conservative amino acid substitutions at 
each position. The mutattonally sensitive 
domains have been superimposed on the crystal 
structure of one subunit of the HIV-1 protease in 
(b). The diagram has been rotated 90° in an anti­
clockwise direction when compared to the structure 
in fig. 17 above.
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The ultimate aim of the structural studies of viral proteases is to understand their 
mechanisms so that specific inhibitors can be designed and with HIV-1 and -2 such 
compounds have already been prepared. Two main approaches to developing inhibitors have 
been taken, with the conventional way being the use of peptide substrate analogues. This has 
resulted in the production of a number of successful inhibitors including compounds that 
inhibit the HIV proteases in the nanomolar range (Roberts et a/,,1990). These compounds do 
not inhibit cellular aspartic proteases and so provide a good starting point for the production of 
an anti-viral agent. The second approach taken to find an inhibitor of the HIV proteases makes 
use of computer modelling and X-ray crystallography data bases to search for compounds that 
will fit into the substrate binding pocket of the enzymes. DesJarlais et al. (1990) used this 
method to predict that the antipsychotic agent, haloperidol, would bind to the HIV-1 protease 
and found that it was indeed an effective inhibitor. Haloperidol was found to inhibit in the 
micromolar range, concentrations which unfortunately would be too toxic for human use, but 
nevertheless, demonstrate the potential of this approach for searching for viral inhibitors.
Much interest surrounds the control of the protease activity in HIV and other 
retroviruses. The observations that chemically synthesised HIV protease is able to cleave 
peptide substrates and that fusion proteins purified from E.Coli undergo autocatalytic 
processing suggests that no other elements are required for activity (Schneider and Kent, 1988; 
Boutelje et a/., 1990). In vivo, however, it is imperative that cleavage of the gag and gag-pol 
poiyproteins does not take place until after the virus particles are assembled. Premature 
processing would prevent the assembly of the virus particles as has been shown by the 
preparation of recombinant HIV-1 coding for a protease that is more active than the wild type 
enzyme (Krausslich, 1991). So what controls the activity of the HIV proteases in the cell? 
Perhaps a natural inhibitor of the enzymes is present in the cytoplasm or alternatively the 
dimerisation could hold the key to the activation step. It has been proposed that in the cell the 
gag-pol poiyproteins are too distal for dimerisation to take place, but that fusion to the plasma 
membrane through the N-terminal, myristylated MA protein serves to concentrate the 
poiyproteins. This significantly increases the occurence of dimerisation. Furthermore, if
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dimerisation takes place before budding of the viral particles from the plasma membrane then 
the protease would autocatalytically cleave at its N-terminus releasing itself and the other pol 
proteins into the cytoplasm (Navia et a/., 1*989). As a result the activity would be diluted in the 
cell. In contrast if dimerisation and autocatalysis take place after formation of the virus 
particles then the enzyme will be confined within the virion and a rapid cascade of maturation 
cleavages can ensue. In any case the role of dimerisation in the activation of retroviral 
proteases is necessary, if not sufficient, and so provides another target for a specific antiviral 
agent. The potential for such an approach has been explored by.Babe et aL (1991) who 
prepared heterodimers of the HIV-1 and -2 proteases. Although the 2 enzymes are highly 
related both structurally and functionally they differ in 55% of their residues, a factor that is 
reflected in their surprisingly diverse isoelectric points; 9.9 for HIV-1 and 5.1 for HIV-2 
(Gustchina and Weber, 1991). The mixing of purified HIV-1 and -2 was found to cause severe 
inhibition of HTV protease activity against synthetic peptide substrates. Heterodimer formation 
was confirmed by the appearance of a species with intermediate isoelectric point. The 
inhibition results from the fact that around 50% of the amino acids from the HTV proteases 
reside at the dimer interface and some of these differ between types -1 and -2 (Wlodawer et 
a/.,1989). As a result the inter-subunit contacts are not formed correctly and enzyme activity is 
lost. Babe et al. (1991) suggest further that heterodimers can be used to identify the critical 
contact points between monomers. The design of specific compounds that bind to these could 
lead to inhibition of dimer formation and thus to the production of an effective antiviral agent.
In addition to examining the processing of the viral poiyproteins, some effort has also 
been devoted to searching for cellular substrates of the HIV proteases. Tomasselli et al. (1991) 
have shown that calcium free calmodulin is a substrate for both the HIV-1 and -2 proteases, but 
that the processing sites are different in the 2 enzymes. Shoeman et al. (1991) have 
concentrated on the intermediate filaments and shown that vimentin, a-actinin, a-spectrin, 
tropomysin, and actin are all cleaved at specific points by the HIV-1 protease. In a separate 
report fibronectin is described as a non-viral substrate for the HIV-1 protease (Oswald and von 
der Helm,1991). It could be that these in vitro observations are artifacts and not relevant to the 
situation in vivo. The possibility cannot be ruled out, however, that some of these proteins are
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cleaved by the HIV proteases in vivo. Indeed the cleavage of specific cellular proteins could be 
an integral part of the virus lytic cycle and it has been proposed that cleavages of specific 
cytoskeletal proteins might be necessary for the release of virions from the cell (Shoeman et al,, 
1991). Alternatively the cleavage of host proteins may simply be toxic to the cell and this point 
emphasises the need for strict control of viral protease activity within the cell.
2.6 DNA VIRUSES
Unlike the RNA viruses discussed above, DNA viruses produce monocistronic RNA 
and do not synthesise poiyproteins, so they only require proteases for the processing or 
activation of precursor proteins to mature functional units. Proteolytic processing has been 
shown to play an essential role in the life cycles of a number of DNA viruses including the 
adeno-, vaccinia, African swine fever and herpes simplex viruses. The adenovirus protease is 
by far the best characterised of this group; but even it falls a long way behind its picorna- and 
retroviral counterparts. The adenoviruses have already been described in section 1, with 
particular reference being made to its protease in section 1.8. The Ad2 protease will also be 
discussed in more detail in the introductions to chapters 1-3, so for the moment attention will 
be turned to the other DNA viruses.
Vaccinia Virus,
Vaccinia virus is a member of the Poxviridae and is a large, enveloped virus containing 
a linear double strand DNA genome, comprising 192 000 base pairs and with the potential to 
code for at least 200 proteins (Sarov and Jolik,1972; Goebel et a/.,1990).
Proteolytic processing of 3 of the vaccinia virus structural proteins, termed P4a, P4b 
and P25K is essential for the production of mature infectious virions. Limited proteolysis 
gives rise to the mature core proteins which are referred to as 4a, 4b and 25K respectively.
2 T 1 r
25K 4a 23K L 4b
P25K P4a P4b
Fig. 19 Proteolysis of Vaccinia Virus Proteins
Schematic diagrams of the 3 Vaccinia virus proteins known to be proteolytically processed. 
Arrows indicate the sites of cleavage by an as yet unidentified protease.
Pulse labelling experiments using vaccinia infected cells have revealed that there is a
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considerable lag period between the synthesis of the core protein precursors and their 
processing. VanSlyke et a/.(1991a) suggest that this could be because the precursor proteins 
must assemble in immature virus particles before the cleavages can take place. Alternatively, 
they propose that post translational modifications of either the substrates, or the protease, may 
be required late in infection before processing can proceed.
Recent work identifying the cleavage sites in P4a, P4b and P25K will be discussed in 
chapter 1 (VanSlyke et a/.,1991a,b). As yet, it is not known whether the protease responsible 
for the maturation cleavages in vaccinia is of viral or cellular origin.
African Swine Fever Virus.
African swine fever virus (ASF), like vaccinia, is a large enveloped double stranded 
DNA virus with a genome of 170 (XX) base pairs that is responsible for a highly contagious 
disease in domestic pigs. Three of the ASF structural proteins; pi50, p37 and p34 are derived 
from larger precursor proteins termed pp220, pp60 and pp39. The protease responsible for 
these processing events has not been identified, but the cleavage sites have been established 
and will be discussed in chapter 1 (Lopez-Otin et a/., 1989).
In the future it will be interesting to learn if any other, less abundant vaccinia and ASF 
viral proteins are also proteolytically processed and to establish the role of the proteolysis in 
their lytic cycles.
Herpes Simplex Virus.
Herpes simplex virus 1 (HSV-1) is a member of the double strand DNA Herpesviridae 
family and is an icosahedral enveloped virus (Booy et al.,1991). A 45-kDa HSV-1 protein, 
referred to as ICP35, has been shown to be proteolytically processed to give a 39-kDa protein 
via several intermediates (Braun et a/., 1984). ICP35 is present in large amounts in 
intermediate capsids, but only trace amounts of the protein are present in mature virions. This 
has given rise to the suggestion that it plays an important role in virion assembly and DNA 
encapsidation. In a recent report by Preston et al. (1992) a second viral protein, termed UL26, 
has been shown to be essential for the proteolysis of ICP35. A temperature sensitive mutant, 
tsl201, defective in UL26, was isolated and shown to be unable to process ICP35 or to 
assemble mature virions at the non-permissive temperatures. The suggestion, therefore, is that
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the 70-kDa UL26 protein is a protease, although the possibility that the UL26 plays an indirect
role in the processing of ICP35 has not been ruled out. In any case, the tsl201 mutant could 
prove invaluable in future studies aimed at further characterising the role of proteolysis in
HSV-1 infections.
The above discussion serves to emphasise the essential role that proteases play in the
infectious cycles of many viruses. Further consideration will be given to the substrate 
specificities and mechanisms of the virus encoded enzymes in chapters 1 and 2 respectively. 
The focal point of this thesis, however, is the adenovirus protease and its further 
characterisation should prove useful from several viewpoints. It is hoped that it will enable us 
to learn more about the role that the protease and its substrates play in the complicated life cycle 
of the adenovims described in section 1. It is also envisaged that the work might be extended to 
provide a model for the study of proteolysis in other viruses and in particular in the DNA 
viruses (section 2.6). In the longer term, the information obtained could provide the basis for 
future studies aimed at designing and synthesising specific inhibitors as anti-viral agents.
In an attempt to achieve these aims the substrate specificity, mechanism, expression and 
control of the adenovirus protease will be investigated in chapters 1-4 respectively. Chapter 4 
will also consider the role that the processing of the adenovirus pre-terminal protein plays in the 
replicative cycle of the virus.
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CHAPTER 1
Substrate Specificity of the Ad2 Protease
INTRODUCTION
The aim of this chapter is to define the precise requirements for the substrate specificity 
of the adenovirus protease. Based on observations by Tremblay et al. (1983) it has become 
generally accepted that the enzyme cleaves at glycine, alanine containing bonds (for reviews 
see: Krausslich and Wimmer,1988; Kay and Dunn,1990). Such a broad specificity, however, 
is not in keeping with the enzyme's selective nature and the recent identification of a 
glycine-methionine cleavage site in the 11-kDa protein (Weber and Anderson, 1988) suggests 
that a rigorous examination of the Ad2 protease specificity is required. A definition of the 
enzyme's substrate specificity would not only enable the prediction of cleavage sites in all the 
viral substrates, but would also provide a basis for the rational design of specific inhibitors as 
anti-viral agents. Before examining the specificities of other virus encoded proteases a 
description of the established and predicted processing sites in the Ad2 proteins will be given. 
SUBSTRATES OF THE AD2 PROTEASE
The Ad2 protease has previously been shown to cleave 6 viral proteins, namely, the 
pTP, nia, pVI, pVII, pVIII and an 11-kDa protein (Anderson et a/.,1973; Boudin et a/.,1980; 
Tremblay et a/.,1983; Weber and Anderson,1988). The cleavage sites in pVI and pVII were 
identified by N-terminal sequencing of the mature proteins, VI and VII (Akusjarvi and 
Persson,1981; Sung et a/.,1983). The amino acids in the vicinity of the cleavage sites in pVI 
and pVn are shown in fig.1.1 along with the Berger and Schechter (1970) notation for 
referring to the surrounding residues. It was the similarity between these 2 sites that led 
Tremblay et al. (1983) to propose that the protease has a specificity for G-A bonds. Sequence 
analysis of the other Ad2 protease substrates gave rise to the proposal that A-G bonds might 
also be substrates of the enzyme (Tremblay et </., 1983; Hannan et a/.,1983).
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Fig. 1.1 Cleavage Sites in pVI and pVII
Alignment of the established pVI and pVII cleavage sites showing the Berger and 
Schechter (1970) notation for identifying surrounding residues. The arrow shows the 
cleaved bond and conserved residues are boxed.
Smart and Stillman (1982), on the other hand, took a broader look at the pVI and pVH sites 
and proposed that a similar sequence in the pTP (MTGG-V) could be the target for the action of 
the protease. More recently one of the cleavage sites in the 11-kDa protein, that gives rise to 
the basic core protein, mu, has been shown to be LTGG-M leading to the suggestion that the 
protease recognises the sequence GG-X (Weber and Anderson, 1988). The possibility that the 
protease cleaves other viral or cellular proteins cannot be ruled out and indeed, there have been 
suggestions that the L4 100-kDa protein and the 23-kDa protease itself, are processed (Morin 
and Boulanger, 1986; Chatterjee and Hint, 1987). Table 1.1 lists all the proposed and 
established cleavage sites of the Ad2 protease.
Protein Putative Cleavage
Site
Status
pVI MSGG-AFSW Confirmed
pVII MFGG-AKKR Confirmed
pvm TNSG-AQLA
LAAG-AAQD
QIGG-AGRS
pTP MTGG-VFQL
ma YTGG-FEVP
11-kDa LTGG- MRRA Confirmed
23-kDa VNTA- GRET
Table 1.1 Putative Cleavage sites in Adenovirus Proteins 
This table lists sequences in Ad2 proteins which have been proposed as cleavage 
sites for the virus encoded protease. Confirmed indicates that the sites have been 
established by sequencing studies. For references see text.
Consider next, the substrate specificities of other viral proteases.
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SUBSTRATE SPECIFICITIES OF VIRAL PROTEASES
As discussed in section 2 of the main introduction, virus encoded proteases of restricted 
specificity play essential roles in the infectious cycles of many viruses. Much time has been 
devoted to investigating the substrate specificities of these enzymes, with the design of 
substrate analogues as inhibitors being the ultimate goal. In the first instance the cleavage sites 
in the natural substrates must be identified by N-temunal sequencing of the mature proteins. 
The precise requirements for specificity can then be established by varying the amino acids at 
each of the positions around the scissile bond and measuring the effects of the changes on the 
efficiency of processing. This can be achieved either by mutagenesis of the sites in the natural 
substrates or through the use of a range of synthetic peptides. Information is available 
concerning the bonds cleaved by the picoma-,como-, poty-, toga-, flavi- and retroviral 
proteases. Cleavage sites in proteins from the DNA vimses vaccinia and African swine fever 
have also been identified by N-terminal sequencing. Selected aspects of the substrate 
specificities of the proteases from these viruses will be considered in turn.
PJcomaviruscs
The picomaviruses code for 2 proteases, termed 2A and 3C, which are required for the 
separation of their poiyproteins into functional units (see p35). The 2A and 3C cleavage sites 
in the poliovirus polyprotein are shown in fig.1.2.
Although the poliovirus polyprotein contains eight Y-G bonds, only two of these are 
cleaved by its 2A protease. This indicates that elements of the enzyme's specificity must reside 
outside the P! and P% positions. Comparisons of the VP1-2A cleavage sites from different
strains of the polio-, rhino- and coxsackie viruses reveal that in each case the P2 position is 
occupied by a threonine and that one of the hydrophobic amino acids methionine, leucine, 
isoleucine or valine is present at P4. These observations led to the suggestion that the P2 and 
P4 residues provide additional detenuinants of specificity (Lee and Wimmer,1988).
Mutagenesis at the P2 position, however, has shown that its identity is not important for cis 
cleavages at the VP 1-2A site in the poliovirus polyprotein (Hellen et a/.,1990). Skem et al. 
(1991) investigated the specificity of the rhinovirus 2A protease by mutating the VP1-2A site
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and studying the effects of the mutations on cis cleavages. Their studies indicate that 
processing is not affected by substitutions at Pb but that all mutations altering the glycine at
Pj' abolish the cleavage at the VP1-2A site. Changes of the amino acids at the P2 -P9' 
positions were also found to reduce the efficiency of the processing at the VP1-2A site. These 
residues, however, are equivalent to amino acids 2-9 of the 2A protease and so may be 
structurally or functionally important to the enzyme. Finally, there is a suggestion that the 2A 
proteases have different specificities for cis and trans cleavages, with the requirements for the 
trans cleavages being more stringent (Alvey et a/., 1991). The elucidation of the specificities of 
the 2A proteases in trans, would be of particular interest in view of their role in the cleavage of 
p220 during the shut-off of host cell protein synthesis.
VP0-VP3 T L P R L Q
▼
G L P V M IP
VPS'VPl Q K A L A Q — G L G Q M 3 C
2A-2B E E A M E Q — G I T N Y
2B-2C P Y V I K Q - G D S W L
2C-3A M E A L F Q - G P L Q Y 3C3A-3B L F A G H Q - G A Y T G
3B-3C R T A K V Q - G P G F D
3C-3D Y F T Q S Q — G E I Q V
VPP2A K D I: T T Y — G F G H Q 2A3C-3CD' K L L D T Y — G I N L P
Fig. 1.2 Cleavage sites in the poliovirus polyprotein.
The sites in the poliovims type 1 (Mahoney) polyprotein cleaved by the 3CD, 3C and 
2A proteases are listed above. The location of each site in the polyprotein is given in 
italics on the left (see fig.l la, p37) and the protease responsible for each cleavage is 
shown on the right in bold. The arrow indicates the cleaved bond in each case. The 
figure is adapted from Hellene/ al.(\9S9).
In contrast to the 2A proteases, the substrate specificities of the polio- and rhinovirus 
3C proteases have been extensively studied using both synthetic peptide substrates and site 
directed mutagenesis of the natural cleavage sites in the viral poiyproteins. The 8 sites cleaved 
by the poliovirus 3C protease are listed in fig. 1.2 and it can be seen that in each case a Q-G 
bond is cleaved. Indeed, the poliovirus 3C protease has stringent requirements at Pj^ and Pj' 
with the only permissible substitutions being those of serine and alanine at Pj' (Kean et
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a/., 1990). In addition to the P1 and PJ positions, the amino acid at P4 has been shown to 
have a strong influence on the efficiency of cleavage, with alanine and valine being the 
preferred residues at P4 for the polio- and rhinovirus 3C proteases respectively (Blair and 
Semler,1991; Cordingley et a/.,1990). The 3CD site in the poliovirus polyprotein, which is 
processed slowly in vivo and in vitro, contains a threonine at P4. Pallai et al. (1989)
demonstrated that a single substitution of the threonine with an alanine at P4 in the 3CD site 
increased its processing by 2 orders of magnitude, further demonstrating the importance of the 
P4 position in defining the substrate specificity of the 3C protease. It has also been shown that 
the bonds cleaved most efficiently by the polio- and rhinovirus 3C proteases have a proline 
residue in the P2' position (Pallai et a/., 1989; Cordingley et a/., 1989). This has led to 
speculation that the 3C proteases recognises Q-G bonds at (--turns and to the proposal that the 
preferred substrate specificity of the poliovirus 3C protease is AXXQ-GP. The strong 
influence of the neighbouring residues on the rates of cleavage of the different Q-G bonds in 
the poliovirus polyprotein is thought to be important in the regulation of gene expression 
during the infectious cycle (Hellen et a/., 1989).
Positive Strand RNA Plant Viruses
The genome organisations and proteolytic processing strategies of the como-, poty- and 
nepoviruses are very similar to those of the picomaviruses (see p39). It is perhaps not 
surprising, then, that the substrate specificities of the cowpea mosaic vims (CPMV), 24-kDa 
protease and the potyvims NIa proteases closely resemble those of the picomavims 3C
proteases.
The CPMV 24-kDa protease preferentially cleaves at Q-G bonds, but serine, alanine 
and methionine are also acceptable at Pj', albeit with a processing efficiency that is markedly 
reduced (Vos et a/., 1988). Indeed the cleavage of the Q-M bond in the M-RNA polyprotein 
does not take place unless a 32-kDa virus protein is also present. The 24-kDa protease also 
shows a preference for alanine at P4 and alanine or proline residues are found at P2 in all of the 
enzymes natural cleavage sites (Wellink and van Kammen,1988).
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The cleavage sites of the NIa and HC-Pro proteases from 4 different potyviruses are 
shown in fig. 1.3. The NIa proteases have a 3C-like specificity recognising Q-G, Q-S or Q-A 
bonds (Riechmann et al.,1992). There is a strong preference for a hydrophobic residue at the 
P4 position, with valine being present at P4 in all the sites in the tobacco vein mottling virus
(TVMV) polyprotein. The P6 position is occupied by a glutamate residues in all the NIa 
cleavage sites in the tobacco etch virus (TEV) polyprotein.
HC-Pro-50K
TEV
YNVG-GM
TVMV
YKVG-GL
PPV
YLVG-GL
PVY
YRVG-GV
50K-71K EIIYTQ-S NNVRFQ-S QAVQHQ-S YEVRHQ-S
71K-6K ETIYLQ-S EAVRFQ-S ECVHHQ-T QFVHHQ-A
6K-NIa EPVYFQ-G EQVKFQ-G EEVVHQ-G ETVSHQ-G
NIa-58K ELVYSQ-G DLVRTG-G EFVYTQ-S DVWEQ-A
58K-30K ENLYFQ-S ETVRFQ-S NWVHQ-A YEVHHQ-A
Fig.1.3 The HC-Pro and NIa cleavage sites from four potyviruses.
The amino acids surrounding the HC-Pro and NIa cleavage sites from tobacco etch virus (TEV), 
tobacco vein mottling virus (TVMV), plum pox virus (PPV) and potato virus Y (PVY) are listed. 
The positions of the cleavages are on the left in italics and refer to the nomenclature of the TEV 
polyprotein (see fig. 12). The HC-Pro and 50K proteins are separated by HC-Pro, whilst all the 
other cleavages are catalysed by the NIa protease. In each case the position of the cleavage site is 
indicated by a dash (-). The figure has been adapted from Reichmanne/ a/.(l 992).
The consensus sequences for the TVMV and TEV NIa substrates have been described as 
XXVR(K)Q-G(S) and EXXYXQ-G(S) respectively (Dougherty and Carrington,1988). 
Interestingly, it has been noted that the TVMV and TEV NIa proteases are unable to recognise 
each other’s cleavage sites. Parks and Dougherty (1991) took advantage of this observation 
and constructed hybrids of the TEV/TVMV NIa proteases in an attempt to identify the substrate 
binding regions in the enzymes. Their work suggests that the amino acids required for 
substrate binding are contained within the C-terminal 150 amino acids of NIa.
No investigations have been carried out to identify the substrate specificities of the 
potyvirus HC-Pro proteases, which carry out single processing events at their own C-termini. 
It is noted, however, that the HC-Pro cleavage sites identified in 5 different potyviruses are all 
of the form VG-GL(M,V) and are surrounded by additional hydrophobic amino acids 
(fig.1.3).
Togaviruses and Flaviviruses
Alphaviruses are members of the Togaviridae family and code for an nsP2 protease,
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which is required for the separation of their non-structural proteins (see p41). The 3 nsP2 
cleavage sites have been identified in 6 different alphavirus poiyproteins and are listed in 
fig. 1.4 (Strauss and Strauss,1990). The proteases appear to show a strong preference for a 
glycine residue at the P2 position and amino acids with small side chains are present in the Pj
and Pj' positions, except at the nsP3-nsP4 cleavage site, where the Pj' residue is a tyrosine in 
all cases. Interestingly, it has been noted that the nsP2-nsP3 bond is cleaved first, followed by 
the nsPl-nsP2 one and that the nsP3-nsP4 link is processed very slowly.
SIN MID S F RR ONN VEE
nsPl-nsP2 DIGA^ RAGA-G HAGA-G RAGA-G RAGA-G EAGA-G
nsP2-NsP3 GVVA-A TAGC—A TAGC-A TAGC-A RAGC-A EAGC-A
NsP3-NsP4 GWG-Y RAGA-Y RAGA-Y RAGA-Y RAGG-Y DAGA-Y
Fig. 1.4 The nsP2 cleavage sites from six alphavirus poiyproteins
Sequences around the cleavage sites in the non-structural proteins from Sindbis virus (SIN), 
Middelburg virus (MID), Semiliki Forest virus (SF), Ross River virus 0RR), O'Nyong-nyong virus 
(ONN) and Venezuelan equine encephalitis virus (VEE). The locations of the cleavage sites are given 
in italics on the left (see fig. 13) and the scissile bond is marked by a dash in each case. This figure is 
adapted from Strauss and Strauss (1990).
Thus the presence of the bulky tyrosine residue at Pj' in the latter could serve to regulate the 
complete processing of nsP3 and nsP4 (de Groot et a/., 1990). Mutagenesis studies have 
shown that a glycine at P2 is a key element in defining the nsP2 substrate specificity. Changes
of glycine to valine at P2 were found to eliminate processing, whilst glycine to alanine 
substitutions reduced it significantly (Shirako and Strauss, 1990).
The capsid proteins of the alphaviruses have also been shown to possess protease 
activity. The sindbis virus 26-kDa capsid protein cleaves at the carboxyl side of the tryptophan 
residue at its own C-terminus, in keeping with its classification as a chymotrypsin-like serine 
protease (Choi etal. ,1991).
The flavivirus NS3 proteases are required for the processing of the virus non-structural 
proteins (see p43). The 4 cleavage sites have been identified in several different flaviviruses 
including the Yellow fever and Dengue viruses. In every case the Pj and P2 positions are 
occupied by one of the basic amino acids, arginine or lysine. It has also been noted that amino 
acids with short side chains are frequently present at the other positions in the vicinity of the
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NS3 cleavage sites (Strauss etal.,V)%T, Preugschat et al, 1991; Chambers et al.,1991).
The substrate requirements of the pestivirus proteases, typified by the BVDV p20 and
p80 proteins remain to be elucidated (Wiskerchen and Collet, 1991).
RewMue.
The cleavage sites of the HIV-1 and RSV proteases in their respective gag-pol 
poiyproteins are listed in fig.1.5. A striking feature of the sites Is the variety of amino acids
present at the various positions, including Pj and Pf.
RS.V Sites HIV-1 Sites
1 G T S C V - H C G T A 1 V S Q N V - p I V Q N
2 P P V V G - S G L V P 2 K A R V L - A E A M S
3 P V V A M — P V V I K 3 T A T I M - M Q R G N
4 I A A A M - S S A I Q 4 R P G N F - L Q S R P
5 Q P L I M - A V V N R 5 V S F N F - P Q I T L
6 P P A V S - L A M T M 6 C T L N F - p I S P I
7 R A T V L - T V A L H 7 G A Q T F - V V N L R
8 T F Q A V - P L R E A 8 I R K I L - F L D G I
9 S P L F A - G I S D W
Fig. 1.5a Retroviral Protease Cleavage Sites
The sequences of the cleavage sites in the Rous sarcoma virus (RSV) and human immunodeficiency 
virus type 1 (HIV-1) gag-pol poiyproteins. The numbers in bold to the left of each sequence refer to 
the positions of the sites in the respective poiyproteins with site 1 being nearest to the N-terminus of 
the polyprotein in each case (see fig.15 and 16 for the organisation of the RSV and HIV poiyproteins).
The scissile bonds are indicated by a dash and the figure is adapted from Hellene/ a/X1989).
The F-P bond occurs at a number of junctions in retroviral poiyproteins, but other residues
acceptable in the Pi and Pj' positions include L-F, M-S, M-M, L-A and F-L. Although the
principle features of substrate recognition are similar for the RSV, HIV-1 and HTV-2 proteases,
there are subtle differences in the requirements at each of the positions (Tomasselli et a/.,1990;
Tozser et a/., 1991). This means that they are not able to hydrolyse the same sets of substrates.
Most investigations have concentrated on the specificity of the HIV-1 protease and so it 
will be described here. Darke et al. (1988) showed that the HIV-1 protease was able to 
recognise and cleave the 7 amino acid peptide, SQNV-PIV, corresponding to the gag MA-CA 
site (see fig. 16, p48). This observation revealed that the primary determinants of specificity 
for the HIV-1 protease must reside within the P4 to P3 positions. It was noted, however, that
the Km value for the cleavage was high, at 9mM and so the possibility exists that there are 
secondary binding sites, perhaps in the flaps of the retroviral protease (see fig.17. p49).
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Alternatively, the high Km value could reflect the inability of the peptide substrate to adopt the 
optimal conformation for a significant proportion of time (Kay and Dunn, 1990).
The importance of each of the P4-P3' positions in defining the substrate specificity of 
the HIV-1 protease has been examined extensively using peptide substrates. Studies by 
Konvalinka et al. (1990) revealed that hydrophobic or aromatic residues are preferred at Pi and
the branched amino acids isoleucine and leucine at P2. They found, however, that there are
few restrictions at the P3 position and suggest that P3 can be occupied by any amino acid
except proline. Margolin et al. (1990) examined the P2' position and showed that peptides
containing isoleucine, leucine or alanine at P2' all bound to the HIV-1 protease with equal
efficiencies. The hydrolysis of the peptide containing isoleucine at P2', however, was 20 fold 
greater than for the alanine and leucine containing peptides. The processing of peptides 
containing glycine, phenylalanine and tryptophan at P2' was negligible and these results led
Margolin et al. (1990) to conclude that small hydrophobic amino acids are preferred at P2'.
Other investigators have considered the effects of the mutagenesis of cleavage sites in 
the HTV-1 gag-pol polyprotein and have shown that hydrophobic residues are preferred at Pj
and P/, that neither proline nor the branched chain amino acids, valine and isoleucine, are
acceptable at Px and that small apolar amino acids are preferred at P2 (Billich and
Winkler, 1991). Finally, Poorman et al. (1991) have examined all the known cleavage sites of 
the HTV-1 and HTV-2 proteases in viral and cellular proteins. The results of their studies are 
shown in table 1.2 and in accord with the peptide and mutagenesis studies reveal that the 
HIV-1 protease shows the highest stringency for particular amino acids at P2, Pj and P2’,
whilst the HIV-2 protease also has high stringency at Pf. The lack of a primary consensus 
sequence to describe the substrate specificities of the HIV proteases serves to emphasise the 
importance of secondary structure in substrate recognition by viral proteases.
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P4 P3 P2 Pi Pi’ P * p • P3 P4’
0.8 1.2 1.8 3.3 1.2 4.1 1.1 0.8
HIV-l
P (2.8) Q (6.5) V (6.2) F (13.7) F (4.5) E (15.0) F (3.2) F (3.2)
A (2.4) 
S (2.2)
E (4.7) N (5.3)
I (5.33)
L (6.8)
M (4.2) 
N (2.8)
Y (2.2)
P (4.0)
Y (3.5)
M (2.2)
Q(6.5) T (2.9)
E (2.1) 
R (2.1)
P (2.8) 
M (2.2) 
S (2.2)
1.8 15 2.4 2.5 3.0 3.5 05 1.4
P (4.6) Q(11.1) N(11.4) M (8.9) P (9.1) E (13.5) Q(3.1) F (7.5)
HIV-2 G (3.5) 
R (3.5) 
Y (3.0) 
S(2.6)
F (2.7) 
E(2.5)
1(3.7)
V (2.7) 
A (2.6)
E (2.5)
L (7.4)
Y (3.0)
F (2.7)
M (5.4) 
F (5.1)
A (5.0) 
T(3.4)
Q(8.4) 
y (2.7)
E (2.5) Q (5.7) 
P (2.3)
Table 1.2 Specificity of the HIV-1 and HIV-2 proteases
This table has been adapted from Poormane/ a/.(1991) who carried out statistical analysis of the 
substrate preferences of the HIV-1 and 2 proteases using all the known cellular and viral protein 
substrates. The positions of the amino acids around the scissile bonds are labelled in bold according 
to Berger and Schecter (1970) and the selectivity parameter for each position is given in italics. The 
parameter was calculated by Poorman et a/(1991) and a high value indicates a specific requirement 
by the protease at that position. The amino acids occuring most frequently at each position are 
listed along with their relative abundances.
DNAVrus. Proteases
Apart from the adenovirus, cleavage sites have been identified in proteins from 2 other 
DNA viruses; African swine fever (ASF) and vaccinia virus (VV).
Lopez-Otin et aL (1989) reported that 3 of the ASF structural proteins, pl50, p37 and 
p34 are derived from the precursors pp220, pp60 and pp39 respectively (fig.l.6a). They 
showed further that the proteolytic cleavage, in each case, was at a GG-X sequence and 
proposed that GG-X is an important recognition sequence for the processing of a variety of 
viral and cellular proteins including those of the adenovirus.
Proteolytic maturation of at least 3 major structural proteins, p4a, p4b and p25K, is 
essential for the formation of infectious vaccinia progeny. In each of the substrates, the Pj and
P2 positions are occupied by glycine and alanine residues, respectively (VanSlyke,1991a and 
b) and the cleavage sites are listed in fig.l.6b.
Summary
In conclusion the substrate specificities of viral proteases are complex and varied with 
secondary structure apparently playing an important part. This is particularly obvious for the
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(a) ASF pp220 I L G G A D E
pp60 R V G G - A A L
pp39 F N G G — G D K
(b) VV P25K V I A G A K S
P4b I S A G - A R N
P4a (l) F Y A G - S P E
P4a (2) T N A G - T C T
Fig. 1.6 Cleavage sites in DNA virus proteins
The amino acids surrounding the established cleavage sites in African swine 
fever virus (ASF) and vaccinia virus (VV) proteins. The data is from 
Lopez-Otin et a/.(1989) and Vanslyke et a/(1991b) and the precursor proteins 
are included in italics. There are two cleavage sites in P4a with site 1 being 
nearest to the N-terminus (see fig. 19). The position of the cleavage sites is 
marked by the filled arrow.
picomavirus 3C and retrovirus proteases where it has been suggested that the scissile bonds 
form part of a p-turn (Kay and Dunn, 1990).
The number of residues permitted in the Pj and Pj' positions is considerably greater 
than for most cellular proteases; but there tends to be more stringency at other positions further 
away from the scissile bond and in particular at P2 and P4. Several of the proteases including 
those from alphaviruses, flaviviruses, the vaccinia and African swine fever viruses have been 
shown to have specific requirements at both Pj and P2.
Finally, Wellink and van Kammen (1988) made the observation that the N-termini 
created by viral proteases usually consist of glycine, serine, alanine, threonine, methionine or 
valine, giving them a longer half life in the cytoplasm than proteins with one of the other amino 
acids at their N-terminus. They go further to suggest that viruses employ proteases with a 
specificity towards these amino acids at the Pj' position and note that nsP4 of the alphaviruses 
is an exception to this, having a tyrosine at its N-terminus and also, perhaps significantly, a 
short half life.
The proposal in this chapter is to synthesise a series of peptides based on the known 
cleavage sites of pVI and pVII, to test them as substrates for the adenovirus protease and in so 
doing to define its substrate specificity. Using this information and that already available on 
the molecular weights of the precursor and mature proteins it should be possible to predict the 
cleavage sites in all the known Ad2 substrates.
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METHODS
1
All peptides were synthesised by solid phase fluorenyl methoxycarbonyl (Fmoc) 
polyamide chemistry using a semi-automated CRB Pepsynthesiser II essentially as described 
by Atherton et al. (1988). The peptides synthesised were: MFGGAKKR, MFGGAKK, 
FGGAKK, MSGGAFSW, SGGAFSW, VSGGAFSW, YSGGAFSW, QSGGAFSW, 
ESGGAFSW, LSGGAFSW, TSGGAFSW, ISGGAFSW, MSAGAFSW, MSGSAFSW, 
MSGGGFSW, MSGAGFSW, MSGSGFSW, LAGGFRHR, MRGFGVTR, MGGRGRHL, 
SLGGGVPW and MTGGVFQ.
1.1 Reagent Grade and Purifiaation,
The success of this technique is absolutely dependent on high grade solvents free from 
aqueous or amine contaminants. The Pepsyn KA resin (0.01 mequivalents/g), the Fmoc 
pentafluorophenyl ester derivatives of amino acids, o-rings and filters required for the 
synthesis were all obtained from CRB. Dimethylformamide (DMF), ethanol, methanol, 
acetonitrile and trifluoroacetic acid (TFA) were all HPLC grade from Rathbum. Piperidine was 
purchased from Applied Biosystems and ethanedithiol, anisole, tertiary amyl alcohol, 
4-dimethylaminopyridine (DMAP) and 1-Hydroxybenzotriazole (HOBt) from Aldrich. Diethyl 
ether and acetic acid were obtained from May and Baker and the molecular sieves, 
difluoronitrobenzene (FDNB) and other chemicals from Sigma. All solid reagents were stored 
in the presence of silica gel as recommended by the manufacturers.
The primary solvent for peptide synthesis, DMF, was routinely tested for 
dimethylamine using FDNB. This is because dimethylamine can react with the Fmoc 
protecting groups and so when present, even at low concentrations, it can significantly reduce 
the final yield of peptide.
FDNB test,for DMF
The DMF was tested by adding an equal volume of the solvent to 5mM FDNB in 
ethanol and leaving it at room temperature for 20 minutes. An absorbance of < 0.15 at 391nm, 
when read against a blank of 2.5mM FDNB in ethanol, indicated that the solvent was of a high
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enough grade to use. Tests were carried out in duplicate.
Where the absorbance reading for the FDNB test was greater than 0.15, 50g of heat 
activated molecular sieves (2 hours at 200°C) were added to 2.5 litres of DMF and left at room 
temperature for several weeks, after which the DMF was retested and if satisfactory was ready 
for use. After storage on molecular sieves it is essential to filter the solvent through a 0.2 p 
nylon filter (Anachem) to prevent blockage of the lines and valves in the Pepsynthesiser 
machine.
1.2 Svnthesis of Peptides
0.5 - lg of Pepsyn KA resin was washed with 3x 5ml of DMF to remove fines. The 
resin was packed into a 5 x 1cm column and the plunger adjusted to 2mm above the resin to 
remove air bubbles. All the lines in the Pepsynthesiser were flushed out with fresh DMF and 
the flow through was checked using the FDNB test. Bottles A and B were filled with DMF 
and 20% v/v piperidine in DMF, respectively, and the lines primed. The main lines were given 
a final 10 minute wash with DMF to remove all traces of piperidine and the flow rate was 
adjusted to 3 ml/minute before the reaction column was attached.
The synthesis of the peptides was controlled in part by CRB software using an Apple 
lie computer. The programme used is shown in fig.1.7 alongside a schematic diagram to 
represent the various steps in the cycle. The first step in each cycle was a 15 minute wash with 
DMF, carried out prior to the addition of derivatised amino acids in 5 fold excess. Each amino 
acid was recirculated for 1.5 hours through the column to allow complete coupling. This was 
verified by removing a few grains of resin and carrying out a ninhydrin or isatin test (see 1.3 
below). The excess amino acids were then washed from the column and all the lines, prior to 
the deprotection step. This involved flowing 20% v/v piperidine in DMF (Reagent B) through 
the column for 5-10 minutes to remove the Fmoc protection group from the last amino acid 
attached. The lines were then washed for 15 minutes with DMF and the cycle was repeated 
until the N-terminal amino acid had been coupled and deprotected. The Fmoc amino acids used 
were all pentafluorophenyl esters except for serine and threonine, in which cases 
3,4-dihyd^o-4-oxob^nzotriazin-3-yl (Dhbt) esters were used. On the addition of these amino 
acids the resin immediately turned bright yellow, but as coupling progressed the colour
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disappeared, giving an internal indicator for coupling and so making the ninhydrin test
redundant.
Programme
1 FLOW A
FLOW B 
FLOW A 
CALL
2
3
4
5
6
7
8
9
10
(load amino acid)
RECIRCULATE
FLOW S
FLOW A
RECIRCULATE
FLOW A
CALL
Time (minutes)
5
10
15
150
1
5
0.5
5
11 REPEAT
Internal reference amino acidSide chains protected as acid
OCH2CO-Nle-NH-Polyamide resin
Base-labile Fmoc 
protecting group
Ammo acids activated 
as anhydrides or active
esters
Range of reversible 
linkage agents
Polar polyamide support 
solvated by dipolar aprotic
solvents
Fig. 1.7 Solid Phase Peptide Synthesis
The CRB programme used to control the synthesis of the peptides on an Apple lie computer, is shown in (a) 
above. Amino acids were applied to the column at step 4 and allowed to recirculate round the reaction column 
for 1.5 hours (step 5). Steps 6-9 are wash steps and step 2 involves application of 20% v/v piperidine in DMF 
to the column in order to deprotect the N-terminal amino acid. The chemistry of Fmoc polyamide synthesis is 
shown in (b) and the diagram was taken from Atherton and Sheppard (1989).
All the derivatised amino acids were dissolved in a minimum volume of DMF (1- 3ml) 
and centrifuged for 3 minutes in a microcentrifuge to remove any insoluble particles that might 
block the valves in the machine. The coupling of the first amino acid to the resin was always 
done in the presence of the catalyst DMAP. 6- 12mg DMAP were taken up in 200pl of DMF 
and loaded onto the column through the injection syringe immediately before the amino acid. 
Another step taken to ensure complete coupling of the first residue was to put it on twice, 
omitting the deprotection step in the first cycle. DMAP was used for both couplings. 
Generally speaking the subsequent amino acids were added in the absence of a catalyst unless
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the ninhydrin test indicated incomplete coupling (see 1.3 below). In this case the deprotection 
step was bypassed and the catalyst HOBt (6-12mg taken up in 2(X)pl of DMF) was added to the 
column immeditely before a second application of the same amino acid.
After the deprotection of the N-terminal amino acid was complete, the resin was 
removed from the column and placed in a sintered glass funnel. It was washed sequentially 
with 10ml each of DMF, t-amyl alcohol, glacial acetic acid and t-amyl alcohol followed by 3x 
10ml diethyl ether. The resin was placed in a vacuum desiccator for 2-20 hours to dry before 
being cleaved (see 1.4 below).
1.3 Monitoring of the Svnthesis
(a) Spcctrophotometric Analysis.
The continuous flow synthesis and the uv-absorbing Fmoc protecting groups enable the 
acylation and deprotection reactions to be monitored spectrophotometrically. An 8pl flow cell 
was inserted and aligned in a Cecil spectrophotometer attached immediately downstream from 
the reaction column. The synthesis was monitored at a wavelength of 320nm and a full scale 
deflection of 2. The changes in absorbance were recorded on a chart recorder (chart speed 
0. Imm/minute). A typical trace for a single coupling/ deprotection cycle of an amino acid is 
shown in fig.l.8a. Occasionally the deprotection was slow, as indicated by a more gradual 
decline of the trailing edge of the deprotection peak (fig.l.Sb).
Fig. 1.8 Monitoring of
Peptide Synthesis.
Traces (a) and (b) each show the 
coupling of a single Fmoc amino acid 
during solid phase peptide synthesis. 
The synthesis was monitored at 320nm 
with a full scale deflection of 2 
absorbance units and a chart speed of 
0.1 mm/minute. Trace (a) shows a 
normal deprotection peak, whilst trace 
(b) shows a shorter, broader peak. The 
latter indicates that the N-terminus of 
the peptide is not readily accessible to 
the solvent.
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This gave an indication that the Fmoc groups were less accessible to solvent than normal and 
was a warning that the next amino acid might be difficult to couple. In such a case the catalyst, 
HOBt, was added before the next amino acid. The size of the deprotection peak should be 
constant throughout each synthesis and a decrease in size is usually indicative of a problem. 
When a significant decrease in the area of the deprotection peak was observed the synthesis 
was continued but samples of resin were taken for subsequent hydrolysis and amino acid 
analysis. Reagents were also rechecked to try and establish the root of the problem.
(b) NinhycWn (Kaiser) Test.
Small samples of resin (5mg) were removed at the end of the DMF wash following 
deprotection and 1 hour after the addition of each amino acid. Both samples were washed with 
2ml each of DMF, t-amyl alcohol, acetic acid and t-amyl alcohol, followed by 4ml of diethyl 
ether. The washing was carried out in sintered glass filters under suction. A few beads of 
resin were transferred to eppendorff tubes and 2 drops each of (a) 10% ninhydrin in ethanol,
(b) phenol - 80g in 20ml ethanol and (c) 20pM potassium cyanide in 98% pyridine were added. 
The tubes were placed in a heating block set at 120°C for 5 minutes. A strong blue colour was 
indicative that amino groups were present, whilst a brown/yellow colour showed complete 
coupling. When the N-terminal residue was aspartic acid, asparagine, glutamine or glycine a 
weaker blue or brown colour was observed (Kaiser et a/.,1970). In the case of the secondary 
amino acid proline the isatin colour test gives a stronger reaction with the imino group and so 
was preferred.
(c) IsaiinTett.
Small samples of resin were taken, washed and dried as described for the ninhydrin test 
and a few beads were placed in an eppendorff tube along with 2 drops of isatin solution 
(prepared by adding 2g of isatin to 60ml of benzyl alcohol, stirring for 2 hours, filtering and 
adding 2.5g of t-butoxycarbonyl phenylalanine to 50ml of the filtrate). The beads were heated 
for 5 minutes at lOO>C and then allowed to cool before being washed x3 with acetone. A blue/ 
red colour indicated the presence of imino or amino groups, whilst colourless beads were 
indicative of complete coupling (Atherton and Sheppard,1989).
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1.4 Cleavage ofTeptideafromResin.
The final cleavage step is a critical factor in determining the overall yield and the quality 
of the peptide. The cleavage of the peptide from the solid support is combined with the 
removal of the side chain protecting groups. The 4-hydroxy-methyl-phenoxy-acetate linkage 
between the peptide and the resin is acid sensitive and is readily cleaved by 95% TFA in 1-2 
hours. The cations generated in this reaction are relatively stable and have the potential to react 
with electron-rich amino acid side chains such as those of methionine, cysteine, tryptophan and 
tyrosine. This risk can be reduced by the inclusion of carbonium scavengers in the cleavage 
mixture. The cleavage of peptides including arginine in their sequence will be dealt with 
separately since the side chain of arginine is protected by the 4-Methoxy-2,3,6- 
trimethylbenzene sulphonyl- group (Mtr), which is removed at a much slower rate than the 
other side chain protecting groups.
(a) Cl<aivage of Non-arginineConuining Peptides.
0.5g of resin were placed in a clean, dry round bottom flask along with 19ml of TFA, 
0.5ml of anisole and 0.5ml of ethanedithiol. The flask was attached to the base of a rotary 
evaporator in the vertical position (no vacuum) which was switched on at low speed to provide 
mixing. l(X)pl samples were taken from the flask after 12 and 3 hours and dried down in
eppendorff tubes under a stream of N2. The residue was taken up in lOOp of ddH2O and
extracted with 2x 2(X)>.il of diethyl ether. The aqueous layer was filtered through a 0.2p nylon 
filter before being analysed by reverse phase chromatography on an HPLC (see below). A
typical trace showing the cleavage of the octapeptide MSGGAFSW can be seen in fig.l.9a.
Time (minutes)
Fig. 1.9a Cleavage of MSGGAFSW 
HPLC traces showing the cleavage of the 
peptide MSGGAFSW as an example of a 
non-arginine containing peptide. The full scale 
deflection was set at 0.5 and the solvent 
gradient was from 0 to 50% B in 20 minutes 
as described in method 1.5 below. The traces 
on the left and right show the amounts of 
peptide cleaved from the resin after 1 and 3 
hours exposure to TFA respectively (see 
method 1.4 above).
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After 3 hours, or when the cleavage reaction appeared to be complete, the resin was filtered 
through a sintered glass funnel and washed with 2x lOml of TFA. The TFA was removed by 
rotary evaporation under vacuum at 40°C leaving an oily residue. 30ml of diethyl ether were 
added to the residue and after the suspension had settled the ether was decanted or pipetted off. 
This process was repeated 4 or 5 times until all traces of ethanedithiol and anisole had been 
removed. After the final wash the last traces of ether were removed by rotary evaporation and 
at this stage the peptides appeared as a dry, white coat on the inside of the flask. The peptides 
were taken up in 5ml of water and lyophilised.
(b) Cleavage of Arginine Containing Peptides.
0.5g of resin were placed in a flask along with 19ml TFA, 333mg of redistilled phenol,
333pl ' of ethanedithiol and 333pl of anisole. The flask was mixed and samples were taken each 
hour and analysed by reverse phase HPLC, as described for the non-arginine containing 
peptides. The removal of arginine can be readily monitored by HPLC as can be seen from the 
traces in fig. 1.9b showing the cleavage of peptide, LAGGFRHR. The peptide with both 
arginines protected by Mtr groups is the most hydrophobic, followed by the peptide with a
single Mtr group, with the fully deprotected peptide having the shortest retention time.
HPLC traces showing the cleavage of the peptide LAGGFRHR, as an example of a peptide that contains 
two arginines. The peak labelled 1 corresponds to the peptide with both arginines protected with Mtr 
groups, whilst peaks 2 and 3 are the peptides with a single Mtr group (one of the arginine residues protected). 
Peak 4 is the fully deprotected peptide. The details of the cleavage and HPLC are given in methods 1.4b and 
1.5 respectively.
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Generally it was found that peptides with a single arginine were fully deprotected after 6 hours, 
those with 2 arginines required 10 hours whilst those with 3 or 4 arginines required to be left 
overnight in TFA. After deprotection was complete the drying and ether extraction steps were 
identical to those described for non-arginine containing peptides. Fmoc pentafluorophenyl 
ester derivatives of arginine are now available with different side chain protection groups that 
are more susceptible to acid hydrolysis (Ramage and Green, 1987). The use of such a 
derivative would remove some of the problems associated with arginine containing peptides. 
1.5 Monitoring of Cleavage of Peptides by Reverse P^hase HPLC.
A reverse phase column (18 p bondpack-Anachem) was used to monitor the cleavages 
of the peptides synthesised. The solvents used were (A) 0.1% TFA in ddl^O and (B) 0.1% 
TFA in acetonitrile. The peptides were separated on a solvent gradient from 0 to 50% B in 20 
minutes and then from 50 to 1^%o B in 10 minutes. The flow rate was 1ml per minute and the 
flow through was monitored at 226 nm on a full scale deflection of 0.5. The peak areas were 
determined where necessary using a Shimadzu C-RIB integrator.
2 ANALYSIS AND PURIFICATION QF .PEPTIDES.
2.1 Purification of Peptides By Reverse Phase FPLC.
Peptides were purified on a reversed phase column (PepRPC, Pharmacia) using the 
solvents (A) 0.1% TFA in ddH^0 and (B) 0.1% TFA in acetonitrile. The solvent gradients 
used varied depending on the retention times of the individual peptides, but all went from 0 to 
100% B in 35 minutes. Typically 5mg of peptide was loaded onto the column per run. Most 
of the peptides were taken up at a concentration of 5 mg/ml in ddH2O, but in the case of some 
of the more acidic peptides O.1M ammonium bicarbonate was used to aid solubility. The full 
scale deflection was 2 and the flow through was monitored at 226nm. The flow rate was 
0.7ml/ minute, 0.7 ml fractions were collected and fractions corresponding to the peptide peaks 
were pooled and dried down by rotary evaporation. Peptides were washed with ether to 
remove residual TFA, dried, taken up in ddH2O and lyophilised as before. The compositions 
of all the peptides were confirmed using amino acid analysis.
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2.2 Amino Acid Analysis.
lOjonoles of each peptide were hydrolysed in 300|rl of 6M HCl for 5 hours at lO8°C. 
Hydrolysates were dried in vacuo, and amino acid analysis carried out using reverse phase 
HPLC and pre-column derivitisation with o-phthaldialdehyde (OPA). The method used was 
based on that described by Roth (1971).
The OPA reagent was prepared by dissolving lOmg of OPA (Sigma) in lOOpl 
p-mercaptoethanol, 5ml of 0.8M sodium borate pH 12.5 and 4ml of H2O and was stable for 3
days. The hydrolysed peptide was resuspended in 15pl of H2O, filtered and added to 30pl of 
OPA reagent, mixed and left for 90 seconds before injection onto an HPLC reverse phase 
column (Ultrasphere-ODS, Altex). Derivatised amino acids were separated using the gradient:
Time (minutes) %B
0 20
5.5 20
50 100
50.1 20
55 20
The buffers used were (A) O1M sodium acetate pH5.3 and (B) 90% methanol and the 
flow rate was 1ml per minute. The excitation and emission wavelengths were 340nm and 
450nm respectively and the full scale deflection was 0.5. Peak areas were determined using a 
Shimadzu C-RlB integrator and retention times were compared with those of standard amino 
acid mixtures. It is noted that tryptophan is destroyed by the hydrolysis procedure so cannot 
be detected using this method.
3 CELLS A^P ADENOVIRUS PRHARAW,N
3.1 Maintenance of HeLa C^e^lls Spinner and Monolayer Cultures.
HeLa cells were grown in suspension culture in S-MEM (GIBCO-BRL) with 5% 
newborn calf serum (Seralab) at 37°C to a density of 5 x 10° cells/ml. They were passaged 
every 3 to 4 days to give a cell concentration of 2 x 10° cells/ml.
Monolayer HeLa cultures were maintained in plastic 75cm° bottles (Sterilin) in 25ml
modified G-MEM (GIBCO-BRL) supplemented with 10% newborn calf serum (Seralab) in an
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atmosphere of 5% CO2 at 37°C. Cells were passaged every 3. to 4 days on reaching 
confluence as follows. Spent medium was poured off and the cells were washed with 5ml of 
Trypsin/EDTA. 5ml of fresh Trypsin/EDTA were added and left on the cells for 2 minutes or 
until cells started to come off the plastic. Trypsin/EDTA was poured off and the cells were 
resuspended in 10ml of MEM/10% calf serum. 2ml of the cell suspension were transferred to 
a new 75 cm3 bottle along with 25ml of MEM/10% calf serum and returned to 37°C.
Procedures for checking the viability of cells in tissue culture and storing them at -70°C 
are described by Freshney (1987).
3.2 Preparation of Adenovirus Type 2
6 litres of HeLa cells were grown in suspension culture, as above, to a density of 
3x103 cells per ml. The cells were centrifuged for 15 minutes at 2500rpm (15(X)g) in a Mistral 
6L centrifuge and then resuspended in 250ml of S-MEM prior to infection with 1ml of Ad2 
arcton extract (103 p.f.u./ml). Virus was allowed to absorb onto the cells in the absence of calf 
serum for 2 hours at 37OC after which the cells were made up to 6 litres with S-MEM and 
newborn calf serum was added to 2%. Cells were harvested at 72 hours post infection by 
centrifugation as before. The infected cell pellet was washed xl with cold phosphate buffered 
saline pH6.2 (PBS) and then resuspended in 48ml of lOmM Tris/HCl pH7. 12ml of the cell 
suspension and 10ml of trichloro-trifluoro-ethane (arcton) were added to each of four 50ml 
sterile centrifuge tubes and shaken for 30 minutes at 4°C using a mechanical shaker. Extracts 
were centrifuged at 2500rpm (800g) for 15 minutes at 4°C using an BBC CENTRA-3R bench 
top centrifuge. The top (aqueous) layer was removed and clarified by centrifugation at 
lOOOOpm (lOOOOg) for 30 minutes at 4°C using a JA17 rotor in a Beckman J2-21 centrifuge 
before being stored at -70°C. This fraction contained infectious virus and was used either as 
the seed for subsequent virus preparations or subjected to further purification as described 
below. The titre of the virus was determined by carrying out plaque assays as described by 
Freshney (1987).
3.3 Purification of Adenovirus Type 2.
Purified virus was obtained by fractionating the arcton extracts, prepared in 3.2 on
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caesium chloride density gradients as described previously by Russell and Blair (1977). 
Gradients were set up in 14cm3 ultraclear centrifuge tubes (Beckman) by pipetting 3ml of 2M 
CsCl, lOmM Tris/HCl pH7.5, ImM EDTA into each tube. This was gently underlayed with 
3ml of 3M CsCl, lOmM Tris/HCl pH7.5, ImM EDTA using a syringe to give a step gradient. 
The tubes were filled to about 3mm from the top by overlaying the caesium chloride with the 
arcton extract. Tubes were balanced and centrifuged in the sw40Ti rotor in a Beckman 
L8-55M ultracentrifuge for 2 hours at 30 OOrpm (10(X)00g) and 2(PC. The virus band was 
removed using a syringe (fig.l.lO). The virus was stored in 50% glycerol at -20°C. When
Fig. 1.10 Purification of Ad2
Diagram showing the position of the virus band after 
centrifugation of an arcton extract on a discontinuous 
CsCl gradient (method 3.3). The higher bands include 
empty virus particles and are referred to as top 
components.
----- Virus Band
highly purified virus was required the viral band was diluted 1:3 with lOmM Tris/HCl, ImM 
EDTA, pH7.5 and purified on a second CsCl gradient. This time a continuous gradient was 
prepared, from 5ml 3M CsCl and 5ml 2M CsCl, in each tube using a gradient maker. The 
CsCl gradients were overlayed with the diluted virus band and centrifuged for 18 ■ hours as 
before. The viral band was removed and stored as described above.
4 ASSESSMENT OF. . PEPTIDES AS SUBSTRATES . AND INHIBITORS
4.1 Preparation of Disrupted Virus
Disrupted, purified Ad2 was used as the source of protease in all the experiments 
described in this chapter. The purified virus band, prepared as described in method 3.3, was 
dialysed for 15 hours at 4°C against lOmM Tris/maleate, 20% glycerol, pH6.8 and then stored
in lOOpl aliquots at -70°C.
4.2 Assessment of Pepiides as Substrates of the A<22 Protease
5pg of each peptide (lmg/ml in 25mM phosphate, 0.2M NaCl, pH7) were incubated
with 5pl of disrupted purified virus for 0,1, 2, 5 and 12 hours at 37°C. Reactions were
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stopped by the addition of 0.1% TFA and the samples were filtered through 0.2p nylon filters 
prior to analysis by HPLC. Peptides were separated on a reverse phase column
(Ultrasphere-ODS, Altex) using a number of different gradients based on:
Time(minutes) %B
0 0
5 0
10 20
25 35
30 100
30.1 0
40 0
with the buffers being (A) 0.1% TFA and (B) 0.1% TFA in acetonitrile. The flow rate was 
1ml per minute and the full scale deflection was set at 0.5, for tryptophan containing peptides, 
or otherwise at 0.1. The flow through was monitored at 226nm.
In order to confirm that digestion had taken place and if so, to ascertain the point of 
cleavage, it was necessary to carry out amino acid analysis. 50pmoles of each peptide were 
incubated with 25pl of disrupted purified Ad2 at 37®C. Where digestion was evident, an 
incubation time giving about 50% digestion was chosen. Where preliminary analysis gave no 
indication of digestion, 12 hour incubation times were chosen. Samples were analysed by 
HPLC essentially as described above, but 1ml fractions were collected and the full scale 
deflection was set at 1-2. All the fractions were dried down and hydrolysed in preparation for 
amino acid analysis which was carried out as described in method 2.2.
4.3 Assessment of Peptides as Inhibitors of the Ad2 Protease
HeLa cells, infected with wild type Ad2, were labelled with 35S methionine for 2 hours 
at 48 hours post infection and harvested as described in the methods section of chapter 2. lOpl 
of the resulting cell extract were incubated with lOpl of each of the peptides (1 mg/ml) for 6 
hours at 37°C. Reactions were stopped by boiling and the samples were analysed by 
SDS-PAGE and autoradiography as described in chapter 2.
5 COMPUTER MODELLING AND SEARCHES
The structures of the peptides were simulated on the CHEM-X software package 
(Chemical Designs Ltd.) by energy-minimisation of random structures. The Staden
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programmes (Staden, 1986) were used to translate the Ad2 genome in the 6 different reading 
frames and to search for proteins containing the sequences M(L,I)XGG and M(L,I)XGXG. 
Programmes in the Wisconsin computing package were used to carry out hydrophobicity and 
secondary structure predictions of the adenovirus proteins (Devereux et f^Z.,1984).
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RESULTS
1 Peptide Substrates for Ad2 Protease
The initial aim of this section is to establish whether or not synthetic peptides can be
used as substrates for the adenovirus protease. Five peptides, based on the established 
cleavage sites in pVl and pVll, were synthesised and incubated for 1-12 hours with disrupted, 
purified Ad2 as the source of protease (table 1.3). The samples were analysed by reverse 
phase HPLC and fractions were collected for amino acid analysis.
The octapeptides MSGGAFSW (pVl) and MFGGAKKR (pVll) were both cleaved by 
the protease and amino acid analysis confirmed the GA bond to be the scissile one in each case.
Protein Peptide Cleaved
pVII
F G G - A K K 
MFGG-AKK 
MFGG-AKKR
No
Yes
Yes
pVI SGG-AFSW
MSGG-AFSW
No
Yes
Table 1.3 Minimum requirements for a synthetic peptide substrate 
The above table shows 5 peptides that were synthesised based on the Ad2 protease 
cleavage sites in pVI and pVII. The dash indicates the position of the scissile bond in 
the natural substrate and the column on the right indicates whether or not the peptides 
were cleaved by the protease in vitro.
ln contrast, the corresponding peptides lacking the P4 methionine, SGGAFSW and 
FGGAKK, were not cleaved by the protease. These results show that a minimum requirement 
for peptide substrates of the Ad2 protease is that 4 amino acids must be present on the 
N-terminal side of the cleaved bond. The specific cleavage of MFGGAKK at its GA bond 
indicates that the maximum number of amino acids required to the C-terminus of the scissile 
bond is 3 (table 1.3).
The FPLC profiles of the 1 hour digestions of MSGGAFSW and MFGGAKKR are 
shown in fig^H alongside the CHEM-X models of the 2 peptides. The efficiency of the 
MFGGAKKR cleavage was slightly greater than that of MSGGAFSW, with about 10% more 
peptide being cleaved in the first hour. Comparing the sequences of the pVl and pVll cleavage
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Time (minutes)
Fig. 1.11 Digestion of the peptides MSGGAFSW and MFGGAKKR
HPLC profiles of 1 hour incubations of the peptides MSGGAFSW and MFGGAKKR with disrupted 
purified Ad2 as a source of protease. Amino acid analysis identified the peaks as (1) MSGGAFSW,
(2) AFSW, (3) MSGG, (4) MFGGAKKR, (5) MFGG and (6) AKKR. The gradients for the separations 
are described in method 4.2. Above each profile is the CHEM-X molecular model (see method 5) of the 
appropriate octapeptide and the arrow marks the position of the cleavage site.
sites, it is immediately apparent that the residues occupying the P2’ -P4' positions, FSW in pVI
and KKR in pVII, are completely different. Furthermore, it is noted that the P3 position is 
occupied by a serine in the pVI peptide and a phenylalanine in the pVII peptide. These residues 
differ significantly in size and polarity, suggesting that P3 does not contribute to the specificity 
of recognition. It seems probable, therefore, that the primary substrate specificity of the Ad2 
protease is contained within positions P4. p2. Pl and Pf. Accordingly, a close examination of 
the requirements at each of these positions was undertaken.
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2 Consensus Sequence for Ad2 Protease Substrates.
The pVI derived octapeptide, MSGGAFSW, was selected as the reference peptide for 
these studies. It was chosen in preference to MFGGAKKR because the presence of a 
tryptophan residue facilitates detection at 226nm.
The residues at P4, P2, Pj and Pf were varied in turn to produce 12 distinct 
octapeptides (table.1.4). Each was incubated with disrupted Ad2 and the resulting samples 
were analysed by HPLC and amino acid analysis as described in method 4.2. Five of the 
peptides, LSGGAFSW, ISGGAFSW, MSGGQFSW, MSGAGFSW and MSG££FSW were 
cleaved efficiently by the protease at GA, GA, GG, AG and SG bonds, respectively, with 
tetrapeptides being generated in each case. The remaining 7 peptides YSGGAFSW, 
XSGGAFSW, QSGGAFSW, ESGGAFSW, TSGGAFSW, MS AGAFSW and MSG&AFSW 
were not cleaved by the protease, even after 12 hour incubations.
Postion
varied Peptide
Relative
susceptibility
MSGG-AFSW 1.0
YSGG-AFSW 0.0
QSGG-AFSW 0.0
ESGG-AFSW 0.0
1*4 TSGG-AFSW 0.0
VSGG-AFSW 0.0
LSGG-AFSW 0.8
ISGG-AFSW 0.9
P2 MSAG-AFSW 0.0
pl MSGS-AFSW 0.0
pl' MSGG-GFSW 1.5
Pl & Pl ’ MSGA-GFSW 1.511 oc
MSGS-GFSW 1.2
Table 1.4 Cleavage of octapeptide variants of the pVI site.
The ability of a series of octapeptides to act as substrates for the Ad2 protease was 
examined. The right hand column shows the cleavage rate of each peptide relative to the 
reference peptide MSGGAFSW; with a value of 0.0 indicating that the peptide was not 
cleaved.
The P4 Position
The substitution of 7 amino acids for the methionine at P4 in the reference peptide
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revealed that the Ad2 protease has very specific requirements at this position. Peptides with 
valine, tyrosine, glutamine, glutamate or threonine at P4 were not hydrolysed by the protease. 
Indeed, of the amimo acids tested, only methionine, leucine and isoleucine were found to be 
permissible at P4. Thus one of the requirements of the Ad2 protease specificity appears to be
that a hydrophobic residue must be present at P4. The observation that valine is not acceptable 
indicates that the size of the side chain is also important and strongly suggests that only 
methionine, leucine and isoleucine will be recognised by the adenovirus protease at P4.
The P2 Position
The resistance of the peptide, MSAGAFSW to the protease reveals that even the 
conservative change of a glycine to an alanine at P2 is sufficient to prevent cleavage. This 
result gives a strong indication that the Ad2 protease will only cleave peptides with a glycine at 
P2. Thus the P2 position is a primary determinant of the enzyme's specificity.
The Pi Position
The requirements at the Pj position are not as clear and are dependent, to some extent at
least, on the identity of the residue at Pj'. This is demonstrated by the fact that the glycine to
serine substitution at Pj in MSGGAFSW prevented cleavage, but that an additional alanine to
glycine substitution at Pj' resulted in the efficient cleavage of the peptide, MSGSGFSW. It
appears, therefore, that a serine is only permissible at Pj if a glycine is present at Pj’.
The P/Position ■
Rate studies reveal that the peptides with a glycine substituted for the alanine at Pj' 
were cleaved more efficiently than MSGGAFSW, suggesting that glycine is the preferred 
amino acid at this position. Indeed, MSGGGFSW proved to be the best substrate of all being 
cleaved at a rates 50% greater than MSGGAFSW (table 1.4).
Based on this systematic study M(L,I)XGX-X is suggested as a preliminary consensus 
sequence to describe all of the peptides cleaved by the Ad2 protease. It is noted, however, that
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some peptides (e.g. MSGGAFSW) fit this consensus sequence, but are not hydrolysed by the
protease, so clearly a more specific notation is required. At present, all the peptides cleaved by 
the protease are either of the form:
M(L,I)XGG-X or M(L,I)XGX-G
and so it is proposed that these sequences define the substrate specificity of the Ad2 protease.
It is conceded, however, that some peptides conforming to these sequences will probably not 
be cleaved. This is because an exhaustive study of the amino acids, permitted at P3, Pj and
Pf, has not been carried out and it is likely that there will be additional restrictions at some of 
these positions. For example, a charged residue such as arginine or aspartate may not be 
permitted at Pj and the presence of a proline residue anywhere in the sequence might have a 
detrimental effect on the peptide's secondary structure. It is also possible that some peptides of 
the form M(L,I)XGX-X will be substrates of the Ad2 protease. Nevertheless, the primary 
determinants of the enzyme's substrate specificity have been shown to reside in the P2 and P4 
positions and the validity of the above consensus sequences will be tested by an examination of 
the natural substrates of the Ad2 protease.
3 Cleavage Sites in Ad2 Proteins.
The Ad2 genome was translated in its 6 reading frames using the Staden programmes 
and a search was carried out to determine how frequently the sequences M(L,I)XGG-X and 
MLL,I)XGX-G occur in viral proteins. The search identified 25 such sites in Ad2 open reading 
frames, including 14 sites in pVI, pVII, pVIII, pTP, Ilia and the 11-kDa protein (table 1.5),
Peptides corresponding to the 4 predicted cleavage sites in the pTP and one of the sites 
in pVIII were synthesised and assessed as substrates for the Ad2 protease as described above. 
The peptides LAGG-FRHR (pVIII), MRGF-GVTR and MGGR-GRHL (both pTP) were 
cleaved at rates of 0.2, 0.5 and 0.6 relative to the reference peptide MSGG-AFSW 
(fig.1.12). Amino acid analysis confirmed that the hydrolysed bonds were G-F, F-G and 
R-G respectively. Thus at least 3 cleavage sites in Ad2 proteins appear to have been 
successfully predicted, 2 in the pTP and 1 in pVIII. In contrast, the peptides corresponding to 
the 2 remaining predicted sites in the pTP, SLGGGVPW and MTGGVFQ were not hydrolysed
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Protein Putative 
Cleavage Site
Turn
Predicted?
Hydrophilic
Index
Serotypes
Sequenced
Conserved?
pVI MSGG-AFSW Yes 0.7 2 -
IVGL-GVQS No -1.0 2, 41 Yes
pvn MFGG-AKKR Yes 1.2 2,5 Yes
pvmi LAGG-FRHR Yes 1.2 2,3,41 Yes
IRGR-GIQL Yes 1.1 2,3,41 Yes
IGGA-GRSS Yes 0.8 2,3,41 Yes
pTP MRGF-GVTR Yes 0.8 2,5,7,12 Yes
MGGR-GRHL Yes 1.8 2,5,7,12 No
LGGG-VPTQ Yes -0.6 2,5,7,12 No
MTGG-VFQL Yes 1.5 2,5,7,12 Yes
ma LGGS-GNPF Yes 0.7 2,5 Yes
IIK MAGH-GLTG No 1.3 2 -
LTGG-MRRA Yes 1.0 2 -
MRGG-ILPL Yes 2.2 2 -
Hexon LGGI-GVTD Yes -0.5 2,5,40,41 No
LLGN-GRYV Yes 0.4 2,5,40,41 Yes
Penton LEGG-NIPA Yes 1.5 2,5 Yes
LPGC-GVDF Yes -2.4 2,5 Yes
LI 52K LAGT-GSGD Yes 0.2 2 -
Polymerase IRGG-RCYP Yes 1.5 2,5,7,12 Yes
ElB 21K LSGG-YLLD Yes 0.7 2,4,5,7,1240,41 No
E3B 14.5K LTGG-DD Yes 1.1 2,3,5,7 Yes
ElB 52K ISGN-GAEV Yes 0.4 2,5,7,12,40, 41 Yes
D-172 ISGG-VLEG Yes -2.0 2 -
LAGS-GSGS Yes 0.3 2 -
E4 34K IAGG-QVLA Yes -0.1 2 -
Table 1.5 Secondary Structure and Conservation of Predicted Cleavage Sites 
Cleavage sites predicted by the concensus sequences are shown as octapeptides, with the exception of 
the E3B 14.5K sequence which is at the C-terminus. Turn regions, and the maximum hydrophilicity 
value between and P j were predicted using the Peptidestructure program in the Wisconsin 
package (Devereux gf al, 1984).
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Time (min)
Fig. 1.12 Confirmation of putative cleavage sites in pVni and pTP.
FPLC traces (PepRPC column) from protease digests of (a) LAGGFRHR from pVIII, (b) 
MRGFGVTR from the pTP and (c) MGGRGRHL from the pTP. Incubations of lOO|pg of peptide 
with 20pl of purified disrupted Ad2 at 37°C were for 12 hours (LAGGFRHR), 5 hours 
(MRGFGVTR) and 2 hours (MGGRGRHL), Amino acid analysis showed the numbered peaks to 
contain (I) LAGGFRHR, (2) FRHR, (3) LAGG, (4) MRGFGVTR, (5) GVTR, (6) MRGF, (7) 
MGGRGRHL, (8) GRHL and (9) MGGR. Peptides were eluted with a 5 minute isocratic step at 
0.1% (v/v) TFA, followed by a 25 minute gradient to 0.1% (v/v) TFA in 20% (v/v) acetonitrile. 
CHEM-X models are shown in adjacent panels with the cleaved bond arrowed.
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by the protease and further studies are required to confirm the identity of the scissile bond in 
the pTP giving rise to the TP (see chapter 4).
Two additional approaches were taken in an attempt to establish the significance of the 
predicted cleavage sites in the viral proteins. Firstly protein sequences were examined in other 
adenovirus serotypes in order to determine which of the sites are conserved (table 1.5). 
Secondly the programmes from the Wisconsin package were used to predict the probable 
secondary structures and hydrophilicity values of all the potential cleavages sites and the values 
obtained are included in table 1.5. Five of the sites, namely LGGG-V in the pTP, IVGL-G 
in pVI, LGGI-G in the hexon, LPGC-G in the penton and ISGG-V in D-172 were predicted to 
be in hydrophobic regions of the protein so might not be surface exposed. The predicted 
secondary structure at all the potential cleavage sites, except MAGH-G in the 11-kDa protein 
and IVGL-G in pVI, was a p-tum. This perhaps is not surprising given that all the potential 
cleavage sites contain at least 2 glycine residues.
In conclusion the consensus sequences derived to define the substrate specificity of the 
Ad2 protease, have survived this examination of the viral proteins. In the first instance they 
were used to select a relatively small number of potential cleavage sites, including sites in all 
the known substrates of the enzyme. Furthermore, peptides corresponding to 3 of the 
predicted sites were synthesised and found to be cleaved efficiently by the protease. The work 
also confirms that there are additional restrictions at Pf in peptide substrates, since 
SLGGGVPW and MTGGVFQ, which contain valine residues at Pj', were not hydrolysed,
despite the fact that a glycine is present at Pj in each case. This serves to remind us that not all 
peptides of the form M(L,I)XGX-G or M(L,I)XGG-X are substrates of the Ad2 protease and 
suggests that some of the sites predicted in table 1.5 will not be cleaved.
4 Molecular M<djelhng.
The CHEM-X molecular modelling package was used to predict the structures of a 
series of peptides, including all those synthesised. The models were constructed by energy 
minimisation of random structures and a selection of models is included to portray the key 
elements of substrate specificity of the adenovirus protease (fig.llll, 1.12 and 1.13).
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(a)
MSGGAFSW
(b)
MSAGAFSW
(0 (d)
MSGSAFSW
(C)
LSGGAFSW
(g)
VSGGAFSW
LGGGVPTQ
MSGGGFSW
(0
ESGGAFSW
<h)
ISGGAFSW
MTGGVFQ
Fig. 1.13 CHEM-X Models of Selected Peptides
The models were created through the CHEM-X package using energy minimisation of random 
structures. The N-terminus is to the left; filled arrows indicate cleavage while open arrows 
indicate the analagous position in peptides which were not cleaved by the protease.
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The P2 and P4 positions have already been shown to be the primary determinants of
specificity and fig. 1.13b demonstrates how even the small methyl side chain of alanine at P2 
protrudes and presumably is large enough to prevent access of the protease to the G-A bond. 
Comparisons of the models of MSGGAFSW (fig. 1.13a) and ESGGAFSW (fig.l3f) reveal 
only minor differences in the size and orientation of the amino acids at P4. The fact that 
ESGGAFSW is not a substrate (table 1.4), suggests that there are specific requirements for a 
hydrophobic residue at P4. Size, however, would still appear to be important since peptides
containing the small branched hydrophobic amino acid, valine, at P4 were not hydrolysed 
(fig-Wg).
CHEM-X models (fig.l.X2b and c) show that the side chain of Pj is oriented in a 
direction away from those of the critical P4 and P2 residues. This would explain why peptides
containing glycine, alanine, serine, phenylalanine and arginine at Pj are all cleaved (tables 
1.4 aad 1.5). On t heother haad, mcolels of MSGGAFSW (cleeaed) aad MSGGSASW (not 
cleaved) demonstrate that the residue at the Pj position can affect the orientation of the Pj' 
residue and so in some cases does dictate whether or not a peptide will be cleaved ( fig.lJ4a
and c).
The CHEM-X models also demonstrate that the side chain of the Pj' residue must be
fridntde away from the scissile bond. The branched side chain of the valine residues at Pj' in 
LGGGVPTQ (f^^.l.l^^i) and MTGGVFQ (fig.l^j) can be seen to protrude further across 
the Pi-Pi' bond than the alanine in MSGGAFSW (fig. 1.13a). In contrast the bulky 
phenylalanine in the peptide, LAGGFRHR, which was cleaved, appears to be oriented well 
away from the scissile bond (fig,1.12a).
Molecular modelling has enabled us to visualise the features of secondary structure 
shared by all the peptide substrates of the Ad2 protease and these features are exemplified in the 
model of MSGGGFSW (fig.l^d) which was found to be the best substrate.
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5 Assessment of Peptides as Inhibitors of the Ad2 Protease.
Finally the possibility that some of the peptides synthesised, during the course of this 
project, might act as specific inhibitors of the Ad2 protease was considered. Particular 
attention was paid to the peptides that were not cleaved by the protease in these preliminary
investigations.
The assay used relies on the use of 35S methionine labelled Ad2 proteins as substrates, 
with the digestion of pVII to VII by the protease, being monitored by SDS-PAGE and 
autoradiography. A full description of the assay is given in chapter 2. The extracts used 
contained endogenous protease activity and were incubated for 6 hours at 37°C in the presence 
of a selection of peptides at concentrations of 0.5mg/ml. Only SGGAFSW and FGGAKK 
were found to inhibit the protease to any significant extent (table. 1.6). Interestingly, these
Peptide % Inhibition
MFGGAKKR —
FGGAKK 55%
MSGGAFSW -
SGGAFSW 60%
YSGGAFSW -
QSGGAFSW -
ESGGAFSW —
TSGGAFSW -
MSAGAFSW -
MSGSAFSW -
GGGGGG —
Table 1.6 Assessment of peptides as inhibitors.
The effects of selected peptides on the cleavage of pVII to VII in the35S 
assay (see chapter 2). The peptides were incubated with the labelled Ad2 
infected extracts fw 6 hours at 37° C and the digestion of pVII to VII was 
monitored by SDS-PAGE and autoradiography. Quantitative data was 
obtained by scanning densitometry. In the control experiment without any 
added peptide 90% digestion of pVII to VII was observed.
peptides are based on the cleavage sites from pVI and pVIl, respectively, but both lack the P4
residue. Parallel incubations were carried out with (Gly)6, but this peptide did not inhibit the 
protease. These results are initial observations that must be confirmed, in the future, in 
kinetically significant experiments. Neverthless, they may provide a starting point for the 
design of a specific inhibitor of the Ad2 protease.
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DISOJSSIQM
Using peptide synthesis and computer modelling the substrate specificity of the Ad2
protease has been defined, with elements of both primary and secondary structure being 
important. The peptide, MSGGAFSW, based on the established pVI cleavage site, was 
selected as the reference peptide, since the presence of a tryptophan residue facilitated its 
detection. In terms of the primary structure of the substrates, the results show that the major 
requirements are at the P2 and P4 positions. P2 must be a glycine and only methionine, leucine 
and isoleucine have been shown to be acceptable at P4. The other major requirement appears to
be that the side chain of Pf must point away from the scissile bond. The secondary structure
that enables this is best portrayed in fig.l.l3d and is characterised by an area between the P4 
position and the cleaved bond devoid of intrusive side chains. At this stage it is important to 
note that proteolytic processing normally takes place at peptide bonds in relatively flexible 
interdomain segments or in surface loops of proteins (Neurath,1989). Thus the presence of a 
potential cleavage site in the primary structure of a protein does not necessarily mean that it will 
be accessible to the protease in the native molecule.
A search for the sequences M(L,I)XGGX and M(L,I)XGXG picked out 15 of the Ad2 
proteins. These included all the known substrates of the protease, namely, pVI, pVII, pVIll, 
pTP, 11K and Ilia. The main purpose of this discussion will be to consider the significance of 
all the predicted cleavage sites in the Ad2 proteins. Fig.1.14 shows the positions of the 
predicted sites in the known substrates of the protease.
pVI and pVII
In addition to the established cleavage sites at G33-A34 and G24-A25 in pVI and pvn, a
second site was predicted towards the C-terminus of pVI at L240-G241 Evidence that this site 
is cleaved in vivo comes from work by Anderson (1990) who noted that the only cysteine in 
the Ad2 pVI is the penultimate residue at position 249 and went on to show that pVI, but not 
VI, was labelled with 35S cysteine.
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pVIII
pVHI, with an apparent MW of 26-kDa, is cleaved to generate a protein of apparent 
MW 13-kDa, as determined by SDS-PAGE (Weber, 1976). As yet, only G-A and A-G bonds 
have been considered as potential cleavage sites (Hannan et al., 1983). Consequently, these 
authors proposed that either a single cleavage at amino acid 105 (TNSG-AQLA) with the 
retention of the amino terminus of pVIII, or a double cleavage at amino acids 22
(LAAG-AAQD) and 156 (QIGG-AGRS) takes place. None of these sequences, however, fits 
the consensus sequence, proposed in this project and so we would not expect any of them to be
The locations of the predicted cleavage sites in pVI, pVII, pVIII, pTP, pllla and the 11-kDa protein are 
indicated by arrows (see table 15). The shaded area represents the retained fragments of the proteins, 
namely VI, VII, VIII, TP, Ilia and mu respectively. The N- and C-termini are marked in each case.
cleaved by the Ad2 proteinase. Three sequences from pVIII, however, centred on amino acids 
111, 131 and 157, respectively, do satisfy the conditions outlined above. These are 
LAGG-FRHR, IRGR-GIQL and IGGA-GRSS respectively. Cleavage at all of these sites 
would be consistent with the results of Hannan etal. (1983), whose comparative 125I and 35S 
labelling studies on pVIII and VIII suggest a cleavage site near the centre of the protein, with 
the retention of the N-terminus. The peptide based on the site centred at position 111, 
LAGG-FRHR, was synthesised and shown to be cleaved by the adenovirus protease, albeit at
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a slower rate than any of the other peptide substrates. The fact that a phenylalanine was 
acceptable in the Pf position was surprising, until a close examination was made of the 
computer model (fig. 1.12a), which shows that, although this is a large and bulky residue, 
the ring structure is bent well away from the cleaved bond. It is proposed, therefore, that a 
cleavage at Gin-Fn2 releases the 13-kDa polypeptide VIII from the N-terminus and that the 
C-terminal portion of the precursor, which includes the 2 additional cleavage sites, is broken 
down further . The phenylalanine in Pj' is not only unexpected as far as the adenovirus 
protease is concerned, but is also unusual as far as substrates of viral proteases in general are 
concerned (Wellink and van Kammen, 1988). The only other . viral proteases known to cleave 
a substrate with an aromatic group in the Pf position are the alphavirus nsP2 proteases. In
this case the nsP3-nsP4 cleavage involves a tyrosine at Pj' and processing takes place at a 
much slower rate than at the other cleavage sites in the polyprotein. Perhaps slow processing 
of the pVIII protein is required by the adenovirus and the presence of a phenylalanine at Pf
ensures this.
Preterminal Protein (pTP)
Smart and Stillman (1982) have shown that the pTP (87-kDa) is cleaved, via a 62-kDa 
intermediate (iTP), to the 55-kDa terminal protein (TP) when incubated with a source of Ad2 
protease. Four putative cleavage sites were found in the pTP. Two of these were separated by 
only 8 amino acids; the sequences MRGF-GVTR and MGGR-GRHL, centred on residues 168 
and 176 respectively. These peptides were synthesised and both were found to be cleaved by 
the protease. Cleavage at either or both of these sequences would give a protein with a MW of 
around 62-kDa. This would explain the presence of the intermediate when the pTP is cleaved. 
A split band at 62-kDa has been observed on some gel systems, indicating that it may contain 2 
species (Leith et al., 1989). The MRGF-GVTR, but not the MGGR-GRHL site is conserved 
in the pre-terminal proteins of the other adenovirus serotypes in which it has been sequenced 
suggesting that this is the main site giving rise to the iTP. The bond cleaved by the protease to 
give the 55-kDa terminal protein is slightly more elusive. Two sequences were predicted as 
potential cleavage sites; MTGG-VFQL and LGGG-VPTQ. The peptides MTGGVFQ and
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SLGGGVPW incorporating the putative cleavage sites were synthesised, but neither was 
cleaved by the protease. The modelling studies on LGGGVPTQ and MTGGVFQL 
(fig.l.l3i and j) show that the valine intrudes slightly more than the alanine at Pf in 
MSGGAFSW. It seems probable that the cleavage site is at one of these 2 positions and that 
the tertiary structure, which cannot be mimicked by a 7 or 8 residue peptide, pulls the valine 
into an orientation which allows the protease access. The LGGG-V site is not conserved in the 
pre-terminal proteins from other serotypes that have been sequenced, suggesting that the 
MTGG-V site originally suggested by Smart and Stillman (1982) is the cleavage site giving rise 
to the mature 55-kDa terminal protein. Further support for this hypothesis comes from results 
which suggest that the TP is produced much more slowly than the iTP (see chapter 4). As with 
the processing of pVIII-VIII it could be advantageous to the adenovirus if the generation of the 
mature TP is controlled.
pHIa
The 66-kDa capsid-associated viral protein, nia, has been shown to result from the 
cleavage of a slightly larger 67-kDa molecule (Boudin et a/., 1980). The putative site, reported 
here, is situated only 15 residues from the C-terminus of the precursor polypeptide and 
cleavage at this point would account for the 1-kDa loss in molecular weight.
L2 11-kDa protein
The last of the viral proteins that has been shown to be cleaved by the protease is the L2 
11-kDa protein. The computer search picked out 3 putative cleavage sites in the 11-kDa 
protein; MAGH-G, LTGG-M and MRGG-I. Cleavage at the LTGG-M site was previously 
demonstrated by Weber and Anderson (1988) and more recently Anderson etal, (1989) 
located the second cleavage site in the 11-kDa protein that gives rise to the basic protein mu and 
they have used sequence analysis to show that this is at the G-I bond predicted in table 1.5.
It seems probable, therefore that the 11-kDa protein is cleaved in 3 places with the G-M and 
G-I cleavages resulting in the production of the mature protein.
Other Adenovirus Proteins
Consider now the predicted cleavage sites in adenovirus proteins that have not been 
previously shown to be cleaved by the protease (table 5, fig.1.15). It is possible that some,
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previously shown to be cleaved by the protease (table 5, fig.1.15). It is possible that some, 
if not all, of these sites are hidden in hydrophobic or highly structured areas of their proteins 
and so are not accessible to the protease. On the other hand, their processing may not have 
been noticed if the proteins are present at a low copy number, or if only a small percentage of 
the proteins are cleaved, perhaps as a result of a conformational change at a particular point in 
the infectious cycle. Surprisingly, both of the adenovirus coat proteins, the hexon and the 
penton, have putative cleavage sites near the centre of their amino acid sequences. The 
LLGN-G sequence at 564 to 569 of the hexon is located at the base of the tower region in a 
highly conserved segment of random structure (see fig.2, p8), whereas the LLGI-G sequence
The locations of the predicted cleavage sites in the hexon, penton, LI 52/55K, E1B 55K, E2B 
polymerase, E3 14.5K, E1B 21K, E4 34K and D172 proteins are indicated by the arrows (see table 
1.5). 1cm represents 100 amino acids and the N- and C-termini of the proteins are marked.
(residues 428 -432) is in the tower region and is not conserved in the various serotypes 
(Roberts et al., 1986; Toogood et al., 1989). The position of these sequences within the
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quarternary structure of the of the hexon, making them inaccessible from the inside of the 
virion, could explain why the protein does not appear to be cleaved. On the other hand, it has 
been suggested that viral proteases may play a part in uncoating (Krausslich and Wimmer, 
1988). Although there is no direct evidence for this in the case of the adenovirus, the Ad2 tsl 
mutant, which lacks protease activity, is defective in uncoating (Miles et ai, 1980; Hannan et 
al., 1983). A report by Varga et al. (1990) reveals that the hexon undergoes a conformational 
change at low pH and that the N-terminus of the protein becomes exposed and susceptible to 
proteolysis. Since the major route of Ad2 internalisation is by receptor mediated endocytosis 
and the virions are subsequently located within endosomes, such a conformational change at 
low pH could have a significant part to play in uncoating. The penton base also undergoes a 
conformational change at low pH so the possibility remains that the putative cleavage sites in 
the coat proteins are hidden from the viral protease when the other maturation cleavages take 
place. On entering a mildly acidic environment, such as that of the endosomes, however, the 
coats of the virions undergo a conformational change, perhaps exposing the cleavage sites in 
the hexon and/or the penton to the protease present inside the virions. This could be the first 
step in uncoating and is an indication that the presence of putative cleavage sites in both of the 
major coat proteins of the adenovirus should not be dismissed without due consideration.
The potential cleavage site in the LI 52/55-kDa proteins is also of interest, since the 
latter are unusual among the viral late proteins, in that they are synthesised at early and late 
times during infection. This has led to proposals that they have a dual role in the lytic cycle. 
The 52/55-kDa proteins are phosphoproteins and are required for viral assembly, but they are 
not thought to be components of the mature virion (Hasson et a/., 1989). It is noted that the 
predicted site, LAGT-GSGD has a glycine at Pf and is not significantly different from some 
of the known substrates of the protease (tables 1.4 and 1.5).
Of the remaining predicted sites in adenovirus proteins only those in the ElB 55-kDa, 
E2B polymerase and E3 14.5-kDa proteins are conserved in other serotypes. In the 
polymerase and 14.5-kDa sites the charged residues arginine and aspartic acid are present at 
Pj' and it remains to be established that such amino acids are permissible at this position. 
Furthermore, the site in the E3 14.5-kDa protein is only 2 residues in from the C-terminus and
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so processing would be difficult to detect. The site in the ElB 55-kDa protein is conserved in 
serotypes 2, 4, 5, 7, 12, 40 and 41, but further investigations would be required to establish 
whether or not it is processed.
Finally, it is noted that no potential cleavage sites were found, in either the L4 100-kDa 
protein or the L3 23-kDa protein. This suggests that, contrary to the proposals of Morin and 
Boulanger (1986) and Chatterjee and Flint (1987), the l(X)-kDa and 23-kDa proteins are not 
processed by the virus encoded protease. It cannot be ruled out, however, that a sequence of 
the form M(L,I)XGX-X could be cleaved, but to date there is no evidence to suggest this. 
Comparisons with substrate specificities of other viral proteases.
Table 1,7 displays the preferred substrate specificities of a selection of viral proteases 
including that of the Ad2 protease outlined above. As can be seen there are a number of 
similarities. In particular, the alphavirus nsP2 protease and the Ad2 protease both require a
P4 P3 P2 Pi Pi' P2'
Rhino (2A) G
Polio (3C) A Q G P
CMPV (24K) A AP Q G
TEV (NIa) V RK Q G
TVMV (Nia) Y Q G
Sindbis (nsP2) G GA GA
VF (NS3) RK RK
Ad2 (23K) MLI G G
Vaccinia (?) A G
ASF (?) G G
Table 1.7 Preferred substrate specificities of viral proteases
The table shows the preferred substrate specificities of a number of viral proteases in the B to f>' 
positions. In most cases the data is derived from comparisons of the natural substrates of the 
enzymes; but in the cases of the rhinovirus 2A, poliovirus 3C, Sindbis virus nsP2 and the adenovirus 
23K proteases the results are derived from mutagenesis and/or peptide studies. The cleavage sites of 
the vaccinia and African swine fever viral proteins are included, although the identity of the proteases 
remains to be confirmed. The specificities of the HIV proteases are given in fig. 1.5 and table 1.2 so 
are not included in this table. For references see introduction to this chapter.
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glycine at P2 and appear to have a preference for enzymes with a small side chain in the Pf 
position. Also of interest are the cleavage sites in the other DNA virus proteins, where the Pj
and P2 residues have been shown to be AG and GG in vaccinia and African swine fever virus 
proteins respectively. Furthermore a number of the viral proteases appear to have specific 
requirements at the P2 and P4 positions including the 3C proteases of the picoma- and related 
viruses. There has also been a suggestion that a number of proteases including the 
picomavirus 3C proteases cleave at p-turns (Hellen et a/.,1989). In this regard, it may be of 
significance that all the predicted cleavage sites in the Ad2 proteins, except F/GL-G in pVI and 
MAGH-G in the 11-kDa protein, are predicted to be at p-turns (table 1.5). The question as to 
whether similar substrate specificities means that some of these enzymes from different viruses 
are structurally and mechanistically related will be considered in chapter 2.
Applications
The defined substrate specificities of selective proteases have been used to engineer 
appropriate cleavage sites into the interdomain regions of a fusion proteins (Sassenfeld,1990). 
In the future it is possible that the coding sequence for MSGGG could be included in such a 
system and assessed for cleavage by the Ad2 protease. This in itself would not be of great use 
unless a pure, abundant source of active enzyme was available. Attempts to clone and purify 
the Ad2 protease will be made in chapter 3.
Having defined a substrate specificity for the Ad2 protease we are now in a position to 
consider how best to design a specific inhibitor for the enzyme. As a preliminary step to doing 
this some of the peptides synthesised were tested as inhibitors. Particular attention was paid to 
the peptides that were not cleaved by the Ad2 protease. The results (table 1.6) showed that 
the only peptides that inhibited the enzyme to any significant extent were FGGAKK and 
SGGAFSW. This was surprising in view of the fact that the P4 residue is missing in these 
peptides. It appears then that binding can take place in the absence of a hydrophobic residue at 
P4, but that the latter may be required to orientate the peptide correctly, in the active site of the 
protease, to allow cleavage. Further evidence for this comes from the observation of a possible 
inhibitory effect by the acetylated peptide, AC-GGA-ONH2, on the Ad2 protease (Tremblay et
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a/., 1983).
If it is possible to design a peptide inhibitor for the Ad2 protease, the question arises as 
to whether it will be effective against the enzymes from other serotypes. A recent report shows 
that the Ad2 pVII precursor was cleaved by nuclear extracts from cells infected with serotypes 
1,2,3,4,5,6,7 and 9, suggesting that the proteases from different serotypes do, in fact, have 
very similar, if not identical, substrate specificities (Houde and Weber, 1990b). Further 
evidence for this comes from the observation that the 23-kDa putative protease is highly 
conserved in all the serotypes so far sequenced (Houde and Weber, 1990a).
Finally in this regard, the similarities in substrate specificities of a number of viral 
proteases raises the interesting possibility that an inhibitor effective against a range of viral 
proteases could be designed. Before embarking on such studies a greater understanding of the 
mechanisms involved in these proteases and pure sources of active enzymes would be 
desirable. The work carried out in the remaining chapters endeavours to achieve these aims for 
the adenovirus protease, to some extent at least.
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CHAPTER 2
Characterisation and Classification of the Ad2 Protease
INTRODUCTION
The aim of this chapter is to find out more about the mechanism and classification of the 
Ad2 protease. After describing the work that has already been done to this end, a brief 
definition of the four classes of proteases will be given. This will be followed by a summary 
of recent studies undertaken to classify other viral proteases.
CHARACTERISATION OF THE ADENOVIRUS PROTEASE
Bhatti and Weber (1978) developed an assay for the adenovirus protease using 35S 
methionine labelled, Ad2ts 1 infected cell extracts as substrates. In their assay, labelled 
precursor proteins act as substrates and the cleavage of pVII-VII can be readily monitored by 
SDS-PAGE and autoradiography. All attempts to characterise the enzyme to date have made 
use of this assay and as a result, some of its properties have been defined. The Ad2 protease 
has been shown to operate best at neutral pH, with no activity being detected below pH5 or 
above pH9.5. It is reported that the enzyme is nuclear localised and that it is packaged within 
the virion at a low copy number estimated at 5-10 copies per virion (Bhatti and Weber, 1979a,b; 
Anderson, 1990). Whilst the protease activity from purified virus was activated by 5mM 
dithiothreitol (DTT), the thiol reagent had no effect on the nuclear localised enzyme and indeed 
the latter was found to be inhibited by p-mercaptoethanol (Tremblay et a/., 1983). This result 
serves to emphasise the need for a cleaner assay system, so that any observations made can be 
attributed to the enzyme and not to effects on complex substrates or additional components 
present.
Limited inhibitor studies revealed that phenylmethylsulphonylfluoride (PMSF), 
tosyl-lysine chloromethyl ketone (TLCK) and tosyl-phenylalanine chloromethyl ketone 
(TPCK) gave 64, 90 and 100% inhibition of pVII-VII processing when each was present at a
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concentration of ImM (Bhatti and Weber, 1979a). Diisopropylfluorophosphate (DFP) was also 
reported to inhibit the enzyme, although the concentrations and degree of inhibition were not 
given (Tremblay et a/., 1983). Based solely on these observations it has generally become 
accepted that the adenovirus codes for a chymotrypsin-like serine protease (Krausslich and 
Wimmer,1988; Hellen et a/., 1989; Kay and Dunn,1990). Similarly, the mapping of the 
mutation in Ad2tsl to the L3 open reading frame, coding for a 23-kDa protein, has led to the 
assumption that the latter is the protease (Yeh-Kai eta/.,1983). Although this is likely to be the 
case, it cannot be ruled out that the 23-kDa protein plays an essential regulatory role and is not, 
itself, the protease.
CLASSIFICATION OF PROTEASES
Proteases have been divided up into 4 mechanistic classes according to the amino acid 
or ion usually associated with the catalytic process. These are termed serine, cysteine, aspartic 
and metallo proteases (Barrett, 1977). In terms of the cleavage of the peptide bond the overall 
process is identical for all the proteases; but the various groups required to carry out the 
cleavages are different. In simple terms a nucleophile in the form of an oxygen or sulphur 
atom attacks the slightly electrophilic carbonyl carbon atom in the peptide bond. General base 
catalysis is required to remove the proton from the attacking nucleophile and an electrophilic 
atom is required close to the carbonyl oxygen to increase the polarisation of the C-O bond. 
After the formation of the intermediate, general acid catalysis takes place to facilitate the 
departure of the amine group (Dunn, 1989).
The serine proteases include the well characterised trypsin, chymotrypsin and subtilisin 
and each has a catalytic triad (His, Asp, Ser), the residues of which make up the charge relay 
mechanism of the enzyme. The residues adjacent to the active centre amino acids are well 
conserved among serine proteases, as is the secondary structure of these evolutionarily related 
enzymes (Polgar,1987). In papain, the best characterised of the cysteine proteases, a 
thiolate-imidazolium ion pair is formed between Cys25 and His159 with the sulphur atom of the 
cysteine side chain acting as the nucleophile (Brocklehurst et a/,,1987). In both serine and 
cysteine proteases an ester is formed between the nucleophilic oxygen or sulphur atom and the 
acyl portion of the peptide linkage. This acyl enzyme intermediate is stabilised in each case by
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hydrogen bonding to 2 backbone -NH- groups.
The oxygen atom of a water molecule serves as a nucleophile in the aspartic and metallo 
proteases in which no covalent acyl enzyme intermediates are formed. In aspartic proteases the 
H2O molecule is hydrogen bonded to the carboxyl groups of 2 highly conserved aspartic acid
residues. In the metallo proteases the H2O is coordinated to a divalent metal ion, usually Zn+2, 
and the carboxyl group of a glutamic or aspartic acid residue. The latter serves as a general 
base to remove a proton and to assist the attack of the water molecule on the peptide carbonyl 
carbon atom (Auld and Vallee, 1987).
The assignment of a protease to one of the mechanistic classes is not a trivial process 
and usually requires an examination of the enzyme’s physical properties, a study of its 
susceptibility to a range of inhibitors, comparisons of its amino acid sequence with those of 
established proteases and site directed mutagenesis. For absolute proof of its mechanism active 
site labelling and X-ray crystallography are required. Tables 2.1, 2.2 and 2.3 list some of 
the properties that may be used to distinguish the 4 classes. Kinetically significant pH 
optimum values of an enzyme can be used to predict the catalytically important residues (table 
2.1). Table 2.2 lists a set of diagnostic protease inhibitors and their effects against the 
various classes, whilst table 2.3 includes a set of sequence motifs commonly associated with 
proteolytic enzymes.
Amino Acid pKa
Aspartic Acid 3.9
Glutamic Acid 4.3
Histidine 6.0
Cysteine 8.3
Tyrosine 10.1
Lysine 10.8
Arginine 12.5
Serine 13.0
j Threonine 13.0
Table 2.1 pK Values of Ionisable Amino Acid Side Chains 
The values given are for the individual amino acids and will vary under the 
influence of their immediate environment within the protein structure.
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Inhibitor
Protease Class
Serine Cysteine Aspartic Metallo
DFP Inhibited - - -
PMSF Inhibited (Inhibited) - -
DCI Inhibited - - -
SBTI Inhibited - - -
PCMB - Inhibited - -
Cystatin - Inhibited - -
E-64 - Inhibited - -
DTT - Activated - Inhibited
Pepstatin - - Inhibited -
EDTA - - - Inhibited
o-Phenanthroline - - - Inhibited
Table 2.2 Diagnostic Protease Inhibitors
A list of the more common inhibitors which can be used to aid the classification 
of proteases. The inhibition of cysteine proteases by PMSF is reversible by 
DTT. A dash (-) indicates no effect.
Protease Motif Predictive
Success
False
Positives
Trypsin-like 
Serine Proteases
GDSGG 87% 4
L S
V S A T H C
I A
M G
92% 2
Subtilisin-like 
Serine Proteases
T
G TS XS XPXXS A ~ A A
V
100% 2
Cysteine
Proteases
S
QXXXGXCWXXTE - A
G
100% 1
Eukaryotic 
Aspartic Proteases
L S S
I D T G T T
V A A
F NA
100% 21
Table 2.3 Active Site Sequence Motifs
The table shows some of the characteristic motifs encompassing active site residues of 
proteases, taken from the Wisconsin package. The active site residue is underlined in each 
case, X denotes no preference and the vertical columns indicate alternatives at that position. 
Also shown are the % of known proteases of the appropriate class detected by the motif, 
and the number of false positives from approximately 30 000 sequences in the database.
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The use of these techniques in the characterisation of viral proteases has proved
successful in a number of cases, but also serves to demonstrate the problems involved with 
classification.
VIRALPROTEASES.
So far the structures and mechanisms of 3 viral proteases, those from HIV-1, RSV and
Sindbis virus, have been elucidated by X-ray crystallography. The classification of other viral 
proteases has been achieved mainly by sequence alignments and site directed mutagenesis.
Such studies have shown that the vast majority of viral proteases appear to be either 
trypsin-like or aspartic proteases. The only major exceptions at present appear to be the nsP2 
proteases of the alphaviruses, which have recently been proposed to be papain-like cysteine 
proteases (Gorbalenya et a/.,1991).
Trypsin-like Proteases
A list of viral proteases that are currently thought to be related to trypsin is given in 
table 2.4. As can be seen these include the 2A and 3C proteases of the picoma- and related 
viruses, the NS3 protease of the flaviviruses and the capsid protein of the sindbis virus. A 
surprising feature of the list is that many of the enzymes are categorised as trypsin-like cysteine 
proteases. To the classical enzymologist this is perhaps a contradiction in terms, but an 
increasing body of evidence supports the existence of such a subclass.
It is suggested that this group of cysteine proteases is structurally and mechanistically 
related to the cellular serine proteases and not to papain. In other words they contain a His, 
Asp, Cys catalytic triad in place of the cysteine/histidine thiolate imidazolium ion pairing of 
papain. Computer based alignments of primary and secondary structures have revealed that the 
2A and 3C proteases are homologous to the small and large structural subclasses of trypsin-like 
enzymes respectively (Gorbalenya eral, 1986; Brenner, 1988; Bazan and Fletterick, 1988). 
Subsequent alignments have predicted that the flavivirus NS3 and pestivirus p80 non-structural 
proteins are also trypsin-like proteases. Unlike the picomaviral enzymes, however, it is 
proposed that a serine is the active site residue (Bazan and Fletterick, 1989; Gorbalenya et 
a/., 1989). Significantly, recent work has shown that both NS3 and p80 are proteases and
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mutagenesis studies support the proposed active site residues (Chambers et al., 1991; 
Wiskerchen and Collet, 1991). Table 2.4 includes the predicted active site histidine, cysteine 
and serine residues of a number of viral proteases aligned with the corresponding sequences
from cellular enzymes. A number of site directed mutagenesis studies have been carried, out in
Cellular Trypsin
*
AAHCG
*
NDI
*
GDSGG
Cellular Chymotrypsin AAHCY NDI GDSGG
Entero- Polio (type 1) 3C PTHAS RDI GQCGG
Rhino- Rhino (type 14) 3C PTHAQ RDI GQCGG
Cardio- EMCV 3C NRHMA RDI ' GWCGS
Aphtho- FMDV 3C PRHLF RDI GYCGG
Como- CPMV 24K CKHFF WDL EDCGS
Poty- TEV NIa NKHLF RDM GQCGS
TVMV Nia NQHLF RDI GQCGS
Flavi- YFV NS3 MWHVT EDL GTSGS
Pesti- BVDV p80 VDHVT TDS GWSGL
Cellular a-lytic protease AGHCG NDR GDSGG
Alpha- Sindbis capsid PLHVK YDM GDSGR
Entero- Polio (type 1) 2A NYHLA RDL GDCGG
Rhlno- Rhino (type 1) 2A MYHLM RDL GDCGG
Table 2.4 Proposed active site residues of trypsin-like viral proteases
A subset of the viral proteases that have been classified as being trypsin-like serine or cysteine 
proteases taken from Bazan and Fletterick (1989). The virus family is indicated m bold on the left and 
the identity of the virus or cellular protease is given in column 2. The amino acids surrounding the 
predicted active site histidine, aspartate and serin<Vcysteine residues are listed for each protease. In 
most cases the active site residues have been predicted by sequence alignments with trypsin/ 
chymotrypsin or the smaller bacterial a-lytic proteases (Bazan and Fletterick,1989; Gorbalenya et al, 
1989). The active site residues in the capsid protein of the alphavirus, Sinbis, however, have been 
confirmed by X-ray crystallography. For references see text.
an attempt to confirm the identity of these active site residues. Although most are able to do 
so, few are extensive enough to be absolutely conclusive (Sommergrubber et a/., 1989; Cheah 
et a/.,1990; Kean et a/.,1991; Yu and Lloyd, 1991). One interesting observation is that the 
replacement of the predicted active site cysteine of the polio 3C protease with a serine did not 
completely abolish protease activity. This taken in conjunction with the observation that a 
serine to cysteine mutation in trypsin does not remove all its protease activity suggests that 
serine and cysteine may be interchangeable, to some extent at least, in the trypsin-like proteases 
(Lawson and Semler,1991).
Extensive inhibitor studies have been carried out on the rhinovirus 3C protease by Orr 
et al. (1989) revealing that its inhibitor profile fits better into the cysteine than the serine class. 
It is not, however, inhibited by the peptide based inhibitors, E64 and cystatin, regarded as
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diagnostic of cysteine proteases. Again these observations are in accord with the existence of a 
subgroup of proteases that link the cysteine and serine classes.
Finally consider the best studied of the viral proteases belonging to this group, the p26 
capsid protein of the Sindbis virus, which has been crystallised. p26 is responsible for a single 
autocatalytic cleavage that removes it from the other structural proteins and is rather more 
conventional than some of its viral counterparts in that it is a trypsin-like protease with an active 
site serine. Sequence alignments and mutagenesis studies suggested that His14i, Aspj63 and
Ser2i5 make up the catalytic triad and this was confirmed by the elucidation of its crystal 
structure (Hahn et a/.,1985; Hahn and Strauss, 1990; Choi et a/.,1991). Fig.2.1 shows the 
structure of p26 and the positions of the active site residues. Also note that after autocatalytic 
processing, the C-terminus of the protein remains in the active site cleft where it is proposed to 
inhibit the enzyme (Choi et a/., 1991).
Fig. 2.1 Structure of the Sindbis Virus p26 Capsid Protein
The alpha carbon trace of the Sinbis virus p26 protease is shown above. The location of 
the active site residues are marked along with the C-terminus of the protein. Note the 
position of the C-terminus in the active site cleft (from Choi et al., 1991).
Viral Aspartic Proteases
At present this group of enzymes is made up entirely of the retroviral proteases, 
although putative aspartic protease sequences have been found in vaccinia, hepadna- and
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parapoxvirus proteins (Slabaugh and Roseman,1989; Nassal et al.,\9%9', Mercer et al., 1989). 
As yet, however, none of these proteins have been shown to have protease activity so this 
discussion will concentrate on the classification of the retroviral proteases.
Initial reports showed that the AMV, pi5 protease was inhibited by p-chloromercuri- 
benzoate (PCMB) and N-ethylmaleimide (NEM), suggesting that it was a cysteine protease, 
whilst the murine retrovirus proteases were inhibited by PMSF which is specific for serine 
proteases. When the amino acid sequences of a number of retroviral proteases had been 
determined, however, it was realised that the preliminary classifications were incorrect 
(reviewed in Krausslich and Wimmer, 1988). All the enzymes contained a highly conserved 
sequence similar to the sequence around the active site aspartic acid residue of cellular aspartic 
proteases (table 2.3). They were also inhibited by pepstatin A, although at higher 
concentrations than their cellular counterparts (Katoh et al.,1987). The fact that the retroviral 
enzymes contain only one conserved active site aspartate and are about half the size of other 
aspartic proteases has led to the suggestion that they are active as dimers (Pearl and 
Taylor, 1987). Elucidation of the crystal structures of RSV and HIV-1 confirmed this 
revealing that 2 polypeptides combine in an asymmetric manner, each providing one of the 
necessary active site aspartic acid residues as is shown in fig.2.2 (Leis et al., 1989; Navia et 
a/.,1989). It has been proposed that the cellular aspartic proteases, which contain 2 
homologous domains, may have evolved through gene duplication and fusion from a
Fig. 2.2 Structure of the HIV-1 Protease
Alpha carbon trace of the HIV-1 protease taken from Navia et al. (1989). The trace of one 
of the monomers is shown in bold and the positions of the active site aspartate residues are 
marked, with one being donated by each subunit. Note also the position of the flaps over 
the active site.
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primordial enzyme to which the retroviral proteases are equivalent. Krausslich (1991) 
constructed a plasmid designed to produce fused dimers of the HIV-1 protease. He went on to 
show that when substituted for the wild type monomer in gag-pol, the dimeric protease was 
capable of efficiently cleaving the polyprotein. The presence of the dimer, however, was 
found to give premature processing of the polyproteins in cells which prevented assembly of 
the virus (Krausslich,1991). This emphasises further the crucial role that dimerisation plays in 
the control of retrovirus protease activity and infers that the viral enzymes are more than simply 
backward ancestors of their cellular counterparts (Burstein et al.,1991).
A more detailed understanding of the mechanism of the HIV-1 protease has been 
obtained by the complete mutagenesis of the enzyme and also by the determination of 
kinetically significant pKa values (Loeb et al., 1989; Hyland et al.,1991).
Other Viral Proteases
At present the nsP2 proteins of alphaviruses are among the few well characterised viral 
proteases that have not been assigned to the trypsin-like or aspartic groups. The protease 
activity is located at the C-terminus of nsP2, but the sequence contains no obvious protease 
motifs. Site directed mutagenesis studies show that Cysagi and His558 of the Sindbis virus 
nsP2 protease are required for activity and the current proposal is that the enzyme is a member 
of the papain-like cysteine protease class (Strauss and Strauss, 1990). This proposal has been 
supported by Gorbalenya et al. (1991) who have carried out sequence alignments of the 
alphavirus nsP2 proteins with the papain-like proteases. The sequences, however, differ quite 
considerably from papain and more studies are required to establish with certainty the 
mechanism by which nsP2 operates.
At present, like nsP2, the Ad2 protease must be included in the fifth group of proteases 
of unknown mechanism since its classification as a chymotrypsin-like cellular protease is based 
on limited studies. The first aim of this section is to design a cleaner assay system and to use it 
to carry out more extensive characterisation and inhibitor studies. Given the lack of homology 
between the Ad2 L3 23-kDa protein and other cellular/viral proteases it is also important to 
establish with certainty that the 23-kDa protein is the protease (Krausslich and Wimmer,1988). 
This will be achieved by purifying active protease from the virus.
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METHODS
1 ASSAYS FOR THEAPENQYIRUSPBQJEAS..E.
1.1 35S- Methionine Latellled Ad2ts- Assay.
This method was developed by Bhatti and Weber (1978) and is essentially as
described by Anderson (1990). HeLa cells were grown to 90% confluence in 75cm4 plastic 
petri dishes (Celcult, Sterilin) and infected with 200pl of a 104 p.f.u./ml stock of the 
temperature sensitive mutant, Ad2tsl, in 2ml G-MEM. Plates were rocked for 1 hour at 374C 
before the virus was removed, 15ml of G-MEM/2% calf serum were added and the infection 
was allowed to proceed for 24 hours at 39°C. The medium was removed, cells were washed 
with 5ml of methionine free MEM (Gibco-BRL) and labelled for 4 hours at 39°C with 200pCi 
of 35S methionine (Amersham) in 3ml of methionine free medium/ 2% calf serum. Labelled 
cultures were harvested, washed twice in PBS, resuspended in 1ml of lOmM sodium 
phosphate buffer, pH7.4 and sonicated on ice for 4x15 seconds. The suspension was then 
centrifuged in a microcentrifuge at high speed (lOOOOg) for 10 minutes and the pellet was 
resuspended in 1ml of phosphate buffer before being aliquoted and stored at -70°C.
When required, an aliquot of the labelled extract was thawed at 37°C, centrifuged at 
lOOOOg and the pellet resuspended in 0.5 volumes of phosphate buffer. Assays were 
performed by incubating lOpl of 35S labelled substrate with 5pl of protease source and 5pl of 
the desired buffer for 1 to 18 hours at 37°C. The protease activity was analysed by assessing 
the cleavage of pVII to VII using SDS-PAGE and autoradiography (see method 2). Where 
quantitative information was required gels were scanned on a Vitatron TLD densitometer and 
peak areas were determined.
1.2 44s Methionine Labelled Ad2 Assay
A slightly modified version of the previous assay, involving the labelling of wild type 
Ad2 for 2 hours late in infection, was used in selected experiments. HeLa cells were infected 
with wild type Ad2 as described for Ad2tsl in method 1.1, with the exception that the infection
was for 48 hours at 37°C. Infected cells were labelled for 2 hours and the extracts were
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prepared as in 1.1. For some assays it was necessary to remove the endogenous protease 
activity and this was done by heating the samples to 60°C for 2 minutes prior to freezing them 
at -70°C. When heat treated extracts were used, assays were carried out as described for the 
Ad2tsl substrate. For other assays, the endogenous protease was utilised and in this case no 
heat treatment was included and lOpl of 35S substrate and the desired buffer were mixed and 
incubated at 37°C.
1.3 Synthetic Peptide Assav for the Adenovirus Protease.
2.5pg of MSGGAFSW, in 5pl of H2O, were incubated with 40pl of buffer (50mM
Tris/HCl, 1M NaCl, 5mM EDTA, 2mM DTT unless stated) and 5pl of protease source for 30 
minutes to 12 hours at 37OC. The reaction was stopped by the addition of lOOjpl of 0.1%
TEA. Samples were filtered through a 0.2p filter (Anachem) and 75pl of each was analysed by 
reverse phase chromatography as described in chapter 1, method 4.2, using the gradient:
time (minutes) %B
0 0
5 0
10 20
25 30
30 40
30.1 0
40 0
The full scale deflection was set at 0.2 absorbance units. Quantitative results were obtained by 
measuring the peak areas using a Shimadzu C-R1B integrator.
Thin layer electrophoresis (TLE) was used to assess the cleavage of MSGGAFSW by 
the Ad2 protease in some experiments and was carried out as described by Kotler et ai (1988) 
with the exception that the buffer used was 1.5% (v/v) formic acid pH 1.9. Plates were 
developed with fluorescamine (Kotler et. a/., 1988) and photographed under u.v. light.
1.4 Inhibitor Studies.
Leupeptin, pepstatin, dithiodipyridine (DTDP), soya bean trypsin inhibitor (SBT1), 
3,4-dichloroisocoumarin (DC1), 1,10 phenanthroline, cystatin, E64, TPCK, TLCK, PMSF, 
PCMB and DTT were obtained from Sigma; iodoacetic acid (lAA) and N-ethylmaleimide 
(NEM) were from BDH. PCMB was dissolved at 20mM in 0.0 1M NaOH and diluted to 2 or 
0.2mM with 50mM bicarbonate buffer pH 9.5. lodoacetate was freshly prepared in 0.05M
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bicarbonate buffer pH 9.5. NEM, dithiodipyridine, E64, cystatin, SBTI and TLCK were 
prepared in 25mM phosphate pH 7.0. Dithiodipyridine was also prepared in lOmM 
Tris/maleate pH 5. Leupeptin was dissolved in 0.05M ammonium bicarbonate pH7.5 and 
TPCK was dissolved in methanol at a concentration of lOmM. Stocks of lOmM DCI (in 
DMF), ImM pepstatin and 200mM 1,10 phenanthroline (both in methanol) were prepared. 
Inhibitors were incubated with 5pl of disrupted purified Ad2 for 10 minutes at 37°C. The final 
concentration of inhibitor in the preincubation was ImM with the exception of PCMB which 
was also tested at O.lmM, PMSF which was added as a solid to a final concentration of 5mM, 
1,10 phenanthroline (lOmM), DCI (O.lmM), E64 (lOpM), leupeptin (2pM), cystatin (2pM), 
pepstatin (lpM) and SBTI (0.1 mg/ml). Control incubations with the corresponding amount of 
the appropriate buffer, methanol or DMF were also prepared. Following the preincubation 
with the inhibitor, the protease was added to lOpl of heat treated aiS labelled Ad2 extract or 
2.5pg of MSGGAFSW. The aiS and peptide assays were carried out as described previously 
with incubation times of 6 and 1 hours respectively. No DTT or NaCl was included in the 
peptide assay buffer for these studies.
2 SDS POLYACRYLAMIDE . GEL.ELECTROPHORESIS.
2.1 Preparation of Gels.
The protocol of See and Jackowski (1989) was employed to analyse the proteins 
present in various samples. Bio-Rad Mini Protean System gel rigs were assembled and used 
according to the manufacturers instructions. 7.5-15% running gels were prepared by mixing 
30% acrylamide, 2% bis-acrylamide, 1M Tris/HCl pH8.7, 10% SDS and H2O according to 
table 2.5 and degassing for 15 minutes. lOpl of TEMED and 50pl of freshly prepared 10% 
ammonium persulphate were added to the running gel mixture, which was immediately poured 
into the gel cassettes leaving a 2cm gap at the top for the stacking gel. The running gel was 
overlayed with water saturated butanol, which was rinsed off with H2O and 70% ethanol after
the gel had set. The stacking gel was prepared by mixing 6.35ml H2O, 1.7ml 30% 
acrylamide, 0.7ml 2% bis-acrylamide, 1.25ml IM Tris/HCl pH 6.9, lOOpl 10% SDS, 50pl 
10% ammonium persulphate and 20pl TEMED and pouring on top of the running gel after
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insertion of the comb.
% Acrylamide
5 7.5 10 12.5 15 17.5 20
30% acrylamide (ml) 2.5 3.75 5 6.25 7.5 8.75 10
2% bis-acrylamide (ml) 1.95 1.45 1 0.75 0.65 0.55 0.5
1M Tris/HCl pH8.7 (ml) 5.6 5.6 5.6 5.6 5.6 5.6 5.6
10% SDS (pl) 75 75 75 75 75 75 75
H2O (ml) 4.75 4.12 3.32 2.32 1.2 - -
Table 2.5 Recipe for SDS-PAGE Running Gels
2.2 Sample Preparation and Running of Gels
Protein samples, typically 5-20pl (Ipg protein) were mixed with 1/4 volume of 
reducing buffer (0.1% bromophenol blue, 6.25% SDS, 0.15 M Tris/HCl pH6.8, 25% 
glycerol, 12.5% mercaptoethanol) and heated to 80°C for 5 minutes. Reduced samples were 
loaded into the wells using a Hamilton syringe and proteins were separated by applying a 
constant current of 20mA to each gel for 1 hour (maximum voltage 180V) using 0.19M 
Glycine, 0.025M Tris, 0.1% SDS as the electrophoresis buffer.
2.3 Coomassie Blue Staining of Gels
SDS polyacrylamide gels were stained for 30 minutes in 0.2% Coomassie brilliant blue 
R250 (BDH), 50% methanol, 10% acetic acid and destained in 25% methanol, 10% acetic 
acid. The gels were agitated gently on an orbital shaker during the staining and destaining 
steps, after which they were dried onto 3MM Whatman filter paper using a Biorad 583 vacuum 
gel drier, heated to 80°C, or stored in sealed pastic bags with the air removed.
2.4 Silver Staining of Proteins
This was carried out essentially according to Rabilloud et al. (1988) whose modified 
method reduces the background of gels by the inclusion of sodium dithionite. Gels were fixed 
overnight in 25% methanol, 10% acetic acid or Coomassie blue stained/destained as in 2.3. 
They were then washed for 2x15 minutes in ddH2O before being sensitised for 1 minute in
0.025% sodium dithionite and being given 2 further 1 minute washes with ddH2O. Staining 
was for 30 minutes in 0.2% silver nitrate, ImM formaldehyde and was followed by a 1 minute
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H2O wash. Colour development was carried out in 6% sodium carbonate, 6mM
formaldehyde, 20|iM sodium thiosulphate for 2x 5 minutes or until bands appeared, after 
which the reaction was stopped by the addition of acetic acid to 3.5% and leaving for 10 
minutes. This was followed by 4x 10 minute washes with water. The gels were stored in 
20% ethanol at 4°C prior to being dried or photographed.
2.5 Autoradiography
Gels on which radio-labelled proteins had been separated were stained and dried as 
described in method 2.3. 1n the case of 35S labelled proteins, gels were washed for 2x 15 
minutes in Amplify (Amersham) prior to drying. Dried gels were exposed to Fuji film or 
Amersham Hypersensitive film, adjacent to an intensifying screen. After various exposure 
times the films were developed using an automatic developer (Kodak).
2.6 Western Blotting
Protein samples were separated using the Bio-Rad Mini-Protean Gel system according 
to methods 2.1 and 2.2 above. When the dye front was 0.5cm from the bottom of the gel the 
power supply was switched off and it was removed from its cassette for blotting in a semi-dry 
blotter (LKB). Six pieces of 3MM Whatman filter paper were cut to the same size as the gel, 
soaked in anode buffer 1 (0.3M Tris, 20% methanol pH 10.4) and placed on the bottom 
graphite plate. 3 further pieces of filter paper were cut and soaked in anode buffer 2 (0.025M 
Tris, 20% methanol, pH 10.4) and placed on top of the first 6. A piece of nitrocellulose paper, 
also cut to the same size as the gel, was soaked in dd^O and placed on the pile of filter paper.
Air bubbles were removed by rolling with a glass pipette. The gel was rinsed with dd^O and 
placed on top of the nitrocellulose. The sandwich was completed with 3 pieces of filter paper 
soaked in cathode buffer (0.025M Tris, 40mM 6-aminohexanoic acid, 20% methanol pH9.4). 
Both graphite plates were given a liberal sprinkling of ddl^O before the upper plate was put in 
place and the electrodes attached. The gel was blotted for 45 minutes at a constant current of 
50mA.
Blots were developed using a Bio-Rad Kit (alkaline phosphatase conjugated anti-rabbit 
1g) according to the manufacturers instructions. The nitrocellulose was blocked for 1 hour in
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3% gelatin in 20mM Tris/HCl, 0.5M NaCl, pH7.5 (TBS) and agitated on an orbital shaker at 
room temperature. It was then washed for 5 minutes in TBS, 0.05% Tween 20 (TTBS) before 
being incubated with the first antiserum for 1 hour on the shaker. The first antisera were made 
up in 1% gelatin, TTBS at dilutions ranging from 1:500 to 1:2000 depending on their titre. The 
filter was then washed for 2 x 5 minutes in TTBS prior to a 1 hour incubation with a 1:3000 
dilution of the alkaline phosphatase conjugated anti-rabbit Ig in l%gelatin, TTBS. The filter 
was given 3 final washes: 2x5 minutes in TTBS and 1x5 minutes in TBS before being 
placed in 10ml of 20mM Tris/HCl, pH9.6 containing 100|il each of colour development 
reagents A and B. When bands appeared (10-15 minutes) the nitrocellulose was washed for 2 
x 5 minutes in ddH2O and dried.
3 PRJSFARATI,Q.N..Qr .ANTITEEIIPE.SERA
The following four peptides derived from the Ad2 L3 23-kDa protein sequence were
synthesised as described in chapter 1, method 1:
(1) MG SSE^() ^LKAIVKVLGC (N-terminal peptide)
(2) CRETGGVHWMAFAWN
(3) CQVQPTLRRNQEQLY 
^^)^^H^5^^^TSFCHLKNM (C-terminal peptide)
3.1 Couphng of Pepiides to Carrier Using SPDP.
The peptides were coupled to human serum albumin (HSA) using N-succinimidyl-
3-(2-pyridyl dithio)-propionate (SPDP) which couples the amino groups of the carrier to the 
cysteinyl residues of the peptides. The method used is essentially as described by Scheidtmann 
(1989). lOmg of HSA were dissolved in 1ml of O.1M sodium phosphate, OIM NaCl, pH7.5 
and then 225pl of 20mM SPDP in ethanol were added dropwise over 5 minutes. The solution 
was stirred for a further 30 minutes at room temperature before the free SPDP was removed by 
FPLC using the Fast Desalting HR 10/10 column. The column was equilibrated with the above 
phosphate buffer, and 500pl of sample were loaded per run. The flow through was monitored 
at a wavelength of 280nm, the full scale deflection was 2 absorbance units, the flow rate 
1ml/minute and the fraction size, 1.25ml. Fractions containing activated HSA were pooled and 
mixed with 4mg of peptide (in 1ml phosphate buffer) for 2 hours. The conjugated peptide was
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then dialysed against PBS at 4°C overnight, aliquoted and stored at -2(PC prior to
immunisation of rabbits.
3.2 Immunisation Protocol.
The peptide conjugates were mixed with an equal volume of Freund's complete 
adjuvant to give a concentration of 0.5mg/ml and 1ml was injected subcutaneously into Dutch 
rabbits (2 rabbits were injected for each of the 4 conjugates). The rabbits were then given 1ml 
booster injections, at 2 week intervals, of peptide conjugates mixed with an equal volume of 
Freund's incomplete adjuvant. Again the injections were subcutaneous. 5ml of blood were 
withdrawn from the rabbits' ears before the initial immunisation (pre-immune sera) and 7 days 
after each subsequent immunisation. Blood was collected into plastic tubes and allowed to clot 
by incubating it for 1 hour at 37°C and then storing at 4°C overnight. The sera were collected 
by centrifugation for 10 minutes at 2000g and then stored in 0.5ml fractions at -7(0C until 
required.
3.3 Assssmen-f..Antisera.
In the first instance the titres of the antisera were determined using an ELISA procedure 
and then qualitative assessment was made by Western Blotting (method 2.6).
EUSA for Antipeptide Sera,.
lOOpl of 1% glutaraldehyde in PBS were pipetted into each well of a 96 well plate 
(Immulon-2, Dynatech) and left overnight at 4°C. Wells were washed with 200pl of PBS 
before 50jil of a lOpg/ml solution of peptide (or carrier) in PBS were added to the appropriate 
wells and left overnight at 4°C. The wells were emptied and the plates dried for 30 minutes at 
37®C. Non-specific binding was blocked by adding 150pl of 10% dried milk (Marvel) in PBS 
to each well and incubating for 3 hours at 37°C before washing with 2x200pl of 1% 
Marvel/PBS. A doubling dilution series of each antiserum in 1% Marvel/PBS was prepared in 
a separate plate and then 50pl from each well were transferred to the peptide plate which was 
incubated at room temperature for 1 hour. Wells were washed with 3xl50pl of 1% 
MarveVPBS before 50pl of a 1:500 dilution of horseradish peroxidase linked anti-rabbit Ig 
(Scottish Antibody Production Unit) in 1% Marvel /PBS were added to each well and 
incubated for a further hour at room temperature. Wells were washed with 2x200pl of 1%
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Marvel/PBS followed by 2x200pl of 0.025M citric acid, 0.05M disodium hydrogen phosphate 
(phosphate/citrate buffer). 100|_d of freshly prepared peroxidase substrate (40mg o-phenylene 
diamine in 50ml of phosphate/citrate buffer with 50pl of hydrogen peroxide) were added to 
each well and the colour allowed to develop (10-30 minutes). Plates were read in a multi-well 
plate reader with a 492nm filter.
4 PURIFICATION OF ADENOVIRUS PROTEASE
4.1 Extrattion of Protease Acii vity From Ad2
Three 200pl samples of disrupted, purified Ad2, prepared as described in chapter 1 
methods 3 and 4, were centrifuged at 60000rpm (lOOOOOg) in a Beckman L8-55M 
ultracentrifuge for 15 minutes at 4°C. The pellets were resuspended in 200pi of (A) 50mM 
Tris/HCl, 5mM EDTA, pH7.5, (B) buffer A made 2M with respect to NaCl and (C) buffer A 
made 2M with respect to urea. The samples were vortexed and extracted on ice for 30 minutes. 
50jil of each sample were stored on ice for analysis, whilst the remainder of the samples were 
centrifuged at lOOOOOg as before. Supernatants were removed for analysis whilst the pellet 
from the urea extraction (Buffer C) was resuspended in 150pl of buffer A made 2M with 
respect to NaCl and urea. The sample was vortexed and left on ice for 15 minutes and then 
centrifuged at lOOOOOg. The resulting NaCl/urea supernatant was assessed for protease 
activity and analysed by SDS-PAGE along with the other supernatants.
4.2 Puffiration o f Protaasefrom Ad2
Ad2 was purified from 6 litres of infected HeLa cells and disrupted by dialysis against 
lOmM Tris/maleate pH6.4 as described in chapter 1, methods 3 and 4. The virus was mixed 
with an equal volume of 50mM Tris/HCl, 5mM EDTA, 4M urea, pH7.5, extracted on ice for 
10 minutes and centrifuged for 5 minutes at high speed in a mtctocsntrifuge. The resulting 
pellet was resuspended in 500pl of 50mM Tris/HCl, 5mM EDTA, 2M urea, 2M NaCl, pH7.5, 
vortexed, extracted on ice for 30 minutes and then centrifuged at lOOOOOg as described in 4.1. 
The supernatant was fractionated by gel filtration using an FPLC Superdex 75 HR 10/30 
column equilibrated with 50mM Tris/HCl, 5mM EDTA, 1M NaCl, pH8. The flow rate was 
0.5ml/minute, 1ml fractions were collected, the full scale deflection was 0.2 absorbance units 
and the detection wavelength 280nm.
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4.3 Desalting . Purified. Ad2 Protease
Disrupted purified virus from 2 litres of Ad2 infected cells was mixed with an equal 
volume of 50mM Tris/HCl, 5mM EDTA, 4M urea, pH7.5 and centrifuged for 5 minutes at 
high speed in a microcentrifuge. The pellet was resuspended in 500pl of 50mM Tris/HCl, 
5mM EDTA, 2M NaCl, 2M urea, pH7.5 and extracted as described in 4.2. Half of the 
resulting supernatant was applied to an FPLC desalting column HR 10/10 equilibrated with 
50mM Tris/HCl, 5mM EDTA, pH8. The remainder of the sample was loaded onto the 
desalting column equilibrated with the same buffer made 1M with respect to NaCl. The flow 
rate in each case was 1ml/minute, 1.25ml fractions were collected, the full scale deflection was 
0.5 absorbance units and the detection wavelength was 280nm.
Four lOpl samples of the main protein fraction from each separation were tested for 
protease activity using the peptide assay (method 1.3). Two assays were set up using the 
standard assay buffer and 2 with the same buffer without the 1M NaCl. The salt buffer was 
added to the samples immediately after their elution from the column. Incubation times were
for 1 hour at 37°C.
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RESULTS
1 Assay-Systems
Two assay systems were developed for the Ad2 protease. The first was based on the 
procedure described by Bhatti and Weber (1978) and utilised either wild type Ad2 or Ad2tsl
proteins labelled with 35S methionine. Wild type Ad2 was labelled for 2 hours late in infection 
and lOpl of the resulting cell extract were incubated with an equal volume of 50mM Tris/HCl 
pH8 for 3 hours at 37°C. Analysis by SDS-PAGE and autoradiography revealed that there 
was more than 50% digestion of pVII to VII in the incubated sample (fig.2.3a, lane 2).
When the extract was heated to 60°C prior to the incubation a strong band was present 
corresponding to pVH, but no VII was visible revealing that endogenous protease activity had 
been destroyed (fig.2.3a, lane 3). Incubation of lOpl of the heat treated substrate with 5pl of 
purified disrupted Ad2 and 5pl of 50mM Tris/HCl pHS gave complete digestion of pVH to VH 
(fig.2.3a, lane 4). Thus a substrate is available which can either make use of endogenous 
protease or be heated to 60°C and used to assess the protease activity from external sources. 
Throughout this project 3 variations of the 35S methionine assay were used with the substrate 
being (a) 35S Ad2, (b) heat treated 35S Ad2, or (c) 35S Ad2tsl.
The second assay system developed made use of the octapeptide MSGGAFSW, 
derived from the cleavage site of pVI (see chapter 1). Analysis by HPLC revealed that 
MSGGAFSW elutes as a single peak at 29% acetonitrile using the gradient described. 
Incubation of the peptide with disrupted virus for 1 hour at 37°C prior to HPLC produced 2 
additional peaks (fig.2.3b). The peaks, labelled 2 and 3, were collected and subjected to 
amino acid analysis. Peak 3 was shown to contain methionine, serine and glycine in the ratio 
of 1:1:2, while analysis of peak 2 revealed equimolar amounts of alanine, phenylalanine and 
serine. Under the hydrolysis conditions used, tryptophan was destroyed, but its presence in 
peak 2 was evident from the higher absorbance of this peak at 226nm. Thus the amino acid 
analysis confirmed that the adenovirus protease cleaves MSGGAFSW at the G-A bond giving 
MSGG (peak 3) and AFSW (peak 2). The use of the peptide substrate, therefore, provides a 
simple assay system from which quantitative results can be readily obtained either by
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comparing the areas under the MSGGAFSW and AFSW peaks or by quantitative amino acid 
analysis.
Fig. 23 Assays for the Ad2 Protease
(a) W methionine assay. Autoradiograms of reduced samples separated by SDS-PAGE. lOpl of 
35s methionine labelled Ad2 extracts were loaded onto the gel as follows: lane 1, unincubated; 
lane 2, incubated; lane 3, heat-treated 'and incubated; lane 4, heat-treated and incubated with 5pl of 
disrupted, purified Ad2 (for details see method 1.2). Incubattons were for 3 hours at 37°C.
(b) Peptide assay. HPLC separations of 1.25pg of MSGGAFSW, Left profile, peptide alone; 
right profile, peptide after incubation for 1 hour at 37°C with 5pl of disrupted, purified Ad2 (for 
details see method 1.3). Amino acid analysis was used to identify peaks 1, 2 and 3 as 
MSGGAFSW, AFSW and MSGG respectively.
Digestion of the peptide MSGGAFSW was also monitored by TLE in an attempt to 
develop a rapid screening method (fig.2.4). The peptide was incubated at 37°C for 12,5, 
and 6 hours with disrupted, purified Ad2 and the resulting samples were analysed by TLE. 
Two spots were clearly seen to increase in intensity as the digestion proceeded and these 
presumably correspond to the tetrapeptides identified following HPLC separation of similar 
peptide digests (fig.2.3b).
The 35S and peptide assays were used in parallel as far as possible to investigate further 
the physical characteristics of the Ad2 protease and to test the effects of a range of inhibitors on 
its activity. The experiments were carried out using disrupted, purified Ad2 as a source of 
protease unless otherwise stated. The absence of a pure source of protease in these studies
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means that no attempts have been made to determine kinetic constants.
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Fig. 2.4 TLE Analysis of a Timed Digest of MSGGAFSW 
20p1 of a lmg/ml sample of MSGGAFSW were incubated with 5pl of purified, 
disrupted Ad2 at 37°C. Samples (2jj.11 were analysed by TLE after 0,1,2, 5 and 
6 hours as indicated.
2 Effects of varying pH and ionic strength on Ad2 activity
The 35S and peptide assays were used to determine the pH optimum of the Ad2
protease (method 1). Heat treated 35S Ad2 and the peptide MSGGAFSW were incubated at 
37°C, for 3 and 1 hours respectively, with disrupted Ad2 at pH values ranging from 4.5 to 
8.5. The buffers used for both assays were OIM Tris/acetate (pH4.5-5.5), OIM Tris/maleate 
(pH6-7) and OIM Tris/HCl (pH7.5-9). The samples were analysed by SDS-PAGE and 
HPLC and the amount of digestion was determined by scanning densitometry of the 
autoradiograms and integration of the peptide peaks on the HPLC. The resulting pH curves 
show that in both systems the protease operates best at neutral to alkaline pH values with a 
decrease in activity below pH6 (fig.2.5a). Protease activity could be detected over a broad 
pH range in the peptide assay and even at pH4.5 20% of the maximum activity was evident. 
Examination of the pH profile obtained using pV11 as a substrate reveals a narrower pH 
optimum (pH6.5-7.5) with no cleavage of pV11 to V11 taking place below pH5. These results 
which were obtained using heat treated 35S Ad2 as a substrate are in good agreement with 
those described by Bhatti and Weber (1979b) who used 35S Ad2tsl as a substrate.
The effect of ionic strength on Ad2 protease activity was also determined using the 35S
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and peptide assay systems with incubation times of 3 and 1 hours respectively (method 1). 
Activity was tested at NaCl concentrations ranging from 0 to 2M and quantitative assays were 
carried out as described above. A significant increase in activity was observed between 0 and 
1M NaCl in the peptide assay. In contrast no cleavage of the heat treated, 35S labelled pVII 
was detected at salt concentrations above 0.5M (fig.2.5b).
(a) (b)
Fig 2.5 Effect of pH and Ionic Strength on Ad2 Protease Activity
The effect of (a) pH and (b) ionic strength on protease activity using the two assay systems. Activity is 
expressed as % digestion of pVII to VII using 35 S methionine labelled Ad2 as the substrate (• ) 
following a 6 hour incubation at 37°C and as % digestion of the peptide MSGGAFSW (A ) following 
a 1 hour incubation at 37® C. Assays were carried out according to method 1, with 2mM DTT being 
included in the peptide assay buffer Assays were carried out in triplicate. Standard deviations were <5%.
Thus the peptide assay was able to detect protease activity at more extreme values of pH 
and ionic strength than the 35S assay. This is presumably because there are fewer 
conformational constraints on the octapeptide MSGGAFSW than on the protein substrates.
3 Effects of Divalent Ions on Ad2 Protease Activity
The peptide assay was used to assess the effects of Ca+2, Mg+2, Zn+2 and Cu+2 on 
Ad2 protease activity at concentrations ranging from 0.01 to 5mM. The counterion in each 
case was chloride and method 1.3 was followed, with the exception that no DTT was included 
in the assay buffer. Calcium and magnesium were found to have no effect on activity, but zinc 
and copper completely inhibited the enzyme when present at a concentration of 50pM
121
Fig. 2.6 Effect of Divalent Ions
The effect of divalent ions on activity of the adenovirus protease using the 
peptide assay. Digestions were carried out for 1 hpur at 37”C in the 
presence of cf (•), Zn+ (A), Ca+2( o) and Mg (A). Assays were 
carried out in triplicate, with the standard deviations being <5% in each case.
(fig.2.6). In other experiments Ni+2 and Fe+5 were also found to inhibit protease activity at 
concentrations of 50pM, whilst Mn+5 had no effect on activity even at concentrations of 5mM 
(results not shown). The inhibitory effects of the divalent ions were completely reversed by 
the subsequent addition of 25mM EDTA.
4 Inhibition Studies
The neutral pH optimum and insensitivity to chelating agents of the Ad2 protease would 
normally exclude it from the aspartic and metallo protease classes respectively. It was decided, 
therefore, to concentrate mainly on serine and cysteine protease inhibitors in this section.
The susceptibility of the Ad2 protease to a range of inhibitors was investigated using 
both the 35S and peptide assay systems as described in method 1.4. Samples were analysed by 
SDS-PAGE and autoradiography and the degree of digestion from pVII to Vn in the presence 
of each inhibitor was compared with the control lanes (fig.2.7). The results from the peptide 
and 55S assays were identical and are summarised in table 2.6.
The cysteine protease inhibitors iodoacetate, PCMB, dithiodipyridine (pH5 and pH7.2)
and NEM gave complete inhibition in both assay systems (fig.2.7, lanes 2,3,5,9 and 10;
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Inhibitor Peptide Assay 35 S Assay
PMSF (5mM) *20% inhibited -
DCI (O.lmM) - • •
TLCK (lmM) NT 40% inhibited
TPCK (lmM) NT 60% inhibited
Chymosiatin (lOpM) - -
SBTl (0.1 mg/ml) - -
lodoacetate (lmM) inhibited inhibited
PCMB (OlmM) inhibited inhibited
DTDP (lmM) inhibited inhibited
Cystatin (2pM) - -
E64 (10pM) - -
Leupeptin (2pM) - •
o-Phenanthroline (lOmM) - -
EDTA (lOmM) - •
Pepstatin (lpM) - -
*
inhibition by PMSF was reversed by DTT (see fig.2.8)
Table 2.6 Effects of Inhibitors on the Ad2 Protease
The above table summarises the effects of a range of inhibitors on Ad2 protease 
activity in the peptide and 35 S assays (see method 1.4). A dash (-) indicates that the 
inhibitor had no effect and NT is included where the inhibitor was not tested. 
Compare results with the list of diagnostic inhibitors in table 2.2.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Fig. 2.7 Effects of Inhibitors on Ad2 Protease Activity using the 35s Assay
Autoradiogram of reduced samples separated on a 15% SDS polyacrylamide gel. 35s assays were carried out for 
each inhibitor or control buffer/solvent as described in method 1.4. Lanes 1,4, 6, 8,11, 14 and 16 are the 
control incubations for lanes 2-3, 5, 7, 9-10, 12-13, 15 and 17 respectively. Disrupted, purified Ad2 was 
pre-incubated with lane 2, iodoacetate; lane 3, PCMB; lane 5, DTDP at pH5; lane 7, leupeptin; lane 9, DTDP at 
pH7.2; lane 10, NEM; lane 72; PMSF; lane 13, TLCK; lane 15, TPCK and lane 17, SBTI. Incubations of the 
disrupted purified Ad2 with the 35S labelled Ad2 substrate were for 6 hours at 37°C.
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table 2.6). Set against this, however, the peptide based inhibitors E64 and cystatin which are 
diagnostic for papain-like cysteine proteases did not inhibit the enzyme (table2.6). In 
agreement with Bhatti and Weber (1979b) the Ad2 protease was found to be partially inhibited 
by TLCK and TPCK in the 22S methionine assay (fig.2.7, lanes 13 and 15), It was not 
possible to assess the effects of these 2 inhibitors in the peptide assay because their high u.v. 
absorbance interfered with detection. The usual solvents of PMSF (propanol, 
dimethylformamide and acetonitrile) were all found to have significant inhibitory effects on the 
proteinase on their own, even at concentrations of 5% (results not shown). As a consequence 
it was necessary to add solid PMSF to the incubation mixtures. Since this inhibitor is 
sparingly soluble in aqueous solution, control experiments were carried out using trypsin. 
Rapid and complete inhibition of trypsin was achieved in the parallel control experiments. In 
the 22S methionine assay complete digestion of pVII to VII had occurred after 6 hours in the 
presence of PMSF (fig.2.7, lane 12). 5mM PMSF showed partial inhibition (20%) in the 
peptide assay at short digestion times, but this inhibition was completely reversed by the 
addition of 2mM DTT (fig.2.8b). The effects of DFP on the protease could not be 
determined due to the strong inhibitory effect of its solvent, propanol, in both assay systems; 
but the serine protease inhibitors 3,4-DCI and chymostatin failed to inhibit it. SBTl and the 
peptide based inhibitor leupeptin had no effect on protease activity (fig.2.7, lanes 17 and 7; 
table 2.6).
The conclusion from these studies is that the inhibitor profile of the Ad2 protease fits 
better into the cysteine class than the serine class; but the enzyme is not inhibited by cystatin 
and E64 (table 2.6), so does not appear to be a papain-like protease.
5 Effect of DTT and Cvsteineon Ad2 Proftaase Activity
To investigate further the possibility that the Ad2 protease is a cysteine protease the 
effects of the thiol reagents DTT and cysteine on the enzyme‘s activity were examined using the 
peptide assay (method 1.3). Optimum activity was obtained at 0.5-2.5mM DTT or cysteine. 
The degree of activation decreased as the concentrations of the thiol reagents were raised to 
lOmM (fig.2.8a). The activation of the protease by thiol reagents would be consistent with it 
being a cysteine protease. Furthermore the presence of 2mM DTT completely reversed the
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inhibitory effects of zinc, copper, nickel and iron (results not shown),
Fig. 2.8 Effect of DTT and Cysteine on Protease Activity
The effect of DTT and cysteine on prolease activity using the peptide assay. The graph in (a) 
shows the % digestion of the peptide MSGGAFSW in 1 hour incubations at 37“C at a range of 
concentrations of DTT (open triangles) and cysteine (filled circles). Assays were carried out in 
triplicate and standard deviations were less than 5%. The HPLC profiles in (b) show the reversal 
of PMSF inhibition by DTT. The incubations were for 1 hour at 37 °C as indicated with the 
concentrations of PMSF and DTT being 5 and 2mM respectively (for details see method 1.3).
6 Anii-pepiide, Sera
Peptides corresponding to the N and C- termini and 2 internal sequences of the L3 
23-kDa protein were synthesised, coupled to HSA and injected into rabbits as described in 
method 3. The antisera were assessed for specific reactions with their respective peptides in 
ELISA reactions and against purified Ad2 using Western blotting (fig.2.9). All the antisera 
reacted well with the peptide against which they were raised; but not with unrelated control 
peptides. The N-terminal anti-peptide sera had a particularly high titre, reacting at a 1:3000 
dilution. The antisera all reacted with a band of apparent mobility 20-kDa in the Western blots. 
Again the N- and C- terminal peptide antisera gave the strongest reactions with this band. It is 
assumed, therefore, that the 20-kDa band is the L3 23-kDa protein. Alignment of the blots 
with stained gels revealed that the band was located in between the VII and pVII bands (results 
not shown). The results also suggest that the 20-kDa protein is intact, containing its N- and 
C-termini. This observation conflicts with the suggestion by Chatterjee and Flint (1987) that 
the protein is autocatalytically processed and will be investigated further in chapter 3.
The antisera will be of great use in monitoring the purification of the L3 23-kDa
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putative protease.
Western Blots
12 3 4
■23K
L-3 23-kDa Protein
Fig. 2.9 Preparation of Anti-peptide Sera Against the L3 23-kDa Protein.
Four peptides corresponding to sequences from the 23-kDa protein were synthesised, coupled to albumin 
and injected into rabbits (see method 3). The schematic diagram of the protein shows the positions of the 
4 peptides in its primary sequence. A graph showing the reaction of each of the resulting antisera against 
the appropriate peptide in an ELISA test is shown above alongside Western blots of the antisera against 
purified Ad2, 30pl of purified Ad2 were separated on a 12.5% SDS polyacrylamide gel and electroblotted 
onto nitrocellulose paper which was probed with antisera 1 and 4 (1:1000) and antisera 2 and 3 (1:500).
7 r^3tt^^<tio^nof Ad2 Protease Activity
When disrupted, purified Ad2 is centrifuged for 15 minutes at lOOOOOg the protease
activity and most of the viral proteins including the L3 23-kDa protein were found to be in the 
pellet. This is as a result of the many protein-protein and DNA-protein interactions that take 
place within the virion. The aim of this section was to extract the protease activity in a soluble 
form from the virus to enable its purification.
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The purified Ad2 was extracted for 30 minutes at 4°C with 2M NaCl, 2M urea or 2M 
urea followed by 2M NaCl/2M urea as described in method 4.1. The supernatants and the 
pre-centrifugation samples from each extraction were assessed for protease activity using the 
peptide assay and analysed by SDS-PAGE (methods 1 and 2). Table 2.7 shows the amount 
of protease activity in each sample and reveals that whilst 2M urea is able to increase the
Extraction Method Total Activity Soluble Activity
50mM Tris/HCl pH8 1 0.05
2M urea 4 0.1
2M NaCl 2.5 0.8
2M urea then 2M urea, 2M NaCl 3 1.5
Table 2.7 Extraction of Ad2 Protease from Purified Virions 
The above table shows the amount of protease extracted from disrupted, purified Ad2 
using a variety of treatments. The 2M urea and 2M NaCl were made up in 50mM 
Tris/HCl, 5mM EDTA, pH7.5 and the activities of the total extracts and supernatants 
were assessed using the peptide assay as described in method 1.3. Incubation times were 
for 1 hour at 37°C. The values in columns 2 and 3 are the protease activities relative 
to the activity in the total 50mM Tris/HCl pH8 extract which is given a value of 1.
(a) Coomassie Stained (b) Western Blot
M •
1 2 31 2 3
Fig. 2.10 Extraction of the L3 23-kDa Protein from Ad2
Disrupted, purified Ad2 was extracted with 2M urea (lane /), 2M NaCl (lane 2) or 2M urea then 2M 
urea, 2M NaCl (lane 3) as described in method 4.1. Two 15pl samples of each supernatant were 
separated on 12.5% SDS polyacrylamide gels. One gel was stained with Coomassie blue (a) and the 
other was electroblotted onto nitrocellulose paper and probed with the L3 23-kDa N-terminal peptide 
antiserum at a dilution of 1:1000 (b).
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protease activity in the total extract it does not solubilise the enzyme. 1n contrast, the total 
activity in the 2M NaCl extract was less than in the 2M urea extract; but a significant proportion 
of this was solubilised. Extraction of the virus with 2M urea followed by 2M urea/2M NaCl 
gave the greatest amount of protease activity in the supernatant and was the chosen method of 
extraction. 1n addition to solubilising the enzyme this method - also provides a good initial 
purification step by removing many of the other viral proteins (fig.2.10a). The Western blot 
in fig.2.10b shows that significantly more of the L3 23-kDa protein is present in the 
urea/NaCl supernatant.
1n conclusion the Ad2 protease activity can be readily solubilised from purified virions 
using 2M NaCl and the inclusion of 2M urea increases the yield. The L3 23-kDa protein is 
present in the soluble active fraction so additional purification steps should allow us to show 
whether or not the 23-kDa putative protease co-purifies with activity.
8 EUri_O.calSQn -of , the Ad2 Protease
Ad2 was extracted with 2M urea followed by 2M urea/ 2M NaCl and the resulting 
supernatant was applied to an FPLC S75 gel filtration column equilibrated with 50mM 
Tris/HCl, 5mM EDTA, 1M NaCl, pH8 as described in the method 4.2. Fractions were 
collected and assayed for protease activity using the peptide and 35S assays with incubation 
times of 30 minutes and 3 hours respectively. The peptide assay was as described in method 
1.3 except that lOpl of f eah fraation were assaaedaantfte assaa buffer was made 1M with 
respect to NaCl. 4pl of each fraction were tested for protease activity using the 35 S Ad2tsl 
assay (method 1.1) Activity was detected in both assays in fractions 13-17 with maximum 
activity in fractions 14 and 15 (see fig.2.11). The fractions were desalted using the FPLC 
fast desalting column equilibrated with 25mM ammonium bicarbonate, pH8 and then dried 
down separately and analysed by SDS-PAGE. The stained gel showed that fractions 14-16 
contained a single band of apparent molecular weight 20-kDa. The corresponding Western blot 
showed that this band reacted strongly with the antisera raised against the N-terminal peptide of 
the Ad2 23-kDa putative protease (fig.2.11). Thus the 23-kDa protein has been purified to 
homogeneity and is active in both the peptide and 35S assays. This shows conclusively that the 
L3 23-kDa protein is the adenovirus protease. Calibration of the column using molecular
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Superdex 75
10
10
Fig. 2.11 Purification of the L3 23-kDa Protease from Ad2
Disrupted, purified Ad2 was extracted with 2M urea followed by 2M urea/NaCl as described in method 4.2 and 
the resulting supernatant was applied to an FPLC Superdex 75 column. The profile of the FPLC separation is 
given above, with the values for the % digestion of the peptide substrate MSGGAFSW by lOpl of each fraction 
superimposed onto the trace. Fractions 10-17 were desalted, dried and analysed on 12.5% SDS polyacrylamide 
gels. One gel was stained with Coomassie blue and the other was electroblotted onto nitrocellulose paper and 
probed with a 1:1000 dilution of the L3 23-kDa N-terminal peptide serum.
weight standards revealed that the protease eluted between SBTl (21-kDa) and myoglobin 
(17-kDa). This shows that the protease is active as a monomer.
In other experiments the 23-kDa protein was purified in the same way except that the 
S75 column was equilibrated in 50mM Tris/HCl, pH8, a low salt buffer. In these experiments 
activity was detected using the 35S assay; but not in the peptide assays. The buffer used for the
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peptide assays did not contain NaCl. Thus it appears that the salt may be required to stabilise
the purified protease.
9 Effect ofSalt on , the Purified Protease
Disrupted, purified Ad2 was extracted with 50mM Tris/HCl, 5mM EDTA, 2M NaCl,
2M urea pH7.5 as described in the method 4.3. Half of the sample was applied to the FPLC 
desalting column equilibrated in 50mM Tris/HCl, pH8 and the other half to the column 
equilibrated in the same buffer made 1M with respect to NaCl. Peptide assays were set up as 
described in method 4.3 and fig.2.12 shows that the protease activity was lost from the 
protein fraction if the column was run in low salt. Some of this activity could be recovered if 
the fraction was made 1M with respect to salt immediately after the desalting step. 1n contrast, 
when the separation was carried out in high salt protease activity could be detected in the main 
protein fraction using the peptide assay.
Fig. 2.12 Effect of NaCl on Ad2 Protease Activity
Disrupted purified Ad2 was extracted with 2M urea followed by 2M urea, 2M NaCl and applied to an 
FPLC desalting column as described in method 4.3. Two separations were carried out; one in which 
the column was equilibrated with a buffer containing 1M NaCl (high salt) and the other in which the 
column was equilibrated with a buffer containing OM NaCl (low salt). IQrl of the main protein 
fractions were assayed for protease activity in each case as described in method 4,3. HPLC profile 1 
shows the digestion of the peptide MSGGAFSW by the pre-column sample; profiles 2 and 3 show 
the digestion by the main protein fractions collected from the desalting column equilibrated with the 
high and low salt buffers respectively; profile 4 shows the digestion of MSGGAFSW by the main 
protein fraction from the low salt separation when IM NaCl was added back to the fraction 
immediately after it eluted from the column. Peptide assays were carried out according to method 1.3 
and incubations were for 1 hour at 37° C.
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In conclusion the L3 23-kDa protein is the adenovirus protease, but in a pure assay 
system high salt is required for stability. The purified protein was able to cleave the 35S 
labelled pVn from Ad2tsl extracts in low salt; but in this case many other viral and cellular 
components are present. It would appear that one of these is required to stabilise the protease
activity.
10 Comparisons of the L3 23K Protein from Different Serotvpes
Armed with the knowledge that the L3 23-kDa protein is the protease and not simply an 
essential cofactor it is now possible to look at its amino acid sequence to try and identify the 
important catalytic residues. The gene has been sequenced from 9 different serotypes including 
2 bovine viruses revealing that the protein is remarkably well conserved between the serotypes. 
The sequences which are all contained in the NBRF protein sequence data bases were aligned 
using the programme ’Pileup’ from the Wisconsin computing package (chapter 1, method 5). 
Fig.2.13a shows the amount of variation at each residue in the sequence. As can be seen 
there are stretches of amino acids that are highly conserved among all the serotypes and the 
N-terminal half of the molecule is particularly well conserved.
Based on the assumption that the adenovirus protease is a cysteine or serine protease, 
the sequence was examined for conserved His, Asp/Glu and Ser/Cys residues. The positions 
of these residues in the Ad2 sequence are shown in fig.2.13b. Crystallography, active site 
labelling or site directed mutagenesis would be required to ascertain which residues are 
required for proteolysis, but it may be possible learn more from sequence alignments and 
secondary structure predictions.
11 Database Searches
The Ad2 protease sequence was searched against the NBRF protein sequence database 
and a subset of the database containing all known protease sequences using the method of 
Coulson et al. (1987). These searches revealed no significant homologies with any known
cellular or viral proteases.
It has been shown that the secondary structure of proteins is conserved to a greater 
extent than primary structure and that comparison of secondary structures is a good means of 
testing whether or not 2 enzymes are related. Gorbalenya has used secondary structure
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Residue Number
Fig. 2.13a Conservation of Protease Sequence
Histogram showing the distribution of conserved regions in the adenovirus protease sequences from 
7 human and 2 bovine serotypes. The index of variability is calculated by first dividing the number 
of amino acids found at a given position by the frequency of the most common. Where the amino 
acids at one position are all of one group (+ve charge, -ve charge, large apolar etc) the value is 
divided by 2 to give the final index. A high value indicates a high variability at that position.
*
1 MGSSEQELKA IVKDLGCGPY FLGTYDKRFP GFVSPHKLAC AIVNTAGRET
51
*
GGVHWMAFAW NPRSKTCYLF EPFGFSDQRL KQVYQFEYES
*
LLRRSAIASS
101 ♦ *PDRCITLEKS TQSVQGPNSA
* *
ACGLFCCMFL HAFANWPQTP MDHNPTMNLI
151 TGVPNSMLNS PQVQPTLRRN QEQLYSFLER
*
HSPYFRSHSA QIRSATSFCH
201 LKNM
FIG 2.13b Sequence of the Adenovirus 23 kDa Protease
The sequence of the 23 kDa protease from adenovirus type 2 is shown with the histidine, cysteine, 
serine and aspartic acid residues conserved in all 7 human and 2 bovine serotypes indicated by an 
asterisk. Derived from sequence alignments created with the Pileup program in the Wisconsin package 
(Devereaux et a/., 1*984).
alignments to compare the adenovirus protease with other viral and cellular proteases without 
success (A.E. Gorbalenya, personal communication). In conclusion, the adenovirus protease 
appears to be different from all the cellular and viral proteases studied to date and the 
elucidation of its crystal structure is required to establish its mechanism and classification with
certainty.
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Two complementary assay systems have been developed for the adenovirus protease. 
The first is based on a method previously described by Bhatti and Weber (1978) and utilises 
35S labelled, Ad2 infected cell extracts as the substrate. The extracts contain endogenous 
activity which can be removed by heating to 60°C if required. 1n some instances it is 
preferable to study the cleavage of pV11 by the endogenous protease, since this is more akin to 
the in vivo situation than the use of heat treated Ad2 or labelled Ad2tsl extracts. The second 
assay utilises the synthetic octapeptide, MSGGAFSW, as a substrate. The digestion of this 
peptide, which is derived from the established cleavage site in one of the natural substrates of 
the protease, pV1, can be readily monitored by HPLC or TLE.
The lack of a pure source of enzyme for the most part of this project has prevented 
kinetic analysis using either the peptide or natural substrates. Preliminary results reveal, 
however, that the Km value for the cleavage of MSGGAFSW by the Ad2 protease is 8mM 
(G.Kemp, personal communication). Although this indicates that the affinity of the enzyme for 
the peptide is low, the Km value is similar to those calculated for peptide substrates of other
viral proteases (Kay and Dunn, 1990). The reason for the low affinity is probably because 
elements of secondary and tertiary structure are involved in the binding. 1n the natural 
substrates amino acids outwith the P4-P4’ region will be required to present the scissile bond in 
the appropriate conformation. The peptide substrates, on the other hand, are relatively flexible 
and so will only adopt the correct conformation for short periods of time.
The advantage of the peptide assay over the 35S assay is that it involves a pure substrate 
free of any other cellular or viral components. 1t is also faster, more cost effective and in the 
future could be used to study the kinetics of inhibitors of the adenovirus protease. The 35S 
assay, on the other hand, utilises a natural substrate of the protease and is more suitable for 
screening crude extracts that may contain cellular proteases. As far as possible, the 2 assays 
were used in parallel to characterise the protease and in the main the results obtained were in 
complete agreement.
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The only major discrepancy came when the effects of pH and ionic strength were 
examined (fig.2.5). Using the peptide assay a slightly broader pH optimum was observed 
and activity was found to increase with NaCl concentration; in contrast to the findings with the 
35 assay, where no cleavage of pVII took place above 0.5M NaCL The narrower pH 
optimum and the inhibitory effects of high ionic strength, found in the 35s assay, are probably 
a function of the influence of pH and ionic strength on the structure of the pVII protein, as well 
as on the enzyme. It appears then that the peptide assay is able to operate under more extreme 
conditions of pH and ionic strength, presumably because the peptide substrate has fewer 
conformational restraints.
Several reasons could account for the stimulatory effect of salt observed in the peptide 
assay (fig.2.5b). Perhaps the most likely of these is that the salt releases the protease from 
associations with other proteins or DNA in the disrupted virus, since extraction with 2M NaCl 
was found to be an effective way of solubilising protease activity (table 2.7). The apparent 
requirement of the purified protein for high salt in the peptide assay, however, suggests that it 
must also play some role in stabilising the enzyme in an active form (fig.2.12). Studies on 
the cleavage of peptide substrates by purified avian retroviral proteases and cellular aspartic 
proteases reveal that high salt not only increases activity, but, in some cases, also alters the 
cleavage site preferences of the enzymes (Kotler gf a/., 1989). The mechanisms behind these 
phenomena remain to be elucidated.
The neutral pH optimum of the Ad2 protease and its activity in the presence of the 
chelating agent, EDTA, would normally rule it out of the aspartic and metallo protease classes 
respectively. Furthermore, pepstatin, which is the diagnostic inhibitor for aspartic proteases, 
did not inhibit protease activity in either assay system and no divalent ions were found to have 
a stimulatory effect on its activity (table 2.6 and fig.2.6). On the contrary, Cu+2, Ni+2,
Fe+2 and Zn+2 were all found to inhibit the Ad2 protease, even at concentrations as low as 
10|iM. Processing of the picornavirus polyproteins has been shown to be inhibited by ImM 
ZnCl2, but no mechanism has been suggested for this inhibition (Butterworth and Korant, 
1974). A number of divalent ions including those of zinc, copper and nickel are known to 
interact with surface exposed imidazole and thiol groups of proteins (Porath et a/,, 1975), so the
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inhibition could be as a result of direct binding to an active site cysteine or histidine residue. 
The aspartic protease of HIV-l has been shown to be inhibited by Cu+2 at concentrations of 
25|iM and its effects have been considered in some detail. It is suggested that the surface 
exposed Cys67 residue forms a weak interaction with His69 and that together they could 
constitute metal binding site (Karlstrom and Levine, 1991). Interestingly cellular aspartyl 
proteases, including pepsin, have not been shown to be inhibited by copper, or any of the other 
transition elements at neutral pH, so these observations open the way for the design of 
substrate analogue inhibitors containing metal ions (Lunblad and Stein,1969; Karlstrom and 
Levine, 1991). The design of such compounds has recently been reported and phenylnorstatine 
derivatives have been synthesised that inhibit the HIV-1 protease with Kj's of 3-24pM (Raju
and Deshpande,1991). Presumably the inhibition of the Ad2 protease by zinc, copper, iron 
and nickel must be mediated by surface exposed cysteine or histidine residues, possibly at the
active site.
Having eliminated the adenovirus protease from the aspartic and metallo classes, the 
effects of a range of serine and cysteine protease inhibitors were examined. The enzyme had 
been previously classified as a chymotrypsin-like serine protease based on reports that it is 
inhibited by DFP, PMSF, TPCK and TLCK (Bhatti and Weber, 1979b; Tremblay er aZ.,1983). 
In agreement with previous studies TPCK and TLCK were both found to partially inhibit the 
protease in the 35S assay (fig.2.7). In contrast, the classical serine protease inhibitors, PMSF 
and 3,4-DCI, failed to inhibit the Ad2 protease in the 35S assay despite rapid and complete 
inhibition of trypsin in parallel control experiments (table 2.6). In the peptide assay partial 
inhibition was observed for PMSF, but only when DTT was excluded (fig.2.8b). It has been 
shown that PMSF, TPCK and TLCK are also effective inhibitors of cysteine proteases. Their 
inhibition by PMSF, however, is readily reversed by DTT and whilst TPCK and TLCK can 
discriminate between members of the serine protease class, they are much less specific 
inhibitors of cysteine proteases (Whittaker and Perez-Villasenor, 1968). Thus the inhibitory 
effects of TPCK, TLCK, 3,4-DCI and PMSF on the adenovirus protease are much more in 
line with it being a cysteine protease than a serine protease.
The complete inhibition of the Ad2 protease by ImM iodoacetate, NEM or DTDP and
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by O.lmM PCMB in both assay systems adds further weight to this argument (table 2.6 and 
fig.2.7). Iodoacetate, NEM and DTDP at neutral or alkaline pH are genera! thiol reagents, 
reacting with the S" ion, so their effect could be at any free thiol group in the protease. 
Inhibition by DTDP at pH5, however, suggests the presence of a thiol group with a very low 
pK. This can be found in the active site of cysteine proteases and indeed DTDP at pH3-5 is 
regarded as a specific active site titrant for cysteine proteases (Willenbrock and Brocklehurst, 
1985). Inhibition by O.lmM PCMB is also regarded as a good indication that an active site 
thiol group is present, as is the activation of an enzyme by DTT or cysteine (Barrett, 1977). 
The activity of the Ad2 protease increased significantly in the presence of 0.5-2mM DTT or 
cysteine as can be seen in the graph in fig.2.8a.
Although the results presented here strongly suggest that the adenovirus protease is a 
member of the cysteine class, the lack of inhibition by E64, leupeptin and cystatin (table 2.6) 
means that a definitive diagnosis cannot be made. E64 is a peptide epoxide that inhibits the 
papain-like cysteine proteases, whilst leupeptin (N-acetyl-Leu-Leu-Arg-al) inhibits most 
cysteine proteases. The arginine in leupeptin means that it will also inhibit serine proteases 
with a trypsin-like substrate specificity (Salvesen and Nagase,1989). Assuming that the 
adenovirus protease is a cysteine protease, its lack of inhibition by E64 and leupeptin could be 
explained by its unusual substrate specificity, described in chapter 1. The large molecular 
weight inhibitors, cystatin and SBTI, also failed to inhibit the protease (table 2.6). These, 
however, tend to be more selective within the cysteine and serine classes respectively and so 
their lack of effect is not surprising.
The conclusion from these inhibitor studies is that whilst the adenovirus protease does 
not appear to be a serine protease, its inhibitor profile differs from the classical papain-like 
cysteine proteases. Interestingly, inhibitor studies carried out on the rhinovirus 3C protease by 
Orr et al, (1989) show very similar results. The only significant difference is that the 3C 
protease is inhibited by the 2 peptide aldehydes, leupeptin and chymostatin, specific for 
cysteine and chymotrypsin-like proteases respectively. Thus, like the adenovirus protease, the 
inhibitor profile of 3C does not fit exactly into either the serine or the cysteine class. As 
mentioned previously, the picomaviral 2A and 3C proteases belong to the recently established
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group of trypsin-like cysteine proteases. Their evolutionary and mechanistic relationship with 
serine proteases in conjunction with an active site thiol group could provide a plausible 
explanation for their unusual inhibitor profiles. One interpretation of the results presented here 
is that the adenovirus protease also belongs to the subclass of cysteine proteases that are related 
to trypsin. In order to test this hypothesis further, the Ad2 protease sequence must be aligned 
with other cellular and viral proteases.
A major aim of this project was to establish with certainty that the L3 23-kDa protein is 
the adenovirus protease. This was achieved with the aid of antipeptide sera raised against 
synthetic peptides corresponding to the N- and C- termini of the 23-kDa protein. The antisera 
both reacted with a protein from purified Ad2 that had an apparent molecular weight of 20-kDa 
(fig.2.9). These results suggest that the 23-kDa putative protease is present in the virus in an 
intact form and that it is not cleaved at A46-G47 as suggested by Chatterjee and Flint (1987). It 
cannot be ruled out, however, that the anti-peptide sera cross react with other regions of the 
protein and this possibility will be considered in chapter 3.
Extraction of protease activity from purified Ad2 in a soluble form required extraction 
with 2M urea followed by 2M urea/2M NaCl and even after such treatment not all the activity 
was released (table 2.7). This indicates that the protease must form strong associations with 
viral proteins and/or DNA. The NaCl/urea supernatant was purified further by gel filtration 
using an FPLC S75 column and the resulting fractions were tested for protease activity using 
the 35S and peptide assays. Analysis of the active fractions by SDS-PAGE revealed that they 
contained a single band of apparent molecular weight 20-kDa and that this reacted with the 
antisera raised against the 23-kDa N-terminal peptide (fig.2.11). It has, therefore, been 
shown that the L3 23-kDa protein of Ad2 is indeed the virally encoded protease. Furthermore, 
the retention time of the protease reveals that it has an apparent molecular weight of 20-kDa, 
showing that it is active as a monomer. Surprisingly, when the Ad2 protease was purified by 
gel filtration in 50mM Tris/HCl, 5mM EDTA, pH8 (low salt) it was active in the 35 assay, but 
not in the peptide assay (fig.2.12). It is concluded that some component of the virus is 
required to activate or stabilise the protease. Purification of the enzyme results in its 
inactivation unless carried out in the presence of high salt, which stabilises the protease in an
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active conformation. Protease purified in low salt can be reactivated in the 35S assay since this 
system includes other viral and cellular factors. The possibility that another component is 
required to activate the adenovirus protease will be investigated in chapter 4.
Having established that the L3 23-kDa protein is the adenovirus protease, its sequence 
was analysed to see if it resembled any of the established viral or cellular proteases. The gene 
which has been sequenced in 9 different adenovirus serotypes is extremely well conserved 
(Houde and Weber,1990a); but differences do exist, so computer alignments can be used to 
identify the important residues (fig.2.13a). Both serine and cysteine proteases contain active 
site histidine residues, so it is significant that there is only one conserved histidine residue, at 
position 54, in the protease sequence. Indeed, it would seem likely that Hisg4 is one of the
catalytic residues in the protease. The fact that His44 is followed by a tryptophan residue, is 
also of interest, in view of the inhibition of the Ad2 protease by a number of divalent ions 
including copper and nickel (fig.2.6). This is because the dipeptide sequence His-Trp has 
been shown to have an unusually high affinity for Ni(II), Co(II) and Cu(II), as demonstrated 
by its use as a polypeptide tag to facilitate the purification of genetically engineered proteins 
(Smith et o/.,1988; Sassenfeld,1990). An attractive explanation for the inhibition of the 
adenovirus protease by a number of the divalent transition elements is that the accessible 
His-Trp dipeptide at the active site of the enzyme is a metal binding site. It is more difficult to 
predict the identities of the other catalytic residues, but assuming that the enzyme is a cysteine 
protease there are 3 conserved cysteine residues in the sequence. These are located at positions 
104,122 and 126, with the neighbouring amino acids being particularly well conserved in the 
case of Cysio4 and Cysi22« In papain the nucleophilic cysteine residue is located 125 residues 
to the N-terminal side of the active site histidine. Since there are no conserved cysteine 
residues on the N-terminal side of Hisg4 it seems unlikely that the adenovirus protease is a 
papain-like enzyme. The inhibitor profile of the Ad2 protease is identical to that of the 
rhinovirus 3C protease which is a member of the subclass of cysteine proteases that are related 
to trypsin. One of the 3 conserved cysteine residues at position 104, 122 or 126 could be the 
nucleophilic residue in such an enzyme. Although unlikely, based on its inhibitor profile, it
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cannot be ruled out that the Ad2 protease is a serine protease and in this case the conserved 
Ser183 or Ser95 could be the active site residue. There are a number of conserved aspartate and 
glutamate residues that could act as the third residue in the catalytic triad. Set against this, 
however, is the fact that computer searches have failed to find any significant homologies 
between the Ad2 protease and trypsin-like enzymes, or any other proteases for that matter.
Thus the classification of the adenovirus protease remains in doubt. Site directed mutagenesis 
and the elucidation of its crystal structure will be necessary to determine whether it is a 
trypsin-like cysteine protease or whether it has a novel mechanism. Expression of the active 
protease in large amounts must be carried out in order to meet these ends and this is the primary 
aim of the next chapter.
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CHAPTER 3
Expression of the Ad2 L3 23 kPa Protein.
Autocatalytically Processed ?
The aim of this chapter is to purify active Ad2 protease in large amounts and to 
establish whether or not the enzyme is autocatalytically processed. The low levels of 
expression of the 23-kDa protein during adenovirus infection make its purification from the 
virus, in sufficient quantities, almost impossible. In the previous chapter the total yield of 
protease obtained from 6 litres of infected Hela cells was only 2pg. It was, therefore, deemed 
necessary to use E.Coli and baculovirus systems to express the Ad2 protease. Such systems 
have enabled considerable advances to be made in the structural and mechanistic 
characterisation of other viral proteases including those of HIV and poliovirus (Graves et 
a/., 1988; Baum et a/., 1991). In the longer term and beyond the scope of this project the 
incorporation of the 23-kDa cDNA into an appropriate vector would provide the means to carry 
out systematic site directed mutagenesis, designed to identify the amino acids constituting the 
active site and substrate binding pockets of the enzyme.
AUTOCATALYTIC PROCESSING OF THE AD2 PROTEASE?
The expression of the 23-kDa protein in several systems should give a clearer picture as 
to what, if any, post-translational modifications it requires. In a report by Chatteijee and Flint 
(1987) it was proposed that the 23-kDa protein is activated by .limited proteolysis to give a 
19-kDa protease and that both species are phosphorylated on a tyrosine residue. They 
suggested further that the cleavage is at the Ala46-Gly4? bond and that autocatalytic processing 
is involved. The evidence for this came from parallel labellings of wild type Ad2 and Ad2tsl 
infected cells with 32P at non-permissive temperatures. Analysis of the mobilities of the 
labelled proteins by SDS-PAGE revealed a band at 23-kDa in the purified Ad2tsl particles.
This was absent in wild type Ad2; but these virions contained several phosphorylated bands, 
missing from the tsl particles, including one with an apparent mobility of 19-kDa. The authors
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also reported that viral proteins with mobilities of 23-kDa and 19-kDa, in Ad2tsl and wild type 
Ad2 respectively, were labelled with 3H DFP in vitro. The latter is a potent inhibitor of serine 
proteinases and is reported to bind specifically to active site serine residues (Barrett, 1977). 
Solely based on this evidence the authors were able to conclude that the 23-kDa protein in 
Ad2tsl, encoded by the L3 mRNAs, is proteolytically processed to give a 19-kDa protein, 
which is the active adenovirus endoprotease. Further support for this theory came from Houde 
and Weber (1990a) who expressed the Ad2 23-kDa putative protease as a fusion product with 
protein A using the vector pRIT2T. They claimed that the purified fusion protein was capable 
of autocatalytic cleavage and that it cleaved its natural viral substrates as well as foreign 
proteins. The expression of an apparently active enzyme in E.Coli led them to conclude that 
mammalian specific post-translational modifications are not required for Ad2 protease activity.
In chapter 2, the active Ad2 protease was found to have an apparent molecular weight 
of 20-kDa and to react with antisera raised against peptides corresponding to its N- and C- 
termini. This suggests that the 20-kDa species contains all 204 amino acids, coded for by the 
L3 23-kDa open reading frame and so contradicts the proposals that the enzyme is 
proteolytically processed (Chatterjee and Flint,1987; Houde and Weber, 1990a). The 
specificity of the antipeptide sera will be confirmed in this chapter by testing them against 
deletion mutants of the 23-kDa protein which lack either residues 1-18 or 181-204. 
BACTERIAL AND BACULOVIRUS EXPRESSION SYSTEMS.
Three sets of vectors will be used to express the 23-kDa putative Ad2 protease:
(1) pGEX-2T, an E.Coli vector that expresses foreign proteins as fusion products with 
glutathione transferase under the control of the beta-gaiactosidase promoter.
(2) pET^fc, an E.Coli vector that expresses foreign proteins under the control of the T7 
promoter.
(3) pAcRP23 and pVL1393. These expression vectors are used to incorporate the genes 
of foreign proteins into the baculovirus Autographa califomica nuclear polyhedrosis 
virus (AcNPV) so that they are under the control of the very strong promoter of the 
polyhedrin gene.
The background to these vector systems will be discussed in turn.
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pGEX-2T
The construction and detailed description of the pGEX series of vectors is reported by 
Smith and Johnson (1988) and a map of pGEX-2T is given in fig.3.1. The plasmids have 
been constructed so that they direct the synthesis of foreign proteins in E.Coli as fusions with
the C-terminus of Sj26, a 26-kDa glutathione S-transferase (GST). The pGEX-2T vector has
Fig. 3.1 Map of the pGEX-2T vector.
The map of the pGEX-2T plasmid is shown with
the BamHI and EcoRI cloning sites marked.
been engineered so that the coding sequence for a thrombin cleavage site (LVPR-GS) is 
included, in frame, at the 3' end of the GST gene. The expression of the fusion proteins is 
under the control of the lacZ promoter and since the plasmids also encode for the lac repressor 
(lad), the fusion proteins will only be expressed in the presence of the inducer molecule 
isopropyl-p D-thiogalactopyranoside (IPTG). Thus the synthesis of a foreign protein, that may 
be toxic to the E.Coli, can be switched on by the addition of IPTG after the cells have reached 
the required level of growth. The vectors include an ampicillin resistance gene, enabling the 
positive selection of transformed cells. Attachment to the carrier molecule GST means that 
proteins can be readily purified by affinity chromatography on a glutathione Sepharose column 
and then be cleaved from the carrier using thrombin. Smith and Johnson (1988) report that 
although insolubility is a frequent characteristic of foreign proteins expressed in E.Coli the 
majority of GST fusion proteins expressed, to date, are at least partially soluble.
In conclusion the pGEX system appears to offer several advantages over other fusion
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protein-producing vectors (Sassenfeld,1990) and seems a good system to verify the report by 
Houde and Weber (1990a) that the 23-kDa protein is capable of autocatalytic processing. It
was also the system chosen for the expression of the N- and C- terminal deletion mutants of the 
23-kDa protein. 
pET Vectors
The pET series of vectors are comprehensively described by Rosenberg et al. (1987) 
and Studier et a/. (1990) and are examples of T7 expression systems that take advantage of the 
highly specific nature of the T7 RNA polymerase. The plasmids used for cloning and 
expressing cDNAs are based on the multi-copy plasmid pBR322 and carry a T7 promoter 
followed by a unique cloning site. A map of pET3c is given in fig.3.2. For efficient 
expression the vectors must be transformed into an E.Coli strain that expresses the T7 RNA
Fig. 3.2 Map of the pET3c vector
A map of the pET3c vector with the positioi of 
the Ndel cioning site indicated.
polymerase such as DH1(DE3) and BL21(DE3). The bacteriophage DE3 present in these 
strains is a lambda derivative that has been engineered to contain the gene for the T7 RNA 
polymerase under the control of the lacUVS promoter. It also carries the lacl gene so that the 
T7 polymerase gene, normally switched off, can be activated by the addition of the inducer 
molecule IPTG. The pET vectors have been used successfully to express many proteins 
including the poliovirus 3C protease (Baum et a/.,1991). Under favourable circumstances the 
resources of the cell are devoted almost entirely to the production of target proteins so that they
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can constitute the majority of the total cell protein.
Baculovirus Expression Systems.
One of the problems with prokaryotic expression systems, including those described 
above, is that they are not able to carry out the post-translational modifications required by 
many eukaryotic proteins. In addition proteins are frequently incorrectly folded to an extent 
that makes them biologically inactive. These problems have led to the increasing use of 
recombinant eukaryotic expression systems to express cloned genes accurately. One such 
system involves the infection of insect cells, in tissue culture, with recombinant baculoviruses 
and has been used to produce high yields of biologically active proteins, including 
interleukin-2, c~myc and influenza haemagglutinin (reviewed in: Miller, 1988).
Several features of the baculovirus infectious cycle make them amenable to genetic 
manipulation. The virus usually used is Autographa califomica nuclear polyhedrosis virus 
(AcNPV) which has an 128-kDa double stranded, circular genome and a biphasic infectious 
cycle. The first phase involves the formation of nuclear capsids 'that bud through the cellular 
membrane to produce extracellular virus. The second phase involves high level expression of a 
32-kDa protein, termed polyhedrin, that is responsible for packaging mature virions within the 
nucleus in large occlusion bodies. The occluded viruses are released after cell death and are 
only required for lateral transmission of the virus. The significance of this is that a gene 
switched on late in infection produces a protein in large amounts that is not required for 
infection in tissue culture. This means that the polyhedrin gene can be replaced with a foreign 
gene so that the latter is placed under the control of the strong polyhedrin promoter. This is 
achieved by cloning the foreign genes into specially designed transfer vectors such as 
pAcRP23 (Possee and Howard, 1987) and pVL1393 (Invitrogen Corporation). The maps of 
these vectors are given in fig.3.3 where it can be seen that they both contain cDNA from the 
AcNPV genome, encompassing the polyhedrin gene, in which unique restriction sites have 
been engineered downstream from the polyhedrin promoter. In the case of pVL1393, the 
promoter is followed by a mutated initiation codon and the bases coding for the N-terminal 
amino acids of the polyhedrin and then the restriction sites for insertion of foreign cDNAs.
This works on the principle that the transcription enzymes will find the polyhedrin promoter
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FigJ.3 Maps of the pAcRP23 and pVL1393 vectors
The polyhedrin promoter is indicated by the arrow and the shaded boxes represent the flanking
bacdlovrus DNA sequences. The location of the BamHI cloning site is marked in each case.
untampered with and will move along to the initiation ATG of the foreign gene, located only a
few bases downstream.
The foreign gene contained within the recombinant transfer vector is introduced 
precisely into the AcNPV genome by homologous recombination. The recombinant virus can 
then be purified by plaque purification as described by Summers and Smith (1987). Since the 
frequency of such recombination events is typically 0.1-1% the identification of recombinant 
virus against a background of parental virus is a time consuming step. Possee and Howard 
(1987) engineered the AcNPV DNA so that it contained the lacZ gene coding for 
P-galactosidase in place of the polyhedrin to give AcRP23-lacZ. Recently Kitts et a/.(19SG) 
noticed that this DNA has a unique restriction site, Bsu36I in the lacZ gene. The recombinant 
baculovirus DNA can, therefore, be linearised by cutting with Bsu36I and the linear form has 
been shown to be recombinogenic; but non-infectious. Kitts et al. (1991) showed that 
recombination of the linearised AcRP23-lacZ with an appropriate transfer vector produces a 
circular genome, competent for replication. The system has the additional advantage that the 
virus expressing the foreign gene can be readily distinguished from AcRP23-lacZ in that it does 
not produce p-galactosidase.
It is hoped that expression of the 23-kDa protein in higher eukaryotic cells will reveal
whether or not it is phosphorylated or post-translationally modified in some other way.
145
methods
1 BASIC CLONING METHODS.
E.Coli and baculovirus expression systems were utilised to express the Ad2 23-kDa 
protein. This involved the insertion of the L3 23-kDa gene into 4 vectors, namely pET3c 
(Studier et aZ.,1990), pGEX-2T (Smith and Johnson, 1988), pAcRP23 (Possee and 
Howard,1987) and pVL1393 (Invitrogen Corporation). A number of standard cloning 
techniques were used in each case and these will be outlined first before the specific details of 
each construct are described. Many of the techniques used were based on methods from the 
Cloning Manual (Maniatis et a/.,1982).
Restriction enzymes and DNA modifying enzymes were all obtained from Amersham, 
Promega or Gibco-BRL unless otherwise stated. All solutions were sterilised by autoclaving 
or sterile filtering. lOx enzyme buffers were stored in 0.5ml aliquots at -20°C.
1.1 Plasmid Preparation.
Bacteria were grown in Luria broth (LB) prepared by dissolving lOg of bacto-tryptone 
(Difco) and 5g of yeast extract (Difco) in 1 litre of .lOmM NaCl and autoclaving the solution. 
All plasmids used in this project contained the ampicillin resistant gene and so ampicillin was 
added to the Luria broth at 0.1 mg/ml (LB/Amp).
5ml of LB/Amp were inoculated with 5pl of an E.Coli strain transformed with the 
required plasmid. The culture was grown for 10-18 hours at 37°C. 2ml of the stationary 
phase culture were inoculated into 1 litre of LB/Amp and incubated with shaking for 16-20 
hours at 37°C. Cells were harvested by centrifugation at l(XXX)pm (12000g) for 5 minutes in 
a Beckman J2-21 centrifuge using the JA14 rotor. The pellet was resuspended in 18ml of 
50mM glucose, 25mM Tris/HCl, lOmM EDTA, pH8 and 2ml- of freshly prepared 20mg/ml 
lysozyme in 0.2M Tris/HCl pH8. A 5 minute incubation at room temperature was followed by 
the addition of 40ml of fresh 0.2M NaOH, 1% SD'S and a second 5 minute incubation; this 
time on ice. 20ml of 5M potassium acetate, pH4.8 (60ml of 5M potassium acetate, 11.5ml of 
glacial acetic acid and 28.5ml of H2O) were added and the mixture was left on ice for a further 
15 minutes. The extract was centrifuged for 5 minutes as before (4°C) and the supernatant
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was filtered through 2 layers of cheesecloth. Plasmid DNA was precipitated with 0.6 volumes 
of isopropanol for 15 minutes at room temperature and the suspension centrifuged at 12000g 
using the JA17 rotor in the Beckman J2-21 centrifuge for 5 minutes. The pellet was 
resuspended in 20ml of 70% ethanol, and centrifuged as just described, before the supernatant 
was discarded and the dry pellet was redissolved in 6ml lOmM Tris, ImM EDTA, pH8. 
Caesium chloride (7.2g) and 100p1 of lOmg/ml ethidium bromide were dissolved in the DNA 
suspension which was then allowed to warm to room temperature before being centrifuged at 
high speed in a microcentrifuge for 5 minutes. The supernatant was pipetted into 4, bell-top 
quickseal tubes (Beckman) which were filled, balanced and sealed according to the 
manufacturers instructions. Samples were centrifuged at l(X)000g for 12-18 hours at 20°C in a 
Beckman UL-55 centrifuge. The plasmid band was removed and extracted with 5x1 volume of 
caesium chloride saturated butan-2-ol to remove ethidium bromide. Two volumes of H2O 
were added to dilute out CsCl, followed by 0.6 volumes of isopropanol. The plasmid DNA 
was left to precipitate for 20 minutes at room temperature before being pelleted by 
centrifugation for 5 minutes at high speed in a microcentrifuge. The DNA pellet was dissolved 
in 400pl of H2O and was precipitated for 10 minutes at room temperature after adding 40pl 3M 
sodium acetate and 1ml of ethanol. Thesuspension was centrifuged as before , the pellet 
washed with 70% ethanol, dried under vacuo and finally dsssolved in 500plof H2O and stored
in aliquots at -70°C. The concentration of the plasmid was determined by measuring its 
absorbance at 260nm and analysing it by agarose gel electrophoresis (see 1.2, below).
1.2 Analysis of DNA.
(a) Concentration of DNA.
The concentrations of DNA samples were determined by measuring the absorbance of 
the sample or an appropriate dilution at 260 nm and applying the formula:
(i) For single stranded DNA 1 absorbance unit indicates a concentration of 50pg/ml.
(ii) For double stranded DNA 1 absorbance unit indicates a concentration of 40pg/ml.
(iii) For oligonucleotides 1 absorbance unit indicates a concentration of 20pg/ml.
The presence of any protein contaminants was determined by measuring the absorbance
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at 260 nm and 280 nm. The ratio between the readings at 260nm and 280nm should be 1.8 for 
pure DNA solution. Values less than this indicate that there are protein or phenol contaminants
in the preparation.
(b) Agarose Gel Electophoresis.
DNA samples were separated by agarose gel electrophoresis in the GNA1OO 
submersible rig (Pharmacia) according to the manufacturers instructions. The preferred buffer 
system was 60mM Tris/acetic acid, 3mM EDTA, pH8 (TAB) and the agarose (Type H, 
medium EEO) was from Sigma. 0.3-2% agarose in TAE was used depending on the size of 
DNA fragments to be separated. 0.7% agarose gels were suitable for most separations. 
Depending on the number of DNA fragments in a particular sample and the size of gel used the 
amount of DNA loaded per track was 0.05-Ipg. Samples were mixed with 1/6 volume of 
0.25% xylene cyanol, 0.25% bromophenol blue, 30% glycerol (DNA loading dye) and applied 
directly to the gels. Phage lambda DNA cut with the restriction enzyme Hindlll (Boehringer) 
was used as the size marker on gels. Gels were run for 1-2 hours at a constant current of
until the dye front had migrated 3/4 the length of the gel and then were stained for 5 
minutes in 0.5pg/ml ethidium bromide in TAE. DNA bands were examined and photographed 
on a UV transilluminator.
1.3 Purification of DNA
(a) Phenol Chloroform Extraction.
DNA solutions were mixed with an equal volume of 1:1 phenol/chloroform (redistilled 
phenol equilibrated with lOOmM Tris/HCl, ImM EDTA, pH8) and centrifuged for 10 minutes 
at high speed in a microcentrifuge. The aqueous layer was stored on ice while the organic 
phase was re-extracted with an equal volume of lOmM Tris/HCl, ImM EDTA, pH8 as before. 
The aqueous phases were pooled and extracted with 2x1 volume of chloroform with the 
centrifugation step as before. DNA was precipitated from the aqueous phase for 5 minutes at 
room temperature following the addition of 1/10 volume of 3M sodium acetate and 2.5 
volumes of ethanol. The DNA was pelleted by centrifugation ' for 5 minutes in a 
microcentrifuge and then dried in vacuo and dissolved in the required amount of HO.
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(b) Extraction of DNA from Agarose Gels. .
Double stranded DNA fragments (>100 base pairs) were purified from agarose gels 
using the Geneclean II Kit (Stratagene) according to the manufacturers instructions.
DNA was separated on the appropriate % of agarose gel as described in method 1.2(b). 
The gels were viewed for the minimum time in UV light and the desired DNA band cut out and
melted in 2.5 volumes of sodium iodide at 55°C for 3-5 minutes.
5pl of "glass milk” were added and the suspension was left at room temperature for 20 
minutes with occasional shaking before being centrifuged for 1 minute in a microcentrifuge. 
The pellet was washed with 3x5(X)pl of ''new wash", air dried and resuspended in 40pl of 
H2O. The suspension was incubated for 3 minutes at 55°C and then centrifuged for 5 minutes 
in a microcentrifuge. The DNA was in the supernatant.
(c) Desalting on G-50 Sephadex Columns. •
G-50 Sephadex (Sigma) was swollen in lOmM Tris/HCl, ImM EDTA, pH8 and 
packed into a 1ml syringe, plugged with glass wool. The resin was equilibrated with 10ml of 
the same buffer and then spun for 5 minutes at 2000g (EEC CENTRA-3R centrifuge) to remove 
the buffer. 50-200pl of DNA solution were loaded onto the column which was centrifuged as 
before and the desalted DNA was collected into an eppendorff tube.
1.4 Polymerase Chain Reaction (PCR).
(a) Preparation of Oligonucleotide Primers.
Oligonucleotide primers, synthesised on an Applied Biosystems 381A synthesiser, 
were resuspended in 200pl of H20,20pl 3M sodium acetate and 2.2pl IM magnesium acetate 
and then precipitated with 3 volumes of cold ethanol. Samples were centrifuged for 5 minutes 
in a microcentrifuge, the precipitation procedure was repeated and the final pellet was air dried 
and dissolved in 4(X)pl of H2O. The oligonucleotide concentration was determined by 
measuring its absorbance at 260nm (the mass of 1 base is 330 daltons) and a lOOpM solution 
was prepared.
(b) Peeparalion of Adenovirus DNA.
Ad2, twice purified by caesium chloride centrifugation (chapter 1, method 3) was 
dialysed against lOmM Tris/HCl, ImM EDTA, 0.6% SDS, pH7.5 and then proteinase K was
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added to lOOpg/ml. The sample was incubated for 2 hours at 50°C and the viral DNA purified 
by phenol/chloroform extraction (method 1.3a). The resulting DNA pellet was resuspended in 
lmM Tris/HCl, 0. ImM EDTA pH 8.
(c) Materials.
Taq polymerase was from Northumbria Biologicals Limited and the 4 deoxynucleotide 
triphosphates (dATP, dTTP, dGTP and dCTP) were from Pharmacia. A stock solution of the 
nucleotide triphosphates (4dNTPs) was prepared so that the concentration of each was ImM.
The lOx PCR buffer comprised O.1M Tris pH8,15mM MgC^,0.5% Tween 20 and 0.5%
NP40.
(d) Setting up PCR Reactions.
Reactions were set up in triplicate in siliconised, sterile eppendorff tubes as follows:
H2O °7pl
lOxPCR lOpl
4dNTPs lOpl
Ad2 DNA (0.25pg) lOpl
Oligonucleotide 1 (lOOpM) lpl
Oligonucleotide 2 (lOOpM) lpl
Taq polymerase Ipl
Tubes were overlayed with 50pl of paraffin oil and placed in a programmable heating 
block. The program used for all the PCR reactions in this project was:
STEP1 ( melting) 9494® for 1.5 minut5S
STEP 2 (annealing) 60°C for 1.5 mmut5 s
STEP 3 (elongation) 72^C for 2 minutns
This cycle was repeated 30 times and was followed by a final step of 7 minutes at 72°C.
(e) Analyrls of PCR Products.
5pl of DNA were pipetted from under the paraffin layer and analysed by agarose gel 
electrophoresis (method 1.2b). The PCR products were separated from primers and free
nucleotides by either purifying the DNA from gels or passing the mixture through a 1ml
Sephadex G-50 column.
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1.5 DNA Modifying Enzymes.
(a) Restriction Endonuclease Digestions.
Enzymes were supplied along with an appropriate lOx buffer. A typical reaction was 
for 2 hours at 37oC and comprised 0.1-5pg of DNA, l-5pl of lOx buffer, l-5pl of 1mg/ml
acetylated BSA and 1-25 units of restriction endonuclease with the reaction volume being made
up to 10-50pl with H2O.
If DNA was to be digested by 2 restriction enzymes that were active in the same buffer 
then the digestions were carried out simultaneously. This not being the case, then the enzymes 
were added sequentially with an intermediate desalting step on a G-50 Sephadex spin column.
(b) Phosphatase Treatment of DNA.
Calf intestinal alkaline phosphatase (CIAP) was obtained from Amersham and the lOx 
CLAP used was 0.5M Tris/HCl, pH9, lOmM MgCl2, ImM ZnCl2, lOmM spermidine. 
Typically 5|ig of linearised plasmid, 5pl of lOxCIAP and 0.5 units of CIAP in a final volume 
of 50pl were incubated for 60 minutes at 37°C. The reaction was stopped by the addition of 
Ijil of 0.5M EDTA and heating for 20 minutes at 65OC. CIAP was removed by 
phenol/chloroform extraction (method 1.3a).
(c) Ligation Reactions.
Insertion of genes into linearised plasmid DNA was carried out using T4 DNA ligase. 
The lOx ligase buffer used was 0.4M Tris/HCl pH7.5, O.1M MgCl2, O.1M DTT, 0.5mg/ml 
acetylated BSA. For plasmids cut with a single restriction enzyme 5' phosphates were first 
removed by CIAP to prevent self ligation. The ligation reaction was for 16 hours at 13°C and 
comprised Ipg cut plasmid, 0.5pg DNA insert, Ipl lOx ligase, Ipl lOmM ATP and 2 units of 
T4 DNA ligase. The reaction was stopped by storing at -20oC.
(d) Polymerase Reactions.
The Klenow fragment of E.Coli DNA polymerase I was used to fill in recessed 3' ends 
of double stranded DNA. The lOx Klenow buffer used was 0.5M Tris/HCl, O.1M magnesium 
sulphate, ImM DTT, 0.5mg/ml acetylated BSA, pH7.2.
T4 DNA polymerase was used to fill in double stranded DNA with protruding 3' ends.
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The lOx buffer for this enzyme was 0.33M Tris/Acetate pH7.9,0.66M potassium acetate, 
O.1M magnesium acetate, 5mM DTT, 1mg/ml acetylated BSA. A solution was made ImM 
with respect to each of the 4 deoxynucleotide triphosphates (dATP, dTTP, dGTP and • dCTP) 
and stored at -2(PC. One unit of the appropriate polymerase enzyme was added to 2pg of 
DNA, 2pl of lOx buffer and 2pl of 4dNTPs in a final volume of 20pl. Incubations were for 30 
minutes to 1 hour at room temperature for Klenow polymerase or 30 minutes at 37°C in the 
case of T4 polymerase. The Klenow reaction was stopped by the addition of 1pi of 0.5M 
EDTA and the T4 polymerase reaction by heating at 70°C for 5 minutes. Both enzymes could 
be removed by phenol/chloroform extraction (method 1.3a).
(e) T4 Polynucleotide Kinase.
T4 polynucleotide kinase (Amersham) was required to phosphorylate dephosphorylated 
5' ends of DNA and the 5x kinase buffer used was 0.5M Tris/HCl pH7,6, O.1M MgCl2, 
50mM DTT, ImM spermidine, ImM EDTA.
Dephosphorylated DNA (l-50pmoles of 5' ends) was added to 10-20 units of T4 
kinase, 5pl of lOmM ATP, lOpl of 5x kinase and made up to 50pl with HO. The reaction
was allowed to proceed at 37°C and stopped by adding 2pl of 0.5M EDTA prior to extraction 
with phenol/chloroform (method 1.3a).
1.6 Transformation of E.Coli with Plasmid DNA.
The strain of E.Coli normally transformed was JM1OI. Other strains of E.Colt used 
were DH1(DE3), DH5 and BL21(DE3). The procedure followed for transformations was the 
same for all the strains. The selected bacterial strain was inoculated into 5ml of LB and 
incubated at 37°C overnight with shaking. 500pl of the stationary phase culture were 
inoculated into 20ml of LB and grown at 37°C with shaking until they reached 0.15 
absorbance units at 6(Xnm (1-2 hours). Cells were placed on ice and 1.5ml aliquots 
centrifuged in a microcentrifuge for 2 minutes. Each cell pellet was resuspended in 5(X)pl of 
cold lOmM MOPS, lOmM rubidium chloride, pH7 (Buffer A), centrifuged as before and the 
pellet resuspended in 500pl of cold lOmM MOPS, 50mM calcium chloride, lOmM rubidium 
chloride, pH6 (buffer B). Cells were left on ice for 1 hour, centrifuged as before and the pellet
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suspended in 200pl of buffer B. 3pl of DMSO (frozen in aliquots at -20°C and not reused) 
were added to each tube followed by 0.2pg of DNA and the cells were incubated on ice for 30 
minutes. 4ml of LB were added to the cells which were incubated at 37°C with shaking. After 
2 hours cells were centrifuged at 2000g and the pellet was resuspended in 1ml of LB.
50-200jl were plated out on LB/Amp plates (see below) with an L-shaped glass rod. Plates 
were incubated, agar side up, at 37°C overnight and then stored at 4°C until required.
Typically, control transformations were set up (a) no DNA added, (b) uncut plasmid 
and (c) cut, ligated plasmid (no insert). The control 'no DNA' transformed cells were plated 
on LB plates and LB/Amp plates.
Preparation of LB and LB!Amp Plates.
15g of Bacto-agar (Difco) were added to 1 litre of LB and autoclaved. The agar was cooled to 
50°C and ampicillin was added to l(0)pg/ml where required. 30ml of agar were poured into 
85mm petri dishes and any bubbles were removed by flaming with a bunsen burner. The 
plates were allowed to set and could be stored for up to 1 week at 4°C. Before use the plates
were dried for 15 minutes in a UV cabinet at 45°C.
1.7 Mini Preparations of Plasmid DNA from. Single Colonies.
Using a sterile toothpick individual colonies were picked from LB/Amp plates and 
grown in 3ml of LB/Amp overnight at 37°C. 1ml of each overnight culture was centrifuged in 
a microcentrifuge for 30 seconds and the pellet resuspended in l(0)|d of H2O. An equal 
volume of 2x lysis buffer (O.1M NaOH, 2% SDS, lOmM EDTA) was added, the samples 
were vortexed and boiled for 2 minutes. lOOpl of 1M magnesium acetate were added, the 
samples were vortexed and left to stand on ice for 2 minutes prior to being centrifuged for 30 
seconds as above. The supernatant was NOT removed and 50pl of 5M potassium acetate were 
added, the samples were vortexed and left on ice for 2 minutes and centrifuged as before. The 
supernatants were transferred to sterile tubes containing 0.6ml of 95% ethanol, mixed and left 
on ice for 2 minutes. Samples were centrifuged for 2 minutes in a microcentrifuge and the 
resulting pellets were washed with 5(0)pl of 70% ethanol and centrifuged as before. The 
pellets were dried in vacuo and dissolved in 40pl of Ol.mM EDTA, lOmM Tris/HCl pH 8. 
One unit of RNase (Boehringer) was added to each sample and the DNA was analysed by
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restriction endonuclease digestion and agarose gel electrophoresis. Typically 5^d of DNA was 
used for each restriction digest.
1.8 Replica Plating of .Transformed g.C.rll..Colo.ni.es-
Identical 50 square grids were drawn on an 82mm Hybond-N filter (Amersham) and 
the base of an 85mm petri dish. The latter was taped to the base of an LB/Amp plate keeping it 
in the same orientation as the filter, which was placed directly ■ onto the agar of a second 
LB/Amp plate. Using sterile toothpicks individual colonies were picked and streaked onto a 
grid on the filter and the corresponding grid on the master plate. Both plates were incubated, 
agar side up, at 37°C overnight and stored at 4°C until required.
(a) Preparation rf Filters.
The nylon filters were lifted from the agar using forceps and placed sequentially 
(colony side up) on filter paper soaked in (1) O.1M HCl for 1 minute, (2) 0.5M NaOH for 15 
minutes, (3) lM Tris/HCl, pH 7.5 for 5 minutes and (4) 1.2M NaCl for 15 minutes. The filter 
was then air dried for 1 hour and placed colony side down on a UV transilluminator for 2 
minutes.
(c) Labelling of DNA Probes.
DNA probes were labelled by random priming using the Klenow polymerase. The 5x 
oligonucleotide labelling buffer (OLB) used was 0.25M Tris/HCl pH8.1, lOmM DTT, 25mM 
MgC^,0.2M KCl and the unlabelled dNTP stock was 0.4mM with respect to dCTP, dGTP
and dTTP. 0.2pg of dsDNA in 3.75|il of H2O were denatured by boiling for 3 minutes and 
then placing on ice. 1.5pl OLB, 0.251x1 1mg/ml acetylated BSA, 0.75pl unlabelled dNTPs, 
lOpCi [a-32P] dATP and 1 unit of Klenow were added and the 7.5|d reaction mixture was left 
for 2.5 hours at room temperature.
0.5ml of TEN (lOmM Tris/HCl pH7.5, lmM EDTA pH8, lOOmM NaCl) and lOOp of 
lM NaOH were added to the labelled DNA and left at room temperature for 10 minutes. The 
solution was then neutralised by the addition of 1O0J of lM HCl.
(d) Hybridisation.
The solutions required for the hybridisation reaction were 3M NaCl, 0.3M sodium
citrate (CCxSSC) and 1% BSA, 1% Ficoll, 1% polyvinyl pyrrolidone, 0.02% azide
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(50xDenhardts). The latter was stored at 4°C. Single stranded DNA was prepared by 
sonicating salmon sperm DNA or calf thymus DNA at a concentration of 2mg/ml in HO and
storing in 1ml aliqouts at -20°C. Immediately prior to use the DNA was boiled for 3 minutes
and then placed on ice. The prehybrtdtsatton and hybridisation solutions were made up as 
follows:
Er&Zhhi&mmMMr
1.5ml 20xSSC 
3ml HO
0.5ml 50xDenhardts 
25pl 20% SDS
50pl denatured DNA
3ml 20xSSC 
2ml 50xiesnhardts 
2.8ml H2O 
20pl 0.5M EDTA pH8 
2<00|ll IMTnsHiCl pH7.5 
250pl denatured DNA 
500pl 10% SDS
The nitrocellulose filter (prepared above) was placed in a sealed plastic bag with 5ml of 
0rehybridisation buffer and incubated in a shaking water bath at 65°C for 3 hours. The filter 
was transferred to a fresh bag containing 8.8ml of hybridisation buffer, 0.1% sodium 
tetraoyrophosohate. The 32P labelled probe was added, the bag sealed and the filters 
hybridised at 65°C overnight. Filters were washed for 3x30 minutes in 500ml of 2x SSC, 
0.25% SDS at 65°C to remove free probe. They were then blotted dry and exposed to Fuji 
X-ray film for 1-5 hours.
1.9 Storage of Transformed E.Coli strains.
Transformed bacteria were grown in LB/Amp overnight and the stationary phase 
cultures were stored at -70°C in 15% glycerol.
2 CLONING. AND EXPRESSION OF 23-KDA PROTEIN IN E.COLI
The 23-kDa protein was expressed as a fusion protein with glutathione transferase 
using the vector pGEX-2T and as an individual entity using the pET3c vector. In addition to 
expressing the intact protein 3 deletion mutants were also expressed.
2.1 Cloning and Expression of the 23-kDa Protein using pGEX-2T.
Three plasmids were constructed by incorporating all or part of the gene encoding the 
Ad2 23-kDa putative protease into the vector pGEX-2T as follows:
0GEX23K(enttre 23-kDa sequence)
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pGEX23KaN (codons for N-terminal 18 amino acids deleted) 
pGEX23KAC (codons for C-terminal 23 amino acids deleted)
In each case the cDNA insert encoding the desired region of the 23-kDa protein was
copied from Ad2 DNA using PCR. The oligonucleotide primers used to do this were:
(1) 5,-CCCCGGATCCAGTGAGCAGGAA.CTGAAAGCCATTGTC-3'
(2) 5,-GCGCGGATCCTGGGGGGTAAATAATCACCCGAGAGTGTACAA-3
(3) 5'-GCGCGGATCCCCATA'rrmTTGGGC>^i^<T^2\'r(^A^C^A^A^G^C^GC-3 ’
(4) 5 ,-TCGCTCCTTCTTCGTTTCTCTCCATGAAGCTGTAGAG-3,
Each oligonucleotide primer was designed to have 4 bases at its 5' end followed by the 
desired restriction site, this being a BamHI site in primers (1) - (3) and an EcoRI site in primer 
(4). The sites recognised by these enzymes are highlighted above. Primers (1) and (3) were 
taken from the +strand of Ad2 and primers (2) and (4) from the -strand. The inserts for the 4 
plasmids were copied from Ad2 DNA by PCR according to method 1.4 using the following 
pairs of oligonucleotide primers:
PGEX23K - (1) and (2) 
pGEX23KAN - (3) and (2) 
pGEX23KAC - (1) and (4)
The PCR products were purified from agarose gels and digested with either BamHI or 
BamHI and EcoRI as appropriate. The products were then purified from agarose gels and
ligated to pGEX-2T x BamHI or pGEX-2T x BamHI, EcoRI. Ligation products were 
transformed into JMlOl cells and plated onto LB/Amp plates (methods 1.5 and 1.6).
Screening of Colonies
For each construct 6 colonies were selected at random and grown overnight in 3ml of 
LB/Amp at 37°C. 50pl of each densely grown culture were inoculated into 5ml of LB/Amp 
and bacteria were grown at 37°C with shaking until they reached 0.6 absorbance units at 
650nm. To 1ml of each culture 4pl of O.1M p-D-isopropyl-thiogalactopyranoside (IPTG) were 
added and the cells were induced for 3 hours at 37°C with shaking. Cultures were harvested 
by centrifugation for 1 minute in a microcentrifuge, the cell pellets were washed with 1ml of 
cold 50mM Tris/HCl, ImM EDTA, pH8 and resuspended in 2(Xp.l of the same buffer made
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0.5% with respect to NP-40. Samples were sonicated for 4 x 15 seconds on ice and 15fl of 
each were analysed by SDS-PAGE and Western Blotting (chapter 2, method 2).
2.2 Cloning ,and Expression., of . the 23-kDa,Ad2. gene using pET3c.
This work was carried out in the Brookhaven National Laboratory under the 
supervision of Dr C.W. Anderson.
The 23-kDa putative Ad2 protease had previously been expressed in pET3 and the 
construction of the resulting plasmid, pT7AD23K6 is described by Anderson (1990).
(a) Construction ofpT7AD23K12
The cDNA fragment encoding the 23-kDa protein was prepared by digestion of 
pT7AD23K6 with the restriction endonucleases Ndel and Pstl. The resulting DNA fragment 
was purified from an agarose gel and ligated to pET3c that had been digested with the same 
restriction enzymes. The ligation product was then transformed into DH1(DE3) cells and 
plated onto LB/Amp plates.
(b) Construction ofpT7AD23K10 (N-terminal deletion mutant)
A plasmid pT7AD23K10 was constructed, encoding the 23-kDa gene with a 27 base 
pair deletion covering the coding region for amino acids 5-13 of the protein. This was 
achieved by copying the DNA from the linearised plasmid, pT7AD23K6 x EcoRV, using the 
oligonucleotide primers:
(5) 5’-CCCtCATATGGGCTCC^CAGATCTTGGTTGiTGGGCC-3l
(6) 5’-GGCCCTTTCGTCTTCAAG-3'
Primer (5) matches with the +strand across the Ndel site (highlighted) at the initiation 
codon (underlined) through to the TCA codon for Ser4 of the 23-kDa protein, then with the
bases coding for AspH to Pro19 of the same protein. Primer (6) matches with the opposite
strand at a site just distal to the EcoRI site of pET3.
The PCR product was purified from an agarose gel, digested with the restriction 
endonucleases Ndel and Kpnl and then purified a second time from an agarose gel. The 
plasmid pT7AD23K6 was digested with the same restriction enzymes and the cut vector was 
separated from the insert by agarose gel electophoresis. The cut vector and PCR product were 
ligated together and then transformed into DH1(DE3) cells and plated onto LB/Amp plates.
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(c) Screening Coiontes
For each construct 6 colonies were selected and the nature of their transformants
assessed by carrying out mini preparations of their plasmid DNA followed by selected
restriction enzyme digestions (EcoRI, NdeI,BglII/NruI for pT7AD23K12 and EcoRI,NdeI,
KpnI/Ndel for pT7AD23K10 ),
(d) Expression of Cioned, Proteins
Correctly constructed plasmids were transformed into BL21(DE3) cells in order to 
express the 23-kDa protein and its deletion mutant and the resulting strains were grown up in 
LB/Amp overnight at 37°C. 5pi of the stationary phase cultures were inoculated into 100ml of 
LB/Amp or M9/Amp. The M9 minimal medium was prepared by mixing 5ml of 20x M9 (lOg 
NH4CI, 30g KH2PO4 and 60g Na2HP0>4 made up to 5(Xml with H2O, filtered through a 0.2p
nylon filter and autoclaved), 2ml of 20% glucose (sterile filtered) and 0.1ml of IM MgS0>4
(sterile filtered) and making up to 100ml with sterile H2O.
The l(X)ml cultures were grown overnight with shaking at 30°C and then transferred to 
a 37°C shaker. The absorbance of the cultures at 600nm was monitored and on reaching 0.4 
units the expression of the proteins was induced by the addition of IPTG to 0.4pM. At 0, 1,2 
and 3 hours after the addition of the IPTG, 1ml samples were withdrawn from the cultures and 
labelled for 5 minutes at 37°C with 20pCi of 35S methionine. The bacteria were sedimented by 
centrifugation for 5 minutes in a microcentrifuge and washed x2 with PBS, pH6.2. They were 
then disrupted by boiling in lOOpl of SDS gel loading buffer. 15pl of each sample was 
analysed by SDS-PAGE and autoradiography.
Three hours post induction the cells were harvested by centrifugation for 5 minutes at 
lOOOOg and then washed with 50mM Tris/HCl, pH8,5mM EDTA, 4% glycerol. The pellet 
was resuspended in 5ml of the same buffer and incubated with lOOpgml lysozme for 15 
minutes at 37°C. The lysed cells were frozen and thawed 3 times in a dry ice /ethanol bath and 
then incubated for a further 15 minutes in the presence of lOmM MgCl2 and lOOrg/ml DNasel. 
Samples were centrifuged at lOOOOg for 20 minutes at 40C and the supernatants were assessed 
for protease activity using the 35S Ad2tsl assay (chapter 2, method 1.1). The pellets were
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washed x2 in 50mM Tris/HCl pH8, 5mM EDTA, 4% glycerol and then solubilised by heating 
to 9(PC in 1ml SDS-PAGE loading buffer. The proteins were then purified by gel filtration 
and reverse phase chromatography as described by Anderson (1990). The composition of the 
proteins were verified by tryptic peptide and protein sequence analysis by R.Greene 
(Anderson, 1990).
2.3 Purification of 23-kDa Protein from E.Coli.
lOpl of pT7AD23K12 transformed BL21(DE3) cells were inoculated into 10ml of
LB/Amp and grown overnight at 37°C. 5ml of the densely grown culture were added to 1 litre 
of M9/Amp and grown with shaking at 37°C until the absorbance of the culture at 600nm 
reached 0.4-0.6. The culture was made 0.4pM with respect to IPTG and induced for 4-6 
hours at 37°C with shaking. The cells were harvested by centrifugation for 5 minutes at 
120(X)g in a JA14 rotor using a J2-21 Beckman centrifuge and then washed with 2(Xml of 
50mM Tris/HCl, 5mM EDTA, ImM p-mercaptoethanol, 4% glycerol pH8. The pellet was 
then resuspended in 50ml of the same buffer and stored at -70°C until required.
0.5ml of a 1mg/ml lysozyme solution were added to the 50ml cell suspension and 
incubated for 15 minutes at 37°C before ffeeze/thawing x3 using liquid nitrogen and a 37°C 
water bath. 0.5ml of 1M MgSO4 and 0.25ml of 2mg/ml DNasel were then added to the lysed 
cells, mixed and incubated for a further 15 minutes at 37°C. The sample was centrifuged for 
20 minutes at 12000g (4°C) using a JA17 rotor in a J2-21 Beckman centrifuge and the 
resulting supernatant was dialysed for 2 hours against 3x2 litres of 50mM Tris/HCl pH8 at 
4®C. It was then filtered through a 0.2p nylon filter and loaded onto a 25ml
DEAE-Sepharose-CL6B column equilibrated with 50mM Tris/HCl pH8. The flow rate was 
Iml/minute, the detection wavelength 280nm and the full scale deflection was 2 absorbance 
units. 4ml fractions were collected for 90 minutes or until the absorbance at 280nm had
returned to the baseline. The column was then washed with 200ml of IM NaCl and stored in 
0.02% azide. The flow-through fractions contained the 23-kDa protein and were pooled and 
solid ammonium sulphate was added slowly to the pooled fractions in order to make them 
1.2M with respect to the salt. The sample was then filtered through a 0.2p nylon filter and
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loaded onto an FPLC phenyl Superose HR5/5 column equilibrated with 50mM Tris/HCl, 1.2M
ammonium sulphate pH8. The flow rate was 0.5ml/minute, the full scale deflection 1 
absorbance unit and the detection wavelength 280nm. Once the sample was loaded the
following gradient was applied to the column:
time (minutes) %B
0 30
10 30
15 45
30 45
45 90
45.1 100
50 100
50.1 30
60 30
The buffers used were (A) 50mM Tris/HCl, 1.7M ammonium sulphate pH8 and (B) 
50mM Tris/HCl pH8. Fractions were collected and 5pl of each were analysed by SDS-PAGE 
and Western blotting as described in chapter 2, method 2.
3 CLONING ANDEXPRESSION QF AD2.23-kDa PROTEIN USING
BECOMBINANT-BACULOYIBUSES.
The 23-kDa putative protease gene was cloned into two different baculovirus vectors in 
order to compare expression levels.
3.1 Cloningof the 23-kPa Protein into Baculovrrns Vectoss
(a) CkHUng of 2 3-D a protem buo pAcRP23
The DNA fragment encoding the 23-kDa protein was obtained by digesting the plasmid 
pT7AD23K12 with Ndel and EcoRV, treating it with Klenow polymerase and purifying it 
from an agarose gel. The vector pAcRP23 (Possee and Howard,1987) was linearised with 
BamHI, treated with Klenow polymerase and calf intestinal alkaline phosphatase (CIAP), 
phenol/chloroform extracted and then ligated to the purified Ndel-EcoRV fragment. The 
ligation product was transformed into JMlOl cells and colonies were screened as described in 
method 3.2 (below).
(b) Clming of the 23 --Daapootein ntoe pVL2323
A fragment representing the entire coding region for the Ad2 putative protease was
copied from Ad2 DNA by PCR using the following oligonucleotide primers:
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(7) s’-ggggggatcctataaatatgggctccaagtgagcaggaactgaa 
AGCCAT-3’
(2) 5'-GCGCGGATCCTGGGGGGTAAATAATCACCCGAGAGTGTACAA-3'
Both primers include a recognition site for BamHI close to their 5’ end and primer (7) 
matches exactly with the +strand from the initiation codon of the 23-kDa protein (underlined). 
The sequence TATAAAT is included upstream from the initiation codon since this is reported 
to give increased levels of transcription (Possee and Howard, 1987).
The resulting PCR product was gel-purified, digested with BamHI and then gel 
purified for a second time. The vector pVL1393 (Invitrogen) was also digested with BamHI 
before treatment with CIAP and phenol/chloroform extraction. The PCR insert and vector 
were then ligated together and the ligation product was transformed into JMlOl cells and the 
colonies were screened as described in 3.2.
3.2 Screening of C.oJ^nig,s.
For each of the constructs one hundred colonies were selected at random and replica 
plated as described in method 1.8 Filters were hybridised with a specific 32P labelled probe, 
prepared by random priming of the BamHI digested PCR product prepared in 3.1. Positive 
colonies were identified by autoradiography and 6 positives were selected for each construct. 
The orientations of the protease gene were established by BglH, EcoRI digestions of the 
mini-plasmid preparations from each colony. Large scale plasmid preparations of the two 
correctly constructed vectors, termed pAc23K and pVL23K respectively, were carried out 
ready for transfections with baculovirus DNA.
3.3 Insect Cell Culture.
Spodoptera frugiperda cells (sf9) were maintained in suspension and monolayer 
cultures at 285C in TCI00 medium (Gibco-BRL) supplemented with 10% fetal calf serum 
(FCS) and 50pg/ml gentamycin. For routine maintenance cells were passaged every 2-3 days,
(a) Suspension Cultures
For suspension cultures when the cell count reached 2x105 cells/ml, 80% of the culture
was discarded and replaced with the same volume of TCI00/10% FCS.
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(b) Moroehyer Culmres
Monolayer cultures were maintained in 75cm3 plastic bottles and on reaching 
confluence the medium was decanted and the cells were resuspended in 10ml of TClOO/10% 
FCS. 2ml of the cell suspension were transferred to a second 15cm? bottle which was made
up to 25ml with TClOO/10% FCS.
(c) Freezing of $fr Cetts
When the cell count of a suspension culture reached 106 cells per ml, 10ml aliquots 
were centrifuged for 5 minutes at lOOOg and the cell pellets were gently resuspended in 
1ml of 90% FCS, 10% DMSO (103 cells/ml). The 1ml aliquots were placed in cryogenic tubes 
and cooled at -20°C for 1 hour before being transferred to a -70°C freezer overnight and then 
placed under liquid nitrogen for long term storage.
(d) Thawingof sfr relS s
A 1ml aliquot of frozen sf9 cells was thawed rapidly at 37°C then placed on ice prior to 
being added to 9ml of FCS and centrifuged at lOOOg for 5 minutes at 4°C. The cell pellet was 
resuspended in 5ml of cold TC100/10% FCS and placed at 28°C in a 25cm3 plastic flask.
After 12 hours fresh medium was added to the cells and on reaching confluence (3-5 days) the 
medium was decanted, the cells were suspended in 5ml of TC100/10% FCS and transferred to 
a 75cm3 flask along with 20ml of the same medium. On reaching confluence cells were 
passaged as in (b) above. To set up a fresh spinner culture the medium was decanted from 2 
confluent 75cm3 bottles of sf9 cells and the cells were resuspended in TC100/10%FCS, 
transferred to a spinner flask and made up to 200ml with TC100/10%FCS.
3.4 Preparation of f^^c^uo^\/in.ks DNA.
5(X)ml of sf9 cells were grown in suspension to a density of 103 cells per ml in 
TC100/10%FCS at 28°C as above and the cells were infected at a multiplicity of 1 p.f.u. per 
cell with AcNPV or AcRP23-lacZ virus (Possee and Howard,1987). The infections were 
allowed to proceed at 28°C for 5-6 days until all the cells showed signs of infection (nuclei full 
of inclusion bodies in the case of AcNPV and large round, vacuolar cells in the case of 
AcRP23-lacZ). At this stage cells were harvested by centrifugation at 2000g for 10 minutes at
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4°C. The supernatant, into which the virus is released, was stored at 4°C until required and 
the cell pellet discarded. The supernatant was centrifuged at lOOOOOg for 30 minutes at 4°C in 
a Beckman L8-55M ultracentrifuge. The viral pellet was air dried and then resuspended in 
4.5ml of 0.6% SDS, lOmM Tris/HCl pH7.5, lOmM EDTA, made lOOpg/ml with respect to 
proteinase K and incubated for 2 hours at 50°C. The DNA solution was extracted with 1 
volume of phenol and then with 2x1 volume of chloroform prior to being precipitated for 20 
minutes in a dry ice/ethanol bath following the addition of 10ml of ethanol. The DNA was 
pelleted by centrifugation at 2000g for 10 minutes and washed with cold 90% ethanol before 
being dried by rotary evaporation and resuspended in 200pl of ImM Tris/HCl pH8, O.lmM 
EDTA. Incubation for 15 minutes at 65°C aided resuspension and the DNA was then stored at
4OC.
3.5 Transfections.
(a) pAc23K and AcNPV DNA
5ml of sf9 spinner cells (106 cells per ml) were transferred to a 25 cm3 flask and left at 
room temperature to form a monolayer.
0.5pg of AcNPV DNA and 2pg of pAc23K were mixed and made up to 50pl with 
ddH20 in a siliconised eppendorff tube prior to the addition of 50pl of lipofectin (BRL). On 
gentle mixing with a pipette tip a fine precipitate appeared (a heavy precipitate should not form 
at this stage) and the mixture was left for 10 minutes at room temperature.
The media was decanted from the 25cm3 flask and the sf9 cell monolayer was washed 
with 5ml of Optimem (Gibco-BRL) before 3ml of fresh Optimem were added and the 
transfection mixture was pipetted dropwise and evenly over the cell monolayer. The bottle was 
rocked gently and then placed at 28°C for 4 hours, after which the Optimem was removed and 
the cells were washed with 5ml of TC1(X)/10% FCS and left in 5ml of the same medium at 
28°C for 4 days. At this stage occlusion bodies were present in the nuclei of some of the cells 
so the culture was harvested by centrifugation at 2(X)0g for 10 minutes and the supernatant
stored at 4°C.
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(b) pVL23K and AcRP23-lacZ
0.5jxg of AcRP-lacZ were linearised by incubation with 10 units of the restriction 
endonuclease, Bsu36I for 2 hours at 37°C. The enzyme was inactivated by heat treatment at
65°C for 15 minutes.
0.5|ig of AcRP23-lacZ x Bsu36I and 2pg of pVL23K were transfected into sf9 cells 
exactly as described in (a) except that no occlusion bodies formed in cells since AcRP23-lacZ 
DNA does not encode for the polyhedrin.
3-6 Purification of Recombinant Baculovirus.
Two methods were used in parallel to purify recombinant baculoviruses encoding the 
23-kDa Ad2 protein.
(a) Plaque Purification
6ml of sf9 cells (105 cells per ml) were pipetted into each of twelve 5cm5 petri dishes 
and left overnight at 28°C to form monolayers.
A dilution series of the supernatants from the 4 day transfections (prepared in 3.5) were 
set up in 1ml of TC1X (no FCS) going from lO'1 to 10*5 of neat stock. Fresh tips were used 
for each dilution to prevent carry over.
The medium was removed from the sf9 monolayers in the petri dishes and lOOpl of the 
appropriate virus dilution was pipetted gently onto the cells and allowed to cover the entire 
monolayer (duplicate plates were set up for each dilution). The plates were left for 1 hour at 
28°C in a sealed container. Meanwhile a 3% solution of low melting point agarose (Sigma) 
was autoclaved, cooled to 37°C and mixed with an equal volume of TC1(X/10% FCS (also at 
37°C). When recombinant virus was prepared from AcRP23-lacZ DNA, 1/100 volume of a 
50mg/ml solution of 5-bromo-4-chloro-3-indolyl-p-D-galactoside (X-gal) in DMF was also 
added to the agarose.
4ml of the 1.5% LMP agarose were pipetted gently over the cells in each petri dish so 
that the entire monolayer was covered and the agarose was allowed to set before being 
overlayed with 4ml of TCI 00/10% FCS and left at 28°C. After 5 days the medium was 
removed from above the agarose and replaced with 4ml of 0.05% Neutral Red in TC1(X/10% 
FCS for 6 hours. The stain was removed and the plates left overnight at 28°C.
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Clear plaques (AcNPV - no occlusion bodies in cell nuclei; AcRP23-lacZ - not blue) 
were picked through the agarose using pipette tips, suspended in 50pl of TC1OO and stored at 
4°C until required. To check that the plaques were produced by recombinant virus expressing 
the 23-kDa protein, a 96-well plate was set up with lOOpi of sf9 spinner cells (106 cells per ml) 
in each well. The cells were left for at least 1 hour at room temperature to form monolayers 
and then the medium was aspirated off. 20pl from each plaque stock were pipetted into 
separate wells (duplicate wells for each stock) and the plate was placed at 28°C for 1 hour after 
which 150pl of TC100/10% PCS were added and the plate was returned to 28°C for 60 hours. 
Supernatants were transferred to the equivalent wells of a second plate and stored at 4°C, 
whilst the cells were suspended in 15pl of Laemmli electrophoresis buffer and 5pl of gel 
loading buffer. Samples were boiled for 2 minutes and analysed by SDS-PAGE and Western 
Blotting (chapter 2, method 2).
A second round of plaque purifications was then carried out using the supernatant 
corresponding to the sample containing the largest amount of the 23-kDa Ad2 protein and the 
process was repeated until a homogeneous stock was obtained (only clear plaques present).
(b) Microtitre Plate Assay for Recombinant Viris
This assay is of greatest value if the amount of recombinant virus obtained from the 
transfection is small compared to the parental virus. This was • the case when AcNPV DNA 
was used.
2.5ml of sf9 spinner cells and 2ml of TC100/10% PCS were pipetted into each of 6 
sterile tubes. 500pl of the transfection supernatant (prepared in 3.5) was added to the first tube 
to give a 101 stock, the tube was mixed by inverting it several times and 500pl was then 
transferred to the second tube (10% stock). The process was repeated until a 10 fold dilution 
series from lO% to 10 6 had been set up and then 18Opl of the stocks were pipetted into the 
wells of a 96-well plate as follows. The 10'1 stock was added to all the wells in columns 1-2, 
the 10% stock to the wells in columns 3-4 and so on through to the 10 '6 stock in the wells of 
columns 11 and 12. The plate was sealed and placed at 28°C for 4 days after which the virus 
containing supernatants were transferred from each well to the corresponding well in a second
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plate using a fresh tip for each transfer. The master plate was stored at 4°C.
To the cells in each well of the original plate lOOpl of freshly prepared 0.5M NaOH,
1% SDS were added and left for 10 minutes at room temperature. The lysed cells were 
neutralised by the addition of 150pl of 0.15M Tris/HCl pH8,0.3M NaCl, 0.3M acetic acid. A 
piece of Hybond-N Filter (Amersham), cut to the same size as the plate and soaked in HO was 
labelled for orientation and placed in the vacuum dot blot apparatus (BRL). In order to seal the 
apparatus and ensure efficient suction it was necessary to wet the plastic sections with HO 
before assembly. ISOpJ from each well of the microtitre plate were transferred to the 
corresponding well of the dot blot apparatus and the vacuum was applied to suck the cell 
lysates through the filter. 2x200pl of 0.15M Tris/HCl pH8,0.3M NaCl was then washed 
through each well and the filter was removed from the apparatus and left to air dry for 1 hour. 
DNA was crosslinked to the filter for 2 minutes on a UV transilluminator and hybridised with 
the appropriate probe (methods 1,8 and 3.2). A well from the highest dilution that gave a 
signal was selected and purified further either by setting up a second microtitre plate or by 
plaque purifying it and following the procedure outlined in (a) above.
3.7 Preparation of Recombinant Virus Stocks
5ml of sf9 spinner cells (10® cells per ml) were transferred to to a 25cm3 flask and left 
at room temperature for 1 hour to form a monolayer. The medium was poured out of the flask 
and replaced with 1ml of TCI00 (no FCS) containing SOpl of plaque purified recombinant 
virus stock. The virus was allowed to absorb onto the cells for 1-2 hours at 28OC before being 
removed and replaced with 5ml of TC100/10%FCS. The flask was returned to the 28°C 
incubator and the infection was allowed to proceed for 4-5 days or until most of the cells were 
lysed. The media containing the virus was decanted from the flask and clarified by 
centrifugation at lOOOg for 10 minutes at 4°C.
A monolayer of sf9 cells was set up in a 75cm3 flask using 25ml of a spinner culture as 
above. The monolayer was infected with 500pl of the virus stock harvested from the 25cm3 
flask in 2ml of TC1OO, as described previously and then replaced with 25ml of 
TC100/10%FCS. The infection was allowed to proceed for 4-5 days and the virus stock
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harvested as before.
A 500ml spinner culture (10° cells per ml) was infected with 20ml of the virus stock 
prepared in the 75cm3 flask. The infection was allowed to proceed for 5-6 days until most of 
the cells were lysed and then the medium containing the virus was clarified by centrifugation 
for 10 minutes at lOOOg (4°C). 1ml aliquots of the stock were placed at -7C0C for long term 
storage and the remainder of the stock was stored at 4°C. The titre of the stock was determined 
by carrying out plaque assays as described in method 3.6a, with duplicate plates being set up 
for ten fold dilutions of the stock ranging from 10-1 to 10‘9.
3.8 Expression of the Recombinant 23-kDa Protein in s19 cells.
For maximum yields of the recombinant protein it is necessary to carry out high 
multiplicity infections in excess of Ip.f.u. per cell.
(a) 24 well plates
24 well plates were used to carry out timed infections and monolayers were set up in 
each well by the addition of 1ml of a 10° cells per ml spinner culture of sf9 cells. After the 
monolayers had formed, the medium in each well was replaced with 200|il of the virus stock 
(105 p.f.u. per ml) or TC1OO and the plate was returned to the 28°C incubator for 1-2 hours. 
The virus was then removed and 1ml of TC100/10%FCS was added to each well and the 
infection was allowed to proceed. Cells were harvested at 0, 24, 36, 48,72 and 96 hours post 
infection by transferring the contents of the appropriate well to an eppendorff tube, centrifuging 
the cells at low speed in a bench microcentrifuge for 3 minutes and washing the cell pellet x2 
with PBS. The cell pellet was then resuspended in 8Opl of 50mM Tris/HCl, ImM EDTA,
0.5% NP40 and 20pl of SDS gel loading dye and lOpl of the sample was analysed by 
SDS-PAGE and Western blotting (chapter 2, method 2).
(b) 25cm3 and 75cm3 flasks.
Monolayer cultures of sf9 cells were set up in the 25cm5 and 75cm5 flasks as described 
in method 3.7. The cells were infected with 0.3 and 1ml of a 105 p.f.u. per ml virus stock in a 
total volume of 1 and 2ml of TCI CO respectively and the infection procedure was as described 
in method 3.7. The cells were harvested at 60 hours post infection by centrifugation at lOOOg
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for 5 minutes (4°C) and washed x2 with ice cold PBS, pH6.2. The cell pellets were stored at 
-70°C until required.
(c) Suspension Cultures.
500ml cultures of sf9 cells were grown in suspension until they reached a density of 
3x106 cells per ml. The cells were then pelleted by centrifugation at lOOOg for 5 minutes and
resuspended in 15ml of a 101 p.f.u. per ml stock of recombinant virus. TC1OO was added to a 
final volume of 50ml and the cells were infected for 1-2 hours at 28°C. 450ml of TClOO/10% 
FCS were added to the culture and the infection was allowed to proceed for 60 hours at 28°C. 
The cells were harvested and washed as described previously and the cell pellet was stored at
-70OC
3.9 Purification of the 23-kDa protein from insect cells.
The washed cell pellet from an infection of a 500ml suspension culture of sf9 cells 
(method 3.8c) was suspended in 5ml of ice cold 50mM Tris/HCl, pH8 and homogenised on 
ice with 20 strokes of the tight fitting pestle (pestle B) in a Dounce homogeniser. The nuclei 
were sedimented for 5 minutes at low speed in a microcentrifuge and the supernatant 
(cytoplasmic extract) was clarified by centrifugation for 20 minutes at 26000rpm (30000g) in a 
Beckman TL1OO ultracentrifuge set at 4°C.
The resulting cytoplasmic extract was dialysed against 50mM Tris/HCl pH8 for 2 hours 
at 4°C and purified using DEAE and phenyl Superose columns essentially as described for the 
recombinant E.Crlt protein (method 2.3). The only difference was that a 5ml DEAE 
Sepharose CL6B column was used and 1ml fractions were collected. lOpl of the fractions 
collected from the DEAE and phenyl Superose colums were analysed by SDS-PAGE and 
Western blotting according to chapter 2, method 2.
4 JRQXEINUSTIMAlIQN
(a) at 280nwi
1n order to get a very rough estimate of the amount of protein present in a sample its 
absorbance at 280nm was read and it was assumed that an absorbance of 1 corresponded to
1 mg/ml of protein in the solution.
A
168
(b) Bradford Test
When required the protein concentrations of samples were estimated using the method 
of Bradford (1976), Protein samples, in a total volume of lOpl, were mixed with 1ml of 
Bradford's reagent (0.1 g Coomassie blue G250, 100ml of orthophosphoric acid and 50ml of 
ethanol made up to 1 litre with ddH2O) and incubated at room temperature for 5 minutes. The 
absorbance of the samples were measured at 595nm and the protein concentrations calculated 
by comparison with a standard curve constructed using BSA.
(c) By SDS-PAGE analysis and Coomassie blue staining.
To estimate the concentration of an individual protein in a heterogeneous mixture the 
sample was analysed by SDS-PAGE and Coomassie staining (chapter 2, method 2). The 
intensity of the individual protein band was compared to bands on a standard gel separating 
0.05-Ipg of soya bean trypsin inhibitor (SBTI).
5 EEEPARA1IQIS.QFPQLYCLQNAL ANTISERA
A polyconal antiserum was raised in rabbits against the recombinant E.Coli expressed 
23-kDa protein, purified according to method 2.3. l(X)pg of purified protein in 1ml of PBS 
pH6.2 were mixed with 1ml of complete Freund's adjuvant and injected into Dutch rabbits as 
described in chapter 2, method 3.2. Booster injections of lOOjpg of protein in 1ml of PBS 
pH6.2, mixed with 1ml of incomplete Freund's adjuvant, were given at 2 week intervals. Test 
bleeds and assessment of the antiserum were carried out according to chapter 2, method 3, 
except that the ELISA plates were coated with 50pl of a lOpg/ml solution of purified E.Coli 
expressed 23-kDa protein.
6 EEQ3EASEAS&AY&
The 33S methionine labelled Ad2tsl and the peptide assays for the Ad2 protease were
carried out essentially as described in chapter 2, methods 1.1 and 1.3.
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1 Expression of the Ad2 Protease .as...a Fusion .Protein in E.Crli
The plasmids pGEX23K, pGEX23KAN and pGEX23KAC were constructed and 
transformed into JMlOl cells, as described in the method. 2.1. The resulting cells were 
induced with IPTG for 3 hours, harvested by centrifugation, disrupted by treatment with 
lysozyme and analysed by SDS-PAGE. As a control JMlOl cells, transformed with the parent 
vector, pGEX-2T, were treated in a similar fashion. Duplicate gels were prepared and one was 
stained with Coomassie blue (fig.3.4a), whilst the other was electroblotted onto nitrocellulose 
paper and probed with a polyclonal antisera raised against the 23-kDa protein (fig.3.4b). The 
stained gel reveals that whilst the pGEX-2T transformed cells over express a protein of 
apparent molecular weight 26-kDa (lane 2), the cells transformed with pGEX23K, 
pGEX23KaN and pGEX23KAC express proteins of apparent molecular weight 44-46-kDa 
(lanes 3,5 and 6). In each case, this corresponds to the fusion protein of GST with part or all 
of the Ad2 protease sequence. Lane 4 shows the pGEX23K extract after a 2 hour incubation 
with thrombin. Looking at the corresponding lanes in fig.3.4b it can be seen that there is no 
reaction between the anti-23K sera and any of the proteins in the GST expressing cells (lane2); 
but that bands corresponding to the GST-23K, GST-23KAN and GST-23KAC fusion proteins 
are present in lanes 3,5 and 6 respectively. A band that co-migrates with the Ad2 purified 
protease (lane 1) appears when the GST-23K containing extract is cleaved with thrombin (lane 
4).
The level of expression of the GST-23K fusion protein is extremely high (20mg/Iitre). 
Unfortunately, however, the majority of this is present as insoluble inclusion bodies, making it 
difficult to purify the protein by affinity chromatography using a glutathione Sepharose column 
(data not shown).
As can be seen from lanes 3, 5 and 6 in fig.3.4b there is a significant amount of 
proteolytic degradation of all the fusion proteins. It is possible that the 23-kDa protein is 
cleaving the fusion protein, as was observed by Houde and Weber (1990a). On the other hand 
E.Crli proteases could be responsible for the degradation. When the inductions and
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(a) Coomassie Stained (b) Western Blot
FigJ.4 Expression of the Ad2 Protease as a fusion protein with GST
Samples were analysed on 12.5% SDS polyacrylamide gels and gel (a) was stained with Coomassie blue 
whilst gel (b) was electroblotted onto nitrocellulose paper and probed with a polyclonal antisera raised 
against the 23-kDa protein (1:500 dilution). The samples were IPTG induced JMlOl cells transformed 
with lane 2, pGEX-2T; lane 3, pGEX23K; lane 5, pGEX23KAN and lane 6, pGEX23KAC. Purified 
Ad2 23-kDa protein is in lane 1, whilst lane 4 contains the pGEX23K transformed extract incubated 
with thrombin.
extractions were carried out in the presence of 1mM ZnCl2, a potent inhibitor of the Ad2 
protease, the same degree of digestion was observed. Furthermore, incubations of the fusion 
proteins with disrupted Ad2 did not result in any further degradation (results not shown). 
Therefore, in this case, E.Crlt proteases would appear to be responsible for the proteolysis of 
the GST-23K fusion protein.
2 Specificitv of the Antisera Raised against the N- and C- Termini of the Ad2 Protease. 
The E.Crlt extracts prepared above containing the GST-23K, GST-23KAN and
GST-23KaC fusion proteins were separated by SDS-PAGE alongside protease purified from 
Ad2. The proteins from 2 identical gels were transferred onto nitrocellulose paper and one was 
probed with the N-terminal peptide antiserum (fig.3.5a), whilst the other was probed with the
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C-terminal peptide antiserum (fig.3.5b). Both the antisera reacted with the purified Ad2 
protease and with the GST-23K fusion protein (lanes 1 and 2). The N-terminal peptide 
antiserum reacted with GST-23KaC (lane 4), but not with GST-23KAN (lane 3). Since the 
only difference between GST-23K and GST-23KaN is the first 18 amino acids of the 23-kDa 
protease, the N-terminal peptide antiserum is specific and does not cross react with any other 
region of the 23-kDa protein. In a similar vein, the C-terminal peptide antiserum reacts with 
GST-23KaN (lane 3), but not with GST-23KAC (lane 4), so must be specific for the 
C-terminal residues of the 23-kDa protease.
(a) (b)
N-terminal anlisgra C-terminal antisera
__fusion
proteins
-23-IDa
12 3 4 2 3 4
Fig. 2.5 Specificity of 22-kDa N- and C-terminal peptide antisera
Duplicate 12.5% SDS-polyacrylamide gels were prepared with lane /, purified Ad2; and induced
JMiOi extracts containing lane 2, GST-22K; lane 3, GST-23KAN and lane 4, GST-22KAC.
The proteins were electroblotted onto nitrocellulose paper and probed with (a) the 22-kDa
N-terminal peptide antiserum and (b) the 22-kDa C-terminal peptide antiserum. Both antisera 
were used at a dilution of 1 ; 1000.
In chapter 2 it was shown that the 23-kDa protein is the Ad2 protease. The results 
described above show conclusively that the intact 23-kDa protein is the protease and that the 
enzyme is not autocatalytically cleaved at the Ala33-Gly47 bond as proposed by Chatterjee and 
Flint (1987) and Houde and Weber (1990a).
3 Expression of the Ad2 Protease in E.Coli using pET Vectors
The cloning of the Ad2 protease and a deletion mutant lacking amino acids 5 to 13 into
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Fig. 3.6 Expression of the Ad2 23-kDa protease in E.Coli
(a) Autoradiogram of a 12.5% polyacrylamide gel showing 35s methionine labelled transformed BL21(DE3) 
cells. The labelling was for 5 minutes; 3 hours after the addition of IPTG to the cultures. Bacteria were 
transformed with lane J, pET3c; lane 2, pT7AD23K12 and lane 3, pT7AD23K10. (b) Autoradiogram of a 
12.5% polyacrylamide gel showing the results of the 35g Ad2tsl protease assays of the IPTG induced, 
transformed BL21(DE3) cell extracts. lOpl of substrate were incubated with 5pl of the transformed bacterial 
extracts for 6 hours at 37°C. The samples analysed were BL21(DE3) cells transformed with lane 7, pET3c; lane 
2, pT7AD23K12 and lane 5, pT7AD23K10. (c) Schematic diagram showing the amino acids deleted from the 
23-kDa protease in the protein expressed by pT7AD23K10 transformed bacteria, (d) Western blot showing the 
amounts of soluble 23-kDa protein present in pT7AD23K12 transformed BL21(DE3) cells induced for 4 hours 
with IPTG in lane 7, M9 (25°C); lane 2, M9 (37°C); lane 5, LB (25°C) and lane 4, LB (37°C). The proteins 
were probed with the 23-kDa N-terminal antipeptide serum at a dilution of 1:1000. (e) Autoradiogram of a 
12.5% polyacrylamide gel showing the results of the 35g Ad2tsl assays to assess the amount of protease 
activity in the samples analysed in (d). The lane order is the same as for the Western blot in (d) and the 
incubations were for 3 hours at 37°C.
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the pET3 vector was carried out under the supervision of Dr Carl Anderson at the Brookhaven 
National Laboratory, Long Island, New York (Anderson, 1990). The plasmids pT7AD23K10 
and pT7AD23K12 were constructed and transformed into DH1(DE3) and BL21(DE3) cells as 
described in the method 2.2. The transformed BL21(DE3) cells were labelled for 5 minutes 
with 35S methionine after being induced for 3 hours with DPTG The samples were then 
analysed by SDS-PAGE and autoradiography, and fig.3,6a shows that proteins of apparent 
molecular weights 20-kDa and 17-kDa are being expressed in the pT7AD23K12 and 
pT7AD23K10 transformed cells respectively (lanes 2,3), The sequences of the 2 proteins were 
later verified by tryptic digestion and N-terminal sequencing by R. Greene (Anderson, 1990).
Extracts of the pT7AD23K10 and pT7AD23K12 transformed cells were prepared by 
lysozyme and DNase I treatment as described in the methods section and assessed for activity 
using the 35S assay. Fig.3.6b shows that the intact Ad2 23-kDa protein, expressed from 
pT7AD23K12, specifically cleaves pVII to VII (lane 2). No digestion of pVH to VII took 
place when 35S Ad2tsl was incubated with the pT7AD23K10 transformed extracts (lane 3). 
The incubations were for 6 hours at 37°C. Thus the deletion of residues 5-13 from the 23-kDa 
protein appears to result in a total loss of activity and it is concluded that these residues must 
play an essential structural or catalytic role.
The use of M9 medium instead of LB is preferable for labelling studies and also makes 
protein purification easier. The yields of soluble 23-kDa protein in M9 and LB were compared 
at 2 induction temperatures, 25°C and 37OC, and as can be seen from the Western blot in 
fig.3,6d more protein was obtained at 37®C, compared to 25OC in each case. The amount of 
the 23-kDa protein produced was only slightly greater in LB than in M9 at both temperatures 
and this is reflected in the activity of the extracts as assessed by the 35S assay (fig.3.6e). The 
assays were carried out according to chapter 2, method 1.1 and the incubations were for 3 
hours at 37°C Based on these results and the advantages of M9, it was decided to carry out
future inductions at 37®C in the minimal media.
4 Purification of the Ad2 Protease from E.Coli
The soluble yield of the 23-kDa protein obtained from a 4 hour induction of 
pT7AD23K12 transformed cells was Img per litre of M9 media. The cells were disrupted by
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lysozyme and DNase I treatment and then centrifuged, as described in the methods section.
The supernatant was dialysed against 50mM Tris/HCl pH8 and loaded onto a DEAE sepharose 
column equilibrated with the same buffer. Most of the proteins bound to the column; but the 
23-kDa protease eluted in the flow-through (fig.3.7a). The single anion exchange step 
produced an excellent purification as can be seen from the Coomassie blue stained gel. The 
flow-through fractions from the DEAE column were pooled, made 1.2M with respect to 
ammonium sulphate and loaded onto an FPLC phenyl-Superose column. The 23-kDa protein 
bound tightly to the hydrophobic column and was eluted with the low salt buffer B 
(fig.3.7b). As can be seen from the Coomassie blue stained gel the second column not only 
provided a second purification step, but also served to concentrate the protein. The 
flow-through from the phenyl-Superose column had a high absorbance at 280nm; but when the 
fractions were analysed by SDS-PAGE no proteins appeared to be present (results not shown).
A polyclonal antiserum was raised against the purified 23-kDa protein as described in 
the method 5. The antiserum reacted well in Western Blotting at a dilution of 1:5(X) (see 
fig.3.4b).
5 Activity ofthe Purified 23-kDa Protein Expressed in E.Coli
A small scale purification from 50ml of induced, pT7AD23K12 transformed BL21 cells 
was carried out. Fig.3,8 shows the profile of the DEAE Sepharose separation (5ml column) 
alongside a Western blot of the flow through fractions. The corresponding fractions were 
assayed using the 35S assay and peptide assays. Incubation times were 3 hours for the 35S 
assays and 1-12 hours for the peptide assays. The peak of protease activity, as determined by 
the 35S Ad2tsl assay (fig.3.8) was found to coincide with the fractions containing the 23-kDa 
protein. As can be seen the activity of the purified protein (lanes 4-6) is considerably greater 
than that in the crude extract (lane 1). Presumably the purification of the protease from E.Coll 
extracts has removed some inhibitory factor. The same fractions were tested for protease 
activity using Ae peptide assay with very different results. AlAough MSGGAFSW was 
cleaved rapidly by Ae crude extract, Agestion did not take place at the Gly-Ala bond and it was 
concluded that E.Coll proteases were responsible. In contrast no protease activity was detected 
in Ae flow through fractions, containing the 23-kDa protein. The peptide assays were carried
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Fig. 3.7 Purification of the 23-kDa protease from E.Coli
The recombinant 23-kDa protein was purified from pT7AD23K12 transformed BL21(DE3) cells as 
described in method 2.3 and result 4. The elution profiles from (a) DEAE Sepharose and (b) phenyl 
Superose columns are shown with photographs of Coomassie stained gels of the fractions containing 
the 23-kDa protein superimposed. The left hand lane in the gel in (a) shows the DEAE column load 
and the remaining lanes correspond to flow-through fractions. The Coomassie stained gel of 
fractions 53-55 eluted from the phenyl Superose column is included in (b).
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Fig. 3.8 Activity of the 23-kDa protein expressed in E.Coli
The elution profile of E.Coli expressed 23-kDa protein on a DEAE Sepharose column (see result 5). The 
fractions were assessed for protease activity using the 35S Ad2tsl assay and for the presence of the 23-kDa 
protein by Western blotting with a 1:1000 dilution of the 23-kDa N-terminal peptide antiserum. Lane 1 in 
each case is the column load and lanes 2-8 correspond to fractions 2-8.
out in the presence and absence of 1M NaCl, 5mM EDTA and 2mM DTT; but still no activity 
was detected in the 23-kDa peak fractions.
It is, therefore, concluded that some other factor, be it protein or DNA, must be present 
in the 35S Ad2tsl extracts that acts as a cofactor. One possibility is that a post-translational 
modification, such as phosphorylation, is required for activity and that this cannot be carried
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out in the E.Coll.. It was, therefore, decided to express the 23-kDa protein using the 
eukaryotic baculovirus expression system.
6 Expression of the Ad2 Protease using Recombinant Baculovirus Vectors
The 23-kDa gene was cloned into 2 vectors, pAcRP23 and pVL1393, and the correct 
orientations were determined by EcoRI/Bglll digestions of small scale plasmid preparations as 
described in method 3. The plasmids pAc23K and pVL23K were transfected into sf9 cells 
along with AcNPV or AcRP23-lacZ x Bsu36I DNA. Recombinant viruses expressing the 
23-kDa protein were purified and high titre stocks were prepared (method 3). These were then 
used to infect sf9 cells with a view to purifying the 23-kDa protein.
The expression of the 23-kDa protein was found to be optimal at 48-72 hours post 
infection and the expression levels using the pAc23K and the pVL23K derived viruses were 
virtually identical (fig.3,9). High multiplicity infections of 1 litre of sf9 cells for 60 hours 
with the pVL23K derived recombinant baculovirus resulted in the expression of Img of soluble 
23-kDa protein.
Cell extracts were disrupted by homogenisation in 50mM Tris/HCl, pH8 and clarified 
by centrifugation. The supernatant contained most of the 23-kDa protein and was put through 
the purification schedule developed for the E.Coll expressed protein (see above). 
Unfortunately, however, a number of other proteins from the infected sf9 cells did not bind to 
the DEAE column and even after the phenyl-Superose step the 23-kDa protein was not 
completely pure (fig.3.10). It will, therefore, be necessary to design a better purification 
protocol for the baculovirus expressed protein in the future. In the meantime, it was decided to 
investigate the activity of the partially purified baculovirus expressed 23-kDa protein in both 
protease assays.
7 Activity of the . Ad2 Protease Expressed in Insect Cells.
The cytoplasmic extract from 100ml of sf9 cells, infected with the pVL23K derived 
recombinant baculovirus, was prepared as described previously and dialysed against 50mM 
Tris/HCl pH8. The sample was loaded onto a DEAE Sepharose column and the resulting 
fractions were assessed for the presence of the 23-kDa protein by SDS-PAGE and Western 
blotting (fig.3.11). The same fractions were also tested for protease activity in the 33S and
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Fig. 3.9 Expression of the Ad2 23-kDa protein in insect cells
sf9 cells were infected with recombinant baculovinises for 24-72 hours as indicated and analysed on 
12.5% polyacrylamide gels, (a) Coomassie blue stained gel and (b) Western blot probed with the 23-kDa 
N-terminal peptide antiserum at a dilution of 1:1000. In each case the samples are: lane 1, uninfected 
cells; lanes 2-4, cells infected with the recombinant baculovirus derived from the plasmid pAc23K and 
lanes 5-7, cells infected with the recombinant baculovirus derived from the plasmid pVL1393 (fw details 
see method 3). A Coomassie blue stained gel of cells infected with the virus AcRP23-lacZ is shown in 
(c) as a control.
peptide assays with incubation times of 3 and 12 hours respectively. The results were very 
similar to those obtained for the E.Coli expressed material (compare fig.3.9 and 3.11), in 
that the fractions in the flow-through, containing the 23-kDa protein, were active in the 35S 
Ad2tsl assay; but not in the peptide assay. Again, nx)re protease activity was detected in the
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DEAE flow through (lanes 3-7) than in the crude extract loaded onto the column (lane 1). Thus 
the partially purified baculovirus expressed 23-kDa protein is not able to cleave MSGGAFSW 
and it appears likely that some cofactor must be involved.
Phsnvl Superose Column
St. 48 49 50 51 52 53
fraction number
Fig. 3.10 Purification of the 23-kDa protease from insect cells
The 23-kDa protein was partially purified from sf9 cells infected with the pVL23K derived, 
recombinant baculovirus using anion exchange and hydrophobic interaction chromatography as 
described in method 3. The elution profile from the phenyl Superose column and a Coomassie stained 
12.5% SDS polyacrylamide gel of fractions 48-53 are shown. Molecular weight standards are in lane 1 
and the molecular weights of the protein standards, in kDa, are indicated to the left of the gel.
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Fig. 3.11 Activity of the 23-kDa protein expressed in insect cells
The elution profile of the recombinant baculovirus expressed 23-kDa protein from a DEAE Sepharose column 
is shown. The column load (lane 1) and fractions 2-8 (lanes 2-8) were assessed for protease activity using the 
35s Ad2ts l assay and for the presence of the 23-kDa protein by Western blotting using the 23-kDa 
N-terminal peptide antiserum (for details see method 3 and result 7).
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8 Comparison of the Activities ,of .the E.ColL Baculovirus and Ad2 Expressed Proteases
The Coomassie stained gel and Western blot in fig.3.12a show the relative mobilities 
of the Ad2, E.Coli and baculovirus expressed 23-kDa proteins. As can be seen, they all 
migrate the same distance and have an apparent molecular weight of 20-kDa.
The incubation of 0. lpg of 23-kDa protease, from each source, with lOpl of 35S 
Ad2tsl extract revealed that digestion of pVII to VII took place in each case. The protease was 
extracted from Ad2 by NaCI/urea treatment as described in chapter 2, whilst it was partially 
purified from E.Coli and baculovirus extracts by anion exchange chromatography (see above). 
Although the treatment and levels of purity of the enzymes differed, the E.Coli expressed 
23-kDa protein consistently showed less protease activity than the baculovirus and Ad2 
expressed proteins in the 35S assay (fig.3.12b). It is likely that the percentage of the E.Coli 
expressed protease that is folded correctly is considerably less than that for the Ad2 and 
baculovirus expressed proteins. Only the protease purified from Ad2 was able to cleave the 
peptide MSGGAFSW (fig.3.12b). The activities of the baculovirus and E.Coli expressed 
23-kDa proteins were assessed in the peptide assay in the presence of 0-2M NaCl, 0-5mM 
EDTA and 0-2mM DTT; but no cleavage was detected even after 12 hour incubations at 37°C.
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Fig. 3.12 Comparison of Ad2, E.Coli and baculovirus expressed protease
The activities of the 23-kDa protease expressed in (1) Ad2, (2) E.Coli and (3) baculovirus systems were 
compared using the peptide and 35s Ad2tsl assays (see result 8). The Coomassie blue stained gel and 
Western blot (probed with the 23-kDa N-tcrminal peptide antiserum) of the 3 samples are included above 
the autoradiogram and HPLC profiles of the 35s Ad2tsl and peptide assays respectively. The incubations 
were for 3 and 2 hours at 37°C in the 35s and peptide assays respectively. The single peak in profiles 2 
and 3 is the undigested peptide MSGGAFSW.
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DISCUSSION
The first conclusion drawn in this chapter is that the previous reports, by Chatterjee and 
Flint (1987) and Houde and Weber (1990a), stating that the adenovirus protease is 
autocatalytically processed are incorrect.
It is shown clearly here that the antipeptide sera raised against amino acids 1-17 and 
190-204 of the Ad2 protease are specific and do not cross react with any other sequences in the 
protein (fig.3.5). These antisera both react with the active protease which has a mobility 
between pVU and VII and has an apparent molecular weight of 20-kDa, when analysed by 
SDS-PAGE. This means that the 23-kDa protein from Ad2tsl reported by Chatterjee and Flint 
(1987) to havva slower mobiiliy than pVII, totephosphorylated and to bindDIFPccnnot tee 
the L3 23-kDa protein. Thus the main basis for their conclusion that the Ad2 protease is 
autocatalytically processed is wrong. In the same report they describe a 19-k.Da protein from 
wild type Ad2 which migrates between pVII and VH when analysed by SDS-PAGE. The 
protein was shown to bind DFP and to be phosphorated and although no sequence evidence 
was presented, the possibility that this band is the intact Ad2 protease cannot be ruled out. The 
proposal by Houde and Weber (1990a) that the Ad2 protease is autocatalytically cleaved is 
based on the degradation of an E.Coli expressed fusion protein of protein A and the 23-kDa 
protein; but no sequence information regarding the cleavage site was given. It seems likely that 
what they observed was proteolysis by an E.Coli enzyme that co-purified with their fusion 
protein. Such degradation was observed for the GST-23K fusion protein prepared as part of 
this project (fig.3.4b).
EXPRESSION OF THE AD2 PROTEASE
The other major aim of this chapter was to express and purify large amounts of active 
Ad2 protease and 3 different systems were investigated in an attempt to do this. The insertion 
of the L3 23-kDa cDNA into the pGEX-2T vector resulted in the expression of a GST-23K 
fusion protein, at levels of around 20mg/litre, when transformed bacteria were induced for 4 
hours with IPTG (fig.3.4a). Unfortunately, however, virtually all of the protein was present 
in insoluble inclusion bodies. The level of expression of the 23-kDa protease using the pET3c
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vector was considerably lower, at 2mg/litre; but in this case 25-50% of the protein could be 
readily solubilised by DNasel treatment of the lysed bacteria (fig.3.7). Finally the protease 
gene was inserted into the BamHI sites of 2 baculovirus vectors, pAcRP23 and pVL1393, and 
transfected into sf9 cells with AcNPV or AcRP23-lacZ x Bsu36I DNA. The resulting 
recombinant viruses were purified and each was found to express the Ad2 protease optimally at 
48-72 hours post infection (fig.3.9b). The yields of protease from the pAcRP23 and 
pVL1393 derived viruses, at around lmg/litre, were 2 orders of magnitude lower than the 
levels of expression that have been achieved for other proteins, such as p-galactosidase, in the 
baculovirus system (Possee and Howard,1987). As a control, the AcRP23-lacZ virus 
expressing p-galactosidase was used to infect sf9 cells in parallel experiments and fig.3.9c 
shows that large amounts of the foreign protein were expressed. It is also noted that the 
presence of the TATAAAT sequence upstream from the initiation codon in the pVL23K derived 
virus does not increase the level of expression of the protease. Thus it would appear that the 
23-kDa protein might be toxic to the cells when present at high concentrations.
For the purposes of this project, only the pET3c and baculovirus systems will be 
considered further. In the future, however, it may be possible to solubilise/refold the 
GST-23K fusion protein from inclusion bodies and so take advantage of the high levels of 
expression of the protease achieved using the pGEX-2T vector.
PURIFICATION OF RECOMBINANT AD2 PROTEASE
The E.Coli expressed 23-kDa protein was purified to homogeneity using anion 
exchange and hydrophobic interaction chromatography, with yields of 0.5mg of pure protein 
being obtained per litre of M9/Amp (fig.3.7). The minimal media was preferred to Luria 
broth for bacterial cultures since cleaner protein purifications were achieved. The protein 
purified by this method was injected into rabbits in order to raise a polyclonal antiserum against 
the whole protein. The resulting antiserum reacted well in Western blots at a dilution of 1:500 
(fig.3.4b).
The same purification procedure was followed for infected sf9 cell extracts; but was 
considerably less successful from 2 viewpoints. Firstly, the sample was not homogeneous and 
secondly the % yield was low, with only 0.2mg of protease being recovered from a 500ml
185
culture. In the future if recombinant baculoviruses are to be of use in the expression of the Ad2 
protease, then a better purification schedule must be designed.
Cation exchange, chromato-focussing, gel filtration, single stranded DNA-Sepharose, 
PCMB-Sepharose and zinc chelating columns were tested for their abilities to bind the 23-kDa 
protease (data not included). The DNA affinity (see chapter 4), zinc chelating and PCMB- 
Sepharose columns all gave promising results in small scale purifications and could be of use 
in the future.
ACTIVITY OF THE RECDMRINANT AD2 PROTEASE
The full length 23-kDa protein, expressed in both E.Coli and baculovirus systems, was 
active when assessed in the 35g Ad2tsl assay. An N-terminal deletion mutant expressed by 
BL21(DE3) cells transformed with the plasmid pT7Ad23K10, however, was unable to cleave 
pVII->VII even after 12 hour incubations at 37°C. This shows that amino acids 5-13 are 
essential for activity and presumably must play an important structural or catalytic role. It also 
demonstrates that the pET3c system provides a good means for carrying out site-directed 
mutagenesis of the Ad2 protease in order to assess the importance of individual amino acids to 
the protease (Anderson,1990).
In contrast to their activity in the 35S Ad2tsl assay, neither the E.Coli nor the 
baculovirus expressed 23-kDa protein was able to cleave the peptide MSGGAFSW even after 
incubations for 6 hours at 37®C. It is noted that the cloned protease behaves in a very similar 
fashion to protease purified from Ad2 in the presence of low salt (chapter 2). The possibility 
that the E.Coli or baculovirus expressed protease would cleave the peptide in a high salt 
environment was investigated; but even in the presence of 1-2M NaCl no digestion took place. 
It appears then that in adenovirus infections the protease must be activated in some way and 
that once activated, if the enzyme is purified, then the presence of high salt is able to lock it in 
an active conformation. The addition of salt to the recombinant protease is not sufficient to 
activate it; but a factor present in -the 35S labelled Ad2tsl infected cell extracts is.
CONTROL OF PROTEASE ACTIVITY
As discussed in the main introduction, the control of protease activity is an important 
feature in the life cycle of many viruses. This is particularly true for viruses whose proteases
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are required to carry out maturation cleavages after the assembly of the virus particle. The HTV 
protease is activated by dimerisation and work by Krausslich (1991) has shown that premature 
activation of the enzyme is toxic to the cells and prevents assembly of the virions. Another 
example of activation involving a viral protease is the trans cleavage of p220 by the poliovirus 
2A protease and eIF3. In this system neither 2A nor eIF3 on its own is able to process the 
purified p220 protein; but together they cleave the protein efficiently. This is a cooperative 
event, so much so, that it is not certain whether eIF3 activates 2A or 2A activates eIF3 
(Wyckoff et ai ,1990).
Although it has been demonstrated that the activity of the Ad2 protease is controlled, the 
mechanism of the activation remains to be established. The results in chapter 2 show that the 
enzyme is active as a monomer, ruling out dimerisation and as discussed in this chapter limited 
proteolysis is not involved. The fact that high salt is required to solubilise the protein from the 
virions and that its predicted isoelectric point is 8.6 would be consistent with it being a DNA 
binding protein. It has been shown that in the temperature sensitive mutant, Ad2tsl, the 
23-kDa protein is not packaged in the virus at non-permissive temperatures (Anderson,1990). 
This taken along with the observation that most of the substrates of the adenovirus protease are 
DNA binding proteins means that the possibility that the enzyme binds to, or is activated by, 
DNA is worth considering. Finally in this regard, it has been shown that both the Sindbis 
virus capsid protein and the poliovirus 3C protease bind to RNA so there are precedents for 
viral proteases being associated with nucleic acids (Choi et a/., 1991; Andino et a/.,1990). 
Chapter 4 will consider further the mechanism by which the Ad2 protease activity is controlled.
-•-■<■■■ r'V-
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CHAPTER 4
Control of the Ad2 Protease and Processing of the
Pre-terminal Protein
INTRODUCTION
In the previous chapter it was shown that purified recombinant Ad2 protease is unable to 
cleave the peptide substrate, MSGGAFSW, and the conclusion was drawn that it is
synthesised in an inactive form. It was also demonstrated that the enzyme was not activated by 
limited proteolysis or dimerisation and the suggestion was made that DNA-binding or 
phosphorylation may be involved. The first part of this chapter is devoted to finding out what 
controls the activity of the protease. It is hoped that this will enable the purified recombinant 
enzyme to be activated in vitro and so lead to a plentiful supply of active protease. This in turn 
would enable detailed kinetic, structural and mechanistic studies of the enzyme to be carried
out.
The final section of this project will consider one of the natural substrates of the Ad2 
protease, the pre-terminal protein (pTP). As mentioned previously, the pTP is the protein 
primer for adenovirus DNA replication and is covalently attached to the 5' end of the viral 
DNA. An overview of Ad2 DNA replication was given in the main introduction and so this 
discussion will concentrate on the 3 viral proteins, the pTP, polymerase and DBP, and the 2 
cellular proteins, NFI and NFIII, required for replication.
Replication of adenovirus DNA can be divided into 2 stages, temied initiation and 
elongation, with the protein and divalent ion requirements of each being different (Leith et 
a/., 1989). Initiation of replication involves the covalent attachment of a dCMP base to the 
p-hydroxyl group of Ser580 in the pTP. This process requires ATP and Mg+2 and is dependent
.
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on the precise formation of a multiprotein complex at the origin of replication. The overall 
geometry and stability of the complex is dependent on a number of specific protein-protein and 
protein-DNA interactions. The expression of the replication factors using baculovirus and 
vaccinia vectors has enabled interactions between individual proteins to be considered and as a 
result our understanding of the molecular events involved in initiation has been enhanced 
considerably (Stunnenberg er al., 1*988; Watson and Hay,1990; Bosher er a/.,1990).
The , Pre-terminaLProtein fpTP)
The pTP is a 671 amino acid protein encoded by the E2 region and the covalent 
attachment of the dCMP to its serine residue at position 580 is probably catalysed by the 
adenovirus polymerase although an autocatalytic event cannot be ruled out (Stillman et 
a/., 1981). Even the conservative mutation of Ser->Thr at residue 580 has been shown to 
prevent initiation, showing that the precise orientation of the p-hydroxyl group is critical (Pettit 
et a/., 1989). Indeed studies have shown that the pTP is very sensitive to mutagenesis, with the 
residues at the N-terminus being absolutely required for replication (Pettit et a/.,1989).
The pTP is expressed coordinately with the adenovirus polymerase (pol) early in 
infection and the 2 proteins associate to form a stable heterodimer which can only be 
dissociated in the presence of 1.7M urea (Lichy et n/.,1982). The binding of the pTP-pol 
heterodimer to specific sequences at the origin of replication is the central step in the initiation 
process. It has been shown that whilst the pTP and pol form both specific and non-specific 
interactions with bases 1-18 of the Ad2 genome, the binding of the heterodimer is stronger and 
more specific. Indeed, recently Temperley and Hay (1992) have used DNA footprinting 
assays to show that the pTP-pol binds to bases 9-17 and significantly, these are conserved at 
the origin of replication in all the adenovirus serotypes.
Examination of the Ad2 pTP sequence reveals a potential nuclear localisation signal at 
amino acids 362-373 and its identity as such was confirmed by Zhao and Padmanabhan 
(1988). The binding of pol to the pTP means that this signal is responsible for directing both 
pol and pTP to the nucleus and so ensures that stoichiometric amounts of each are available for 
replication. In addition to its role in initiation, mutagenesis studies suggest that the pTP is 
required for elongation and although this may simply be as a structural component of the
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replication machinery it has been proposed that the pTP acts as a helicase to unwind the dsDNA 
and release the non-template strand (Kenny et a/., 1*988).
As mentioned in chapter 1, the pTP is specifically cleaved to the 55-kDa TP via a 62-kDa 
intermediate and the processing is carried out by the adenovirus encoded protease. Moreover,
4 potential cleavage sites were identified in the pTP using the consensus sequence described 
earlier and the positions of these sites are shown in fig.4.1a. Octapeptides corresponding to 
the cleavage sites A and B were synthesised and found to be efficiently cleaved in vitro. 
Cleavage at both these sites which are separated by only 8 amino acids would be consistent 
with the observation that the 62-kDa iTP appears as a doublet when analysed by SDS-PAGE 
(Leith et a/., 1989). The peptides corresponding to sites C and D were not cleaved by the Ad2
protease in vitro and it was suggested that the presence of a valine at Pf in short peptides was 
not favourable. The similarity between site D and the cleavage sites in pVI and pVH 
(fig.4.1b) and the fact that this site is conserved in other serotypes (fig.4.1a) suggests that 
it is the cleavage site giving rise to the mature TP. The possibility that site C is also cleaved in
Ad2, however, cannot be ruled out.
(a)
NC
A B CD
MRGF~G 
AdS MRGF-G
Ad7 MRGF-G 
Adl2 LQGY-G
MGGR-G LGGG-V MTGG-V
MGGR-G LGGG-V MTGG-V
M-IGR-A VPTG-Q MRGG-V
MADR--G VPTQ-Q LRGG-V
(b)
pVl M S G
i
G-A F S W
pVII M F G G-A K K R
pTP M T G G-V F Q L
Fig. 4.1 Predicted Cleavage sites in the pre-terminal protein
(a) A schematic representation of the Ad2 pTP showing the locations of the 4 cleavage sites predicted in 
chapter 1. Listed below each site are the amino acids in the P4 to Pf positions at each of these sites in 
Ad2, Ad5, Ad7 and Ad 12. Potential cleavage sites are found at A and D in all the serotypes; but not at B 
and C. (b) Comparison of the Ad2 pTP site D with the established pVI and pVII sites.
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In recent reviews on replication little effort has been made to distinguish between the pTP 
and the TP with few, if any, references being made to the iTP (Challberg and Kelly, 1989; Hay 
and Russeil,1989; Stillman, 1989; Salas,1991). Perhaps this is because it is generally accepted 
that the processing of the pTP is required for a packaging or uncoating event and does not take 
place until late in infection (Stillman et a/., 1981). The possibility that the processing to the iTP 
and/or the TP could play a part in the control of DNA replication, however, should be 
considered. Although it has been shown that naked adenovirus DNA can act as a template for 
replication, DNA with the TP or pTP covalently attached to the 5’ end is the preferred template. 
Originally it was thought that this was because the attachment of a protein at the 5' end 
protected the DNA from exonucleases; but this does not appear to be the case. Other 
possibilities include the suggestions that the TP is able to unwind the dsDNA, bind to the DNA 
to change its structure or form a complex with the incoming pTP-pol complex. In any case, it 
should be remembered that in vivo, although the TP-DNA complex is the template for the initial 
replication event, the templates for most of the subsequent rounds of replication are pTP-DNA 
complexes. It is possible that the TP-, iTP- and pTP-DNA complexes are indistinguishable in 
terms of their behaviour in replication or, on the other hand, there may be differences which are 
functionally significant.
Adenovirus Polvmera.se (poll
The Ad2 polymerase is a 1198 amino acid protein with an apparent molecular weight of 
140-kDa when analysed by SDS-PAGE (Field et a/., 1984). It is the enzyme responsible for 
the synthesis of the viral DNA and although it is homologous to the cellular a and p 
polymerases, it differs from them in its insensitivity to the inhibitor aphidicolin. Indeed this 
property provides the basis for a simple assay for specific adenovirus polymerase activity (Shu 
et a/.,1987). The Ad2 pol has been expressed in an active form using recombinant baculovirus 
and vaccinia systems enabling its purification in large amounts (Watson and Hay, 1990; 
Stunnenberg et a/.,1988). The Ad2 pol sequence contains 2 potential zinc fingers and it is 
possible that these form the attachment sites to the DNA (Chen et a/.,1990). In addition to its 
specific association with the pTP and viral DNA, pol is also thought to bind to the DBP and 
NFI. It is clear, therefore, that as well as having an important enzymatic role, pol plays a
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central part in maintaining the stablilty and overall geometry of the replication machinery. The 
specific binding of NFI to pol has been shown by a number of groups and is interesting in that 
it helps to explain why NFI enhances initiation of replication in Ad2 (Bosher et a/,,1990; Chen 
et a/.,1990; Mul and van der Vliet,1992). The association of DBP and pol, on the other hand, 
is less certain, but it is clear that at physiological concentrations the DBP enhances the initiation 
of replication (Leith et a/.,1989). The fact that other non-specific ssDNA binding proteins are 
unable to substitute for the DBP has led Lindenbaum et al (1986) to suggest that the effect 
must be as a result of direct binding of the DBP to pol.
The Adenovirus DNA Binding Protein (DBP)
Like the coding sequences for the pTP and pol, the DBP gene is in the E2 region; but the 
DBP is translated from a different primary transcript (E2a) and so is present in adenovirus 
infected cells in much larger quantities. Indeed, at early times in infection it is the most 
abundant viral protein present, with up to 5x10* molecules per cell. This enables the DBP to 
be purified in reasonable quantities from adenovirus infected cells which have been blocked at 
the replication stage by the addition of hydroxyurea (Rosenfeld et a/.,1987; Leith er a/.,1989).
The DBP is a multifunctional protein that plays a key role in the regulation of adenovirus 
transcription, translation and DNA replication (Seiberg et a/., 1989; Hay and Russell, 1989). It 
is a single stranded DNA binding protein, that is also able to bind to double stranded DNA and 
to RNA. The affinity of the protein for single stranded DNA is considerably higher than for 
double stranded DNA and the complexes formed are much more stable (Cleghon and 
Klessig,1986). The Ad2 DBP has 529 amino acids and an expected molecular weight of 
60-kDa, considerably lower than its apparent molecular weight of 72-kDa as determined by 
SDS-PAGE. The difference is because the protein is heavily phosphorylated with at least 17 
potential phosphorylation sites (Linne and Philipson,1980; Russell et a/.,1989). These are 
mainly serine and threonine residues located in the N-terminal third, of the protein and their 
function is not clear, although one suggestion is that the N-terminal region of the DBP is 
concerned with defining the host range specificity of the virus (Anderson et a/., 1*983; Brough 
et a/., 1985). The DBP contains an N-terminal and a C-terminal domain that are readily 
separated by proteolysis both in vitro and in vivo. It appears that the C-terminal 45-kDa
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fragment is able to carry out most of the functions attributed to the DBP, including the DNA 
binding and it appears that this may be mediated by zinc fingers (Vos et a/., 1988).
The DBP is absolutely required for the elongation stage of replication and EM studies 
show that it binds to the non-template strand of DNA to stabilise it in the single strand form 
(Kedinger et a/., 1978). Although it has been shown that initiation of adenovirus replication 
can take place in vitro in the absence of DBP, there is a requirement for the protein for initiation 
in in vitro systems where physiological concentrations of the factors and templates are used, as 
well as in vivo (Kenny and Hurwitz,1988; Cleat and Hay, 1989). It is proposed that the DBP 
binds to the dsDNA at the origin of replication and alters its structure in such a way as to 
enhance the binding of NFI to bases 19-39. NFI, however, is not required for Ad4 
replication, but there is still a requirement for the DBP in initiation so the protein must have 
some other role, perhaps through a direct interaction with pol as discussed above (Temperley 
and Hay, 1991).
Nuclear Factor I (NFD
Nuclear Factor I (NFI) is a multifunctional cellular protein that is required for the 
replication of Ad2 DNA in vivo and has been shown to be identical to the CAAT transcription 
factor (CTF). NFI (or CTF) is the collective name for a group of proteins ranging in molecular 
weight from 55-65-kDa that are derived from a single gene by differential splicing (Santoro et 
a/., 1988). Whilst the C-terminal domain of the proteins has been shown to be essential for 
transcriptional activation, the N-terminal 222 amino acids are sufficient for DNA binding, 
dimerisation and for Ad2 replication (Bosher et a/., 1991). NFI binds as a dimer to the 
palindromic sequence located at bases 19-39 of the Ad2 genome and manipulation of the 
binding site has shown that its position is critical. Deletions or insertions of 1or 2 bases are 
sufficient to nullify the helper effect of NFI in Ad2 replication. This is presumably because 
NFI interacts with pol and the relative positions of the 2 proteins are controlled by the spacing 
of the pTP-pol and NFI binding sites. As mentioned above the binding of NFI to the DNA is 
significantly enhanced by the presence of DBP (Cleat and Hay,1989; Stuiver and van der 
Vliet,1990). No direct interaction between the DBP and NFI has been shown and so it is 
thought that the cooperative binding results from the DBP's ability to alter the conformation of
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the NFI binding site.
Nuclear Factor III (NFIII)
The presence of NFIII is not absolutely required for Ad2 DNA replication, but its binding 
to base pairs 40-51 of the Ad2 genome has been shown to cause a 2 to 3 fold increase in the 
initiation reaction. NFIII has a molecular weight of 90-95-kDa and also acts as a transcription 
factor, binding to the octamer sequence 5'-ATGCAAAT-3', present in the promoter and 
enhancer regions of a number of cellular genes. Its mutifunctional nature means that it has a 
number of pseudonyms including Oct-1, OTF-1 and NFAl. The protein has 743 amino acids, 
which include a DNA binding region termed the POU domain. This 160 residue fragment has 
been shown to be sufficient for the stimulation of adenovirus replication and contains the DNA 
binding sequence. As for NFI, additional regions of NFIII are required for transcriptional 
activation, suggesting that its modes of action in replication and transcription are distinct 
(Verrijzer et a/.,199O). Despite the fact that the NFI and NFIII binding sites are adjacent in 
Ad2 DNA no interaction or cooperative binding has been shown between the 2 factors and it 
appears that they employ different mechanisms to enhance adenovirus DNA replication (Mul et 
a/.,1990). Since no interaction has been shown between NFIII and NFI or pTP-pol, it is 
possible that NFIII acts indirectly by altering the structure of the DNA in such a way that 
initiation is favoured.
The realisation of some of the interactions and associations described above has led to a 
number of models for the formation of the pre-initiation complex in Ad2 and one such model is 
shown in fig.4.2. One version of the sequence of events is that the DBP binds to the dsDNA 
at the origin of replication to alter its structure in a way that enhances the binding of NFI to 
bases 19-39. NFI then binds as a dimer and acts as a docking mechanism for the pTP-pol 
heterodimer which binds specifically to bases 9-17. The presence of NFIII at bases 40-51 also 
appears to enhance the binding of pTP-pol, perhaps by changing the structure of the DNA. 
Additional interactions may also take place in the formation of the pre-initiation complex and 
among those that have been proposed are associations between DBP and pol and between 
pTP-pol and the TP attached to the 5' end of the template strand.
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Fig. 42 Model for initiation of Ad2 DNA replication
Schematic diagram showing the origin of replication in the Ad2 genome and the binding 
sites for the cellular and viral replication factors. The core sequence comprises bases 9-17 
conserved in all the adenovirus serotypes. NFl binds as a dimer to the palindromic 
sequence at bases 19-39, whilst the NFlll binding site is at bases 40-51. The Ad2 DBP 
also plays a role in stimulating initiation of replication; but its mode of action remains to 
be established so it is not included in the above diagram.
As mentioned previously the cellular factors NFI and NFIII do not appear to have any 
stimulatory effect in DNA replication of the group E virus, Ad4 and it has been proposed that 
in the case of Ad4 the pTP-pol heterodimer has a higher affinity for bases 9-17 at the origin of 
replication. This removes the requirement for the cellular factors. As yet the Ad4 pTP and pol 
genes have not been sequenced, but it has been shown that polyclonal antisera raised against 
the Ad2 pol does not react with pol from Ad4 (Temperley and Hay, 1991).
In this chapter after the control of the Ad2 protease is considered the expression of the 
Ad2 pTP using baculovirus vectors will be described. It is hoped that this will form the basis 
for future studies on the roles of the pTP, iTP and TP in adenovirus DNA replication.
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METHODS
1 DENATUEED_CALEJTUYMUS_DNA_SEEHARDSE
■CURQMAIQGEAEHY.
Cytoplasmic extracts of sf9 cells, infected with the pVL23K derived recombinant
baculovirus, were prepared and partially purified by anion exchange chromatography as 
described in chapter 3, method 3.9. The fractions containing the recombinant 23-kDa protein 
were applied to a 5ml single stranded calf thymus DNA-Sepharose column (Sigma) 
equilibrated with 50mM Tris/HCl, pH8. The flow rate was 0.5ml/minute and the column was 
washed with 25ml of equilibration buffer after the sample was loaded. The column was then 
eluted with 10ml each of the equilibration buffer made 0.2,0.4 and 1M with respect to NaCl. 
1ml fractions were collected and ISpl of each was analysed by SDS-PAGE as described in 
chapter 2, method 2.
2 GEL. ELEC.TRQ.EHQRESIS DNA , BINDING ASSAYS.
The method used for these assays is based on that described by Temperley and Hay 
(1992).
2.1 Labelling.ofDN.A.
5pg of the plasmid pEX8, containing bases 1-600 of the Ad2 genome (Barrett et 
a/., 1987) were cut with the restriction endonucleases EcoRl and Pvu11 to release a 466 base 
pair fragment corresponding to bases 1-466 of the Ad2 genome. The 5' overhang created by 
the EcoRl cut was labelled with [a-32P] dATP using Klenow polymerase and the reaction was 
set up as follows: 5|ig pEX8 x Pvull/EcoRl, 1.5pl lOxKGB (1M potassium glutamate, 0.25M 
Tris/acetate pH7.5,0.5mg/ml BSA, 5mM p-mercaptoethanol), 4 units of Klenow polymerase, 
30pCi [a-32p] dATP made up to 25|il with H2O. The reaction was allowed to proceed for 45 
minutes at room temperature before the labelled fragment was purified by gel electrophoresis.
The gel was prepared by mixing 8ml of lOxTBE (0.5M Tris/borate, lOmM BDTA, 
pH8.3), 8.4ml of 30% acrylamide (29:1, acrylamide: bis-acrylamide), 32.6ml of H2O, 4ml of 
freshly prepared 1% ammonium persulphate and 50pl of TEMED and pouring it into a gel 
cassette of width 0.75mm. 5pl of DNA loading dye (chapter 3, method 1.2) were added to the
- --
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sample and it was loaded onto the gel alongside DNA molecular weight markers. The 
electrophoresis buffer was lxTBE and a constant voltage of 200V was applied to the gel for 2 
hours, after which the gel was removed from the cassette, covered with cling film and exposed 
to X-ray film for 5 minutes. The labelled band was excised from the gel, cut up into small 
pieces and placed in an eppendorff tube along with 400pl of lOmM Tris/HCl pH7.5,0.lM 
NaCl, lmM EDTA. The DNA was eluted from the gel by shaking the tube on a mechanical 
shaker at 37°C overnight. The fragments of gel were removed by filtering the sample through 
glass wool and the DNA was precipitated by adding 1ml of ice cold ethanol and leaving it at 
-70°C for 30 minutes. The labelled probe was sedimented by centrifugation for 5 minutes at 
high speed in a microcentrifuge, air dried and resuspended in lmM Tris/HCl pH8, O.lmM 
EDTA such that each pi contained 100 counts per minute.
2.2 DNA binding Assavs. .
DNA binding reactions were incubated for 30 minutes at room temperature and each 
assay included 0.1 ng of probe and 2pg of unlabelled DNA to prevent non-specific binding to 
the probe. Each reaction was set up as follows: lpl of labelled probe, lpg poly d(A-T), lpg 
poly d(G-C), lpl of 1mg/ml BSA, 0.1 pg of 23-kDa protein (or pTP), 2.5pl of 0.5M Tris/HCl 
pH8 and was made up to 25pl with H2O. Reactions were stopped by the addition of 5pl of 
DNA loading dye and analysed by gel electrophoresis as described in 2.1 (above). The 
resulting gel was dried and exposed to X-ray film overnight.
3 PREPARATION OF ANTISERUM AGAINST THE pTP.
A peptide including the N-terminal 15 amino acids of the Ad2 pre-terminal protein: 
MALSVNDCARLTGQSC
was synthesised as described in chapter 1, method 1. The antiserum was prepared by 
coupling the peptide to HSA and injecting the conjugate into rabbits as described in chapter 2,
method 3.
4 cloning, of the , ptp gene jnto^aculovibu&vectobs.
The methods used to clone the pTP gene into the baculovirus vector pVL1393 were 
essentially the same as those described for the 23-kDa gene in chapter 3, methods 1 and 3. A 
schematic diagram showing the construction of the pVLpTP vector is shown in fig.4.3.
——— ' ' ———— ....L-
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A fragment representing the entire coding region for the pTP was constructed from 2 
regions of the viral genome in 2 stages. The first step involved copying the coding region for 
the N-terminal third of the protein from Ad2 DNA using PCR as described in chapter 3, 
method 1.4. The oligonucleotide primers used were:
(8) 5’-GGGATCCATGGCCTTGAGCGTCAACGACTGCGCACGCCTCAC-3'
(9) 5’-CGAAAAACCTCTCGAGAAAGGCGTC-3’
Oligonucleotide (8) includes a BamHI site at its 5' end followed immediately by the 
codons for the N-terminal 3 amino acids of the pTP, coded for by the exon at map position 39 
in the genome (see fig.8, p22). The remainder of oligonucleotide matches exactly with the 
start of the main coding region for the pTP at map position 26 on the reverse strand. 
Oligonucleotide (9) is identical to a 25 base sequence on the + strand within the main coding 
region of the pTP. The 8(X base pair fragment synthesised in the PCR reaction was purified 
from an agarose gel and treated with T4 polynucleotide kinase and T4 polymerase. It was then 
ligated to the vector pUC13, which had been linearised with the restriction enzyme Smal and 
treated with calf intestinal alkaline phosphatase (CIAP). DH5 cells were transformed with the 
ligated DNA and bacteria transformed with pUC13 containing the PCR fragment, were selected 
by replica plating. The probe used was the purified PCR fragment which was labelled by 
random priming with [a-32P]dATP. Mini plasmid preparations from the 123 positive colonies 
were carried out and the resulting DNA was digested with the restriction enzyme BamHI. Only 
one of the resulting plasmids gave an 8(X base pair fragment when digested with BamHI. The 
plasmid DNA (pUCpTPl) was cut with the restriction enzyme Xhol, then treated with CIAP 
and used in the next stage.
A plasmid comprising the Hind B fragment of Ad2 (base pairs 6231-11555), which 
includes the main coding region for the pTP, in pUC13 was supplied by R. Hay. This plasmid 
was cut with Xhol to release a fragment containing the C-terminal two thirds of the pTP gene. 
The Xhol fragment was purified from an agarose gel, ligated to the CIAP treated, pUCpTPl x 
Xhol and then transformed into DH5 cells. Bacteria transformed with a plasmid containing the 
Xhol fragment were selected by replica plating. The probe used was the Xhol fragment, 
which had been labelled with [a-32P]dATP by random priming, and mini plasmid preparations
... ,
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were carried out for 6 of the positive colonies. KpnI/EcoRI digests were used to select the 
plasmids containing the Xhol fragment in the correct orientation (pUCpTP2).
The BamHI fragment containing the pTP gene was cut out of pUCpTP2 and ligated to 
pVL1393 x BamHI which had been treated with CIAP. The ligated DNA was transformed into 
DH5 cells and transformants were selected by replica plating and probing as described for the 
selection of pUCpTP2. Mini plasmid preparations were carried out for 6 positive colonies and 
the orientation of the pTP gene was checked by KpnI/EcoRV digests.
Fig. 4.3 Construction of the plasmid pVLpTP
A schematic diagram showing the construction of the plasmid pVLpTP as described 
in method 4. The polyhedrin promoter (Phd. Pro.) is marked. The open box (□) corresponds 
to the exon at position 39 coding for the first 3 amino acids of the pTP. The shaded box 
includes the main coding region for the pTP.
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The resulting plasmid pVLpTP was transfected into sf9 cells with pAcRP23-lacZ x 
Bsu36l as described for the plasmid pVL23K in chapter 3, method 3.5. The recombinant virus 
was purified by 3 rounds of plaque purifications, a high titre virus stock was prepared and this 
was used to express the recombinant protein.
5 EURmCATIQNQF:TaEJEC:QMBIMN^pTE.
A 500ml culture of sf9 insect cells was infected with a recombinant baculovirus 
containing the pTP gene as described in chapter 3, method 3.8. Due to reasons that will 
become apparent later (result 6), the pTP recombinant baculovirus used was not that prepared 
in method 4; but instead was a virus prepared and supplied by Lars Rogge (University of 
Munich). The infection time was 72 hours and cells were harvested by centrifugation at lOOOg 
for 5 minutes. After washing twice with PBS the cells were resuspended in 4ml of 25mM 
Hepes/KOH pH8, 5mM KCl, 0.5mM MgClj, 0.5mM DTT and disrupted on ice in a Bounce 
homogeniser with a type B pestle (20 strokes). Nuclei were sedimented by centrifugation for 5 
minutes at high speed in a microcentrifuge and then resuspended in 4ml of the same buffer 
made 0.4M with respect to NaCl and incubated on ice for 15 minutes. Cell debris was 
removed by centrifugation for 5 minutes as before and then the extract was clarified by 
centrifugation at lOOOOOg in a Beckman TL1OO centrifuge. The supernatant was diluted to 
reduce the NaCl concentration to 0.2M and then applied to a 10ml single stranded calf thymus 
DNA-sepharose column equilibrated with 25mM Hepes/KOH pH8, lmM EDTA, 2mM DTT, 
0.2M NaCl and 10% glycerol. The column was washed with 50ml of the equilibration buffer 
and then eluted with 20ml of the same buffer made 0.6M with respect to NaCl. 1ml fractions 
were collected and the protein concentration of each was estimated by reading the absorbance at 
280nm. lOpl of each fraction were analysed by SDS-PAGE. The fractions containing the pTP 
were pooled and 0.5ml of the resulting sample was made 1.2M with respect to KCl before 
being applied to an FPLC phenyl Superose HR5/5 column equilibrated with O.1M potassium 
phosphate pH7, 2M KCl, lmM DTT. The flow rate was 0.5ml/minute, the detection 
wavelength 280nm and the full scale deflection was set at 0.5. A linear solvent gradient going 
from 0-100% bufferB (O.1M potassium phosphate pH7, lmM DTT, 10% glycerol) in 45 
minutes was applied to the column and the pTP eluted at 90-100% B. 1ml fractions were
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collected and lOpl of each were analysed by SDS-PAGE.
6 m vjtoo.eeplica'liqn. . assays
The pTP was labelled in vitro using [a-32P] dCTP in an initiation reaction. The Ad2 
cores (template), uninfected cell extracts (source of NFI and NFIII), purified DBP and partially 
purified pTP/polymerase were provided by LLeith and were prepared as described in Leith et 
aL (1989).
The initiation reactions were set up as follows: 4pl of Ad2 cores, 5jil of 5x buffer, 2.5pl 
of 20mM MnCl2, 2.25pl of 40mM ATP, 8pl of uninfected HeLa cell extracts, 2pg of DBP, 2
units of pTP/pol and lOpCi [a-22p]dCTP made up to 25pl with H2O. The 5x buffer used in 
each case was 25mM Hepes/KOH pH7.5 made 0, 2.5, 5 or 25mM with respect to DTT, The 
incubations were for 90 minutes at 3020 after which the product was digested with micrococcal 
nuclease (Pharmacia, 5 units) in the presence of lOmM CaCl2 for 30 minutes at 37°C. The 
reactions were stopped by the addition of 8pl of SDS-PAGE loading dye and the samples were 
boiled for 2 minutes prior to analysis on 12.5% acrylamide gels (see chapter 2, method 2).
In one experiment the action of the micrococcal nuclease was stopped by the addition of 
Ipl of 0.25M EDTA pH8 and 20pl of disrupted, purified Ad2 were added to 5 reactions, set up 
as above with the 5x buffer containing 5mM DTT. Samples were incubated for 0, 1,2,6 and 
12 hours at 37°C before the addition of lOpl of SDS-PAGE loading dye, boiling and analysis 
by SDS-PAGE as above.
201
RESULTS
1 Effect of Inhibitors on E.Coli and Baculovirus expressed Ad2 protease
In chapter 2 the effects of a range of inhibitors on the native Ad2 protease were 
investigated using the peptide and 35S assays. Here we consider the effect of a number of 
inhibitors on the protease activity of the recombinant 23-kDa protein expressed in E.Coli and 
baculovirus systems. As described in chapter 3, the recombinant material was not active in the 
peptide assay and so only the 35S assay was used in this case. Purified E.Coli or partially 
purified baculovirus expressed protease was pre-incubated with a range of inhibitors for 10 
minutes at room temperature prior to a 3 hour incubation with lOpl of 35S labelled Ad2tsl 
extracts at 37°C (chapter 2, method 1.1). The degree of digestion of pVH to VII, in each case, 
was determined by analysis of the samples by SDS-PAGE and autoradiography. The results 
obtained were identical for the E.Coli and baculovirus expressed material (table 4.1) and in 
virtual agreement with the inhibition profile described for the Ad2 protease in chapter 2.
Inhibitor Activity in 35 S Assay
PMSF (ImM) -
DCI (0.1mM) -
Iodoacetate (ImM) inhibited
PCMB (ImM) inhibited
DTT (2mM) 80% inhibited
o-phenanthroline (lOmM)
EDTA (lOmM) -
pepstatin (2pM) -
a 2-macroglobulin (2pM) inhibited
Table 4.1 Effects of selected inhibitors on recombinant protease
The only difference observed was in the effect of the thiol reagent DTT. In chapter 2 it was 
reported that in the peptide assay purified Ad2 protease was activated up to 5 fold by the 
presence of 0.5-2.5mM DTT, whereas table 4.1 shows that 2mM DTT inhibits the E.Coli
■ - .. - ■■ ■■ ■-> •
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and baculovirus expressed protease.
2 Effect of DTT on Recombinant Ad2 Protease
The 35S Ad2tsl assay was used to investigate the effects of 0-5mM DTT on Ad2 protease
activity. Two sources of protease were used, purified E.Coli expressed 23-kDa protein and 
purified disrupted Ad2 (fig.4.4). lncubation of the respective protease sources with lOpl of 
35S Ad2tsl was for 3 hours at 37°C in the presence of 0, 12, 5 and lOmM DTT. The 
samples were analysed by SDS-PAGE and autoradiography as described previously. The 
results show that the digestion of pVll-Vll by the recombinant protease is reduced by 80% in 
the presence of 2mM DTT and at 5mM DTT virtually no digestion takes place (fig.4.4, lanes 
4,5). The native Ad2 protease was active in the presence of 2mM DTT (lane 9) and only partial 
inhibition was observed at concentrations of 5 and lOmM (lanes 10,11), consistent with the 
results reported for the peptide assay (chapter 2).
Taken together, these results suggest that the cleavage of pVll by the recombinant 
protease is a 2 step process. The first step involves the activation of the protease and is
Ad2 23-kDaE.coli 23-kDa protein
1 2 3 4 5 6 7 8 9 10 11
Fig. 4.4 Effect of DTT on E.Coli and Ad2 expressed protease activity
The effect of 0-lOmM DTT on the activities of the E.Coli and Ad2 expressed 23-kDa protease were assessed 
using the 35g Ad2tsl assay. The assays were examined by SDS-PAGE and autoradiography. Lane 1, 
substrate alone; lanes 2-6, substrate incubated wiih E.Coli expressed protein at 0,1,2,5 and lOmM DTT; 
lanes 7-11, substrate incubated with disrupted purified Ad2 at 0, 1,2, 5 and lOmM DTT. Incubations were 
for 3 hours at 37°C.
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inhibited by DTT and the second step is the proteolysis itself, which is activated by 0.5-2.5mM 
DTT. The protease from purified Ad2 is already in an active form, explaining why it is not 
inhibited by l-2mM DTT in the 35S assay. Thus the differential effect of DTT provides further 
evidence that the Ad2 protease is controlled in some way.
3 Effect of DNA and ATP on Recombinant Protease Activity
The fact that 1M NaCl is required to solubilise the Ad2 protease from purified virus 
suggests that it may be bound to DNA and raises the interesting possibility that the enzyme is 
activated on binding to a specific DNA sequence. Further evidence for this came from gel 
retention assays by Maria Grable, Pat Hearing and Carl Anderson which showed that under 
some conditions purified E.Coli expressed protease can bind to the packaging sequences at 
bases 190-300 of the Ad2 genome (C.Anderson, personal communication). 1t was decided, 
therefore, to see if the addition of Ad2 or calf thymus DNA to the partially purified recombinant 
baculovirus protease would be sufficient to activate it in the peptide assay. The assays were set 
up as described in chapter 2, method 1.3, except that the buffer used was 50mM Tris/HCl, 
O.1M NaCl, pH8. Incubations were for 6 hours at 37°C. l-5pg of purified Ad2 DNA, pEX8 
(a plasmid containing bases 1-600 of the Ad2 genome) or calf thymus DNA (double or single 
stranded) were included in the peptide assay in the presence and absence of 1mM ATP. No 
digestion of the peptide, MSGGAFSW, took place in any of the assays, indicating that DNA 
alone is not sufficient to activate the recombinant Ad2 protease. Calf thymus DNA-Sepharose 
beads were also assayed in case activation involves a matrix; but again no activity could be 
detected in the peptide assay. 1t therefore appears likely that a viral or a cellular protein may be 
involved.
4 Activation of the Baculovirus Expressed Protease by an Ad2 Extract
As described in chapter 2, protease activity can be extracted from purified Ad2 using 2M 
NaCl, 2M urea. The aim of this section is to determine whether the DNA pellet from such a 
purification can be used to activate the baculovirus expressed protease. 1n order to remove as 
much protease activity as possible, the DNA pellet, prepared as described in chapter 2, method 
4.2, was extracted further with 2x 4M Urea, 2x 4M NaCl and 2x 50mM Tris/HCl, pH8. 1t 
was then resuspended in 400pl of 50mM Tris/HCl, pH8 by vortexing and sonication (4xl5s
—■ l: ... ;------- ■' ' ■ '-------
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on ice).
Peptide assays were carried out essentially according to chapter 2, method 1.3, with the 
following modifications. The source of protease was 30pl of a 23-kDa recombinant 
baculovirus extract, partially purified by anion exchange chromatography according to chapter 
3, method 3.9 (0.2pg of 23-kDa protein per assay). lOpl of the resuspended Ad2 DNA pellet 
were included in some of the assays and the final volume was made up to 50pl with 50mM 
Tris/HCl pH8 in each case.
Surprisingly, even after such a rigorous washing procedure the Ad2 DNA pellet still 
contained a small amount of protease activity which could be detected by incubation with 
MSGGAFSW for 30 minutes at 37°C (fig.4,5a, profile 3). This shows that the protease 
must bind very tightly to some other viral component, be it protein or DNA. Examination of 
the protein content of lOpl of the extract by SDS-PAGE reveals that a number of proteins are 
present including the hexon and mu, albeit at low concentrations (fig.4.5c). As mentioned 
previously, incubation of the partially purified baculovirus expressed protease with the peptide 
MSGGAFSW did not result in any digestion of the peptide (fig.4.5a, profile 2). When the 
peptide was incubated with the same baculovirus extract, along with the Ad2 DNA extract, 
however, 60% of the peptide was digested in 30 minutes (fig.4.5a, profile 4). It is 
concluded, therefore, that some component of the Ad2 DNA extract is able to activate the 
cloned protease and that the addition of the recombinant protease to the peptide/ DNA extract is 
analogous to the addition of recombinant protease to the 35S Ad2tsl extracts. In order to verify 
this the effect of DTT on the recombinant protease in the peptide assay was considered.
Assays were set up as above, with lOpl of the Ad2 DNA suspension, 30pl of the 
baculovirus 23-kDa protein extract and 2.5pg of MSGGAFSW being incubated for 1 hour at 
37°C in the presence and absence of 2mM DTT. The results were identical to those obtained in 
the 35 assay in that the cleavage of MSGGAFSW by the baculovirus expressed protease was 
reduced considerably by the inclusion of 2mM DTT (flg.4.5b, profiles 3,4). The parallel 
control experiment in which the peptide, MSGGAFSW was incubated with lOpl of disrupted, 
purified Ad2 in the presence and absence of 2mM DTT showed a 5 fold increase in protease 
activity in the presence of the thiol reagent (fig.4.5b, profiles 1,2).
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Fig. 4.5 Activation of the baculovirus expressed 23-kDa protein
The peptide assay was used to assess the activity of the recombinant baculovirus expressed 23-kDa 
protease as described in result 3. The HPLC profiies in (a) represent 30 minute incubations of 1.25pg of 
the peptide MSGGAFSW (1) alone; (2) with partially purified baculovirus 23-kDa protein; (3) with Ad2 
DNA extract and (4) with baculovirus expressed 23-kDa protein and the DNA extract. The main peak in 
profiles 12 and 3 is the undigested peptide MSGGAFSW. The HPLC profiles in (b) represent 1 hour 
incubations of 1.25pg of the peptide MSGGAFSW with (1) Ad2, OmM DTT; (2) Ad2,2mM DTT;
(3) baculovirus 23-kDa protein and Ad2 DNA extract, OmM DTT and (4) baculovirus 23-kDa protein and 
Ad2 DNA extractt 2mM DTT. The main peak in profile 3 is the digestion product AFSW. The 
Coomassie blue stained gel in (c) shows lOpl of the Ad2 DNA extract
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5 Binding of . Expressed Protease to DNA?
A cytoplasmic extract from 500ml of sf9 cells infected with a 23-kDa recombinant
baculovirus stock was prepared and applied to a 5ml single stranded calf thymus DNA 
Sepharose column, equilibrated with 50mM Tris/HCl pH8, as described in method 1. The 
column was eluted with 10ml each of the same buffer made 0.2, 0.4 and 1M with respect to 
NaCl. 1ml fractions were collected and lOpl of each was analysed by SDS-PAGE, revealing 
that the 23-kDa protein did bind to the DNA column, but that it eluted at 0.2M NaCl 
(fig.4.6a). The fractions containing the 23-kDa protein were active when assessed for 
protease activity using the 35S Ad2tsl assay (results not shown) and the DNA-Sepharose 
column appears to provide a reasonable initial purification step in that it serves to concentrate 
the 23-kDa protein.
Fig. 4.6a Binding of the 23-kDa protein to DNA-Sepharose
A cytoplasmic extract from 500ml of sf9 cells infected with the pVL23K derived recombinant 
baculovirus stock was prepared and applied to a 5ml single stranded calf thymus DNA Sepharose 
column as described in method 1 and result 5. lOpl of the fractions eluted from the column were 
separated on a 12.5% SDS-polyacrylamide gel which was stained with Coomassie blue. Lane 1, 
purified E.Coli 23-kDa protein; lane 2, infected cell extract; lane 3, cytoplasmic extract; lane 4, 
column load and lanes 5-7, peak protein fractions eluted from the DNA Sepharose column with 
0.2M NaCl.
To investigate the proposal that the 23-kDa protein binds specifically to a packaging 
sequence in the Ad2 genome (C.Anderson, personal communication), a 32P labelled dsDNA 
probe was prepared comprising bases 1-466 of the Ad2 DNA as described in method 2. The 
source of 23-kDa protein was the pooled 0.2M NaCl fractions eluted from the single stranded
207
DNA Sepharose column. 5pi of the extract was included in each assay (0. lpg of 23-kDa 
protein) and tested for binding to the probe in the presence of 50mM EDTA, ImM MgCl2,
lmM MnCl2, O.lmM ZnCl2 or 2mM DTT as described in method 2 (fig.4.6b). No binding 
was detected for any of the reactions, but the probe was retarded by the inclusion of 0.1 pg of 
purified pTP as a control (lane 2, also see result 7). In parallel experiments, 5pl of the 23-kDa 
extract were incubated with lOpl of Ad2tsl for 0-3 hours at 37°C. Complete digestion of 
pVn-VII took place within 30 minutes showing that the samples contained active protease.
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Fig. 4.6b DNA binding assays for the 23-kDa protease
The binding of the 23-kDa protein (source: 0.2M NaCl fractions eluted from the DNA-sepharose 
column; see fig.4.6b) to a 32p labelled probe comprising bases 1-466 of the Ad2 genome was 
assessed by gel electrophoresis as described in method 2 and result 5. Assays were set up with 
O.lng of probe as described and the results are shown in the above autoradiogram. Lanes 1 and 3, 
probe alone; lane 2, probe with 0.1 pg of pTP and lanes 4-9, probe with 0.1 pg of partially purified 
23-kDa protein. 50mMEDTA, ImM M$g02, ImM MnCl2, O.lmM ZnCl2 and 2mM DTT were 
included in the assays shown in lanes 5,6,7, 8 and 9 respectively.
In summary, no conclusive evidence has been obtained to suggest that the Ad2 protease 
binds specifically to DNA. A systematic variation of the binding conditions, preferably using 
purified protein, however, would be required to eliminate such a possibility.
6 Expression of the pTP Using Recombinant Baculoviruses.
The gene for the Ad2 pTP was inserted into the vector pVL1393 and transfected into sf9 
cells along with linearised AcRP23-lacZ DNA as described in method 4. The resulting 
recombinant virus was plaque purified and a 10* p.f.u. per ml stock was prepared. This was
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used to infect sf9 cells in a 24 well plate and infected cells were harvested at 24, 48,72 and 96 
hours (chapter 3, method 3.8). A parallel infection was carried out using a recombinant pTP 
stock, prepared and supplied by L. Rogge. The cells from each well were harvested and 
analysed by SDS-PAGE as described in the methods section and the resulting Coomassie 
stained gel is shown in fig.4.7a. In each case good levels of expression were achieved at
Fig. 4.7a Expression of the Ad2 pTP using recombinant baculoviruses
A Coomassie stained 12.5% polyacrylamide gel showing a time course infection of 24-96 
hours for sf9 cells infected with 2 recombinant baculoviruses (for details see result 6). Lane 1, 
uninfected sf9 cells; lanes 2-5, cells infected with the recombinant baculovirus supplied by 
LJtogge (LR) for 24,48,72 and 96 hours; lanes 6-9, cells infected with the recombinant 
baculovirus prepared in this project (method 4) for 24,48,72 and 96 hours.
48-96 hours post infection. The levels of expression of the pTP in the cells infected with the 
German stock, however, were at least 5 fold higher than in those infected with the recombinant 
pTP stock prepared as part of this project. Furthermore the pTP expressed using the German 
stock had a slightly slower mobility when analysed by SDS-PAGE.
To investigate this difference, the antigenicities of the 2 proteins were compared using 2 
polyclonal antisera. The first was an antipeptide serum raised against a peptide corresponding 
to the N-terminal 15 amino acids of the Ad2 pTP which was prepared as described in method 
3. The resulting antiserum reacted with the N-terminal pTP peptide; but not with an unrelated 
peptide, when assessed using an ELISA test and reacted well in Western Blots at a dilution of 
1:500 (results not shown). The other antiserum used was raised in rabbits against purified pTP 
and was also used at a dilution of 1:500 (supplied by R.Hay and J.Bosher). Fig.4.7b shows
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that whilst the N-terminal peptide antiserum reacts well with the pTP in extracts of cells 
infected with the German stock, it does not react with any proteins in cells infected with the 
stock prepared in this project (lanes 3 and 4). The pTP polyclonal antiserum, on the other
pTP antisera N-terminal pTP antisera
— pTP
3 41 2
Fig. 4.7b Expression of the Ad2 pTP using recombinant baculoviruses
Western blots of 12.5% polyacrylamide gels probed with a polyclonal antiserum against the 
whole pTP and an antiserum raised against a peptide containing the N-terminal 15 amino acids 
of the Ad2 pTP. Lanes 1 and 5, sf9 cells infected with the recombinant baculovirus supplied 
by L. Rogge; lanes 2 and 4, sf9 cells infected with the recombinant baculovirus prepared in 
this project.
hand, reacted with proteins in cells infected with both stocks, although the mobility of the 
major band in the extracts prepared using the German stock was slightly slower (lanes 1 and 
2). The other lower molecular weight bands reacting with the • pTP polyclonal antiserum are, 
presumably, degradation products of the pTP.
The conclusion from this analysis is that the protein expressed using the recombinant pTP 
virus, prepared as part of this project, is not the complete pTP. 1ts failure to react with the 
N-terminal peptide antiserum suggests that the N-terminal 15 amino acids are missing. The 
apparent molecular weight of the protein, however, is only slightly less than that of the pTP 
expressed using the German stock and it does react well with the polyclonal antisera raised 
against the pTP. The most likely explanation for this is that an error in the cloning has 
eliminated the initiation codon for the pTP. As a result the protein is translated, using the AUG 
coding for Metjg as the initiation codon. 1n effect this means that the first 18 amino acids of 
the pTP are missing. To confirm this assumption it will be necessary to sequence the BamH1
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insert containing the putative pTP cDNA prepared in this project.
7 Purification of-the Baculovirus Expressed pTP
The pTP was purified to near homogeneity from a nuclear extract of sf9 cells, infected 
with the recombinant baculovirus stock provided by L. Rogge, using a combination of affinity 
and hydrophobic interaction chromatography.
The nuclear extract was prepared and applied to a single . stranded DNA-Sepharose 
column as described in method 5. The pTP bound to the column and was eluted with a buffer 
made 0.6M with respect to NaCl. The fractions containing pTP were pooled and KCl was 
added to give a salt concentration of 1.2M before applying a tenth of the sample onto an FPLC 
phenyl Superose column. The pTP bound tightly to the column and eluted at low salt 
concentrations (see fig.4.8a). The use of a hydroxyapatite column instead of the phenyl 
Superose column, in a method described by Temperley and Hay (1992), was investigated, but 
the purity of the protein appeared less (results not shown).
Fig. 4.8 Purification of the baculovirus expressed pTP
sf9 cells were infected for 72 hours with the pTF recombinant baculovirus supplied by L. Rogge, harvested 
and purified using DNA-5epharose and phenyl-Superose columns as described in method 5 and result 7.
The Coomassie stained 12,5% polyacrylamide gel in (a) shows lane 1, total cell extract; lanes 2-4,0.6M 
NaCl fractions eluted from the single stranded DNA-5epharose column; lanes 5-7, fractions eluted from the 
phenyl-Superose column. The autoradiogram in (b) shows a gel electrophoresis DNA binding assay carried 
out to test the binding of the purified pTP to base pairs 1-466 of the Ad2 genome. O.lng of a 32p labelled 
DNA probe were incubated lane 1, alone; and with 0.1 pg of pTP purified using lane 2, a hydroxyapatite 
column and lane 3, a phenyl-Superose column.
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O.lpg of pTP purified using a ssDNA-Sepharose column and the phenyl Superose column or 
the hydroxyapatite column were tested for their ability to bind to the 32P labelled 466 base pair 
probe corresponding to bases 1-466 of the Ad2 genome (see result 5), The resulting gel 
retention assay showed that the pTP prepared using the phenyl-Superose column bound more 
of the probe (fig.4.8b).
8 Coinfections Using Recombinant pTP and 23-kDa Baculovirus Stocks
Having shown that the 23-kDa protein is the Ad2 protease and that its activity is 
controlled in some way, the question as to whether another adenovirus protein is required for 
activity must be addressed. The coinfection of sf9 cells with recombinant pTP and 23-kDa 
baculovirus stocks (both 107 p.f.u. per ml) was carried out in an attempt to answer this.
The coinfections were carried out essentially as described for single infections in chapter 
3, method 3.8. sf9 cells, in a 24 well plate, were infected with 200pl of various ratios of the 
pTP:23-kDa stocks ranging from 10:0 to 0:10. The infection time in each case was 72 hours 
and the cells were harvested, disrupted and analysed by SDS-PAGE as described in chapter 3. 
Four identical SDS gels were prepared and analysed as follows. One was stained with 
Coomassie blue (fig.4.9a), whilst the proteins from the other 3 were transferred onto 
nitrocellulose paper by Western blotting and probed with the polyclonal antisera raised against 
the 23-kDa N-terminal peptide (fig.4.9b), the pTP (fig.4.9c) and the pTP N-terminal 
peptide (fig.4.9d). The results show clearly that when the cells were coinfected with the pTP 
and 23-kDa stocks digestion of the pTP took place. The main products of the digestion 
appeared to be 2 bands with an apparent molecular weight of around 60-kDa (fig.4.9c) and a 
smaller protein of apparent molecular weight 15-kDa (fig.4.9d). The latter reacts with the 
N-terminal pTP antiserum and is the size that would be expected for the N-terminal fragment 
generated by the cleavage of the pTP to the iTP. Surprisingly the protein appears to be 
relatively stable in the insect cells and can be readily visualised by Coomassie staining 
(fig.4,9a). It is also noted that the antiserum raised against the purified pTP does not react 
with the 15-kDa fragment (fig.4.9c). The doublet present at 60-kDa presumably corresponds 
to the 2 iTP species and supports the proposal in chapter 1 that the Ad2 pTP is cleaved at 2 
sites separated by only 8 amino acids to give the iTP.
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Fig. 4.9 Coinfections of insect cells with recombinant pTP and 23-kDa baculoviruses 
The recombinant baculovirus expressing the full length pTP and the the pVL23K derived recombinant 
baculovirus were coinfected into sf9 cells. The ratio of the pTP:23-kDa virus stock was varied from 10:0 to 
0:10 as indicated. Cells were harvested at 72 hours post infection, disrupted and samples were analysed on 4 
identical 12.5% SDS-polyacrylamide gels. Gel (a) was stained with Coomassie blue, whilst gels (b) to (d) 
were electroblotted onto nitrocellulose paper and analysed by Western blotting. The anttsera used to probe the 
filters are as indicated above (see result 8 for details).
A similar coinfection was set up using the recombinant pTP baculovirus stock prepared 
as part of this project. As discussed above it is believed that the stock expresses the pTP minus 
its N-terminal 18 amino acids. Cells coinfected with this pTP stock and the 23-kDa 
recombinant baculovirus were harvested and analysed by SDS-PAGE as described previously. 
Fig.4.10 shows the Western Blot of the resulting cell extracts probed with the polyclonal 
anti serum raised against the pTP. As for the full length pTP, a doublet band at 60-kDa is 
present in the coinfected cells; but not in the uninfected, pTP or 23-kDa baculovirus infected 
cells. This suggests that the pTP lacking its N-terminal 18 amino acids is processed normally 
by the Ad2 protease.
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Examination of fig.4.9c and 4.10 reveals that in each case a protein is present with an 
apparent molecular weight of 55-kDa. Unfortunately, there is also a band of similar mobility in 
cells infected with the recombinant pTP and 23-kDa baculoviruses alone, albeit in lesser 
amounts. Thus although it has been shown that the pTP is readily processed to the iTP in 
insect cells that have been coinfected with pTP and 23-kDa stocks, evidence that it is efficiently 
processed to the TP in sf9 cells is lacking.
un 110:0 19:1 18:2 17:3 16:4 15:5 14:6 I 3:7 10:10
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Fig. 4.10 Coinfections of sf9 cells with 23-kDa and pTPAN baculovirus stocks 
sf9 cells were infected with the recombinant pTP and 23-kDa baculovirus stocks prepared in this 
project. Cells were infected with ratios of the 2 virus stocks ranging from 10:0 to 0:10 as indicated and 
harvested at 72 hours post infection. The disrupted cells were analysed by 5D5-PAGE and Western 
blotting as described in result 8. The Western blot of the samples probed with the polyclonal 
antiserum raised against the whole pTP is shown above.
9 Digestion of pTP in vitro by Baculovirus Expressed Ad2 Protease
The pTP was purified from infected sf9 cells using a single stranded DNA-Sepharose
column and a phenyl Superose column as described above. The 23-kDa protease was partially 
purified from the cytoplasmic extract of infected sf9 cells using an anion exchange column (see 
chapter 3, method 3.9). 0.2pg of the purified pTP was incubated with 0.2pg of the 
baculovirus 23-kDa protein for 12 hours at 37°C in the presence and absence of lOpl of the 
resuspended Ad2 DNA pellets (see result 4). Two different Ad2 DNA extracts were used, one 
that was washed extensively with 4M NaCl and 4M urea and sonicated as described 
previously. The other extract was prepared by simply resuspending the DNA/protein pellet 
from the 2M NaCl, 2M urea treated Ad2 in 50mM Tris/HCl pH8 by vortexing. The second
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extract contained a considerable amount of intrinsic protease activity.
The samples were analysed by SDS-PAGE and Western blotting using the polyclonal
antiserum raised against the pTP (fig.4.11). The results show that incubation of the pTP 
with the partially purified baculovirus expressed 23-kDa protein gave virtually no digestion of 
the pTP after an overnight incubation (fig.4.11a, lane 2). Incubation with the washed Ad2 
DNA extract gave partial digestion of the pTP to the iTP (lane 3), whilst incubation of the pTP 
with the baculovirus expressed 23-kDa protein and the washed DNA extract resulted in the near 
complete processing of the pTP to the iTP (lane 4). Indeed a band corresponding to the TP 
was also present. When an Ad2 DNA extract with more intrinsic protease activity was used the 
same effect was observed; but more processing took place and a strong band appeared at 
55-kDa corresponding to the TP (fig.4.11b).
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Fig. 4.11 Digestion of baculovirus expressed pTP in vitro
Full length pTP purified from infected sf9 cells was incubated in vitro with partially purified 
baculovirus expressed 23-kDa protease as described in result 9. The incubations were for 12 hours at 
37°C and samples were analysed by SDS-PAGE and Western blotting. The polyclonal antiserum 
raised against the whole pTP (1:500 dilution) was used to probe the samples. Resuspended Ad2 
DNA pellets were added to some of the assays. The DNA pellet used in (a) had been washed 
extensively and so contained less intrinsic activity than the DNA pellet used in (b). Samples were 
incubated as follows, (a) Lane 1, pTP alone; lane 2, pTP and 23-kDa protein; lane 3, pTP and Ad2 
DNA extract and lane 4, pTP, 23-kDa protein and DNA extract, (b) Lane 7, pTP alone; lane 2, pTP 
and DNA extract; lane 3, pTP, 23-kDa protein and DNA extract.
10 In Vitro Replication Assays
Initiation reactions were set up as described in method 6. Fig.4.12a, lane 1 shows that 
the initiation reaction has taken place and that the 32P dCMP is covalently linked to the 80-kDa
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pTP. 1ncubation of the sample with disrupted, purified Ad2 for 1-12 hours (lanes 2-5) shows 
that the pTP is progressively digested to the 55-kDa TP via the 60-kDa intermediate. 1t is noted 
that even after a 12 hour incubation only 50% of the precursor has been completely processed. 
1n parallel experiments in which 35S Ad2tsl extracts were incubated with disrupted purified 
virus, complete digestion of pV11 to V11 took place within 2 hours (results not shown). 
Although the substrate concentrations could not be determined in the assays, it would appear 
that the processing of the iTP to the TP is considerably slower than the processing of the other 
viral protein substrates.
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Fig. 4.12 In vitro replication assays • initiation reactions.
Autoradiograms of 10% polyacrylamide gels, (a) Initiation reactions were carried out as described in 
method 6 and the resulting samples were incubated with 20pl of disrupted, purified Ad2 at 37°C for 
lane 1,0 hours; lane 2,1 hour; lane 5,2 hours; lane 4,6 hours and lane 5, 12 hours, (b) Initiation 
reactions were carried out as described in method 6 in the presence of lane 7, OmM DTT; lane 2, 
0.5mM DTT; lane 3, ImM DTT and lane 4, 5mM DTT.
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Initiation reactions were set up as described in method 6 in the presence of 0,0.5,1 and 5mM 
DTT. The efficiency of the initiation reaction was shown to increase with DTT concentration. 
The amount of labelled pTP processed during the initiation reaction, however, was greatest at 
0.5-ImM DTT (fig.4.12b) in agreement with the results obtained in chapter 2. The source of 
protease in these experiments were the Ad2 cores, which have been shown to contain the 
23-kDa protein (Leith et a/., 1989; Anderson, 1990).
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DISCUSSION
In the course of this chapter the control of the Ad2 protease and the processing of the pTP 
have been investigated. In the main, the results produced are of a preliminary nature and form
the basis for future work to study the regulation of proteolysis and replication during 
adenovirus infection. Nevertheless, a number of significant observations have been made and 
these will be discussed in turn.
In chapter 2 the effects of a range of inhibitors on the Ad2 protease were considered 
using the 35S and peptide assays. In the systems used, however, the inhibitors were not 
pre-incubated with the purified protease and so the possibility that they were acting on some 
other viral component could not be ruled out. Table 4,1 summarises the results of a series of 
assays in which purified E.Coli expressed protease was incubated with a range of inhibitors, at 
their effective concentrations, prior to incubations with 35S Ad2tsl extracts. The results are 
virtually identical to those obtained in chapter 2 (Table 2.6) and confirm that the inhibition 
profile of the Ad2 protease fits better into the cysteine class than into the serine class. In view 
of this it was surprising to note that 2mM DTT inhibited the recombinant protease (Table 
4.1), in contrast to its effect in the peptide assay where protease from disrupted, purified Ad2 
was activated at least 5 fold by 0.5-2.5mM DTT (chapter 2). It was decided to investigate this 
anomaly further by studying the effect of a range of DTT concentrations in the 35S Ad2tsl 
assay using 2 sources of protease; the purified recombinant E.Coli expressed protein and 
purified disrupted Ad2. According to chapter 3, the protease in the virus is already activated; 
but the recombinant 23-kDa protein is inactive. Fig.4.4 shows that whilst ImM DTT 
severely inhibits the recombinant protease, the Ad2 protease is only affected by the thiol 
reagent at concentrations of 5-1 OmM. It is proposed, therefore, that whilst DTT has a positive 
effect on protease activity if the enzyme is present in an active form, it inhibits the activation 
step. This work provides further support for the proposal that the digestion by the recombinant 
Ad2 protease is a 2 step process. Indeed, these results are consistent with an observation made 
by Bhatti and Weber (1979b). These authors reported that the viral protease, but not the
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nuclear Ad2 protease was activated by DTT. From this it would appear that most of the 
protease in the nuclei of infected cells is present in an inactive form, but that the enzyme 
packaged in the virion is fully active.
The next question to be addressed is by what mechanism is the Ad2 protease activated?
Its high isoelectric point (predicted value, pH8.6) and tight association with the viral cores 
(Anderson,1990; chapter 2) have led to the proposal that the enzyme binds directly to DNA. 
Indeed it has been suggested that the purified E.Coli expressed 23-kDa protein binds to a 
packaging sequence located at base pairs 190-3(X) in the Ad2 genome (C.Anderson, personal 
communication). The possibility arises, therefore, that the binding of the protease to a specific 
DNA sequence could be sufficient to activate it. To test this hypothesis, the recombinant 
E.Coli and baculovirus proteases were tested for their ability to cleave the peptide substrate, 
MSGGAFSW, in the presence of Ad2 DNA, base pairs 1-600 of the Ad2 genome, single and 
double stranded calf thymus DNA and calf thymus DNA-Sepharose beads. The assays were 
carried out in the presence and absence of ImM ATP; but no cleavage of the peptide could be 
detected even after incubations for 6 hours at 3?°C. It was concluded, therefore, that DNA 
alone is not sufficient to activate the recombinant protease.
The results in flg.4.5a show that an Ad2 DNA pellet prepared by a series of 4M urea, 
4M NaCl washes did activate the recombinant baculovirus protease. Surprisingly, there was 
still a small amount of intrinsic protease activity in the resuspended DNA pellet, emphasising 
just how tightly the protease is associated with the viral cores. Nevertheless, the addition of 
the partially purified baculovirus expressed 23-kDa protein to the DNA extract resulted in a 10 
fold increase in the rate of cleavage of MSGGAFSW. The Coomassie stained gel in fig.4.5c 
reveals that the DNA pellet contains a number of proteins at relatively low concentrations. It 
seems likely that one of these, perhaps in association with the viral DNA, is sufficient to 
activate the protease.
The effect of DTT on the activity of the recombinant protease in the peptide assay was 
considered and the results are shown in fig.4.5b. Profiles 1 and 2 act as controls and show 
that the protease from disrupted Ad2 is activated 5 fold by 2mM DTT in the peptide assay. In 
stark contrast, the activity of the baculovirus recombinant protease was severely inhibited by
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2mM DTT in the peptide assay (profiles 3 and 4). These findings are consistent with the 
results shown in fig.4.4 where 35S Ad2tsl was used as the substrate. It is proposed, 
therefore, that the use of Ad2 DNA extracts along with the peptide substrate MSGGAFSW 
provides an assay system analogous to the 35S Ad2tsl assay.
Despite the fact that purified Ad2 DNA was not able to activate the recombinant protease, 
the binding of the enzyme to specific DNA sequences could not be ruled out and so the DNA 
binding properties of the baculovirus expressed 23-kDa protein were considered. The latter 
was shown to bind to a calf thymus ssDNA-Sepharose column and to elute at 0.2M NaCl 
(fig.4.6a). The affinity of the protein for non-specific DNA sequences is low; but this is not 
unusual for sequence specific DNA binding proteins (Sorger et a/.,1989). A preliminary gel 
retention assay was set up to test the binding of the partially purified baculovirus expressed 
23-kDa protein to base pairs 1-466 of the Ad2 genome, but no binding was detected 
(fig.4.6b). At this stage no evidence can be presented to suggest that the adenovirus protease 
binds specifically to DNA, but until a wider range of conditions are tested, the possibility 
cannot be ruled out.
In conclusion, it seems clear that the adenovirus protease is activated in some way, but 
the mode of activation remains elusive. The inhibitory and activatory effects of DTT may help 
to provide the answer and perhaps a thiol exchange mechanism is involved. Alternatively, a 
metal ion such as zinc might be required at low concentrations in the activation step and DTT 
could interfere with this. Recently it has been shown that trans cleavages by the poliovirus 2A 
protease are inhibited by 1,10 phenanthroline and one proposal is that the enzyme contains a 
metal binding site (Yu and Lloyd, 1992). The activity of the recombinant baculovirus 23-kDa 
protease in the 35S Ad2tsl assay, however, was not found to be affected by the presence of 
lOmM 1,10 phenanthroline which is an effective chelator of zinc ions (table 4.1). It is clear 
that the protease is closely associated with a viral protein and/or viral DNA and this association 
alone could be sufficient to activate the enzyme. On the other hand, the enzyme may be 
activated first and then bind to the protein/DNA in such a way as to stabilise it in an active 
form. When removed from its association with the viral component the protease rapidly reverts 
to its inactive form, unless extracted in the presence of high salt (chapter 2). The apoenzyme
220
might be unable to associate with the protein/DNA unless it is activated first. Finally in this 
regard phosphorylation of the protease, as suggested by Chatterjee and Hint (1987), remains a 
possibility and the baculovirus system should provide the means to examine the 23-kDa protein 
for post-translational modifications in the future.
Processing of. . the Ad2 pre-terminal protein.
A recombinant pTP baculovirus was kindly provided by L. Rogge and coinfections of the 
23-kDa and pTP viruses were carried out in sf9 cells. The results in fig.4.9a-d show that the 
pTP is processed by the 23-kDa protease in the insect cells, with the major digestion product 
being the iTP. The iTP appeared as a doublet when analysed by SDS-PAGE in agreement with 
the predictions made in chapter 1 that there are 2 potential cleavage sites, Phe and
Arg^-Gly^, separated by only 8 amino acids in the Ad2 pTP. The 15-kDa N-terminal 
fragment generated by the processing of the pTP->iTP was stable in the insect cells, reacting 
strongly with the antiserum raised against the N-terminal 15 amino acids of the pTP. The 
possibility that this fragment has a functional role in the adenovirus infectious cycle is certainly 
worth considering in the future. It was also noted that the polyclonal antiserum raised against 
the fuU length pTP did not react with the 15-kDa N-terminal fragment. Presumably this is 
because the N-terminal domain was not surface exposed in the purified pTP used to immunise 
the rabbits.
In the course of this work an attempt was made to prepare a recombinant baculovirus 
expressing the full length pTP. As discussed in the results section, a virus was constructed 
that expressed a protein reacting with the polyclonal antiserum raised against the pTP. The 
mobility of this protein, however, was slightly faster than the full length pTP and it did not 
react with the N-terminal antipeptide serum. It was concluded that the pTP expressed by the 
recombinant baculovirus, prepared in this project, was probably being translated using the 
AUG codon for Metj9 as its initiation codon. As a result the protein synthesised lacks its 
N-terminal 18 amino acids. It has been shown previously that the N-terminal 18 amino acids 
are essential for the initiation of replication (Pettit et al, 1989) and so the pTP lacking its 
N-terminus could act as a useful control in replication assays; but its identity must be confirmed 
by DNA sequencing of the putative pTP gene in the parent plasmid pVLpTP. Coinfections
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were set up for the 23-kDa and 'defective' pTP baculovirus stocks as described previously. 
Fig.4.10 reveals that the pTP lacking its N-terminus was digested by the protease to give the 
iTP in a similar fashion to the full length pTP (fig.4.9c). Thus despite the fact that the pTP 
requires its 18 N-terminal residues to function in replication, it would appear that the protein 
lacking amino acids 1-18 is processed normally by the protease.
One puzzling feature of the coinfections was that most of the processing of the pTP only 
went as far as the iTP and little, if any, TP was generated. Perhaps this is because, as was 
suggested in chapter 1, the putative cleavage site giving rise to the TP has a valine at Pj and is 
a poor substrate. Additional evidence that the iTP is a poor substrate for the protease comes 
from the in vitro replication assays shown in fig.4.12a, where even after a 12 hour 
incubation with disrupted purified Ad2 more than 50% of the iTP remained unprocessed. 
Indeed, it is possible that the different rates of cleavage of the pTP -> iTP and iTP->TP could 
be significant, with the 2 cleavages being temporally separated in the infectious cycle.
The coinfection experiments also show that no other adenovirus protein or DNA 
sequence is required for the processing of the pTP->iTP by the 23-kDa protein. This means 
that the cofactor is probably cellular, although the possibility that the pTP, itself, or that a 
baculovirus component can act as the cofactor cannot be ruled out. The pTP was purified by a 
combination of affinity and hydrophobic interaction chromatography using DNA-Sepharose 
and phenyl-Superose columns. The resulting protein had DNA binding properties consistent 
with those described by Temperley and Hay (1992) using an alternative purification scheme. 
The exposure of the pTP to high salt (1.2M KCl) in the hydrophobic interaction step was 
deemed to be beneficial as it should serve to remove any fragments of DNA or other cellular 
components that might bind to it non-specifically.
Incubation of the peptide MSGGAFSW with purified pTP and the partially purified 
baculovirus expressed 23-kDa protease, in the presence or absence of purified Ad2 DNA, did 
not result in any cleavage of the peptide (results not shown). Furthermore, a 12 hour 
incubation of the purified pTP with the partially purified baculovirus expressed protease gave 
negligible processing of the pTP (fig.4.11a, lane 2). These results show that the pTP, on its 
own, is not the cofactor. The addition of a crude Ad2 DNA extract, however, resulted in the
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complete processing to the iTP and a clear band at the mobility expected for the TP was also 
present (fig.4.11a, lane 4). The Ad2 DNA extract on its own gave partial processing of the 
pTP->iTP (lane 3). The enhanced cleavage of the iTP->TP in the presence of the Ad2 DNA 
extract could be explained by a conformational change in the pTP/iTP upon binding to the 
DNA. The results from the peptide assay (fig.4.5a), however, indicate that some other factor 
must be involved since the conformation of the peptide will not be changed by the presence of 
the DNA. The results from the coinfections show that although processing of the pTP does 
take place in insect cells it is probably not as efficient as in the adenovirus infected cells. This 
despite the fact that the level of expression of the 23-kDa protein in the insect cells is 
considerably higher. Thus it seems that the activation process can take place in baculovirus 
infected insect cells; but that it is much more efficient in the course of adenovirus infections. In 
the future it would be interesting to construct recombinant baculoviruses expressing other 
substrates of the Ad2 protease and to test for proteolysis of the substrates in coinfections with 
the recombinant 23-kDa virus. Fractionation of uninfected and wild type AcNPV infected sf9 
cells may also help to identify the cofactor.
Finally, in vitro replication assays were set up using Ad2 cores as the source of template. 
The initiation reactions were carried out in the presence of 0-5mM DTT and the processing of 
the pTP to the iTP was found to optimal at 0.5-lmM DTT (fig.4.12b), consistent with the 
effects reported earlier for the cleavage of the peptide MSGGAFSW by protease from purified 
Ad2 (chapter 2). The source of protease in the initiation reactions was concluded to be the Ad2 
cores and the stimulatory effect of DTT is consistent with the protease being present in an 
active form. This work shows that the initiation reaction provides an alternative assay system 
for the Ad2 protease and in the future the use of Ad2 complex (DNA+TP) or a linearised 
plasmid containing the origin of replication as the template would provide a defined system and 
eliminate the endogenous protease. It would be interesting to compare the efficiencies of 
pTP-DNA and TP-DNA as templates in such systems. The purification of the iTP, TP and 
15-kDa N-terminal fragment of the pTP would enable the effects of each on initiation and 
elongation to be considered. It would also be possible to carry out N-terminal sequencing of 
the iTP and TP to confirm the cleavage sites predicted in chapter 1.
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In the course of this chapter a number of systems have been set up to study proteolytic 
processing by the adenovirus protease, both in vivo and in vitro. In the future it should be 
possible to use them to answer the all important question of how the protease is activated. The 
processing of the pTP by the 23-kDa protein in insect cells also opens the way for the study of 
the effects of limited proteolysis of the pTP on adenovirus DNA replication.
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CONCLUSIONS
The aim of this project was to further characterise the adenovirus protease. In the 
course of the work the substrate specificity of the enzyme has been defined and cleavage sites 
have been predicted in all the known substrates of the protease (chapter 1). It has been shown 
that the enzyme contains an essential thiol group and that it is probably a member of the 
cysteine protease class; although it differs from the classical papain-like enzymes (chapter 2). 
The L3 23-kDa protein has been purified from Ad2 and shown to be the protease and to be 
active as a monomer. Furthemiore antipeptide sera raised against the N- and C-termini of the 
protease have been used to demonstrate that it is active in an intact form contrary to previous 
reports that it is proteolytically activated (chapter 3). The enzyme has been expressed in E.Coli 
and insect cells and the recombinant protease was able to cleave pVn-VII in a crude assay 
system containing cell extracts; but was inactive in the peptide assay developed as part of this 
project. A recombinant baculovirus expressing one of the substrates of the protease, the 
pre-terminal protein was constructed, although the expressed protein was shown to lack the 18 
N-terminal amino acids. Coinfections of this recombinant baculovirus, or a virus expressing 
the full length pTP (gifted by L.Rogge), with the 23-kDa recombinant baculovirus were carried 
out in insect cells. The results of these experiments showed that the pTP was processed 
efficiently to the iTP; but not to the TP. One of the main conclusions drawn from the results in 
chapters 2-4 was that although the 23-kDa protein is the Ad2 protease some other factor is 
required for activity and it was suggested that the L3 23-kDa protein is synthesised as an 
apoenzyme. These results have already been discussed in chapters 1-4.
In the main introduction the infectious cycle of the adenovirus was described with 
particular attention being paid to the virus encoded proteins. The essential role that proteases 
play in the life cycles of other viruses was also discussed. In this section it is hoped to put the 
results of this project into context, with particular emphasis being put on future work.
The Role of the Adenovirus Protease in the Lytic Cycle
Six of the adenovirus structural proteins, namely pllla, pVI, pVII, pVIII, the L2 
11-kDa protein and the pTP had previously been shown to be substrates of the Ad2 protease
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(Anderson et a/.,1973; Boudin et a/., 1*980; Weber and Anderson, 1988). With the exception of 
the pTP, a product of the E2B region, all these proteins are encoded by the late transcription 
unit and are synthesised late in infection. This observation, taken along with the fact that virus 
particles are assembled in cells infected with Ad2tsl, at non-permissive temperatures, has led 
to the assumption that the adenovirus protease is only required for a maturation event late in the 
infectious cycle. Set against this, however, it has been shown that coinfection of sf9 cells with 
recombinant baculoviruses expressing the 23-kDa protein and the pTP leads to efficient 
processing of the pTP to the iTP in the insect cells. Thus it would appear that assembly of 
virus particles is not a prerequisite for protease activity. In view of this it is worth considering 
potential roles for the protease at earlier stages of the infectious cycle and in particular during 
uncoating, replication, the switch from early to late infection and virus assembly. In chapter 1 
potential cleavage sites were identified in a number of viral proteins that had not previously 
been shown to be substrates of the protease (table 1.5). It is emphasised, however, that at 
this stage there is no evidence to suggest that any of these sites are cleaved in vivo and future 
investigations will be required.
Uncoating of Virions
In chapter 1 it was postulated that a conformational change in the virion coat, shown to 
take place in low pH, could expose the predicted cleavage sites in the hexon and penton 
proteins to the inside of the virion where the protease is located. Limited proteolysis of the coat 
proteins could be a key step in the uncoating of adenovims particles, a process that is poorly 
understood. If the hexon and/or the penton are cleaved it is likely that only the correctly folded 
proteins in the mature virions would be processed at a precise point early in the infectious cycle 
and so evaluation of this hypothesis might prove difficult.
Switch from Early to Late Infection
The identification of potential cleavage sites in a number of the viral early proteins 
including the ElB 55-kDa protein leads to the suggestion that cleavage of one or more of these 
proteins could play a role in controlling the progress of the lytic cycle. Set against this, 
however, is the observation that infections of HeLa cells with Ad2tsl at non-permissive 
temperatures appear to proceed normally until late stages in the infectious cycle (Weber, 1*976).
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DNA Replication
The possible role of the Ad2 protease in DNA replication through the cleavage of the 
pTP was discussed in detail in chapter 4. Further studies are required to establish the structural 
and functional differences between the pTP, iTP and TP, with one possibility being that the 
cleavage of the pTP by the protease is required to separate the viral DNA from the nuclear 
matrix (Schaack et </.,1990). Also of interest in this regard is the observation that the 
sequences of the Ad2 polymerase protein (table 1.5) and nuclear factor I (results not shown) 
both contain potential cleavage sites. The site in the polymerase is conserved in all the 
serotypes in which the protein has been sequenced and contains an arginine at the Pf position.
To date no peptides with an arginine at Pj have been tested, so it remains to be established 
whether or not a charged residue is permissible at this position. The locations of the 2 sites in 
NFl (MEGG-I and LNGS-G centred at positions 320 and 427, respectively) are interesting in 
that cleavage at both of these sites would leave the DNA binding domain intact. Recent studies 
have shown that the N-terminal 222 amino acids of NFI are sufficient for the stimulation of 
Ad2 DNA replication (Bosher et a/.,1991) and so the possibility exists that the Ad2 protease 
processes NFI to convert it from a cellular transcription to a viral replication factor. It has been 
suggested that the poliovirus 3C protease is responsible for the processing of transcription 
factor TFmC and it is possible that cellular proteins are processed by other viral proteases as 
part of the infectious cycle.
Alternatively the Ad2 protease might be required to switch off DNA replication, 
perhaps by breaking up the replication complex and detatching the viral DNA from the nuclear 
matrix.
Maturation of Virus Particles
Few studies have considered the conformational and functional changes of the 
individual structural proteins during maturation and the identification of the cleavage sites in all 
the established substrates of the protease should enable such work to be undertaken in the 
future.
Charagterisaiio.n..of..th.e Ad2 Protease
Studies have been facilitated by the development of an assay for the Ad2 protease using
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the synthetic peptide MSGGAFSW as a substrate. If kinetic analysis of potential inhibitors is 
to be carried out, however, it would be desirable to have a chromogenic substrate. With 
regards to inhibitors it was noted that peptide substrate analogues lacking the P4 residue,
FGGAKK and SGGAFSW, inhibited the cleavage of pVII to VII in the 35S assay. Although 
these observations require confirmation, it is possible that they could form the basis for the 
design of a specific inhibitor of the Ad2 protease. A number of divalent ions including copper 
and zinc were shown to inhibit the protease at concentrations as low as lOpM. The fact that the 
inhibition could be completely reversed by the subsequent addition of EDTA or DTT to the 
protease suggests that the divalent ions are binding to a thiol group in the protease, perhaps at 
the active site. The observation that zinc is a potent inhibitor of a number of viral proteases 
including those from HIV and poliovirus has led to its classification as a general 'antiviral' 
agent and to the suggestion that zinc supplementation might be of some benefit to AIDS 
patients (Zhang et ftZ.,1991). Recently phenylnorstatine derivatives of substrates have been 
designed that inhibit the HIV-1 protease with Kj's of 3-24pM ' (Raju and Deshpande,1991).
The inhibition of the adenovirus protease by a number of transition elements and the elucidation 
of its substrate specificity means that a similar approach could be taken to design a specific 
inhibitor for the enzyme. The observation by Houde and Weber (1990b) that extracts from 
HeLa cells infected with adenovirus serotypes 1, 3, 4,5, 6,7 and 9 are able to efficiently 
process the Ad2 precursor protein pVII suggests that the substrate specificities of the proteases 
from other adenovirus serotypes are very similar, if not identical, to that described for Ad2. It 
is likely, therefore, that a specific inhibitor of the Ad2 protease would also inhibit the enzymes 
from other serotypes.
The mechanism of the adenovirus protease remains to be elucidated and work described 
in this project and by other workers shows that the sequence of the L3 23-kDa protein bears no 
resemblance to any other viral or cellular proteases. Its inhibitor profile suggests that it may be 
a member of the recently defined subclass of cysteine proteases that are related to trypsin; but 
elucidation of the crystal structure of the active enzyme would be required to confirm this. 
Control of Protease Activity
The results in chapters 2-4 show conclusively that the activity of the Ad2 protease is
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controlled in some way. This may be in order to prevent the premature cleavage of viral 
proteins by the enzyme during the infectious cycle. The HIV protease, the activity of which is 
not required until after assembly of the virus particles, is activated by dimerisation as discussed 
previously. The results in chapters 2 and 3 show that the adenovirus protease is active as a 
monomer and that it is not proteolytically activated. A requirement for high salt concentrations 
to stabilise the purified protein suggests that another cofactor is required to stabilise the enzyme 
in an active form. Other virus encoded proteases have been shown to require cofactors, 
particularly for trans cleavages. For example the poliovirus 2A protease and eIF3 act together 
to cleave the p220 subunit of eIF4 (Wyckoff et a/.,1990) and the flavivirus NS3 protease 
requires another viral protein NS2B for the complete processing of its polyprotein (Chambers 
et a/., 1991). In the case of the Ad2 protease the cofactor could be of viral or cellular origin, 
with the results from the coinfections of insect cells with pTP and 23-kDa recombinant 
baculoviruses suggesting that it is probably of cellular origin (chapter 4). A number of 
mechanisms could operate to control the enzyme. For example, a specific cellular or viral 
factor may be present that inhibits the protease early in infection or alternatively a covalent 
modification such as phosphorylation may be involved. As discussed in chapter 4 there is a 
suggestion that the 23-kDa binds specifically to DNA; but DNA was not found to activate the 
protease in any of the experiments discussed in this project. None of these control mechanisms 
on its own would account for all the observations made in this project.
In order to explain the results the following sequence of events is proposed. The Ad2 
23-kDa protease is synthesised as an apoenzyme and is activated by another protein, perhaps a 
thioredoxin-like enzyme. Upon activation the protease binds to DNA which stabilises it in an 
active form. If the protein is removed from the DNA then it reverts to an inactive form unless 
purified in the presence of high salt which locks it in an active conformation. The involvement 
of a thioredoxin-like enzyme as a control element is an interesting possibility in view of its role 
in the binding of the T7 polymerase to DNA and the assembly of filamentous DNA 
bacteriophages (Gething and Sambrook,1992; Russel, 1991). It might also help to explain the 
observations that DTT inhibits the recombinant 23-kDa protein; but stimulates the active 
enzyme in the purified virions. The binding of the active enzyme to DNA is also worth
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considering since two other viral proteins, the poliovirus 3C protease and the Sindbis capsid 
protease have been shown to bind to RNA (Andino et a/.,1990; Choi et a/., 1991).
In the future it must be a priority to establish how the protease activity is controlled. 
Also of interest would be to determine the location of the 23-kDa protein within both Ad2 
infected HeLa cells and recombinant baculovirus infected sf9 cells. The affinity purification of 
the antisera prepared in this project may be of use in immunofluoresence studies on Ad2 
infected cells and cells infected with the Ad2tsl mutant at permissive and non-permissive 
temperatures. At present it is thought that in Ad2tsl the 23-kDa protease is not packaged 
within the virion (Anderson, 1*990). Presumably the proline to leucine mutation at position 139 
in Ad2tsl affects the structure of the enzyme at non-permissive temperatures. The location of 
this residue on the C-terminal side of the potential active site residues in a relatively variable 
region of the protein (see fig.2.13) means that it may affect the activation step.
In conclusion the adenovirus protease shares a number of features with other viral 
proteases including its unusual substrate requirements and inhibition profile; but this project 
suggests that it may also have some distinct attributes that merit consideration in the future.
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